Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
gsea,Macromolecule Biosynthetic Process (GO:0009059),-0.7765700734094829,-3.1023291839681275,0.0,0.0,0.0,95/167,10.00%,RPL6;RPS29;EEF1A1;RPL37;RPS2;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;APOE;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPL24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL13;RPL38;RPL29;RPL27;RPL22;RPL17;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;RPS18;RPL15;EIF5A;RPL30;RPL39;EEF1G;EEF1B2;IGF2BP3;EEF1A2;RPL26;RPL34;RPL31;RPL36;RPL35A;RPS9;RPL18;PABPC4;EEF2;MRPL52;MRPL41;MRPL36;RPL32;MRPL18;MRPL23;MRPS21;MRPL14;RPL36AL;RPS26;RPL10;MRPL9;MRPS14;MRPS33;INHBA;MRPL11;RPS13;RPL35;MRPS16;RPLP0
gsea,Translation (GO:0006412),-0.7341746834384435,-3.0757099446087057,0.0,0.0,0.0,109/212,10.68%,RPL6;RPS29;EEF1A1;RPL37;RPS2;RPS7;RACK1;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPL24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL13;RPL38;RPL29;RPL27;RPL22;RPL17;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;RPS18;RPL15;MRPS26;EIF5A;RPL30;RPL39;EEF1G;EEF1B2;RPL22L1;IGF2BP3;EEF1A2;RPL26;AURKAIP1;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;PABPC4;EEF2;MRPL52;MRPS24;MRPL41;MRPL36;RPL32;MRPL18;MRPL23;MRPS21;MRPL14;MRPL54;RPL36AL;RPS26;MRPL44;RPL10;CHCHD1;MRPL9;MRPL30;MRPL33;MRPS14;MRPS33;NDUFA7;MRPL57;MRPL11;MRPL39;RPS13;RPL35;MRPS16;RPLP0;MRPL17;MRPS5
gsea,Peptide Biosynthetic Process (GO:0043043),-0.7972071956041149,-3.033527909672327,0.0,0.0,0.0,89/138,10.00%,RPL6;RPS29;EEF1A1;RPL37;RPS2;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPL24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL13;RPL38;RPL29;RPL27;RPL22;RPL17;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;RPS18;RPL15;RPL30;RPL39;IGF2BP3;EEF1A2;RPL26;RPL34;RPL31;RPL36;RPL35A;RPS9;RPL18;PABPC4;MRPL52;MRPL41;MRPL36;RPL32;MRPL18;MRPL23;MRPS21;MRPL14;RPL36AL;RPS26;RPL10;MRPL9;MRPS14;MRPS33;MRPL11;RPS13;RPL35;MRPS16;RPLP0
gsea,Gene Expression (GO:0010467),-0.6533000552228451,-2.956485169321502,0.0,0.0,0.0,111/258,12.65%,RPL6;RPS29;EEF1A1;RPL37;RPS2;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPL24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL13;RPL38;RPL29;RPL27;RPL22;CELF2;RPL17;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;RPS18;RPL15;RPL30;RPL39;IGF2BP3;EEF1A2;RPL26;RPL34;RPL31;RPL36;RPL35A;RPS9;RPL18;PABPC4;MRPL52;MRPL41;HNRNPA2B1;MRPL36;RPL32;MRPL18;MRPL23;TFIP11;MRPS21;MRPL14;RPL36AL;RBM8A;RPS26;ALKBH5;RPL10;MAGOH;MRPL9;MRPS14;MRPS33;HNRNPF;MRPL11;RPS13;RPL35;CHTOP;STUB1;MRPS16;RPLP0;MRPS5;HNRNPK;FMR1;RPL10A;DDX20;MAGOHB;ANGPT2;EIF4EBP2;MRPL12;SRSF3;EXOSC4;EXOSC3;DKC1
gsea,Cytoplasmic Translation (GO:0002181),-0.8922971862095768,-2.8661850103514497,0.0,0.0,0.0,72/89,3.88%,RPL6;RPS29;RPL37;RPS2;RPS7;RACK1;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPL24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL13;RPL38;RPL29;RPL27;RPL22;RPL17;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;EIF4A1;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;RPS18;RPL15;RPL30;RPL39;RPL22L1;EIF4A2;RPL26;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;RPL32
gsea,Energy Derivation By Oxidation Of Organic Compounds (GO:0015980),-0.8352192176599288,-2.7778325843528697,0.0,0.0,0.0,21/35,7.25%,MT3;CYC1;COX6C;UQCRQ;COX8A;COX4I1;COX5B;COX7C;NDUFA4;COX6B1;COX6A1;UQCRB;UQCR10;COX5A;COX7A2;UQCRH;UQCRC1;COX7B;CYCS;UQCR11;UQCRC2
gsea,Cellular Respiration (GO:0045333),-0.713854183058191,-2.7106025484917247,0.0,0.0,0.0,59/83,18.95%,CYC1;COX6C;UQCRQ;NDUFA3;COX8A;NDUFS5;NDUFA1;MDH2;COX4I1;COX5B;COX7C;NDUFA4;COX6B1;COX6A1;UQCRB;NDUFB1;NDUFS8;UQCR10;COX5A;COX7A2;NDUFS2;NDUFB3;UQCRH;NDUFA2;NDUFS7;NDUFB10;NDUFA13;NDUFB11;UQCRC1;COX7B;CYCS;UQCR11;NDUFB8;UQCRC2;NDUFC2;NDUFV2;NDUFA7;NDUFA8;MTFR1L;MTLN;NDUFC1;NDUFV1;NDUFB6;NDUFA5;SDHB;NDUFB9;NDUFA12;NDUFB5;NDUFS6;NDUFB4;SDHA;OXA1L;NDUFB7;NDUFB2;SURF1;NDUFAB1;UQCRFS1;NDUFA10;NDUFA11
gsea,Aerobic Electron Transport Chain (GO:0019646),-0.765260940323872,-2.6990963867399613,0.0,0.0,0.0,52/64,18.63%,CYC1;COX6C;UQCRQ;NDUFA3;COX8A;NDUFS5;NDUFA1;COX4I1;COX5B;COX7C;NDUFA4;COX6B1;COX6A1;UQCRB;NDUFB1;NDUFS8;UQCR10;COX5A;COX7A2;NDUFS2;NDUFB3;UQCRH;NDUFA2;NDUFS7;NDUFB10;UQCRC1;COX7B;CYCS;UQCR11;NDUFB8;UQCRC2;NDUFC2;NDUFV2;NDUFA7;NDUFA8;NDUFC1;NDUFV1;NDUFB6;NDUFA5;SDHD;SDHB;NDUFB9;NDUFB5;NDUFS6;NDUFB4;SDHA;NDUFB7;NDUFB2;UQCC3;NDUFAB1;UQCRFS1;NDUFA10
gsea,Mitochondrial ATP Synthesis Coupled Electron Transport (GO:0042775),-0.7543923013437633,-2.694509706997638,0.0,0.0,0.0,53/66,18.63%,CYC1;COX6C;UQCRQ;NDUFA3;COX8A;NDUFS5;NDUFA1;COX4I1;COX5B;COX7C;NDUFA4;COX6B1;COX6A1;UQCRB;NDUFB1;NDUFS8;UQCR10;COX5A;COX7A2;NDUFS2;NDUFB3;UQCRH;NDUFA2;NDUFS7;NDUFB10;UQCRC1;COX7B;CYCS;UQCR11;NDUFB8;UQCRC2;NDUFC2;NDUFV2;NDUFA7;NDUFA8;NDUFC1;NDUFV1;NDUFB6;NDUFA5;SDHD;SDHB;NDUFB9;NDUFA12;NDUFB5;NDUFS6;NDUFB4;SDHA;NDUFB7;NDUFB2;UQCC3;NDUFAB1;UQCRFS1;NDUFA10
gsea,Oxidative Phosphorylation (GO:0006119),-0.7496261104060812,-2.6723925078379747,0.0,0.0,0.0,41/50,18.95%,NDUFA3;NDUFS5;NDUFA1;ATP5PB;UQCRB;NDUFB1;CHCHD10;NDUFS8;NDUFS2;NDUFB3;UQCRH;NDUFA2;NDUFS7;NDUFB10;NDUFA13;NDUFB11;UQCRC1;NDUFB8;UQCRC2;NDUFC2;NDUFV2;NDUFA7;NDUFA8;NDUFC1;NDUFV1;NDUFB6;NDUFA5;SDHD;NIPSNAP2;SDHB;NDUFB9;NDUFA12;NDUFB5;NDUFS6;NDUFB4;SDHA;NDUFB7;NDUFB2;NDUFAB1;NDUFA10;NDUFA11
gsea,Proton Motive Force-Driven Mitochondrial ATP Synthesis (GO:0042776),-0.7580680748023669,-2.628261214578527,0.0,0.0,0.0,35/42,18.95%,NDUFA3;NDUFS5;NDUFA1;ATP5PB;NDUFB1;NDUFS8;NDUFS2;NDUFB3;NDUFA2;NDUFS7;NDUFB10;NDUFA13;NDUFB11;NDUFB8;NDUFC2;NDUFV2;NDUFA7;NDUFA8;NDUFC1;NDUFV1;NDUFB6;NDUFA5;SDHD;SDHB;NDUFB9;NDUFA12;NDUFB5;NDUFS6;NDUFB4;SDHA;NDUFB7;NDUFB2;NDUFAB1;NDUFA10;NDUFA11
gsea,Proton Motive Force-Driven ATP Synthesis (GO:0015986),-0.7540202856308018,-2.6206293715451014,0.0,0.0,0.0,35/43,18.95%,NDUFA3;NDUFS5;NDUFA1;ATP5PB;NDUFB1;NDUFS8;NDUFS2;NDUFB3;NDUFA2;NDUFS7;NDUFB10;NDUFA13;NDUFB11;NDUFB8;NDUFC2;NDUFV2;NDUFA7;NDUFA8;NDUFC1;NDUFV1;NDUFB6;NDUFA5;SDHD;SDHB;NDUFB9;NDUFA12;NDUFB5;NDUFS6;NDUFB4;SDHA;NDUFB7;NDUFB2;NDUFAB1;NDUFA10;NDUFA11
gsea,Positive Regulation Of Signal Transduction By P53 Class Mediator (GO:1901798),-0.9184856775748028,-2.6141584982987593,0.0,0.0,0.0,8/16,2.29%,UBB;DDX5;RPL37;RPS7;RPS15;RPL17;RPS20;EIF5A
gsea,Aerobic Respiration (GO:0009060),-0.6955986082086649,-2.5812294450055164,0.0,0.0,0.0,42/57,18.95%,NDUFA3;NDUFS5;NDUFA1;MDH2;UQCRB;NDUFB1;CHCHD10;NDUFS8;NDUFS2;NDUFB3;UQCRH;NDUFA2;NDUFS7;NDUFB10;NDUFA13;NDUFB11;UQCRC1;NDUFB8;UQCRC2;NDUFC2;NDUFV2;NDUFA7;NDUFA8;MTFR1L;NDUFC1;NDUFV1;NDUFB6;NDUFA5;NIPSNAP2;SDHB;NDUFB9;NDUFA12;NDUFB5;NDUFS6;NDUFB4;OXA1L;NDUFB7;NDUFB2;SURF1;NDUFAB1;NDUFA10;NDUFA11
gsea,Mitochondrial Respiratory Chain Complex I Assembly (GO:0032981),-0.6848021229319499,-2.579428600661802,0.0,0.0,0.0,37/52,21.78%,NDUFA3;NDUFS5;NDUFA1;NDUFB1;NDUFS8;NDUFS2;NDUFB3;NDUFA2;NDUFS7;NDUFB10;NDUFA13;NDUFB11;NDUFB8;NDUFC2;NDUFA8;BCS1L;NDUFC1;NDUFB6;NDUFA5;NDUFB9;NDUFB5;NDUFB4;NDUFAF8;FOXRED1;NDUFAF2;OXA1L;NDUFB7;NDUFB2;NDUFAB1;NDUFAF3;NDUFA10;TMEM126A;NDUFA11;TMEM186;NDUFAF5;NDUFAF7;NDUFAF4
gsea,NADH Dehydrogenase Complex Assembly (GO:0010257),-0.6848021229319499,-2.579428600661802,0.0,0.0,0.0,37/52,21.78%,NDUFA3;NDUFS5;NDUFA1;NDUFB1;NDUFS8;NDUFS2;NDUFB3;NDUFA2;NDUFS7;NDUFB10;NDUFA13;NDUFB11;NDUFB8;NDUFC2;NDUFA8;BCS1L;NDUFC1;NDUFB6;NDUFA5;NDUFB9;NDUFB5;NDUFB4;NDUFAF8;FOXRED1;NDUFAF2;OXA1L;NDUFB7;NDUFB2;NDUFAB1;NDUFAF3;NDUFA10;TMEM126A;NDUFA11;TMEM186;NDUFAF5;NDUFAF7;NDUFAF4
gsea,"Mitochondrial Electron Transport, NADH To Ubiquinone (GO:0006120)",-0.7566993716614562,-2.5464393003719272,0.0,0.0,0.0,27/34,18.63%,NDUFA3;NDUFS5;NDUFA4;NDUFB1;NDUFS8;NDUFS2;NDUFB3;NDUFA2;NDUFS7;NDUFB10;NDUFB8;NDUFC2;NDUFV2;NDUFA7;NDUFA8;NDUFC1;NDUFV1;NDUFB6;NDUFA5;NDUFB9;NDUFB5;NDUFS6;NDUFB4;NDUFB7;NDUFB2;NDUFAB1;NDUFA10
gsea,Calcium Ion Transmembrane Import Into Cytosol (GO:0097553),0.651675589050462,2.5428749853836896,0.0,0.0,0.0,23/59,9.44%,RYR2;CACNA1C;GRIN2A;CACNA1E;NALF1;SCN1A;GRIN1;CACNA1A;SLC8A1;ATP2B4;SCN8A;CACNA1B;SLC24A2;FLNA;LCK;SCN7A;SLC24A4;HTR2C;PLCG2;PLCH1;PKD2;PLCE1;CACNA1H
gsea,Ribosomal Small Subunit Biogenesis (GO:0042274),-0.6109631188300477,-2.486699675860367,0.0,0.0,0.0,32/80,14.82%,RPS7;RPSA;RPS8;RPS23;RPS28;RPS25;RPS5;RPS24;RPS11;RPS15;RPS6;RPS27;RPS17;RPS4X;RPS16;RPS15A;RPS14;IGF2BP3;RPS9;SNU13;NOL7;EMG1;NPM1;RPS13;RPS27L;UTP3;FCF1;RPS19;UTP11;PNO1;LTV1;NOL11
gsea,Ribonucleoprotein Complex Biogenesis (GO:0022613),-0.5946575302503723,-2.486042682199827,0.0,0.0,0.0,34/112,9.55%,RPS7;RPL5;RPS8;RPS23;RPS28;RPL11;RPS25;RPS5;RPS24;RPL7;RPS11;RPL14;RPS15;RPL38;RPS6;RPS27;RPS17;RPS4X;RPS16;RPS15A;RPS14;IGF2BP3;RPL26;RPL35A;RPS9;MRPL36;SNU13;GLUL;NOL7;EMG1;RPF2;NPM1;PAK1IP1;RPS13
gsea,Ribosome Biogenesis (GO:0042254),-0.5522091009538512,-2.4496989330442838,0.0,0.0,0.0,47/147,14.84%,RPS7;RPL5;RPS8;RPS23;RPS28;RPL11;RPS25;RPS5;RPS24;RPL7;RPS11;RPL14;RPS15;RPL27;RPS6;RPS27;RPS17;RPS4X;RPS16;RPS15A;RPS14;IGF2BP3;RPL26;RPL35A;RPS9;MRPL36;SNU13;GLUL;NOL7;EMG1;NOLC1;WDR55;NOC4L;RPF2;NPM1;PAK1IP1;RPS13;UTP3;FCF1;EXOSC4;EXOSC3;DKC1;RPS19;UTP11;PNO1;LTV1;NOP53
gsea,Mitochondrial Respiratory Chain Complex Assembly (GO:0033108),-0.5881674263326363,-2.430549554306981,0.0,0.0,0.0,50/88,21.78%,NDUFA3;NDUFS5;NDUFA1;COX17;UQCC2;NDUFB1;COA3;NDUFS8;NDUFS2;NDUFB3;NDUFA2;NDUFS7;NDUFB10;NDUFA13;NDUFB11;NDUFB8;NDUFC2;NDUFA8;COX14;BCS1L;COX20;NDUFC1;SCO2;NDUFB6;NDUFA5;COX19;NDUFB9;SAMM50;NDUFB5;CHCHD4;NDUFB4;SDHAF1;NDUFAF8;FOXRED1;NDUFAF2;OXA1L;NDUFB7;NDUFB2;UQCC3;SURF1;NDUFAB1;UQCRFS1;NDUFAF3;NDUFA10;TMEM126A;NDUFA11;TMEM186;NDUFAF5;NDUFAF7;NDUFAF4
gsea,"Synaptic Transmission, Glutamatergic (GO:0035249)",0.7482944282716568,2.3896536123212844,0.0,0.0,0.0,12/25,8.48%,GRIK4;GRIA3;GRIN2A;GRIA1;GRIA4;UNC13B;GRIK5;GRIK2;GRID2;GRID1;GRIK1;UNC13A
gsea,Ribosome Assembly (GO:0042255),-0.6542855746411715,-2.382762874851108,0.0,0.0,0.0,21/44,14.86%,RPL6;RPL5;RPSA;RPS28;RPL11;RPS5;RPS15;RPS27;RPL23A;RPS14;RPL10;RPF2;NPM1;EIF6;C1QBP;RPLP0;RPS27L;MRPL20;RPS19;NOP53;MRPS2
gsea,Heterophilic Cell-Cell Adhesion Via Plasma Membrane Cell Adhesion Molecules (GO:0007157),0.7678653359527453,2.37888879590176,0.0,0.0,0.0,11/24,10.17%,TENM4;NLGN1;TENM2;TENM1;IGSF21;PTPRD;NECTIN1;GRID2;FAT4;ALCAM;CADM1
gsea,Substantia Nigra Development (GO:0021762),-0.6966439293467608,-2.3458231252776356,0.0,0.0,0.0,12/34,5.80%,CALM1;CALM2;CALM3;DYNLL1;YWHAH;ATP5PB;BASP1;INA;COX6B1;YWHAE;CDC42;YWHAQ
gsea,rRNA Metabolic Process (GO:0016072),-0.5728361514078595,-2.3380141563293533,0.0,0.0,0.0,29/84,14.84%,RPS7;RPL5;RPS28;RPL11;RPS25;RPS24;RPL7;RPL14;RPS15;RPL27;RPS6;RPS27;RPS17;RPS16;IGF2BP3;RPL26;RPL35A;EMG1;NOLC1;WDR55;NOC4L;POLR1G;EXOSC4;EXOSC3;DKC1;ZFP36L1;RPS19;TRIR;NOP53
gsea,Calcium Ion Import Across Plasma Membrane (GO:0098703),0.7414886944331943,2.30574686001208,0.0,0.0006031808557782265,0.003,12/24,9.44%,CACNA1C;CACNA1E;NALF1;SCN1A;CACNA1A;SLC8A1;SCN8A;CACNA1B;SLC24A2;SCN7A;SLC24A4;CACNA1H
gsea,Positive Regulation Of Protein Dephosphorylation (GO:0035307),-0.690271771342339,-2.2803588752453954,0.0,0.00014193118348771464,0.003,6/28,0.58%,CALM1;CALM2;HSP90AB1;PPIA;CALM3;DYNLL1
gsea,ncRNA Processing (GO:0034470),-0.5317263823402587,-2.2752211364003383,0.0,0.00013647229181511022,0.003,22/98,7.37%,RPS7;RPL5;RPS28;RPL11;RPS25;RPS24;RPL7;RPL14;RPS15;RPL27;RPS6;RPS27;RPS17;RPS16;IGF2BP3;RPL26;RPL35A;EMG1;NOLC1;RPP21;WDR55;NOC4L
gsea,Positive Regulation Of Phosphoprotein Phosphatase Activity (GO:0032516),-0.8101008327972571,-2.259340490313518,0.0,0.0001752236833181662,0.004,4/16,0.25%,CALM1;CALM2;HSP90AB1;CALM3
gsea,rRNA Processing (GO:0006364),-0.5311372099773451,-2.2335587936913295,0.0,0.00021120711828528962,0.005,32/100,14.84%,RPS7;RPL5;RPS28;RPL11;RPS25;RPS24;RPL7;RPL14;RPS15;RPL27;RPS6;RPS27;RPS17;RPS16;RPS14;IGF2BP3;RPL26;RPL35A;SNU13;EMG1;NOLC1;C1D;WDR55;NOC4L;EIF6;EXOSC4;EXOSC3;DKC1;RPS19;NHP2;NOL11;NOP53
gsea,Positive Regulation By Host Of Viral Process (GO:0044794),-0.759422284339023,-2.1958178081890476,0.0,0.0002447089370477838,0.006,5/15,4.55%,EEF1A1;CFL1;NUCKS1;PPIB;VAPA
gsea,Protein Stabilization (GO:0050821),-0.4663916479572675,-2.1926329639548854,0.0,0.0003154026299726991,0.008,64/175,19.26%,ATP1B1;HSP90AB1;MT3;GAPDH;RPS7;RPL5;PFN2;RPL11;RPL17;HSP90AA1;PARK7;CALR;USP2;CCT2;PPIB;CCT6A;ATP1B2;CDC37;PTGES3;USP27X;LAMP1;PIN1;TTI2;BAG1;PFN1;PINK1;PFDN6;NAPG;PFDN2;CLU;RTN4;POLR2E;PFDN4;BAG5;PFDN5;STUB1;BAG4;RUVBL1;ATF7IP;CRYAB;HIP1R;CCT7;PIK3R1;VBP1;TBL1X;CCT5;CCT8;HSPD1;NOP53;MUL1;TRIM44;TMEM88;SMAD7;LAMP2;HCFC1;EPHA4;PLPP3;SOX4;PEX19;TTI1;FBXW7;PHB2;CREB1;PFDN1
gsea,Protein Targeting To Mitochondrion (GO:0006626),-0.5729440870625182,-2.1905705252640804,0.0,0.000305228351586483,0.008,29/53,21.12%,HSP90AA1;DNAJC19;TIMM8B;TOMM5;NDUFA13;TOMM7;TIMM13;MTCH1;MTCH2;ROMO1;IMMP2L;PAM16;TOMM20;TIMM22;TIMM23;TIMM10;AIP;SAMM50;CHCHD4;TIMM50;TIMM44;HSPD1;DNAJC15;GRPEL1;TOMM22;DNLZ;PMPCA;MTX1;FIS1
gsea,Proton Transmembrane Transport (GO:1902600),-0.6587399675635699,-2.177849143723831,0.0,0.00040657370269918256,0.011,14/33,12.27%,ATP1B1;ATP6V0C;RNASEK;ATP6V1D;ATP6V1A;ATP1A1;ATP6V0E2;ATP1A3;ATP6V0B;ATP6V1F;ATP6V1E1;ATP6AP2;ATP1A2;ATP6V1C1
gsea,Potassium Ion Import Across Plasma Membrane (GO:1990573),-0.6409090545784277,-2.1728601507915046,0.0,0.0005734593272230892,0.016,10/27,11.86%,ATP1B1;KCNJ3;ATP1A1;ATP1A3;KCNJ2;ATP1B2;KCNJ4;KCNJ13;ATP1A2;KCNJ16
gsea,Regulation Of Protein Dephosphorylation (GO:0035304),-0.6367967705284563,-2.169419735877376,0.0,0.0005913799311988109,0.016,8/32,6.48%,CALM1;CALM2;PPIA;CALM3;DYNLL1;YWHAB;ENSA;PIN1
gsea,Regulation Of Trans-Synaptic Signaling (GO:0099177),0.6095383770935234,2.158014453823452,0.0,0.007881563182168825,0.047,16/33,9.26%,GRIK4;GRIA3;NLGN1;GRIA1;CACNA1A;GRIA4;IQSEC2;CACNA1B;BCR;GRIK5;GRIK2;LRP8;GRID2;GRID1;GRIK1;RELN
gsea,Modulation Of Chemical Synaptic Transmission (GO:0050804),0.4809733418889527,2.1575967543121752,0.0,0.00670200950864696,0.048,40/105,12.04%,GRIK4;CLSTN2;DLGAP2;GRIA3;DLGAP1;NLGN1;GRIA1;CACNA1A;GRIA4;IQSEC2;TRIO;MCTP1;CACNA1B;TMEM108;BCR;GRM8;CAMK2A;GRIK5;GRIK2;CNTNAP4;CASK;LGI1;DLGAP3;RIMS1;LRP8;GRID2;GRM7;MYOF;GRID1;DGKI;CHRNA7;GRIK1;UNC13A;RELN;KCNMB4;DLG4;SNCAIP;BEGAIN;SYT1;RIMS2
gsea,protein-RNA Complex Assembly (GO:0022618),-0.4717704987652564,-2.1567374036346503,0.0,0.0007772421952898658,0.02,60/140,21.10%,HSP90AB1;RPL6;RPL5;RPSA;RPS28;RPL11;RPS5;RPS15;RPL38;CELF2;HSP90AA1;RPS27;RPL23A;RPS14;EIF3C;SNRPG;DENR;EIF3H;EIF3F;SNRPF;SNRPD2;PTGES3;RAMAC;RPL10;ZRSR2;EIF2S2;EIF3I;RPF2;EIF6;LSM4;PUF60;SCAF11;EIF3K;RPLP0;EIF5;LUC7L3;SNRNP200;SNRPD1;RPS27L;DDX20;GEMIN7;MRPL20;TXNL4A;RPS19;SNRPE;NOP53;HNRNPC;GEMIN6;CLNS1A;PRMT7;EIF3D;EIF3M;PRPF19;NLE1;DDX1;DDX39B;CDC73;ERAL1;SART1;NOL3
gsea,Regulation Of Dendrite Extension (GO:1903859),0.7358960484397277,2.134321554417631,0.0,0.00593127841515256,0.057,10/15,15.73%,SYT17;RASAL1;RNF157;RIMS1;PLAA;ITSN2;UNC13A;SYT1;RIMS2;NEDD4L
gsea,Positive Regulation Of Dendrite Extension (GO:1903861),0.7358960484397277,2.134321554417631,0.0,0.00593127841515256,0.057,10/15,15.73%,SYT17;RASAL1;RNF157;RIMS1;PLAA;ITSN2;UNC13A;SYT1;RIMS2;NEDD4L
gsea,Lysosomal Lumen Acidification (GO:0007042),-0.7250026152102296,-2.1318078064515986,0.0,0.0011170509811533095,0.03,7/18,8.04%,ATP6V0C;RNASEK;ATP6V1D;ATP6V1A;ATP6V0B;ATP6V1F;ATP6AP2
gsea,Regulation Of Protein Autophosphorylation (GO:0031952),-0.6378644327399425,-2.127000929317087,0.0,0.0011188268968626153,0.031,4/26,0.72%,CALM1;CALM2;CALM3;EPHA7
gsea,Modulation Of Excitatory Postsynaptic Potential (GO:0098815),0.6269404412398762,2.1188937668708356,0.0,0.0066126493818650005,0.069,13/29,12.04%,GRIN2A;NLGN1;GRIN1;TMEM108;SHANK3;CUX2;RIMS1;SHANK1;CHRNA7;WNT7A;RELN;DLG4;RIMS2
gsea,Positive Regulation Of Dephosphorylation (GO:0035306),-0.6898270747784095,-2.1134067401960217,0.0,0.001369511419618299,0.04,5/21,0.58%,CALM1;CALM2;PPIA;CALM3;DYNLL1
gsea,Mitochondrial Gene Expression (GO:0140053),-0.476797178010207,-2.098829091084616,0.0,0.0017893033815758893,0.054,54/102,30.79%,MRPS26;MRPL52;MRPS24;MRPL41;MRPL36;MRPL18;MRPL23;MRPS21;MRPL14;MRPL54;MRPL44;CHCHD1;MRPL9;MRPL30;MRPL33;MRPS14;MRPS33;NDUFA7;MRPL57;MRPL11;MRPL39;MRPS16;MRPL17;MRPS5;MRPL19;MRPL12;MRPL43;MRPL20;MRPS2;TFAM;GATB;MRPL48;MRPS31;MRPL16;TFB2M;MRPL42;GADD45GIP1;MRPL38;MRPL35;TEFM;FASTK;MRPL21;MRPL24;FOXO3;MRPL53;MRPS34;MRPL50;MTERF4;GATC;MRPL27;MRPS18C;MRPL40;FASTKD3;MRPL2
gsea,Platelet Aggregation (GO:0070527),-0.6421192368548342,-2.0925213900632986,0.0,0.0018924157798361947,0.059,13/25,19.52%,PPIA;GNAS;ACTG1;RAP2B;P2RY12;FIBP;VCL;ILK;MYL9;CSRP1;UBASH3B;TLN1;MYL12A
gsea,Mitochondrial Translation (GO:0032543),-0.47461082995944015,-2.082419617194374,0.0,0.002250128518707671,0.071,45/97,26.62%,MRPS26;MRPL52;MRPS24;MRPL41;MRPL36;MRPL18;MRPL23;MRPS21;MRPL14;MRPL54;MRPL44;CHCHD1;MRPL9;MRPL30;MRPL33;MRPS14;MRPS33;NDUFA7;MRPL57;MRPL11;MRPL39;MRPS16;MRPL17;MRPS5;MRPL19;MRPL12;MTIF3;MRPL43;MRPL20;MRPS2;GATB;MRPL48;MRPS31;MRPL16;MRPL42;GADD45GIP1;MRPL38;MRPL35;MRPL21;MRPL24;TUFM;MRPL53;TSFM;MRPS34;MRPL50
gsea,Establishment Of Protein Localization To Mitochondrion (GO:0072655),-0.574600823839217,-2.0759794271608993,0.0,0.002478163521214065,0.079,28/40,28.62%,DNAJC19;TIMM8B;TOMM5;TOMM7;TIMM13;PINK1;ROMO1;PAM16;TOMM20;TIMM23;RALA;TIMM10;AIP;CHCHD4;TIMM50;TIMM44;HSPD1;DNAJC15;GRPEL1;TOMM22;HK1;DNLZ;FIS1;AKT1;MFN2;HK2;TOMM40L;TOMM34
gsea,Negative Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000059),-0.6028053132814564,-2.0745726667949698,0.0,0.002475543898041534,0.08,10/35,8.98%,HSP90AB1;RPS7;RPL5;RPL11;RPL17;PARK7;MAP1A;EIF3H;PML;UBXN1
gsea,Vesicle Budding From Membrane (GO:0006900),-0.6118058843197862,-2.072645109013476,0.001941747572815534,0.002499924254613156,0.083,14/28,17.53%,TRAPPC6B;AP2M1;WASL;VAPA;TRAPPC2L;TRAPPC2;SNX3;CHMP6;TRAPPC1;TMED10;VPS4A;SEC13;CHMP4C;CHMP7
gsea,Protein Localization To Cell Junction (GO:1902414),0.6762315604000212,2.070253797956982,0.0,0.010535558947593022,0.114,7/20,5.23%,NLGN1;PCLO;STAU2;TJP2;TJP1;NECTIN1;SHANK1
gsea,Negative Regulation Of Calcium Ion Transmembrane Transporter Activity (GO:1901020),-0.6901164986939448,-2.070176216717409,0.0,0.002654638802270218,0.089,11/22,12.60%,CALM1;CALM2;CALM3;PPP3CA;FKBP1A;YWHAE;PPP3R1;PPP3CB;ATP1A2;FMR1;SRI
gsea,Regulation Of Lysosomal Lumen pH (GO:0035751),-0.6546942563434489,-2.06933770780364,0.0,0.002674065775855493,0.091,7/23,8.04%,ATP6V0C;RNASEK;ATP6V1D;ATP6V1A;ATP6V0B;ATP6V1F;ATP6AP2
gsea,Potassium Ion Homeostasis (GO:0055075),-0.7023011397719063,-2.069211639431881,0.0,0.002617170759347929,0.091,6/17,10.01%,ATP1B1;ATP1A1;ATP1A3;KCNJ2;ATP1B2;ATP1A2
gsea,Positive Regulation Of Excitatory Postsynaptic Potential (GO:2000463),0.6684826009289351,2.0608776797947743,0.0,0.010820698988506365,0.126,11/22,12.04%,GRIN2A;NLGN1;GRIN1;SHANK3;CUX2;RIMS1;SHANK1;WNT7A;RELN;DLG4;RIMS2
gsea,Positive Regulation Of Cation Channel Activity (GO:2001259),-0.6239304951725,-2.0540537981346065,0.0,0.003227948791126843,0.11,8/27,5.45%,CALM1;CALM2;CALM3;TMSB4X;PPP3CA;ANTKMT;PPP3R1;PPP3CB
gsea,Regulation Of Cell Division (GO:0051302),-0.5120622568929046,-2.0491610239004445,0.0,0.0033069000234382485,0.115,11/61,7.40%,CALM1;CALM2;CALM3;RACK1;FGFR2;CETN2;KLHL9;SH3GLB1;PIN1;PDXP;RAB11A
gsea,Response To Type II Interferon (GO:0034341),-0.648786723254649,-2.0461172702013495,0.0,0.0034536587982010557,0.12,9/24,10.93%,CALM1;GAPDH;RPL13A;CD47;SNCA;AQP4;IRF8;CX3CL1;GCH1
gsea,Protein Insertion Into Mitochondrial Membrane (GO:0051204),-0.6319487863029162,-2.0456464137255668,0.0,0.0033859399982363292,0.12,13/24,13.59%,HSP90AA1;TIMM8B;TOMM5;NDUFA13;TOMM7;TIMM13;MTCH1;MTCH2;ROMO1;TOMM20;TIMM22;TIMM10;SAMM50
gsea,Positive Regulation Of Phosphatase Activity (GO:0010922),-0.7004177147326656,-2.044890272687069,0.0019230769230769232,0.0033208257675010153,0.12,5/18,3.63%,CALM1;CALM2;HSP90AB1;CALM3;MEF2C
gsea,Negative Regulation Of Amide Metabolic Process (GO:0034249),-0.48666269377747884,-2.0448040478754694,0.0,0.003258168677548166,0.12,19/79,9.35%,RTN1;GAPDH;ENC1;RACK1;PRNP;APOE;RPS3;RPL13A;CALR;SERBP1;IGF2BP3;TOB1;BTG2;PIN1;CLU;NCL;RTN4;DHFR;YBX1
gsea,Positive Regulation Of Protein Kinase B Signaling (GO:0051897),-0.5195626556281925,-2.0400528565821032,0.0,0.0033949588642894707,0.126,19/55,12.83%,HSP90AB1;HSP90AA1;PARK7;SPRY2;SEMA5A;P2RY12;IL18;PDGFA;PINK1;FGFR1;RTN4;AXL;C1QBP;CX3CL1;TSPYL5;TEK;MTDH;RASD2;MYDGF
gsea,"RNA Splicing, Via Transesterification Reactions With Bulged Adenosine As Nucleophile (GO:0000377)",-0.4287768544110926,-2.0352986507890876,0.0,0.0035912890367345977,0.132,74/169,25.08%,DDX5;HSPA8;ZMAT2;PRPF4B;SNRPG;SNW1;HNRNPA2B1;SNRPF;SNRPD2;SNRNP27;SF3B2;WBP4;SNU13;SF3B4;TFIP11;FRG1;RBM42;RBM8A;HNRNPA1;PIN1;ZRSR2;MAGOH;IK;RBM22;LSM7;BUD31;LSM4;LSM2;HNRNPF;U2AF1;CTNNBL1;PABPC1;HNRNPK;SNRNP200;SNRPD1;MAGOHB;SRSF3;GEMIN7;RBMX2;LSM8;TXNL4A;SNRPE;SYF2;RBM19;U2AF1L4;HNRNPC;PHF5A;RALY;GEMIN6;SF3B6;SNIP1;RBM4B;U2AF2;SNRPN;CDC40;PRPF19;SLU7;FRA10AC1;LSM5;DDX39B;CWC15;SART1;NCBP2;SNRPB;PPIE;HNRNPH3;HNRNPA3;PRPF38A;BCAS2;HTATSF1;RSRC1;GPKOW;CWF19L1;USP39
gsea,Negative Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903051),-0.6538306832948995,-2.0318134781380093,0.0,0.0037806074173066836,0.142,6/21,3.52%,HSP90AB1;RPS7;RPL5;RPL11;RPL17;GABARAPL2
gsea,Mitochondrial Transport (GO:0006839),-0.5376840759651929,-2.02861520597084,0.0,0.004004783393732298,0.151,22/48,19.12%,SLC25A4;HSP90AA1;DNAJC19;SLC25A5;TIMM8B;TOMM5;TOMM7;TIMM13;PINK1;BAD;TOMM20;BCS1L;TIMM23;TIMM10;SLC25A16;AIP;TIMM44;KIFBP;SLC25A24;OXA1L;VPS35;TOMM22
gsea,Glutamate Receptor Signaling Pathway (GO:0007215),0.5863015330331888,2.0153278605117375,0.0,0.018631586434038547,0.21,10/32,8.35%,GRIK4;GRIA3;GRIN2A;GRIN1;GRIA4;GRM8;GRIK2;GRID2;GRM7;GRIK1
gsea,Negative Regulation Of Protein Metabolic Process (GO:0051248),-0.45021879224260236,-2.0138684581723174,0.0,0.004792216683852433,0.179,31/114,14.19%,HSP90AB1;GAPDH;ENC1;RACK1;PRNP;APOE;CST3;RPS3;RPL13A;CALR;SERBP1;IGF2BP3;TOB1;BTG2;PIN1;PFDN6;ITGAV;PFDN2;CLU;SNX3;NCL;DHFR;YBX1;PFDN4;PFDN5;CSTB;FMR1;CRYAB;LDLR;VBP1;HMGCR
gsea,Regulation Of Phosphoprotein Phosphatase Activity (GO:0043666),-0.5731795277824765,-2.0050763098279965,0.0,0.00543267665609755,0.202,10/34,12.17%,CALM1;CALM2;HSP90AB1;CALM3;FKBP1A;BOD1;CSNK2B;PPP1R11;GSK3B;PPP1R1B
gsea,Ribosomal Large Subunit Biogenesis (GO:0042273),-0.5371833768244003,-2.0042650889880305,0.0,0.005558971353268822,0.207,21/49,21.63%,RPL6;RPL5;RPL11;RPL7;RPL14;RPL23A;RPL26;RPL35A;RPL10;RPF2;NPM1;EIF6;PAK1IP1;RPLP0;MRPL20;NOP53;NIP7;NLE1;PES1;SPATA5L1;LAS1L
gsea,ATP Metabolic Process (GO:0046034),-0.6160038786646541,-2.0039972939426955,0.0,0.005487230181287328,0.207,7/23,10.36%,ATP1B1;ALDOA;HSPA8;OLA1;BAD;ATP1A2;PARP1
gsea,Positive Regulation Of Protein Autophosphorylation (GO:0031954),-0.6581421269111156,-1.994523175646236,0.0019305019305019305,0.006009183171858886,0.228,3/19,0.25%,CALM1;CALM2;CALM3
gsea,Positive Regulation Of T Cell Proliferation (GO:0042102),-0.625449253355185,-1.9936879737023157,0.0,0.00602644310840693,0.232,5/24,5.35%,HMGB1;PPP3CA;RPS3;NCK1;IL18
gsea,Response To Metal Ion (GO:0010038),-0.5450916341283889,-1.990848302768637,0.0,0.006283411768987366,0.246,9/40,9.78%,CALM1;CALM2;CALM3;PPP3CA;PDCD6;PPP1CA;PPP2CA;SNCA;ITPKA
gsea,Negative Regulation Of G Protein-Coupled Receptor Signaling Pathway (GO:0045744),-0.6900823216471201,-1.9899964839394348,0.0,0.006223136506769027,0.248,6/15,7.14%,APLP1;YWHAB;RGS2;LRPAP1;STMN1;SNCA
gsea,Regulation Of Neuron Apoptotic Process (GO:0043523),-0.471708192169303,-1.979253833462252,0.0,0.007042797362458566,0.278,17/78,9.84%,UBB;MT3;PRNP;APOE;EPHA7;SET;PARK7;FAIM2;BDNF;MEF2C;BAX;SOD1;EGR1;CDK5R1;PINK1;CLU;RASA1
gsea,Positive Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043280),-0.4846602920431682,-1.9781100393055842,0.0,0.0069906403807381825,0.28,30/71,23.68%,HMGB1;RACK1;DYNLL1;BEX3;RPS3;ARL6IP5;PDCD6;BAX;NDUFA13;CYCS;MTCH1;ANP32B;SNCA;BOK;BAD;RPS27L;HSPE1;HIP1R;HSPD1;LAPTM5;MUL1;BCL10;FAM162A;VCP;UACA;FIS1;BBC3;DIABLO;HTRA2;CTSD
gsea,Regulation Of Hippo Signaling (GO:0035330),0.6153164436929304,1.9768991095168607,0.003861003861003861,0.027467928201593078,0.294,8/20,19.47%,SHANK2;SCHIP1;MAPK14;DLG5;WWC1;MOB3B;TIAL1;WWC2
gsea,Response To Steroid Hormone (GO:0048545),-0.656296223082447,-1.9743049889535975,0.00205761316872428,0.0072878879756559335,0.294,6/17,10.01%,HSPA8;UBE3A;ATP1A1;ATP1A3;WBP2;ATP1A2
gsea,Protein Insertion Into ER Membrane (GO:0045048),-0.6088485765452747,-1.9711286344045873,0.0,0.007559378250976105,0.31,11/25,16.25%,RAB5IF;EMC10;EMC3;CCDC47;TMEM147;EMC9;EMC8;WDR83OS;EMC6;EMC4;TMCO1
gsea,Ribosomal Small Subunit Assembly (GO:0000028),-0.7024488532087502,-1.9652249336957879,0.0020161290322580645,0.008110353342155121,0.329,6/15,1.79%,RPSA;RPS28;RPS5;RPS15;RPS27;RPS14
gsea,Regulation Of Macroautophagy (GO:0016241),-0.46525430158616204,-1.9642534575226154,0.0,0.008096074551059778,0.329,24/85,17.43%,ATP6V0C;GAPDH;ATP6V1D;ATP6V1A;ATP6V1G2;ATP6V0E2;SESN1;ATP6V0B;BNIP3L;SH3GLB1;UBQLN2;CDK5R1;ATG12;PINK1;ATP6V1E1;PAFAH1B2;SCOC;UCHL1;ATP6V1C1;SNX5;ATP13A2;ATP6V1B2;ATP6V1G1;VPS35
gsea,Positive Regulation Of Cell Communication (GO:0010647),0.6119583429508958,1.9613155632745725,0.002036659877800407,0.030159042788911326,0.334,9/21,12.04%,CLSTN2;ANK3;GRIK2;LGI1;RIMS1;PTPN23;DLG4;SYT1;RIMS2
gsea,Regulation Of Transmembrane Transport (GO:0034762),-0.6376032209033511,-1.9609834086017872,0.0,0.008312173477405508,0.34,7/19,11.86%,ACTB;KCNJ3;KCNJ2;KCNJ4;SNCA;KCNJ13;KCNJ16
gsea,Cytoplasmic Translational Initiation (GO:0002183),-0.5758918883259772,-1.9606383048519616,0.0038535645472061657,0.008214510277199922,0.341,13/27,18.25%,EIF4A1;EIF3C;EIF4A2;EIF3H;EIF3F;EIF2S2;EIF3I;EIF6;EIF3K;EIF5;SLBP;EIF3D;EIF3M
gsea,RNA-templated DNA Biosynthetic Process (GO:0006278),-0.6906465139834844,-1.9586960949053063,0.0,0.008168928116292908,0.346,7/16,14.73%,HSP90AB1;HSP90AA1;NOP10;PTGES3;TERF1;DKC1;NHP2
gsea,Telomere Maintenance Via Telomerase (GO:0007004),-0.6906465139834844,-1.9586960949053063,0.0,0.008168928116292908,0.346,7/16,14.73%,HSP90AB1;HSP90AA1;NOP10;PTGES3;TERF1;DKC1;NHP2
gsea,Positive Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001244),-0.6030155680184737,-1.9558737755525615,0.0,0.008403820074930471,0.359,9/25,8.97%,UBB;RPS7;RACK1;RPS3;EIF5A;NCK1;SOD1;BOK;GSDME
gsea,Chemical Synaptic Transmission (GO:0007268),0.40399209978280326,1.9543892586508997,0.0,0.029703306142323326,0.351,45/200,9.33%,GRIK4;DLGAP2;GRIA3;DLGAP1;GRIN2A;NLGN1;CACNA1E;GRIA1;GRIN1;CACNA1A;ASIC2;GABRA2;CACNB2;PTPRN2;GRIA4;GABRG3;RPS6KA2;GABBR2;AMPH;CACNA1B;CHRNA4;ERC2;UNC13B;PDE7B;CHRM3;KCNQ2;GRIK5;SLC6A1;SPG11;GRIK2;KIF1B;KCNQ3;GRID2;BRSK1;SYN2;GRM7;HTR2C;GRID1;CHRNA7;GRIK1;SLC1A1;UNC13A;GABRB1;RIMBP3;KCNMB4
gsea,Activation Of GTPase Activity (GO:0090630),0.4665452813263032,1.951623549164488,0.0,0.02900294614866972,0.365,39/75,25.21%,SIPA1L3;RALGAPA2;NTRK3;DOCK7;BCR;RALGAPA1;BCAS3;NTF3;GMIP;GARNL3;SGSM1;AGAP1;TIAM1;SIPA1L2;TBC1D9B;TBC1D12;RAP1GAP2;RASGRF1;TBC1D30;EVI5;SIPA1L1;SCRIB;EVI5L;TBC1D25;TBC1D17;RAP1GAP;SGSM2;SGSM3;AGAP3;TBC1D2;SYDE2;APC2;AGAP2;ARHGAP24;GRTP1;TBC1D22A;TBC1D13;TBCK;TBC1D16
gsea,Protein Targeting To ER (GO:0045047),-0.6310078813628668,-1.948410773167215,0.0,0.0094467183814875,0.396,9/19,17.55%,SEC62;SRP14;SPCS2;SRP9;SEC61G;ZFAND2B;SPCS1;SRP72;SRPRB
gsea,Negative Regulation Of Calcium Ion Transmembrane Transport (GO:1903170),-0.692966720728431,-1.9416750759852437,0.002044989775051125,0.010189931122194896,0.417,10/16,11.31%,CALM2;PPP3CA;FKBP1A;VDAC1;YWHAE;PPP3R1;PPP3CB;TMBIM6;ATP1A2;EPO
gsea,Intracellular pH Reduction (GO:0051452),-0.6277946420762083,-1.935878298349998,0.0,0.01061489547392296,0.426,8/21,8.04%,ATP6V0C;RNASEK;ATP6V1D;ATP6V1A;ATP6V0E2;ATP6V0B;ATP6V1F;ATP6AP2
gsea,Calcium Ion Transmembrane Transport (GO:0070588),0.4765283527965409,1.935831032070401,0.0,0.033778127923580675,0.423,20/61,7.94%,CACNA1C;GRIN2A;GRIN1;CACNA1A;SLC8A1;ATP2B4;PKD1;ATP2B3;RYR3;TRPC5;SLC24A2;SLC24A3;TRPM7;MCU;TRPM3;TRPC6;MICU1;TRPC3;SLC24A4;PKD2
gsea,Transition Metal Ion Transport (GO:0000041),-0.5899180877716426,-1.9353298349944512,0.0,0.010556131771898776,0.429,4/24,7.72%,FTH1;MT3;COX17;CUTC
gsea,Purine Ribonucleoside Triphosphate Metabolic Process (GO:0009205),-0.5811993777318698,-1.9334295887240445,0.0,0.01063023678796875,0.434,6/25,10.01%,ATP1B1;HSPA8;RAN;OLA1;BAD;ATP1A2
gsea,Regulation Of Potassium Ion Transport (GO:0043266),0.5691870128908015,1.929608607161932,0.0,0.03467172919140027,0.45,9/23,17.50%,ANK3;DPP6;DPP10;KCNAB1;NOS1;KCNAB2;ANK2;KCNN2;KCNIP2
gsea,Positive Regulation Of Calcium Ion Transmembrane Transporter Activity (GO:1901021),-0.6238475131089009,-1.9178399740944974,0.003913894324853229,0.012851695578003428,0.495,7/22,5.45%,CALM1;ATP1B1;CALM2;CALM3;PPP3CA;PPP3R1;PPP3CB
gsea,Negative Regulation Of Signaling (GO:0023057),-0.6706569703235286,-1.9173390416282843,0.001869158878504673,0.012739606228716553,0.496,9/17,18.71%,HSP90AB1;PPP3CA;AP1AR;PPP3CB;HHIP;LDLR;OPRM1;UBASH3B;PTPN1
gsea,Chloride Transmembrane Transport (GO:1902476),0.5430308773742822,1.9132255784937309,0.0,0.038518917807592,0.501,10/33,9.01%,GABRA2;GABRG3;ANO4;ANO3;ANO6;SLC6A1;ANO2;SLC1A1;GABRB1;ANO10
gsea,Negative Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903321),-0.5160201854027096,-1.9121325579872288,0.0,0.013503175095706184,0.515,19/44,24.69%,RPL5;RPL11;RPS3;PARK7;DNAJA1;SPRY2;COPS9;SQSTM1;VPS28;UBXN1;BAG5;IVNS1ABP;SMAD7;U2AF2;SOX4;CAPN3;SUMO1;GTPBP4;AKT1
gsea,Mitochondrion Organization (GO:0007005),-0.4210588624311514,-1.9115895202759312,0.0,0.013427803143690648,0.516,50/134,22.03%,SLC25A4;PARK7;DNAJC19;RAB5IF;TIMM8B;CHCHD2;COX7A2L;CHCHD10;HIGD2A;TOMM5;BNIP3L;COX7A2;FMC1;BAX;TOMM7;TIMM13;HIGD1A;PINK1;MPV17;TMEM242;TOMM20;BCS1L;MTFR1L;DNAJA3;TIMM23;PARP1;TIMM10;NIPSNAP2;AIP;SAMM50;CHCHD4;TMEM11;TIMM50;TIMM44;HSPD1;MUL1;RAB32;OXA1L;TMEM70;APEX1;MTFP1;TOMM22;PHB2;GABPB1;UCP2;MTX1;USP30;FIS1;HSD17B10;LETMD1
gsea,Intracellular Iron Ion Homeostasis (GO:0006879),-0.5247179319708857,-1.910247251172427,0.0,0.013519220287637934,0.523,6/36,4.48%,FTH1;ATP6V1A;SLC22A17;NDFIP1;BOLA2;SOD1
gsea,Regulation Of Signal Transduction By P53 Class Mediator (GO:1901796),-0.5165850320026716,-1.9078157873181858,0.001968503937007874,0.013798865061305588,0.532,14/42,17.89%,RPL37;RPL5;RPL11;RPS15;RPL17;RPS20;USP2;RPF2;PAK1IP1;PIP4P1;NOP53;KAT6A;MAPKAPK5;SOX4
gsea,Late Endosome To Vacuole Transport (GO:0045324),-0.6395745976804952,-1.8933342283767844,0.0019230769230769232,0.016357031278839838,0.596,9/17,17.53%,LEPROT;CHMP2A;CHMP6;LEPROTL1;TMEM50A;VPS4A;TMEM50B;CHMP4C;CHMP7
gsea,Regulation Of Ryanodine-Sensitive Calcium-Release Channel Activity (GO:0060314),-0.6259980443506664,-1.8932758583244633,0.001953125,0.01618653384719442,0.596,4/18,1.04%,CALM1;CALM2;CALM3;FKBP1A
gsea,Regulation Of Monoatomic Cation Transmembrane Transport (GO:1904062),0.5298719656655395,1.8918979827623037,0.0,0.046887258522494125,0.575,13/32,17.68%,GRIN2A;GRIN1;DPP6;DPP10;KCNAB1;WNK1;WNK3;KCNAB2;NEDD4L;KCNN2;GRIN2B;KCNIP2;HCN1
gsea,Vacuolar Acidification (GO:0007035),-0.587178122701706,-1.890812386404516,0.003937007874015748,0.016479787416073532,0.61,8/25,8.04%,ATP6V0C;RNASEK;ATP6V1D;ATP6V1A;ATP6V0E2;ATP6V0B;ATP6V1F;ATP6AP2
gsea,Regulation Of Type II Interferon Production (GO:0032649),-0.5462012530110444,-1.8885196943428824,0.0,0.016597630156942454,0.617,10/33,14.61%,HMGB1;PRNP;RASGRP1;CD47;IL18;INHBA;C1QBP;MYDGF;HSPD1;LAPTM5
gsea,Activation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0006919),-0.5008835268341139,-1.8868337974290597,0.0,0.01661006241541008,0.622,18/46,18.97%,RACK1;DYNLL1;BEX3;BAX;CYCS;MTCH1;ANP32B;SNCA;BOK;BAD;RPS27L;HSPE1;HIP1R;HSPD1;LAPTM5;MUL1;FAM162A;VCP
gsea,Regulation Of Microtubule-Based Process (GO:0032886),0.5210137640358925,1.8854809759569313,0.0,0.048216171265065846,0.594,18/38,20.45%,MACF1;TAOK1;MARK2;ROCK1;MAPT;CLASP1;CCNL2;PATJ;MPDZ;BICD1;EPHA3;CLASP2;PHLDB1;MID1;MAP6;MARK4;PHLDB2;HDAC6
gsea,Positive Regulation Of GTPase Activity (GO:0043547),0.4076232125729233,1.8827168538055772,0.0,0.047121219581705086,0.602,59/161,18.08%,DOCK9;DOCK10;DOCK11;SIPA1L3;RALGAPA2;NTRK3;DOCK7;NF1;RALGPS1;PKP4;MAP4K4;BCR;RGL1;RALGAPA1;BCAS3;SH3BP1;RGS8;RAPGEF4;NTF3;RASGRF2;GMIP;GARNL3;SGSM1;AGAP1;SOS1;RGS11;SEMA4D;RAP1GDS1;SNX13;RGS7;RAPGEFL1;RASGEF1B;PREX2;SRGAP3;TIAM1;RAPGEF6;SIPA1L2;TBC1D9B;TBC1D12;RAP1GAP2;RALGPS2;ARHGEF7;RASGRF1;RSU1;ARAP1;TBC1D30;EVI5;SIPA1L1;SCRIB;EVI5L;RAPGEF5;TBC1D25;TBC1D17;CCL25;RAP1GAP;SGSM2;SGSM3;RIC1;AGAP3
gsea,Cellular Response To Type II Interferon (GO:0071346),-0.5900532710842233,-1.8814887737368176,0.0019157088122605363,0.01729627325656737,0.634,8/25,10.86%,CALM1;GAPDH;RPL13A;CD47;IFNGR2;AQP4;IRF8;CX3CL1
gsea,"mRNA Splicing, Via Spliceosome (GO:0000398)",-0.3891741111616288,-1.880133168705817,0.0,0.017414251591045836,0.639,84/199,25.30%,DDX5;HSPA8;ZMAT2;PRPF4B;SNRPG;SNW1;HNRNPA2B1;SNRPF;SNRPD2;SNRNP27;SF3B2;WBP4;SNU13;SF3B4;TFIP11;FRG1;RBM42;RBM8A;HNRNPA1;PIN1;ZRSR2;MAGOH;IK;RBM22;LSM7;BUD31;LSM4;LSM2;HNRNPF;PUF60;SCAF11;U2AF1;CTNNBL1;PABPC1;HNRNPK;SNRNP200;SNRPD1;DDX20;SDE2;MAGOHB;SRSF3;GEMIN7;RBMX2;LSM8;TXNL4A;SNRPE;SYF2;RBM19;U2AF1L4;HNRNPC;PHF5A;RALY;GEMIN6;CLNS1A;SF3B6;PRMT7;SNIP1;RBM4B;U2AF2;SNRPN;CDC40;PRPF19;SLU7;PQBP1;FRA10AC1;LSM5;DDX1;DDX39B;CWC15;SART1;NCBP2;SNRPB;PPIE;HNRNPH3;HNRNPA3;PRPF38A;BCAS2;HTATSF1;TGS1;RSRC1;GPKOW;CWF19L1;USP39;STRAP
gsea,Cellular Response To Heat (GO:0034605),-0.5871986668877669,-1.8771883340695488,0.005836575875486381,0.017766298143593748,0.656,16/28,23.64%,HSP90AB1;HSBP1;HSP90AA1;YWHAE;PDCD6;HIKESHI;IER5;RBBP7;STUB1;ZFAND1;SLU7;VCP;PRKACA;DAXX;HTRA2;SUMO1
gsea,Negative Regulation Of Protein Dephosphorylation (GO:0035308),-0.6204346002595907,-1.8769054824893312,0.0,0.017593552953164626,0.656,8/19,12.17%,FKBP1A;YWHAB;YWHAE;ENSA;BOD1;PPP1R11;GSK3B;PPP1R1B
gsea,Regulation Of Protein Ubiquitination (GO:0031396),-0.4346734671372943,-1.8765837879171938,0.0,0.017436562919882465,0.658,41/100,24.69%,HSP90AB1;UBB;FKBP1A;HSP90AA1;RPS3;UBE3A;PARK7;DNAJA1;NDFIP1;SPRY2;SQSTM1;CENPX;NSMCE3;VPS28;UBE2N;PINK1;UBXN1;BAG5;STUB1;TSPYL5;GSK3B;NDFIP2;DNAJB2;IVNS1ABP;LAPTM5;SMAD7;COMMD1;BCL10;TBC1D7;U2AF2;SOX4;FBXW7;FAM107A;PHF23;UBQLN1;DAXX;SUMO1;DERL1;GTPBP4;SEPTIN4;AKT1
gsea,Monoatomic Anion Transmembrane Transport (GO:0098656),0.5189704408866126,1.8763347021055907,0.0,0.04849923750518261,0.629,13/38,13.44%,GABRA2;GABRG3;ANO4;ANO3;ANO6;SLC6A1;ANO2;SLC1A1;GABRB1;ANO10;LRRC8C;LRRC8D;SLC5A6
gsea,'De Novo' Post-Translational Protein Folding (GO:0051084),-0.5630247729578903,-1.8753278827725033,0.006085192697768763,0.017572432241336096,0.661,11/27,16.80%,HSPA8;SELENOF;CCT2;HSPA2;ST13;PTGES3;HSPE1;DNAJC18;CHCHD4;HSPA9;SDF2
gsea,Regulation Of Potassium Ion Transmembrane Transporter Activity (GO:1901016),-0.5698027682970503,-1.873816594299393,0.0,0.017705556728012887,0.666,4/22,5.02%,ATP1B1;VAMP2;YWHAE;ATP1B2
gsea,U2-type Prespliceosome Assembly (GO:1903241),-0.5782068404210348,-1.87376990351763,0.003898635477582846,0.017528501160732755,0.666,14/23,26.45%,SNRPG;SNRPF;SNRPD2;SF3B2;SF3B4;SNRPD1;RBMX2;SNRPE;PHF5A;SF3B6;SNIP1;SNRPB;HTATSF1;SNRPB2
gsea,Anterograde Trans-Synaptic Signaling (GO:0098916),0.39774564454308886,1.8715960701516856,0.0,0.04879062922294987,0.647,30/140,9.33%,GRIK4;DLGAP1;GRIN2A;NLGN1;CACNA1E;GRIA1;GRIN1;CACNA1A;ASIC2;CACNB2;RPS6KA2;GABBR2;AMPH;CACNA1B;CHRNA4;UNC13B;PDE7B;CHRM3;KCNQ2;SLC6A1;SPG11;GRIK2;KCNQ3;SYN2;GRM7;HTR2C;GRIK1;SLC1A1;GABRB1;KCNMB4
gsea,Amyloid Precursor Protein Metabolic Process (GO:0042982),-0.6570741261224372,-1.8686284462796792,0.004219409282700422,0.01824494916450985,0.682,4/15,7.69%,APOE;NSG1;PSENEN;APH1A
gsea,Positive Regulation Of Protein-Containing Complex Assembly (GO:0031334),-0.46088188008354386,-1.8663245344189119,0.0,0.01836756492193954,0.686,17/67,11.74%,RACK1;USP50;HSP90AA1;RPS3;PARK7;BRK1;BAX;PPP2CA;PRKD1;SH3GLB1;SNCA;CLU;PSMC6;MTLN;STUB1;TERF1;GSK3B
gsea,Regulation Of Cardiac Muscle Contraction (GO:0055117),-0.585074339187181,-1.86028951811616,0.0,0.019532762387751017,0.706,5/22,2.88%,CALM1;ATP1B1;CALM2;CALM3;RGS2
gsea,Embryonic Skeletal System Development (GO:0048706),0.6377957041640385,1.856419218363011,0.002070393374741201,0.05581433518801188,0.705,5/16,10.33%,DSCAML1;PCSK5;XYLT1;NOG;DEAF1
gsea,Response To Reactive Oxygen Species (GO:0000302),-0.4653756850274931,-1.856038337300272,0.0,0.020277508025528457,0.717,11/54,7.87%,MT3;APOE;JUN;RPS3;PRDX5;SQSTM1;SOD1;GSTP1;TPM1;MPV17;ROMO1
gsea,Chaperone-Mediated Protein Complex Assembly (GO:0051131),-0.6127495682812985,-1.8557795856894337,0.003898635477582846,0.0201519751793271,0.718,11/19,24.53%,HSP90AB1;HSP90AA1;CCT2;PTGES3;PFDN6;CLU;HSPD1;HOPX;PSMG2;LONP1;BBS10
gsea,Positive Regulation Of Release Of Sequestered Calcium Ion Into Cytosol (GO:0051281),-0.6201643246978159,-1.8557454376594869,0.002004008016032064,0.019961862205937222,0.718,9/19,19.60%,CALM1;CALM2;CALM3;SNCA;CX3CL1;APEX1;GSTO1;CAPN3;THY1
gsea,Ribosomal Large Subunit Assembly (GO:0000027),-0.6081770583163059,-1.85555047796714,0.00202020202020202,0.01981951806802744,0.718,9/20,14.84%,RPL6;RPL5;RPL11;RPL23A;RPL10;RPF2;RPLP0;MRPL20;NOP53
gsea,Tail-Anchored Membrane Protein Insertion Into ER Membrane (GO:0071816),-0.6514725317077671,-1.8522222285917471,0.0038461538461538464,0.020457365027395903,0.732,6/15,12.87%,EMC10;EMC3;EMC9;EMC8;EMC6;EMC4
gsea,Homotypic Cell-Cell Adhesion (GO:0034109),-0.5482812439059932,-1.8492713285837277,0.0,0.02086648821459291,0.736,15/30,21.45%,PPIA;GNAS;ACTG1;RAP2B;P2RY12;FIBP;VCL;ILK;MYL9;CSRP1;PLPP3;UBASH3B;TLN1;MYL12A;MEGF10
gsea,Negative Regulation Of Cytokine Production (GO:0001818),-0.43814395762582414,-1.8463118934068363,0.0,0.02131118224792806,0.745,24/90,18.58%,HMGB1;TMSB4X;PRNP;RAC1;APLP2;NAV3;BANF1;RBX1;TRIB2;ATG12;INHBA;CUEDC2;AXL;C1QBP;PPP1R11;CX3CL1;ATP2B1;EZR;LAPTM5;SYT11;NLRC3;CHID1;TRAF3IP1;SSC5D
gsea,Regulation Of Protein Kinase B Signaling (GO:0051896),-0.436560964889236,-1.8428812554255822,0.0018726591760299626,0.02171589729339057,0.751,26/86,15.03%,HSP90AB1;RACK1;HSP90AA1;PARK7;SPRY2;SEMA5A;P2RY12;PDCD6;IL18;PPP2CA;PPP2R1A;PDGFA;PINK1;FGFR1;RTN4;BANK1;AXL;C1QBP;CX3CL1;TSPYL5;TEK;MTDH;RASD2;MYDGF;NOP53;MUL1
gsea,Regulation Of Cell Death (GO:0010941),-0.504232215049136,-1.8409149166179954,0.0,0.021933859233927325,0.758,17/41,21.49%,PARK7;SNCB;BNIP3L;SNCA;CLU;CHMP2A;CHMP6;CRYAB;VPS4A;WNT16;CHMP4C;ZDHHC17;VPS35;CHMP7;TMEM109;TBK1;CIDEB
gsea,Calcium Ion Transport (GO:0006816),0.43071667033940825,1.8376164700766877,0.0,0.06641175883876164,0.767,29/79,12.72%,RYR2;CACNA1C;CACNA1A;CACNB2;SLC8A1;ATP2B4;PKD1;CHRNA4;ANO6;RYR3;TRPC5;CAMK2A;SLC24A2;SLC24A3;TRPM7;TRPM3;TRPC6;MICU1;CACNG3;TRPC3;SLC24A4;PKD2;CHRNA7;CACNA1H;FYN;ORAI1;GAS6;TRPC1;TRPC4AP
gsea,"Positive Regulation Of Synaptic Transmission, Glutamatergic (GO:0051968)",0.6031536756671128,1.836058216103913,0.004073319755600814,0.06496481217048454,0.773,6/19,9.26%,GRIN2A;NLGN1;GRIN1;SHANK3;CACNG3;RELN
gsea,Regulation Of Release Of Sequestered Calcium Ion Into Cytosol (GO:0051279),-0.5347512757443482,-1.8353427681480463,0.0039603960396039604,0.023016716260286466,0.776,12/32,19.60%,CALM1;CALM2;CALM3;FKBP1A;JPH3;SNCA;CX3CL1;SRI;GSTO1;UBASH3B;CAPN3;THY1
gsea,Embryonic Limb Morphogenesis (GO:0030326),0.5725225200571743,1.8339756763322632,0.0099601593625498,0.0639658936103862,0.78,8/22,9.15%,CACNA1C;NIPBL;ECE1;HDAC1;FBXW4;WNT7A;INTU;NOG
gsea,Regulation Of Protein-Containing Complex Assembly (GO:0043254),-0.4234340528560939,-1.8241502184626561,0.0,0.02585471558855152,0.806,29/91,18.97%,RACK1;APOE;HSPA8;HSP90AA1;RPS3;PARK7;BRK1;CDC42;BAX;TFIP11;SH3GLB1;PINK1;HJURP;CLU;MTLN;ANKRA2;GFAP;ATF7IP;GSK3B;CRYAB;SAR1A;LCMT1;NOP53;HCK;HCFC1;TRAF3IP1;WARS1;SVIP;VCP
gsea,Protein-Containing Complex Disassembly (GO:0032984),-0.46500856412089864,-1.8238472718077585,0.0019342359767891683,0.02573274065842478,0.808,18/56,18.97%,RPL17;HSPA8;MAP1LC3B;PPP1CA;VTI1B;CHMP2A;TSG101;CHMP6;MAP1LC3A;GSK3B;PEX12;VPS4A;SNAP29;LAMP2;CHMP4C;NSF;CHMP7;VCP
gsea,Negative Regulation Of Cation Channel Activity (GO:2001258),-0.5972789828003372,-1.8231301810331761,0.005628517823639775,0.025755615624279245,0.81,9/21,12.60%,CALM2;CALM3;PPP3CA;FKBP1A;PPP3R1;PPP3CB;FMR1;EPO;SRI
gsea,Regulation Of Neurotransmitter Receptor Activity (GO:0099601),0.49569568611364045,1.8189383263672034,0.0041928721174004195,0.07218757552141256,0.813,17/37,18.71%,DLGAP2;DLGAP1;NLGN1;SHISA9;DAPK1;DLGAP3;SHANK1;CACNG3;RELN;DLG4;BEGAIN;SHISA7;DLGAP4;CACNG8;SHISA6;CAPN1;CACNG2
gsea,Protein Transmembrane Import Into Intracellular Organelle (GO:0044743),-0.5399899051030154,-1.8186036991741945,0.0019342359767891683,0.026869877899597255,0.822,12/30,16.24%,DNAJC19;ROMO1;PAM16;TOMM20;TIMM23;PEX12;CHCHD4;TIMM50;TIMM44;HSPD1;DNAJC15;GRPEL1
gsea,Intrinsic Apoptotic Signaling Pathway By P53 Class Mediator (GO:0072332),-0.5382208369895193,-1.81531684374985,0.00392156862745098,0.027654529325042698,0.829,8/26,17.54%,DDX5;SNW1;BOK;PML;RPS27L;CDIP1;HIPK1;TMEM109
gsea,Extracellular Structure Organization (GO:0043062),0.45185587056661947,1.8126641514095725,0.0,0.07423145731777372,0.832,29/60,21.96%,ADAMTS17;SMOC2;COL23A1;ADAMTS20;TGFBR1;COL11A1;NF1;ADAMTS3;COL19A1;ADAMTS18;COL16A1;COL15A1;MMP16;ECM2;COL5A1;COL5A2;RECK;COL4A1;ADAMTS2;ADAMTS16;MATN4;ST7;COL9A2;NDNF;MMP24;COL4A2;PXDN;COL13A1;ADAMTS13
gsea,Regulation Of Dendrite Development (GO:0050773),0.533311849976345,1.8124090087056535,0.0073937153419593345,0.07194066722894717,0.832,14/33,15.73%,HECW1;KNDC1;CSMD3;PACSIN1;LRP8;DCC;SEMA4D;LZTS1;MARK1;BCL11A;ALK;TNIK;DAB2IP;NEDD4L
gsea,Regulation Of Translation (GO:0006417),-0.3814709148932483,-1.8094988411018613,0.0,0.029231065170684082,0.849,34/176,11.19%,GAPDH;EIF1;ENC1;RACK1;RPL5;RPS3;RPS4X;RPL13A;CALR;EIF1B;SERBP1;IGF2BP3;EIF3C;EIF4A2;RPL26;MTPN;EEF2;EIF3H;EIF4H;TOB1;BTG2;NOLC1;EIF5B;RPL10;NCL;NPM1;EIF6;DHFR;YBX1;CIRBP;BZW1;EIF5;FMR1;RPS27L
gsea,Response To Nutrient Levels (GO:0031667),0.5724144994691365,1.8086377207199298,0.00796812749003984,0.07220577494378519,0.84,7/22,10.86%,FLNB;PRKAG2;RPTOR;OTUD3;RICTOR;PPARD;MTOR
gsea,Regulation Of Cellular Localization (GO:0060341),-0.4627549449479827,-1.8083472313017077,0.0,0.029352157251834318,0.852,10/47,10.36%,HSP90AB1;RACK1;FKBP1A;HSP90AA1;REEP5;DNAJB6;CSNK1E;RAB14;MMD;PARP1
gsea,Positive Regulation Of Protein Ubiquitination (GO:0031398),-0.4384181013229323,-1.806782150875139,0.0,0.02948102268587791,0.856,31/73,24.60%,UBB;RPS2;FKBP1A;UBE3A;NDFIP1;PDCD6;CENPX;NSMCE3;PIN1;RBX1;UBE2N;PINK1;STUB1;TSPYL5;GSK3B;NDFIP2;ARRDC4;LAPTM5;SMAD7;COMMD1;BCL10;TBC1D7;FBXW7;FAM107A;PHF23;UBQLN1;SUMO1;DERL1;PEF1;SEPTIN4;DCUN1D5
gsea,Axon Guidance (GO:0007411),0.40059636941100885,1.8038614660423151,0.0,0.07340528232743508,0.848,36/128,10.80%,CNTN5;DSCAML1;SLIT1;PLXNA4;KALRN;CNTN4;MYCBP2;TRIO;SEMA5B;CYFIP1;EPHA10;EPHB1;PLXNC1;NOTCH2;DSCAM;TNR;PLXNA2;LGI1;DCC;NFASC;NFIB;SOS1;SEMA4D;PTK2;EFNA1;PLXNA3;EPHB2;RELN;UNC5A;CNTN6;ALCAM;EFNB2;FYN;NEO1;EPHA6;SMO
gsea,Metallo-Sulfur Cluster Assembly (GO:0031163),-0.5585539004988853,-1.80358054521359,0.001941747572815534,0.02997286578124705,0.86,15/27,22.01%,BOLA2;CIAO2A;NFU1;BOLA1;ISCA2;GLRX5;FDX2;ISCA1;HSPA9;HSCB;NDUFAB1;FXN;BOLA3;IBA57;CIAO2B
gsea,Iron-Sulfur Cluster Assembly (GO:0016226),-0.5585539004988853,-1.80358054521359,0.001941747572815534,0.02997286578124705,0.86,15/27,22.01%,BOLA2;CIAO2A;NFU1;BOLA1;ISCA2;GLRX5;FDX2;ISCA1;HSPA9;HSCB;NDUFAB1;FXN;BOLA3;IBA57;CIAO2B
gsea,Negative Regulation Of Peptidase Activity (GO:0010466),-0.5691068106886068,-1.8030161658511474,0.0,0.029940993613436575,0.867,8/23,10.64%,GAPDH;CST3;PARK7;TIMP3;CTSB;VTN;UBXN1;CSTB
gsea,Positive Regulation Of Peptidyl-Threonine Phosphorylation (GO:0010800),-0.6342116798748743,-1.798502600827301,0.00199203187250996,0.030912611763624243,0.872,3/15,0.25%,CALM1;CALM2;CALM3
gsea,Intermediate Filament Organization (GO:0045109),-0.5957193289694414,-1.797594347882692,0.005671077504725898,0.030939496083036203,0.873,6/17,13.98%,NEFL;INA;DNAJB6;KRT10;GFAP;TCHH
gsea,Regulation Of GTPase Activity (GO:0043087),0.3877599493503657,1.7938770088264298,0.0,0.07841351125116944,0.868,53/155,14.38%,PRKG1;PLXNA4;DOCK9;DOCK10;DOCK11;FGD4;ARHGAP15;PLXNC1;DOCK7;NF1;RALGPS1;PKP4;MAP4K4;RGL1;PLXNA2;OCRL;BCAS3;SH3BP1;RGS8;RAPGEF4;ARFGEF1;RASGRF2;GMIP;BVES;NTRK2;SOS1;RGS11;SEMA4D;RAP1GDS1;SNX13;RGS7;RAPGEFL1;PTK2;WNK1;RRP1B;RASGEF1B;PREX2;PLXNA3;SRGAP3;RAPGEF6;RALGPS2;FGD1;ARHGEF7;RASGRF1;RSU1;ARAP1;RAB3GAP2;CHN2;TBC1D30;EVI5;EPHA3;SIPA1L1;DAB2IP
gsea,Monoatomic Ion Transport (GO:0006811),0.4261803251871005,1.7928661901230607,0.0,0.07711523626635153,0.869,29/72,17.70%,GRIN1;SLC8A1;CHRNA4;ANO6;TMEM63C;SLC9A7;SLC24A2;SLC24A3;TRPM3;TRPC6;ATP10D;SLC24A4;WNK1;SLC9A5;CHRNA7;SLC1A1;GABRB1;ANO10;SLC25A22;SLC26A4;SLC15A4;SLC9A1;SLC25A10;SLC17A5;SLC20A1;SLC26A11;PIEZO2;SLC9A9;SLC8A3
gsea,"Maturation Of SSU-rRNA From Tricistronic rRNA Transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.5232340795258225,-1.7918560115736648,0.00196078431372549,0.0323815436343034,0.884,7/28,13.63%,RPS8;RPS21;RPS16;RPS14;UTP3;TSR2;RPS19
gsea,Regulation Of Hydrolase Activity (GO:0051336),0.44355852848518496,1.7903842984486418,0.0,0.07711778941283101,0.873,22/57,14.38%,PRKG1;PLXNA4;FGD4;ARHGAP15;PLXNC1;NF1;CAMK2A;PLXNA2;OCRL;NOS1;BVES;NTRK2;PTK2;PLXNA3;RAPGEF6;WRN;FGD1;RAB3GAP2;CHN2;EPHA3;SIPA1L1;DAB2IP
gsea,Kidney Development (GO:0001822),0.4741635204403098,1.7881473637171212,0.0,0.07679416084556663,0.876,10/43,8.45%,GREB1L;PCSK5;PKD1;FGF10;TGFBR1;NF1;NIPBL;IFT88;ITGA8;NPHP3
gsea,Response To Unfolded Protein (GO:0006986),-0.5052392921494506,-1.7873285168453397,0.005905511811023622,0.03351460953840761,0.887,12/37,14.55%,HSP90AB1;HSPA8;HSP90AA1;DNAJA1;HSPA2;BAX;TMBIM6;HSPE1;DNAJC4;HSPH1;DNAJB2;HSPD1
gsea,Telomere Maintenance Via Telomere Lengthening (GO:0010833),-0.5824423390346775,-1.7857157415486644,0.0019342359767891683,0.033713240418884155,0.888,7/21,14.73%,HSP90AB1;HSP90AA1;NOP10;PTGES3;TERF1;DKC1;NHP2
gsea,Negative Regulation Of Apoptotic Signaling Pathway (GO:2001234),-0.43422270865623797,-1.7854972701942162,0.00196078431372549,0.033481202258640375,0.888,30/67,27.28%,SLC25A4;GHITM;PARK7;FAIM2;SLC25A5;GRINA;BDNF;NDUFA13;GSTP1;TRIAP1;PINK1;TMBIM6;ITGAV;CLU;TMEM14A;CX3CL1;PSME3;NR4A2;PRELID1;FXN;SLC35F6;NOL3;CFLAR;AKT1;MPV17L;CSNK2A1;RELA;TMBIM1;PSMD10;ITGA6
gsea,Positive Regulation Of Protein Binding (GO:0032092),-0.4644888259588714,-1.785040084986243,0.0,0.03332493627564597,0.888,13/47,12.31%,APOE;RPL11;FKBP1A;RAN;SUB1;BDNF;PPP2CA;PIN1;VTN;ADD2;BAMBI;GSK3B;HIP1R
gsea,Epithelial Cell Differentiation (GO:0030855),-0.45799520317172787,-1.784985855378733,0.0018214936247723133,0.03309935554315769,0.889,15/56,15.26%,BASP1;PTER;FGFR2;VDAC1;KRT10;ALDOC;HSF4;CTSB;TST;PGK1;PCNA;TAGLN2;MAF;JAG1;CBR1
gsea,Autophagosome Maturation (GO:0097352),-0.5013198692867573,-1.7840270551778241,0.002004008016032064,0.03308170442194852,0.889,13/39,18.97%,CALM1;MAP1LC3B;VTI1B;CHMP2A;TSG101;CHMP6;MAP1LC3A;VPS4A;SNAP29;LAMP2;CHMP4C;CHMP7;VCP
gsea,Glycolytic Process (GO:0006096),-0.601320691127757,-1.7824255634601232,0.0038095238095238095,0.03332028716829121,0.891,13/21,19.56%,GAPDH;PGAM1;PKM;ALDOC;TPI1;PGK1;ENO2;LDHA;PGAM2;PFKL;ENO1;HK1;UCP2
gsea,Translational Elongation (GO:0006414),-0.4780936977783277,-1.7799458944708382,0.00196078431372549,0.0338444544329038,0.898,9/38,7.96%,EEF1A1;RACK1;EIF5A;EEF1G;EEF1B2;EEF1A2;EEF2;MRPL44;MTRFR
gsea,RNA 3'-End Processing (GO:0031123),0.48606428736646173,1.7789678197685221,0.008385744234800839,0.08182095398030258,0.89,19/35,25.15%,LIN28B;INTS6L;INTS2;TUT4;NCBP1;CPSF7;INTS6;RPRD2;PAPOLA;TENT4B;RPRD1A;NUDT21;SUPV3L1;CSTF3;INTS7;TENT4A;RPRD1B;PNPT1;INTS14
gsea,Regulation Of Synapse Assembly (GO:0051963),0.47898808143417687,1.7787567697599587,0.001949317738791423,0.0798054670721961,0.89,14/43,8.62%,CLSTN2;NLGN1;SLIT1;MYCBP2;IL1RAPL2;EPHB1;PTPRD;DLG5;SETD5;CUX2;MDGA1;GRID2;WNT7A;EPHB2
gsea,Pyruvate Metabolic Process (GO:0006090),-0.5228654076490717,-1.7771014698081833,0.0019305019305019305,0.03462181626621274,0.903,13/35,11.29%,GAPDH;PGAM1;PKM;VDAC1;ALDOC;TPI1;PGK1;ENO2;DLAT;LDHA;LDHB;PGAM2;PFKL
gsea,Gluconeogenesis (GO:0006094),-0.537965588084008,-1.7767716235252906,0.0036363636363636364,0.034515868101209435,0.903,8/24,10.62%,MDH2;PGAM1;MDH1;TPI1;PGK1;ENO2;G6PC3;PGAM2
gsea,Regulation Of Mitochondrial Membrane Potential (GO:0051881),-0.5338206651594976,-1.7767562531139882,0.00199203187250996,0.03428289456224991,0.903,9/29,9.61%,UBB;PARK7;ARL6IP5;BAX;SOD1;PINK1;TUSC2;BAD;MTLN
gsea,Positive Regulation Of Translation (GO:0045727),-0.4154490261357313,-1.7693496851473527,0.0,0.03659748322426023,0.914,24/90,17.99%,RPL5;RPS4X;PKM;UQCC2;EIF5A;CNBP;EIF3C;RPL26;COA3;EEF2;POLR2G;NPM1;EIF6;YBX1;CIRBP;C1QBP;PABPC1;FMR1;RPS27L;POLDIP3;UPF3A;EIF2B5;SOX4;EIF3D
gsea,Positive Regulation Of Synaptic Transmission (GO:0050806),0.4333451577412936,1.7690515046296804,0.0,0.08494797052210021,0.904,20/63,12.64%,CLSTN2;GRIN2A;NLGN1;SHANK2;GRIN1;ADCY8;GRIK2;SLC24A2;SHANK3;LGI1;RIMS1;CACNG3;CHRNA7;ZDHHC2;EPHB2;RELN;DLG4;SYT1;RIMS2;SHISA7
gsea,Positive Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0030511),-0.6067650966790203,-1.7689894407213371,0.0057361376673040155,0.03617903040085775,0.914,4/17,6.60%,HSP90AB1;SNW1;ZEB2;CITED2
gsea,Positive Regulation Of Cellular Response To Transforming Growth Factor Beta Stimulus (GO:1903846),-0.6067650966790203,-1.7689894407213371,0.0057361376673040155,0.03617903040085775,0.914,4/17,6.60%,HSP90AB1;SNW1;ZEB2;CITED2
gsea,Neuron Projection Guidance (GO:0097485),0.40279405013673364,1.7667805302199286,0.0,0.0847787856479185,0.906,29/107,10.75%,CNTN5;DSCAML1;SLIT1;KALRN;CNTN4;MYCBP2;TRIO;SEMA5B;CYFIP1;EPHA10;EPHB1;NOTCH2;DSCAM;TNR;LGI1;DCC;NFASC;SOS1;SEMA4D;PTK2;EFNA1;PLXNA3;EPHB2;RELN;CNTN6;EFNB2;FYN;NEO1;EPHA6
gsea,Renal System Development (GO:0072001),0.4907709227819055,1.7666546027524506,0.0022172949002217295,0.08285598612547256,0.907,10/34,15.18%,GREB1L;PCSK5;PKD1;TGFBR1;IFT88;ITGA8;NPHP3;ARL3;PROX1;PYGO2
gsea,Regulation Of Apoptotic Process (GO:0042981),-0.34235104546631717,-1.765574804335394,0.0,0.03714865483305207,0.921,113/481,16.57%,UBB;ACTB;MT3;HMGB1;PPIA;PTMS;RACK1;TPT1;PTMA;OLFM1;HSP90AA1;JUN;RPS6;ARL6IP1;ANP32A;RPS3;CFL1;PARK7;MORF4L1;CALR;PRDX5;FAIM2;ARHGDIA;DNAJA1;MLLT11;VDAC1;NME2;MAGED1;ARL6IP5;HIGD2A;ARF4;BNIP3L;MORF4L2;SPRY2;MEF2C;SQSTM1;PLK5;PLK2;BAX;SOD1;TRIM35;CTSB;SAP18;GSTP1;YWHAZ;TRIAP1;GLO1;EGR1;IER3IP1;USP27X;MTCH1;BEX1;ANP32B;CITED2;MTCH2;HIGD1A;WDR73;RPL10;SNCA;BOK;BAG1;PINK1;TMBIM6;CLU;BAD;RTN4;NPM1;TMEM14A;ANP32E;DNAJA3;AXL;C1QBP;RASA1;HMGN5;BAG4;CTNNBL1;SOX9;HNRNPK;RUVBL1;CX3CL1;CLIP3;MRGBP;TRIM24;DDX20;XBP1;GSK3B;CRYAB;TEK;HIP1R;MTDH;BABAM2;PIK3R1;LSM8;MYDGF;UBE2Z;UTP11;NME1;RHOB;LCMT1;PIM3;HSPD1;NOP53;ATP13A2;POU3F3;EGR3;PRELID1;BCL10;AKT1S1;CBX4;HSPA9;HCK;APEX1;CTSH
gsea,Limb Development (GO:0060173),0.5613862107959627,1.76423444398398,0.0044444444444444444,0.08279943096217701,0.913,9/22,19.60%,PCSK5;FGF10;ZNRF3;INTU;NOG;CIBAR1;LNPK;IQCE;MEGF8
gsea,Protein-Containing Complex Assembly (GO:0065003),-0.355435862793963,-1.76304340159429,0.0,0.03786485769270149,0.924,64/252,17.55%,HSP90AB1;CALY;VAMP2;RPL38;FKBP1A;HSP90AA1;NSG1;NSG2;ELOB;RAB5IF;CLTA;CAPZA2;COX7A2L;CHCHD10;HIGD2A;STXBP6;AP2M1;COX7A2;NCK1;WASL;CCT2;PDCD6;GPX4;TMED2;PTGES3;PPP2R1A;HIGD1A;SNCA;BOK;TRAPPC2L;PFDN6;NAPG;TBCC;CLU;BAD;TRAPPC2;PML;ADRM1;PDCL;CSNK2B;PFDN5;CHMP2A;ADD2;SOX9;CX3CL1;TBCA;TRAPPC1;HIP1R;SRP19;CENPW;TMED10;VBP1;SAMM50;CHCHD4;HSPD1;GTF2B;SMAD2;VAMP3;HOPX;TMEM70;NIFK;CD247;AP2S1;SRPRB
gsea,Positive Regulation Of Signaling (GO:0023056),0.5015639343015359,1.7613275324778435,0.008456659619450317,0.08301961960438499,0.915,11/28,12.04%,CLSTN2;GRIK2;OCRL;ECE1;LGI1;RIMS1;BVES;PTPN23;DLG4;SYT1;RIMS2
gsea,Intracellular Monoatomic Cation Homeostasis (GO:0030003),-0.39200529061367695,-1.7599896260518935,0.0,0.038718958273211035,0.929,16/119,5.02%,FTH1;ATP1B1;MT3;TPT1;PRNP;ATP6V1A;ATP1A1;CALR;ARF1;ATP1A3;SLC22A17;NDFIP1;BOLA2;KCNJ2;SOD1;ATP1B2
gsea,Positive Regulation Of Chemokine Production (GO:0032722),-0.6064108003488918,-1.759346625452678,0.0036101083032490976,0.03872111080552766,0.929,3/18,5.58%,HMGB1;IL18;EGR1
gsea,Regulation Of Cytokinesis (GO:0032465),-0.4544259170367134,-1.7552408394201258,0.001996007984031936,0.04012472327709193,0.941,10/54,7.40%,CALM1;CALM2;CALM3;CDC42;CETN2;KLHL9;SH3GLB1;PIN1;PDXP;RAB11A
gsea,Regulation Of Intracellular Steroid Hormone Receptor Signaling Pathway (GO:0033143),-0.5635754576787357,-1.7535689528745577,0.002066115702479339,0.04054372072531712,0.943,3/20,6.95%,DDX5;PARK7;RNF6
gsea,External Encapsulating Structure Organization (GO:0045229),0.4392269175768516,1.7530451720868583,0.0,0.08826993323521956,0.925,28/58,21.96%,ADAMTS17;SMOC2;COL23A1;ADAMTS20;COL11A1;NF1;ADAMTS3;COL19A1;ADAMTS18;COL16A1;COL15A1;MMP16;ECM2;COL5A1;COL5A2;RECK;COL4A1;ADAMTS2;ADAMTS16;MATN4;ST7;COL9A2;NDNF;MMP24;COL4A2;PXDN;COL13A1;ADAMTS13
gsea,Hexose Biosynthetic Process (GO:0019319),-0.5163120141721915,-1.7499932412089063,0.005545286506469501,0.04179617621851056,0.947,8/27,10.62%,MDH2;PGAM1;MDH1;TPI1;PGK1;ENO2;G6PC3;PGAM2
gsea,Receptor Signaling Pathway Via JAK-STAT (GO:0007259),0.5592022591543272,1.7484044150329128,0.00819672131147541,0.08998759028088496,0.931,8/20,16.13%,PKD1;IL31RA;JAK2;PKD2;STAT2;PIAS1;CSF2RA;FER
gsea,Diacylglycerol Metabolic Process (GO:0046339),0.5585751313860963,1.7463466234542526,0.0041753653444676405,0.08944188179156849,0.933,11/19,18.12%,DGKG;DGKH;DGKQ;DGKB;DGKI;PLCE1;PNPLA2;DGAT1;PGS1;DGKA;DAGLA
gsea,Defense Response To Gram-positive Bacterium (GO:0050830),-0.615312176096382,-1.745699730063248,0.007352941176470588,0.04308738612814961,0.952,6/15,12.60%,FAU;RPL39;IL18;ROMO1;PPP1R11;CHGA
gsea,Positive Regulation Of Cellular Component Biogenesis (GO:0044089),-0.4208551219913487,-1.740294811856755,0.0074487895716946,0.04503949556010144,0.954,20/67,18.97%,RACK1;PFN2;RPS3;PARK7;BRK1;BAX;SH3GLB1;PFN1;CLU;MTLN;CHMP2A;TSG101;CX3CL1;GSK3B;CHGA;VPS4A;ATP13A2;WARS1;SYNPO;VCP
gsea,Positive Regulation Of Cell Junction Assembly (GO:1901890),0.4591062143710642,1.7373464798051335,0.004016064257028112,0.09565443071216374,0.947,15/46,9.00%,CLSTN2;NLGN1;EPHB1;NRG1;ROCK1;PTPRD;CNTNAP2;MAP4K4;DLG5;CUX2;GRID2;COL16A1;WNT7A;EPHB2;NPHP4
gsea,post-Golgi Vesicle-Mediated Transport (GO:0006892),0.4308981427063352,1.7366352256035653,0.003929273084479371,0.09427675743102401,0.948,18/56,13.10%,VPS13A;VPS13C;MYO1B;MON2;DOP1B;GBF1;SEC16A;EXOC6B;VPS35L;CCDC93;VPS54;DNM2;AP1G2;ARL3;VTI1A;KLHL20;MYO5A;GGA3
gsea,RNA-mediated Gene Silencing (GO:0031047),0.550424109329997,1.7360787941176006,0.006072874493927126,0.09290593661266762,0.948,10/20,18.72%,MOV10;DICER1;CELF1;AGO4;AGO1;TNRC6B;FAM172A;DHX9;TARBP2;HELZ
gsea,rRNA Modification (GO:0000154),-0.5939587257015101,-1.7359236828043407,0.0018083182640144665,0.04674642952840402,0.955,9/17,28.14%,TRMT112;NOP10;FBLL1;DKC1;NHP2;TFB2M;TSR3;FBL;MRM1
gsea,Negative Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032435),-0.5163688293032279,-1.735504702333943,0.016245487364620937,0.046641201415864114,0.956,7/29,8.98%,HSP90AB1;RPL11;PARK7;MAP1A;EIF3H;USP14;UBXN1
gsea,Regulation Of Peptidyl-Threonine Phosphorylation (GO:0010799),-0.5229834680126288,-1.7334403613416038,0.008247422680412371,0.04714805490694833,0.958,4/26,3.46%,CALM1;CALM2;CALM3;SPRY2
gsea,Positive Regulation Of DNA Biosynthetic Process (GO:2000573),-0.4335525006568982,-1.7320302697783885,0.003669724770642202,0.04730271423705813,0.958,18/54,19.64%,HSP90AB1;HSP90AA1;CCT2;CCT6A;PTGES3;HNRNPA1;PCNA;GINS2;CCT7;DKC1;MAPK3;CCT5;CCT8;GINS4;MAPKAPK5;RFC3;PDGFB;MAPK1
gsea,Antimicrobial Humoral Response (GO:0019730),-0.5786941008260723,-1.7301936246192045,0.00749063670411985,0.047699560644177644,0.958,6/18,8.29%,GAPDH;FAU;RPL30;RPL39;ROMO1;HMGN2
gsea,Intracellular Protein Transmembrane Transport (GO:0065002),-0.4697563061699155,-1.7300728671283123,0.001941747572815534,0.04741653961176107,0.958,15/43,16.24%,SEC62;DNAJC19;ROMO1;PAM16;SEC61G;ZFAND2B;TOMM20;TIMM23;PEX12;CHCHD4;TIMM50;TIMM44;HSPD1;DNAJC15;GRPEL1
gsea,Positive Regulation Of Axonogenesis (GO:0050772),0.482963768013512,1.7299958797544512,0.0038240917782026767,0.0958623901248585,0.948,10/33,8.02%,PLXNA4;MACF1;PLXNC1;SHTN1;MAPT;PLXNA2;NTRK2;SEMA4D;PLXNA3;TIAM1
gsea,Actin Cytoskeleton Reorganization (GO:0031532),0.46234141467103135,1.729587477671069,0.004132231404958678,0.09435913848981947,0.948,21/42,20.48%,FGF10;MCU;FLNA;CDC42BPA;PARVB;RICTOR;PTK7;MYH9;EFS;THSD7B;TNIK;SIPA1L1;PHACTR1;MKLN1;FER;FARP2;ATP2C1;PARVA;AUTS2;DMTN;NEDD9
gsea,Maturation Of LSU-rRNA (GO:0000470),-0.5560336044340894,-1.7282707596345508,0.011472275334608031,0.04786787366671649,0.958,10/20,26.38%,RPL7;RPF2;ZNHIT3;EIF6;RPL35;NIFK;PES1;LAS1L;DDX18;NSA2
gsea,Negative Regulation Of Kinase Activity (GO:0033673),-0.45114933358961234,-1.724370429771555,0.0057251908396946565,0.04929413730309076,0.963,23/51,24.81%,PPIA;CAMK2N1;YWHAG;PARK7;GSTP1;TRIB2;IRS2;SNCA;WWTR1;CAMK2N2;CDKN1B;AKT1S1;UBASH3B;WARS1;THY1;PPP2R5A;RTRAF;TAF7;DBNDD1;DUSP19;PAK2;DVL1;DBNDD2
gsea,mRNA Processing (GO:0006397),-0.35373129556804256,-1.7231882876995523,0.0,0.049489945688876595,0.966,79/201,25.08%,DDX5;HSPA8;ZMAT2;PRPF4B;SNRPG;SNW1;HNRNPA2B1;SNRPF;SNRPD2;SNRNP27;SF3B2;WBP4;SNU13;SF3B4;RAMAC;TFIP11;FRG1;RBM42;RBM8A;HNRNPA1;PIN1;ALKBH5;ZRSR2;MAGOH;IK;RBM22;LSM7;BUD31;LSM4;LSM2;HNRNPF;SCAF11;U2AF1;CTNNBL1;PABPC1;HNRNPK;SNRNP200;SNRPD1;MAGOHB;SRSF3;GEMIN7;RBMX2;LSM8;TXNL4A;SNRPE;SYF2;RBM19;MBLAC1;U2AF1L4;HNRNPC;PHF5A;RALY;GEMIN6;SF3B6;SNIP1;RBM4B;U2AF2;SNRPN;CDC40;PRPF19;SLU7;FRA10AC1;LSM5;DDX39B;CWC15;SART1;NCBP2;SNRPB;PPIE;HNRNPH3;PRKACA;HNRNPA3;PRPF38A;BCAS2;HTATSF1;RSRC1;GPKOW;CWF19L1;USP39
gsea,Negative Regulation Of Sequestering Of Calcium Ion (GO:0051283),0.5208153977152241,1.7208014495783643,0.00423728813559322,0.09996869126709321,0.952,9/26,11.53%,RYR2;FLNA;LCK;HTR2C;PLCG2;PLCH1;PKD2;PLCE1;PLCG1
gsea,Modulation By Host Of Viral Process (GO:0044788),-0.5746246549146253,-1.7207337741346536,0.005703422053231939,0.05022294065705902,0.966,4/17,4.13%,CFL1;NUCKS1;CDC42;PPIB
gsea,Negative Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001243),-0.44630164676213674,-1.7199286332675852,0.005780346820809248,0.05022688931187914,0.966,19/50,24.69%,PPIA;TPT1;PARK7;DNAJA1;NDUFA13;PINK1;TMBIM6;CLU;BAG5;EPO;XBP1;TRIM32;ENO1;PTPN1;NOL3;CXCL12;CCAR2;HTRA2;AKT1
gsea,Late Endosome To Vacuole Transport Via Multivesicular Body Sorting Pathway (GO:0032511),-0.5213233612645126,-1.7196495575862247,0.005964214711729622,0.05007746849497092,0.966,11/23,17.53%,LEPROT;VPS28;TSG101;CHMP6;LEPROTL1;TMEM50A;STAM2;UBAP1;TMEM50B;CHMP4C;CHMP7
gsea,Carbohydrate Catabolic Process (GO:0016052),-0.5408167559800998,-1.719463236110644,0.0038095238095238095,0.04986457530304575,0.966,13/28,19.56%,GAPDH;PGAM1;PKM;ALDOC;TPI1;PGK1;ENO2;LDHA;PGAM2;PFKL;ENO1;HK1;UCP2
gsea,Spliceosomal snRNP Assembly (GO:0000387),-0.48178697599736925,-1.7188535374218668,0.001851851851851852,0.04983457712907053,0.966,18/36,25.30%,SNRPG;SNRPF;SNRPD2;LSM4;LSM2;SNRPD1;DDX20;GEMIN7;SNRPE;HNRNPC;GEMIN6;CLNS1A;PRMT7;PRPF19;SART1;SNRPB;TGS1;STRAP
gsea,Positive Regulation Of Protein Catabolic Process (GO:0045732),-0.41655234084396325,-1.7170485938688402,0.0,0.05028521475587465,0.968,25/71,19.27%,APOE;HSP90AA1;PSMC3;CD81;OAZ1;PSMC2;PLK2;NDUFA13;PSMC5;VPS28;RBX1;PSMC6;FMR1;GSK3B;EZR;ASB5;CDKN1B;TRIM32;NSF;VPS35;ADAM9;RDX;VCP;FBXW7;TNFSF12
gsea,Dendritic Spine Organization (GO:0097061),0.5183194317231739,1.7167196342618056,0.01364522417153996,0.10163225086001525,0.959,14/25,10.85%,PAK3;DOCK10;EPHB1;CTNND2;SHANK3;SHANK1;DIP2A;ITGA3;CHRNA7;WNT7A;EPHB2;IGF1R;FYN;DLG4
gsea,Regulation Of Fibroblast Proliferation (GO:0048145),-0.50692621365888,-1.714952803852839,0.00196078431372549,0.05083729890486164,0.969,12/29,22.51%,FTH1;GSTP1;PDGFA;CDK4;EMD;NLRC3;TRIM32;MED9;PDGFB;CDC73;B4GALT7;CD300A
gsea,Receptor Signaling Pathway Via STAT (GO:0097696),0.5423166248934611,1.7132507814967055,0.01440329218106996,0.10301597888382073,0.962,9/20,21.41%,PKD1;IL31RA;JAK2;PKD2;STAT2;PIAS1;CSF2RA;THPO;GHR
gsea,Cognition (GO:0050890),0.4687386792519932,1.7106417866443853,0.008,0.10374710719385494,0.964,10/35,7.97%,CYFIP1;CHRNA4;NF1;DOP1B;NIPBL;SOBP;SETD5;CUX2;GPR155;CHRNA7
gsea,Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043281),-0.45284952499957026,-1.7090428244003686,0.0017985611510791368,0.053457912822618255,0.977,11/50,8.39%,HMGB1;EPHA7;ARL6IP1;DNAJB6;ARL6IP5;PDCD6;NDUFA13;CYCS;TRIAP1;SNCA;BAD
gsea,Regulation Of Proteasomal Protein Catabolic Process (GO:0061136),-0.44525203667736263,-1.7089406211057512,0.005813953488372093,0.053174912146959755,0.977,12/47,13.07%,HSP90AB1;UBB;APOE;PSMC3;PSMC2;GABARAPL2;USP14;PSMC5;PINK1;PSMC6;FMR1;PSME3
gsea,Regulation Of Release Of Cytochrome C From Mitochondria (GO:0090199),-0.5122383284549084,-1.7087856586695558,0.005545286506469501,0.05295124922426276,0.977,13/30,21.80%,GHITM;MLLT11;BAX;TRIAP1;PINK1;CLU;BAD;PRELID1;FAM162A;FXN;NOL3;CIDEB;BBC3
gsea,Negative Regulation Of Proteasomal Protein Catabolic Process (GO:1901799),-0.49325064867199203,-1.7080929353908922,0.005434782608695652,0.05302938630114514,0.977,10/34,14.84%,HSP90AB1;RPL11;PARK7;MAP1A;EIF3H;GABARAPL2;UBXN1;BAG5;AQP11;NOP53
gsea,Regulation Of Sodium Ion Transport (GO:0002028),0.4999921240967307,1.7075368549666554,0.00796812749003984,0.10460778630970224,0.965,8/29,7.38%,NKAIN2;ANK3;SPTBN4;ATP2B4;NKAIN3;NOS1;WNK1;WNK3
gsea,Protein Import Into Mitochondrial Matrix (GO:0030150),-0.5967986177278259,-1.707456628837774,0.012145748987854251,0.05299594190462326,0.977,9/16,20.17%,DNAJC19;ROMO1;PAM16;TOMM20;TIMM23;TIMM50;TIMM44;GRPEL1;DNLZ
gsea,Negative Regulation Of Macromolecule Biosynthetic Process (GO:0010558),-0.40784271461155375,-1.7067950627885382,0.004073319755600814,0.05302477499388408,0.977,16/75,11.74%,GAPDH;ENC1;RACK1;RPS3;RPL13A;CALR;SERBP1;IGF2BP3;TOB1;GSTP1;BTG2;NCL;DHFR;YBX1;FMR1;GSK3B
gsea,Regulation Of Telomerase RNA Localization To Cajal Body (GO:1904872),-0.5738147333577164,-1.7045401079111773,0.010683760683760684,0.053901033266721673,0.978,8/17,14.73%,CCT6A;NOP10;RUVBL1;CCT7;DKC1;CCT5;CCT8;NHP2
gsea,Positive Regulation Of Protein Metabolic Process (GO:0051247),-0.36545546247717753,-1.7028279596621287,0.0,0.054277801731293165,0.978,44/154,19.97%,RPL5;APOE;HSP90AA1;RPS4X;RASGRP1;EIF3C;RPL26;OAZ1;AURKAIP1;MTPN;EEF2;PLK2;NDUFA13;IL18;VPS28;RBX1;CLU;BAD;NPM1;RAB1B;EIF6;INHBA;CIRBP;STUB1;FMR1;RPS27L;GSK3B;EZR;POLDIP3;ASB5;ABCB10;UPF3A;CDKN1B;TRIM32;BCL10;NSF;VPS35;SOX4;EIF3D;RDX;VCP;TNFSF12;CAPN3;NFKBIA
gsea,Protein Transport (GO:0015031),-0.3480181567356035,-1.6994487759302828,0.0,0.05559647216047336,0.981,84/255,24.02%,RAB3A;APOE;VAMP2;YWHAH;DNAJC19;TMED9;ARF1;VPS29;ARL6IP5;STX7;ARF4;RAB6B;PDCD6;CANX;TMED2;RAMP2;ARL1;RAB14;RAB6A;ARF3;SYNDIG1;STX16;HIKESHI;NAPG;RAB24;ROMO1;PAM16;ARF5;CLU;NPM1;RAB1B;RAB22A;TMED4;SNX17;RAB18;TIMM23;CHMP2A;TMED7;RAB31;ARL5B;SAR1A;TMED10;SURF4;ARRDC4;ARL4C;COPG2;TIMM50;TIMM44;ERP29;COPG1;RAMP1;LAPTM5;SEC13;BBS2;RUFY1;COPB2;DNAJC15;RAB32;LAMP2;GRPEL1;HSPA9;NSF;LRP1B;ZDHHC17;VPS35;TMED1;SLU7;SYS1;SCAMP3;EHD1;SNX4;RAB5A;RAB11B;RAB5B;RAB5C;IL10RA;ARFRP1;MIA3;TVP23B;VPS26B;SNX33;RAB35;ARF6;TMED5
gsea,Negative Regulation Of Cell Death (GO:0060548),-0.44778054407748263,-1.6983480060192713,0.007326007326007326,0.0557846001009242,0.981,22/52,25.01%,MT3;PARK7;BNIP3L;PSMC5;SNCA;PINK1;CHMP2A;DPP8;CHMP6;CHGA;VPS4A;WNT16;ATP13A2;CHMP4C;VPS35;CHMP7;TMEM109;TRAF2;HTRA2;AKT1;NUP62;GPNMB
gsea,Positive Regulation Of Transport (GO:0051050),-0.462675675978702,-1.698033289860152,0.003787878787878788,0.05562980708734577,0.981,11/39,12.50%,ACTB;CALY;APOE;CHCHD10;SNCA;BOK;CLIP3;CEBPB;GSK3B;HIP1R;CD151
gsea,Positive Regulation Of Inflammatory Response (GO:0050729),-0.44637673444884024,-1.697603797421097,0.005758157389635317,0.055523266349407456,0.982,13/48,13.63%,CAMK2N1;CD81;CD47;IL18;NINJ1;GPRC5B;DDT;SNCA;PLA2G7;C2CD4B;CX3CL1;CEBPA;RPS19
gsea,Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032434),-0.39030958673864635,-1.6964811442651087,0.0038684719535783366,0.05576151105460073,0.982,25/97,15.65%,HSP90AB1;RACK1;RPL11;PARK7;SUMO2;ELOB;MAP1A;COP1;EIF3H;CSNK1E;GABARAP;RBX1;TRIB2;ZYG11B;CLU;UBXN1;BAG5;STUB1;GSK3B;CEBPA;DNAJB2;NOP53;DDA1;SMAD7;COMMD1
gsea,Regulation Of Calcium Ion Transmembrane Transporter Activity (GO:1901019),-0.5342231704364937,-1.6964149017039807,0.016293279022403257,0.0554780084345729,0.982,5/21,6.63%,CALM1;CALM2;FKBP1A;YWHAE;JPH3
gsea,Regulation Of Monoatomic Ion Transport (GO:0043269),-0.541089051984637,-1.6943984895456412,0.008016032064128256,0.05613861866219873,0.982,9/20,21.24%,KCNJ3;KCNJ2;KCNJ4;KCNJ13;KCNJ16;CLDN10;PDZK1;RAB11B;KCNJ12
gsea,Positive Regulation Of Endothelial Cell Proliferation (GO:0001938),-0.4311136157050391,-1.6931168712753157,0.005649717514124294,0.05648653145033039,0.982,20/53,21.64%,HMGB1;EMC10;SEMA5A;PDCD6;VEGFC;PRKD1;NELL2;FGFR1;VEGFB;TEK;MYDGF;NRARP;EGR3;SIRT6;BMPR2;EGFL7;PDGFB;TNFSF12;JCAD;NRAS
gsea,Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage By P53 Class Mediator (GO:0042771),-0.5700146806171716,-1.6924331652584481,0.014925373134328358,0.05645577813138375,0.982,7/15,22.42%,SNW1;PML;RPS27L;CDIP1;HIPK1;TMEM109;DDIT4
gsea,Memory (GO:0007613),-0.43750055646445274,-1.6902574799618686,0.0058823529411764705,0.05727386072805875,0.983,16/51,15.30%,CAMK2N1;PRNP;APOE;TAFA2;MAP1A;BDNF;ATAD1;CALB1;PLK2;FGF13;PPP3CB;EIF4EBP2;SLC8A2;LDLR;SYT11;PJA2
gsea,Secondary Alcohol Metabolic Process (GO:1902652),-0.49739422352556206,-1.687409613750836,0.0076481835564053535,0.058524236650745035,0.984,12/27,23.16%,APOE;IDH3B;LCAT;SQLE;IDH3A;PIP4P1;ANGPTL3;IDH3G;IDH2;FDX1;GBA2;OSBPL5
gsea,Chaperone Cofactor-Dependent Protein Refolding (GO:0051085),-0.5212332564991483,-1.6834299022641237,0.018218623481781375,0.060339829754252866,0.985,8/22,16.80%,HSPA8;HSPA2;ST13;PTGES3;HSPE1;DNAJC18;HSPA9;SDF2
gsea,Positive Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001238),-0.5774015987142711,-1.6817278427572104,0.01855287569573284,0.060883670777751385,0.987,11/16,35.94%,PML;INHBA;BCL10;TNFSF12;HYAL2;TRAF2;HTRA2;PAK2;DEDD2;CYLD;PPP2R1B
gsea,Regulation Of Small GTPase Mediated Signal Transduction (GO:0051056),0.3927287296553884,1.6800082251886805,0.004048582995951417,0.12977401446502118,0.986,36/95,20.04%,KALRN;TRIO;DOCK3;FGD4;ARHGEF28;ARHGAP15;MYO9A;MYO9B;ITSN1;BCR;SH3BP1;RASGRF2;GMIP;PREX2;SRGAP3;TIAM1;TNFRSF25;PLCE1;RELN;FGD1;ARHGAP18;ARHGEF17;RASGRF1;ARHGEF3;ARAP1;CHN2;ARHGAP31;RABL3;ARHGEF2;SPATA13;DNMBP;ARHGAP32;ARHGEF10L;STARD13;ARHGEF4;SYDE2
gsea,mRNA Destabilization (GO:0061157),0.4549383660746691,1.679035846944217,0.015625,0.12854227050821865,0.986,19/38,27.42%,MOV10;ROCK1;KHSRP;CELF1;TUT4;AGO4;TRIM71;CNOT1;GIGYF2;DIS3L2;FXR1;YTHDF3;FTO;DHX36;DCPS;RIDA;ROCK2;PDE12;RC3H1
gsea,Regulation Of Cilium Assembly (GO:1902017),0.4090236256379325,1.6761401031046748,0.004016064257028112,0.12902708706047128,0.986,25/63,19.66%,CROCC;MPHOSPH9;CCDC88A;IFT140;IFT88;LIMK2;SDCCAG8;ENTR1;CDKL1;TBC1D9B;INTU;DYNLT2B;ODF2L;HTT;TBC1D30;EVI5;RABEP2;TBC1D24;EVI5L;TBC1D17;CDK10;SGSM3;WDPCP;TBC1D2;MARK4
gsea,Negative Regulation Of Programmed Cell Death (GO:0043069),-0.34505487264647094,-1.6758970842112564,0.0018552875695732839,0.0634034781555491,0.988,68/257,19.48%,MT3;PTMS;TPT1;PTMA;ARL6IP1;CFL1;PRDX5;FAIM2;ARHGDIA;DNAJA1;VDAC1;NME2;HIGD2A;ARF4;BNIP3L;SPRY2;PLK2;GPX4;GSTP1;YWHAZ;TRIAP1;GLO1;PSMC5;CITED2;HIGD1A;WDR73;RPL10;SNCA;BAG1;TMBIM6;NPM1;TMEM14A;DNAJA3;AXL;RASA1;HMGN5;DPP8;BAG4;SOX9;HNRNPK;CX3CL1;XBP1;GSK3B;CRYAB;TEK;MTDH;BABAM2;PIK3R1;LSM8;MYDGF;UBE2Z;PIM3;HSPD1;LAPTM5;POU3F3;EGR3;PRELID1;CBX4;HSPA9;HCK;CTSH;ZFAND6;TMEM109;FXN;CD27;PHB2;ASCL1;CAPN3
gsea,Regulation Of Potassium Ion Transmembrane Transport (GO:1901379),0.4779657010002476,1.6758890980657424,0.01875,0.12721512737495314,0.986,7/27,8.44%,DPP6;DPP10;BIN1;KCNAB1;NOS1AP;FLNA;KCNAB2
gsea,Acylglycerol Metabolic Process (GO:0006639),0.4905884512636746,1.675854963412877,0.012738853503184714,0.1251762421131158,0.986,14/27,17.33%,DGKG;GCK;DGKH;DGKQ;DGKB;DGKI;LMF1;PNPLA2;DGAT1;GK5;PGS1;LYPLA2;MGLL;DGKA
gsea,Organelle Membrane Fusion (GO:0090174),-0.5332866471662339,-1.6745276818942147,0.008,0.06386277458078164,0.988,7/19,15.69%,VAMP2;STX7;STX16;VCPIP1;GOSR1;SYT11;VAMP3
gsea,Skeletal Muscle Tissue Development (GO:0007519),-0.5187258614095126,-1.6739654228135492,0.00945179584120983,0.06386903256947157,0.988,6/23,5.45%,PPP3CA;MYL6;ZBTB18;MEF2C;IGSF8;PPP3CB
gsea,Positive Regulation Of Mitochondrion Organization (GO:0010822),-0.4507880553312599,-1.6725814616000776,0.003875968992248062,0.06429631231033774,0.988,18/46,23.43%,PARK7;MLLT11;CHCHD10;BAX;BOK;PINK1;BAD;RALA;GSK3B;HIP1R;SPIRE1;MUL1;FAM162A;VPS35;FIS1;CIDEB;BBC3;HTRA2
gsea,Regulation Of Calcium Ion Transport (GO:0051924),0.457115025111888,1.6724572584294886,0.006060606060606061,0.12685308283319016,0.986,14/37,17.30%,CACNB2;CAMK2A;PLPP4;NOS1;TRPC6;CAMK2G;WNK3;PKD2;ORAI1;ANK2;INPP5K;IL16;EGF;CRACR2A
gsea,Extracellular Matrix Organization (GO:0030198),0.38231741332735314,1.672229598894203,0.0,0.12519772637746812,0.987,42/94,24.56%,ADAMTS17;SMOC2;COL23A1;ADAMTS20;TGFBR1;COL11A1;NF1;ADAMTS3;COL19A1;LAMC1;ADAMTS18;COLGALT2;COL16A1;COL15A1;MMP16;ECM2;GAS6;COL5A1;COL5A2;RECK;BMP1;COL4A1;ADAMTS2;ADAMTS16;MATN4;COL12A1;ST7;COL9A2;NDNF;SH3PXD2B;MMP24;ELN;COL4A2;CTSK;PXDN;COL13A1;ADAMTS13;SPINT1;TLL1;NID2;ADAMTS1;NPNT
gsea,Regulation Of Translational Initiation (GO:0006446),-0.4283974883717066,-1.671614323521709,0.004,0.06449737374637031,0.988,13/55,12.15%,EIF1;EIF1B;EIF4A2;NCK1;EIF3H;EIF4H;EIF5B;POLR2G;NPM1;BZW1;EIF5;FMR1;EIF4EBP2
gsea,Respiratory Chain Complex IV Assembly (GO:0008535),-0.5300663305768268,-1.6711795022613398,0.012522361359570662,0.06443896348762172,0.988,19/24,33.82%,COX17;COA3;COX14;COX20;SCO2;COX19;SURF1;SMIM20;PET100;COX15;SCO1;COA6;STMP1;UQCC5;UQCC6;TMEM223;FASTKD3;SLC25A46;COA5
gsea,Regulation Of Protein Neddylation (GO:2000434),-0.52829289057354,-1.670608229628418,0.018255578093306288,0.06435067189488092,0.988,6/18,13.16%,RPL5;RPL11;COPS9;COPS6;GPS1;COPS8
gsea,Negative Regulation Of Protein-Containing Complex Assembly (GO:0031333),-0.4510674345539608,-1.6702991790510167,0.012072434607645875,0.06423902411617033,0.988,15/41,18.53%,HMGB1;HSPA8;PARK7;RPL13A;CDC42;TFIP11;CLU;GSK3B;CRYAB;LCMT1;NOP53;NLRC3;TRAF3IP1;THRA;SVIP
gsea,Positive Regulation Of Leukocyte Chemotaxis (GO:0002690),-0.5041937777244412,-1.6699904438508295,0.011627906976744186,0.06414058457869552,0.988,11/25,21.27%,HMGB1;CALR;VEGFC;PLA2G7;AKIRIN1;C1QBP;VEGFB;MAPK3;CSF1R;MAPK1;CXCL12
gsea,Endosome Organization (GO:0007032),-0.4475780326419823,-1.6692489542601838,0.006060606060606061,0.0641812331422872,0.988,11/47,8.86%,ATP6V0C;RNASEK;USP50;ATP6V1D;ATP6V1A;ATP6V0B;SQSTM1;ATP6V1F;ATP6AP2;SNX3;RAB22A
gsea,Negative Regulation Of Cysteine-Type Endopeptidase Activity (GO:2000117),-0.5122038793945477,-1.668609396419651,0.013059701492537313,0.06413186809444883,0.988,6/26,7.14%,MT3;CST3;ARL6IP1;DNAJB6;TRIAP1;SNCA
gsea,Muscle Cell Development (GO:0055001),0.5764209642648839,1.667483396345367,0.01956521739130435,0.12867858256602163,0.989,8/17,14.11%,SLC8A1;BIN1;DMD;ACTN2;SGCZ;ACTN4;TTN;ANK2
gsea,Inorganic Anion Transmembrane Transport (GO:0098661),0.43777233672675014,1.666537169592874,0.006289308176100629,0.12759407557280422,0.989,14/45,14.65%,GABRA2;GABRG3;ANO4;ANO3;ANO6;SLC6A1;ANO2;SLC37A3;SLC1A1;GABRB1;ANO10;SLC25A10;SLC5A6;SLC20A1
gsea,O-glycan Processing (GO:0016266),0.47956105560159346,1.6628855302821899,0.01639344262295082,0.1294108021123395,0.99,14/29,24.58%,GALNT14;GALNT10;ST3GAL3;GALNT9;GALNT7;GALNT3;XXYLT1;ST3GAL2;GALNT11;ST3GAL4;GALNT12;POMGNT1;B3GNTL1;B3GNT2
gsea,Prostaglandin Metabolic Process (GO:0006693),-0.5823963800218891,-1.6608726794825233,0.019801980198019802,0.06798788977872562,0.992,10/16,23.17%,GSTM1;PTGDS;GSTP1;PTGES3;HPGDS;PRXL2B;DAGLB;PNPLA8;PTGR1;TBXAS1
gsea,Long-Term Memory (GO:0007616),-0.571785336444967,-1.6596889440377147,0.011787819253438114,0.06823933026103078,0.993,5/16,15.30%,CAMK2N1;PRNP;CALB1;LDLR;PJA2
gsea,Protein Autophosphorylation (GO:0046777),0.36682585110448984,1.659357946789524,0.006263048016701462,0.13100851645991007,0.991,36/127,15.07%,SMG1;TAOK1;CDK12;MARK2;RB1CC1;EPHB1;DAPK1;STK10;CAMK2A;FLT3;SIK2;LCK;PIKFYVE;NTRK2;WNK2;PTK2;JAK2;WNK3;MAPKAPK2;IGF1R;GRK5;FYN;ERBB4;MTOR;STK26;CHEK2;MAP3K3;STK4;TAF1;ULK3;ALK;TNIK;TAOK2;FAM20C;ACVR1B;PASK
gsea,Positive Regulation Of Proteasomal Protein Catabolic Process (GO:1901800),-0.38794750571965453,-1.6592855456781075,0.005952380952380952,0.06809989993794865,0.993,23/80,15.72%,RACK1;PSMC3;SUMO2;ELOB;PSMC2;COP1;CSNK1E;GABARAP;PSMC5;RBX1;TRIB2;ZYG11B;CLU;PSMC6;STUB1;FMR1;GSK3B;CEBPA;DNAJB2;NOP53;DDA1;SMAD7;RNF185
gsea,Negative Regulation Of Amyloid-Beta Formation (GO:1902430),-0.5618534891468079,-1.658661071246013,0.030612244897959183,0.06809652079051655,0.994,6/15,8.47%,RTN1;PRNP;APOE;PIN1;CLU;RTN4
gsea,Positive Regulation Of Developmental Growth (GO:0048639),0.45280602643096113,1.658124796328656,0.00808080808080808,0.13017050816099002,0.991,16/38,15.73%,MACF1;SHTN1;SYT17;MAPT;RASAL1;RNF157;RIMS1;PLAA;SEMA4D;ITSN2;UNC13A;SYT1;RIMS2;L1CAM;LIMK1;NEDD4L
gsea,Golgi To Endosome Transport (GO:0006895),0.5793873069689541,1.6579786071841347,0.017408123791102514,0.1284602885420257,0.991,5/15,5.26%,VPS13A;VPS13C;MON2;DOP1B;GBF1
gsea,Phosphatidylethanolamine Metabolic Process (GO:0046337),0.5409363496625468,1.6571242790103364,0.026915113871635612,0.1276477946246917,0.992,8/17,18.28%,PLA2G4E;PCYT2;CHKA;SFI1;ETNK1;ETNK2;CHKB;PLA2G3
gsea,Negative Regulation Of Protein Phosphorylation (GO:0001933),-0.37401529437036407,-1.6568794150176682,0.003883495145631068,0.06889721858547722,0.994,14/120,7.14%,CALM1;CALM2;PPIA;CALM3;RACK1;CAMK2N1;PRNP;YWHAG;PARK7;NCK1;SPRY2;GSTP1;TRIB2;SNCA
gsea,Negative Regulation Of Cell Adhesion (GO:0007162),0.4138982769895388,1.6566896966436917,0.006237006237006237,0.1263328792379952,0.992,19/56,16.91%,PLXNA4;NRG1;RIPOR2;PLXNC1;TBCD;DSCAM;PLXNA2;SEMA4D;SPOCK1;PTK2;PLXNA3;GCNT2;EPHB2;NEXMIF;ADAM22;CDH13;CORO2B;DUSP1;RND1
gsea,Negative Regulation Of Amyloid Precursor Protein Catabolic Process (GO:1902992),-0.5398989441470528,-1.6547955196039954,0.024439918533604887,0.06980602325131062,0.995,6/17,8.47%,RTN1;PRNP;APOE;PIN1;CLU;RTN4
gsea,Regulation Of Protein Localization (GO:0032880),-0.3992040147942091,-1.6546527109870477,0.0019455252918287938,0.06952320166776264,0.995,25/68,25.09%,HSP90AB1;RACK1;FKBP1A;HSP90AA1;DNAJB6;MAP1A;BDNF;CSNK1E;RAB14;PIN1;MMD;PARP1;VCPIP1;VPS4A;ATP13A2;GPC1;RABGAP1L;VCP;FBXW7;RAB11B;TOR1A;SUMO1;CTSD;DVL1;RSL1D1
gsea,Heme Biosynthetic Process (GO:0006783),-0.5699961193833454,-1.654030346380411,0.01730769230769231,0.06959910219409696,0.996,8/16,27.59%,PGRMC1;ALAD;NFE2L1;FXN;ABCB6;SLC25A38;COX15;FECH
gsea,Positive Regulation Of Protein Localization To Membrane (GO:1905477),0.39125493404353,1.6519856429620694,0.004132231404958678,0.1294057046935351,0.992,16/65,10.19%,ANK3;SORBS1;PRKN;DPP10;ATP2B4;PRKCE;TCAF1;PLS1;C2CD5;WNK3;ITGA3;AKT2;EPHB2;SLC5A3;NECAB2;FYN
gsea,Regulation Of Nervous System Process (GO:0031644),0.561495954730131,1.6504953827872544,0.013916500994035786,0.1292763293600361,0.993,8/16,14.34%,DLGAP2;DLGAP1;TMEM108;DLGAP3;HTR2C;CHRNA7;BEGAIN;DLGAP4
gsea,Regulation Of Cardiac Muscle Contraction By Calcium Ion Signaling (GO:0010882),-0.5619468216435414,-1.6493699139278257,0.02131782945736434,0.07211978252745305,0.996,4/15,0.25%,CALM1;ATP1B1;CALM2;CALM3
gsea,Regulation Of Autophagy (GO:0010506),-0.3431777388085581,-1.6492865489778392,0.0,0.07181285722220945,0.996,57/196,24.81%,ATP6V0C;EEF1A1;HMGB1;GAPDH;ATP6V1D;ATP6V1A;PSAP;ATP6V1G2;ATP6V0E2;VDAC1;TMEM59;VPS29;EEF1A2;ATP6V0B;SQSTM1;PLK2;RRAGA;PRKD1;SH3GLB1;UBQLN2;PIP4K2A;BOK;CDK5R1;PINK1;ATP6V1E1;RRAGD;BAD;GFAP;UCHL1;GSK3B;ATP6V1C1;MTDH;SNX5;TRIM32;ATP13A2;EIF4G2;ATP6V1B2;ATP6V1G1;VPS35;CISD2;FOXK1;SVIP;FBXW7;TBK1;DCAF12;PIK3C2A;ENDOG;IL10RA;PRKACA;MTMR9;UBQLN1;USP20;VPS26B;HTRA2;RAB39B;AKT1;KEAP1
gsea,Regulation Of Interleukin-8 Production (GO:0032677),-0.47831855583703864,-1.6477691535381134,0.012522361359570662,0.07246526333972032,0.996,19/36,37.27%,HMGB1;TMSB4X;PARK7;BCL10;SSC5D;HYAL2;MAVS;RELA;MAPKBP1;LAMTOR5;EHHADH;CACTIN;ANXA4;CD33;MYD88;HSPA1A;STAT3;DDIT3;ARRB1
gsea,Phosphorylation (GO:0016310),0.3189025317903197,1.6475944525543322,0.0,0.13081250239357484,0.993,118/352,21.39%,PRKG1;DGKG;PAK3;SMG1;TAOK1;PRKAG2;GCK;PRKCE;EPHA10;MARK2;RB1CC1;PRKDC;CHUK;MAPK10;EPHB1;BIRC6;RPTOR;TGFBR1;ROCK1;CDK14;DAPK1;DGKH;PRKCG;TNK2;MAP4K4;STK10;CAMK2A;CDK8;SIK2;NEK7;LIMK2;LCK;BRSK1;WNK2;COQ8B;CSNK2A2;DGKQ;PTK2;LMTK3;JAK2;CDKL1;WNK1;DGKB;WNK3;DGKI;MAPKAPK2;GRK3;IKBKB;CDC42BPA;NEK10;MAP3K5;EPHB2;RICTOR;MAST2;NEK11;PIK3CD;MARK1;GRK5;FYN;EPHA6;MTOR;STK26;CHEK2;GNPTAB;STK4;TAF1;MAST1;GAS6;PRKG2;TAF6;CHEK1;MAP4K3;CDK20;STRADA;TTBK1;CERKL;GRK4;GRK2;RPS6KA1;ALK;TNIK;TAOK2;EPHA3;FAM20C;ACVR1B;CSF2RA;GK5;PASK;LIMK1;PICK1;FER;PRKCD;BCKDK;STRADB;CDK10;DGKA;CLK3;ILF3;GRK6;STK3;BRAF;CAMK2D;MAP4K5;COPS2;CDK9;PI4KA;MARK4;PIK3CA;BIRC5;CDC25B;TLK1;PXK;ABL1;CERK;COQ8A;FGGY;TESK2;PRAG1
gsea,Cardiac Ventricle Morphogenesis (GO:0003208),-0.499979280284981,-1.6474867190598848,0.011583011583011582,0.07231168511106223,0.996,10/25,17.89%,FKBP1A;FGFR2;CPE;MEF2C;TPM1;NPY5R;JAG1;SMAD7;HEY1;SOX4
gsea,Cellular Response To Steroid Hormone Stimulus (GO:0071383),-0.5702110882867306,-1.6460226258002264,0.02459016393442623,0.07276495627385558,0.997,4/15,10.01%,HSPA8;ATP1A1;ATP1A3;ATP1A2
gsea,Inner Mitochondrial Membrane Organization (GO:0007007),-0.4665723906403736,-1.6444368450111326,0.01171875,0.07340363919606373,0.997,14/32,20.75%,GHITM;TIMM8B;NDUFA13;TIMM13;ROMO1;TIMM22;IMMT;TIMM10;SAMM50;TMEM11;HSPA9;UQCC3;MICOS10;MTX1
gsea,Positive Regulation Of Mononuclear Cell Migration (GO:0071677),-0.5705422545033225,-1.6437832378660964,0.022429906542056073,0.07339774582709749,0.997,6/15,13.85%,HMGB1;CALR;CD47;PLA2G7;C1QBP;JAM2
gsea,Collagen Fibril Organization (GO:0030199),0.5021254342948794,1.643100699904286,0.019823788546255508,0.1341283745085793,0.995,10/24,15.25%,TGFBR1;COL11A1;NF1;ADAMTS3;COLGALT2;COL5A1;COL5A2;BMP1;ADAMTS2;COL12A1
gsea,Regulation Of Supramolecular Fiber Organization (GO:1902903),-0.5075719912883878,-1.6422736989546345,0.01694915254237288,0.07392249139985137,0.997,5/23,3.13%,APOE;HSPA8;MAP1B;PARK7;MAP1A
gsea,Mitochondrial Membrane Organization (GO:0007006),-0.47219314699517634,-1.6400975693742177,0.017786561264822136,0.07476142572085433,0.997,11/30,20.75%,SLC25A4;GHITM;SLC25A5;BAD;IMMT;SAMM50;TMEM11;TIMM50;HSPA9;MICOS10;MTX1
gsea,Iron Ion Transport (GO:0006826),-0.5450493596808882,-1.6400886212937111,0.02074688796680498,0.07442078374928741,0.997,1/18,0.01%,FTH1
gsea,Neuron Projection Extension (GO:1990138),-0.45030110010468627,-1.6388759678246783,0.0136986301369863,0.07483000069519331,0.997,8/36,7.20%,HSP90AB1;NRN1;HSP90AA1;MAP1B;SEMA5A;PPP3CB;LLPH;NELL2
gsea,Embryonic Organ Morphogenesis (GO:0048562),0.5261710337160326,1.6344850616436826,0.020366598778004074,0.14192244966778425,0.996,4/19,3.15%,RYR2;DSCAML1;NIPBL;FBN2
gsea,Extrinsic Apoptotic Signaling Pathway (GO:0097191),-0.4270398658719722,-1.6328584086279714,0.01615798922800718,0.07813268246967042,0.997,18/48,25.77%,MLLT11;BAX;GABARAP;BOK;ITGAV;BAD;INHBA;GSK3B;HIPK1;DELE1;SIVA1;CD27;TNFSF12;TGFB2;DIABLO;DAXX;P2RX7;CASP8AP2
gsea,Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071900),-0.3927100528312718,-1.6326755095511094,0.00946969696969697,0.07786772463949275,0.997,27/79,26.00%,CALM1;CALM2;ACTB;CALM3;CDK5R2;CDC37;PPP2CA;TRIB2;SNCA;CDK5R1;HRAS;TSG101;MACROH2A1;SLC8A2;CDKN1B;CCND3;CSF1R;THY1;RHOA;DUSP19;CCNG2;CAB39;GTPBP4;CCNI;AKT1;BCCIP;ETAA1
gsea,Regulation Of Protein Binding (GO:0043393),-0.3798248726326639,-1.631771560266205,0.007722007722007722,0.07810516036778478,0.998,21/88,13.25%,RACK1;RPL11;FKBP1A;RAN;PARK7;TLE5;SUB1;BAX;CSNK1E;PPP1CA;PPP2CA;TFIP11;LRPAP1;PIN1;VTN;TMBIM6;ADD2;BAMBI;GSK3B;HIP1R;DNAJB2
gsea,Positive Regulation Of Cellular Metabolic Process (GO:0031325),-0.4702285197340574,-1.6308164671041114,0.017045454545454544,0.07836185477477818,0.998,13/32,24.78%,MT3;YPEL3;GHITM;CHCHD2;ROMO1;ARG2;CBR1;PRELID1;DCXR;PDGFB;IL10RB;SLCO1C1;B2M
gsea,Vesicle Organization (GO:0016050),-0.3892061304348134,-1.6289651977331305,0.003929273084479371,0.07905311188403566,0.998,25/76,20.08%,USP50;VAMP2;TRAPPC6B;STX7;AP2M1;WASL;SQSTM1;STX16;TRAPPC2L;TRAPPC2;RAB22A;CHMP6;PLEKHA3;TRAPPC1;SAR1A;VPS4A;GOSR1;SYT11;VAMP3;CHMP4C;CHMP7;PLEKHF2;PI4K2B;PHETA1;EPS15
gsea,Maturation Of SSU-rRNA (GO:0030490),-0.4499830881484674,-1.627369887756296,0.01509433962264151,0.07974347323384863,0.998,12/37,19.43%,RPS8;RPS28;RPS16;RPS14;IGF2BP3;SNU13;UTP3;TSR2;RPS19;NOL11;MPHOSPH10;NOP14
gsea,Neuron Projection Organization (GO:0106027),-0.5495970230387883,-1.626740045804335,0.026156941649899398,0.07980988982205381,0.998,6/15,14.50%,PRNP;ARF1;ATP1A3;MAP1A;GSK3B;KIFBP
gsea,snRNA Processing (GO:0016180),0.5289893125326274,1.619921893291708,0.024844720496894408,0.157033238179528,0.996,7/17,20.13%,INTS11;INTS6L;INTS2;INTS6;TUT1;INTS4;INTS7
gsea,Negative Regulation Of Endopeptidase Activity (GO:0010951),-0.5122693609199489,-1.6186342120861632,0.015655577299412915,0.08481176719965881,0.998,5/22,7.32%,MT3;GAPDH;CST3;TIMP3;VTN
gsea,Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000058),-0.44735810969998646,-1.6182514931979743,0.0066518847006651885,0.08469293297867572,0.998,12/36,20.85%,RPS7;RPL5;RPL11;RPL17;UBE3A;CLU;PML;LAPTM5;COMMD1;FBXW7;RNF139;NUB1
gsea,Regulation Of Cell Motility (GO:2000145),0.3762829513805107,1.6180672680775132,0.008247422680412371,0.1571731516010133,0.996,20/84,11.01%,PLXNA4;MACF1;DOCK10;SRCIN1;HACE1;PLXNC1;FRMD5;ROCK1;RAF1;TNR;PLXNA2;OCRL;FLNA;ABL2;PLXNA3;AKT2;ARHGAP18;FYN;ERBB4;TMSB10
gsea,Negative Regulation Of Supramolecular Fiber Organization (GO:1902904),-0.397266414484835,-1.6175136808936057,0.006109979633401222,0.0848408759445836,0.998,22/63,13.58%,APOE;PFN2;HSPA8;NAV3;ARPIN;FGF13;TUBB4A;STMN1;CHADL;SNCA;PFN1;PFDN6;PFDN2;CLU;PFDN4;PFDN5;TWF1;CLIP3;CRYAB;HIP1R;LDLR;VBP1
gsea,Positive Regulation Of Lamellipodium Assembly (GO:0010592),-0.5289538534907466,-1.6166063893065674,0.031067961165048542,0.08510164711681134,0.998,7/19,12.71%,RAC1;BRK1;CDC42;ARPC2;ACTR2;AKIRIN1;PIK3R1
gsea,Positive Regulation Of Neuron Differentiation (GO:0045666),-0.46469057089646343,-1.6154694283874926,0.014314928425357873,0.085561571530476,0.998,12/31,21.21%,PCP4;MEF2C;NEUROD2;BRINP3;GPRC5B;FGFR1;MMD;ADRA2C;TRIM32;NBL1;ASCL1;RHOA
gsea,Regulation Of Metal Ion Transport (GO:0010959),0.4788163998388089,1.6153138723012297,0.014675052410901468,0.15865667109819948,0.997,7/26,7.07%,NKAIN2;ANK3;SPTBN4;NKAIN3;NOS1;CAMK2G;WNK1
gsea,Positive Regulation Of Cellular Component Organization (GO:0051130),-0.39017035008456435,-1.6136306889340386,0.005628517823639775,0.08626433344226132,0.998,19/83,13.37%,CALY;RACK1;APOE;RPS3;PARK7;TMED9;BRK1;NEUROD2;BAX;SH3GLB1;SNCA;CLU;MTLN;CLIP3;GSK3B;ADGRL1;CD151;SURF4;LMAN1
gsea,Modulation By Host Of Viral Genome Replication (GO:0044827),-0.522237688373627,-1.6124982157244372,0.026804123711340205,0.0866589206540249,0.998,4/18,4.55%,EEF1A1;NUCKS1;PPIB;VAPA
gsea,Inorganic Cation Import Across Plasma Membrane (GO:0098659),0.39545539454323,1.6114681268568056,0.0020833333333333333,0.16162268263963733,0.997,17/66,7.66%,CACNA1C;CACNA1E;NALF1;SCN1A;CACNA1A;SLC8A1;ATP2B4;SCN8A;CACNA1B;KCNK9;KCNJ6;SLC6A1;SLC9A7;SLC24A2;SCN7A;SLC24A4;SLC9A5
gsea,Peptidyl-Serine Modification (GO:0018209),0.34871650316392877,1.6112300736283505,0.006085192697768763,0.15989686978459228,0.997,37/144,13.86%,SMG1;PRKCE;PKD1;MARK2;PRKDC;CHUK;TGFBR1;ROCK1;MAPK14;CSNK1G1;PRKCG;CAMK2A;MGAT5B;NEK7;GALNT16;BRSK1;CSNK2A2;DGKQ;WNK1;SBK1;MAPKAPK2;IKBKB;AKT2;RICTOR;MAST2;MARK1;MTOR;STK4;MAPK12;CAMK1G;TAF1;MAST1;GAS6;TTBK1;GRK2;GALNT3;ULK3
gsea,Positive Regulation Of Monoatomic Ion Transport (GO:0043270),0.47660881310447595,1.608652512494303,0.021912350597609563,0.16126488325649835,0.997,9/28,14.11%,ANK3;CACNB2;ANO6;CAMK2A;TRPC6;WNK3;ORAI1;PKP2;ANK2
gsea,Negative Regulation Of Protein Localization To Plasma Membrane (GO:1903077),-0.5595487908312523,-1.6045632060795827,0.027777777777777776,0.09176075329006378,0.998,3/15,5.64%,TMEM59;AP2M1;LRPAP1
gsea,Regulation Of Wound Healing (GO:0061041),0.5297081819107933,1.604105473609276,0.018633540372670808,0.16469709652535003,0.997,9/20,20.11%,PRKCE;NRG1;CASK;ARFGEF1;PTK2;EPHB2;SRSF6;KANK1;DMTN
gsea,Vesicle Fusion (GO:0006906),-0.39715782859728677,-1.6022270805353356,0.001937984496124031,0.09308269354843429,0.998,18/62,17.53%,VAMP2;STX7;ARL8B;STXBP6;STX16;PIP4K2A;SNCA;VTI1B;CHMP2A;CHMP6;VPS4A;GOSR1;SYT11;ATP13A2;YIPF4;VAMP3;CHMP4C;CHMP7
gsea,Negative Regulation Of Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage (GO:1902230),-0.5493885827612797,-1.6011332600671406,0.018726591760299626,0.09362504671449208,0.998,6/17,23.35%,TPT1;TRIAP1;CLU;TRIM32;CXCL12;CCAR2
gsea,Glycerophospholipid Biosynthetic Process (GO:0046474),0.3620909308250609,1.6008034378076776,0.004032258064516129,0.16679961265120555,0.998,37/92,24.33%,DGKG;SLC44A5;DGKH;PITPNM2;OCRL;PIP5K1B;SYNJ1;PCYT2;PIKFYVE;CHKA;DGKQ;PLCG2;SFI1;MTMR7;DGKB;MBOAT2;FAR1;MTMR1;ETNK1;ETNK2;ABHD4;SLC44A2;CHKB;INPP5K;PGS1;CDS1;DGKA;ACP6;PI4KA;PLA2G4A;VAC14;PNPLA3;MTM1;INPP5J;HDHD5;PI4KB;SYNJ2
gsea,Negative Regulation Of Apoptotic Process (GO:0043066),-0.32193854206042133,-1.5991603694283312,0.001869158878504673,0.09473151544701293,0.998,70/315,16.57%,MT3;PTMS;TPT1;PTMA;APOE;SET;ARL6IP1;CFL1;PARK7;PRDX5;FAIM2;ARHGDIA;DNAJA1;VDAC1;NME2;GRINA;DNAJB6;HIGD2A;BDNF;ARF4;BNIP3L;SPRY2;MEF2C;PLK2;SOD1;GSTP1;YWHAZ;TRIAP1;GLO1;CITED2;HIGD1A;WDR73;RPL10;SNCA;FZD3;BAG1;PINK1;TMBIM6;CLU;NPM1;TMEM14A;DNAJA3;AXL;RASA1;HMGN5;BAG4;SOX9;HNRNPK;CX3CL1;XBP1;GSK3B;CRYAB;TEK;MTDH;BABAM2;PIK3R1;LSM8;MYDGF;UBE2Z;PIM3;NR4A2;HSPD1;TLE1;POU3F3;EGR3;PRELID1;CBX4;HSPA9;HCK;CTSH
gsea,Regulation Of Dendritic Spine Development (GO:0060998),0.5247693347107755,1.5987358043873994,0.0255863539445629,0.16753465164754924,0.999,6/18,5.23%,PTPRS;NLGN1;TANC2;DLG5;SHANK3;SHANK1
gsea,Negative Regulation Of TORC1 Signaling (GO:1904262),-0.4979706732357076,-1.598547978940654,0.02626641651031895,0.09471601118412143,0.998,6/21,19.59%,SESN1;ITFG2;SEH1L;SEC13;KICS2;SESN3
gsea,Positive Regulation Of Vasculature Development (GO:1904018),-0.40862449641015774,-1.597915651050868,0.013207547169811321,0.09479046762185836,0.998,17/57,16.57%,EMC10;SEMA5A;PDCD6;VEGFC;RAMP2;NINJ1;PRKD1;VEGFB;XBP1;TEK;MTDH;MYDGF;HIPK1;RHOB;ANGPTL3;BTG1;CTSH
gsea,Negative Regulation Of Transferase Activity (GO:0051348),-0.47579894671100337,-1.5952905350289388,0.020146520146520148,0.09621105435301663,0.998,9/28,15.55%,PARK7;EIF4A2;BANF1;IRS2;BAG5;TERF1;GSK3B;CDKN1B;SMAD7
gsea,Stress-Activated Protein Kinase Signaling Cascade (GO:0031098),0.519663555560911,1.5946344734123452,0.026923076923076925,0.17117394492636656,0.999,7/18,15.79%,MAPK14;MAP3K7;IKBKB;MAP3K5;STK26;TAOK2;MAPK11
gsea,Aminoglycan Biosynthetic Process (GO:0006023),0.5389262099054792,1.5934873587004248,0.03913894324853229,0.1706087911464838,0.999,10/16,24.58%,EXT2;XYLT1;HEXA;GCNT2;HS3ST2;EXT1;XYLT2;UGDH;B3GNTL1;B3GNT2
gsea,Regulation Of Amyloid-Beta Formation (GO:1902003),-0.4574862845492133,-1.5930823644806917,0.02178217821782178,0.09753067518047001,0.998,9/29,16.89%,RTN1;PRNP;APOE;PIN1;CLU;RTN4;TMED10;APEX1;EPHA4
gsea,Regulation Of Neuron Migration (GO:2001222),0.48232511581730714,1.592781368741161,0.025540275049115914,0.16949607957801038,0.999,12/24,16.46%,NTNG2;SHTN1;NIPBL;CAMK2A;PLAA;ULK4;SRGAP3;NEXMIF;RELN;DAB2IP;PHACTR1;ARHGEF2
gsea,Positive Regulation Of ATP-dependent Activity (GO:0032781),-0.4625035503158609,-1.591695331173911,0.0234375,0.09814935591462932,0.998,9/29,13.25%,ATP1B1;PFN2;GABARAPL2;ATP1B2;TPM1;PFN1;CHTOP;TOR1AIP2;DNAJB2
gsea,Positive Regulation Of Apoptotic Process (GO:0043065),-0.3339476278298662,-1.5907984974867222,0.0,0.09835556183531427,0.998,41/185,17.16%,HMGB1;RACK1;PRNP;DYNLL1;EPHA7;OLFM1;JUN;RPS6;RPS3;TLE5;DNAJA1;MLLT11;ARL6IP5;BNIP3L;SQSTM1;BAX;SOD1;TRIM35;SAP18;USP27X;MTCH1;MTCH2;SNCA;BOK;CDK5R1;CLU;BAD;C1QBP;CTNNBL1;CLIP3;DDX20;HIP1R;UBE2Z;UTP11;RHOB;HSPD1;BCL10;BTG1;CTSH;FAM162A;PTRH2
gsea,Regulation Of Programmed Cell Death (GO:0043067),-0.34709264570903536,-1.5905983503668333,0.003656307129798903,0.0981250816419713,0.998,39/141,20.33%,ACTB;TPT1;HSP90AA1;ANP32A;RPS3;MORF4L1;CALR;NME2;MAGED1;BNIP3L;MORF4L2;PLK5;BAX;CTSB;BEX1;ANP32B;PSMC5;PINK1;CLU;RTN4;ANP32E;DPP8;SOX9;RUVBL1;MRGBP;TRIM24;CRYAB;NME1;LCMT1;NOP53;AKT1S1;APEX1;ZDHHC17;TMEM109;VCP;BRMS1;CIDEA;DMAP1;IRF3
gsea,Positive Regulation Of Angiogenesis (GO:0045766),-0.3900227979939626,-1.5902254843268742,0.0074487895716946,0.09793543700124506,0.998,25/66,25.44%,PKM;EMC10;SEMA5A;PDCD6;VEGFC;RAMP2;NINJ1;PRKD1;VEGFB;XBP1;TEK;MTDH;MYDGF;HIPK1;RHOB;ANGPTL3;SIRT6;BTG1;CTSH;TNFSF12;EMP2;JMJD8;JAK1;S100A1;HYAL1
gsea,Multivesicular Body Assembly (GO:0036258),-0.45782624480863887,-1.5888790695440926,0.015384615384615385,0.09852777443891009,0.998,13/27,27.50%,VPS28;RAB11A;CHMP2A;TSG101;CHMP6;STAM2;VPS4A;UBAP1;CHMP4C;CHMP7;VPS36;STAM;CHMP3
gsea,RNA Splicing (GO:0008380),-0.3627849177944241,-1.5887194850085964,0.007380073800738007,0.09825113763067916,0.998,43/94,28.58%,PRPF4B;SNRPG;SNRPF;SNRPD2;SF3B2;WBP4;SF3B4;PPP2CA;PPP2R1A;ZCRB1;RBM8A;ZRSR2;MAGOH;LSM4;SCAF11;U2AF1;LUC7L3;SNRPD1;MAGOHB;TXNL4A;IVNS1ABP;PDCD7;LSM1;HNRNPC;MBNL1;SNRPN;MPHOSPH10;SLU7;DDX39B;NOL3;NCBP2;SNRPB;RP9;HNRNPH3;CCAR2;BCAS2;RSRC1;USP39;PRMT1;RRAGC;PRPF6;PRPF18;DHX16
gsea,Vesicle-Mediated Transport Between Endosomal Compartments (GO:0098927),0.4837301661292461,1.5885399872425683,0.015904572564612324,0.17313524564004645,0.999,11/22,21.74%,HOOK1;MYO1D;EEA1;PTPN23;HOOK2;ANKRD27;HOOK3;STX8;KIF16B;PXK;WDR81
gsea,Epithelial Tube Morphogenesis (GO:0060562),0.48182913153818746,1.5882978415344258,0.032119914346895075,0.1716126865568,0.999,5/22,7.94%,RYR2;PKD1;FGF10;MTSS1;PKD2
gsea,Positive Regulation Of Dendritic Spine Development (GO:0060999),0.5194574796563238,1.5877285698592114,0.03543307086614173,0.17044667139078057,0.999,7/18,9.26%,NLGN1;DLG5;SHANK3;CUX2;LRP8;SHANK1;RELN
gsea,Ganglioside Metabolic Process (GO:0001573),0.5434428679145524,1.5843388182133682,0.03386454183266932,0.17257458290910802,0.999,4/15,6.99%,ST6GALNAC3;ST6GALNAC5;HEXA;HEXB
gsea,Positive Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903322),-0.38313251871241466,-1.5841990941421926,0.011741682974559686,0.10122212757340297,0.998,27/72,24.60%,UBB;FKBP1A;UBE3A;NDFIP1;CENPX;NSMCE3;PINK1;STUB1;TSPYL5;GSK3B;NDFIP2;RASD2;LAPTM5;MUL1;SMAD7;COMMD1;BCL10;TBC1D7;UBA2;FBXW7;FAM107A;PHF23;UBQLN1;SUMO1;DERL1;SEPTIN4;DCUN1D5
gsea,Positive Regulation Of Synapse Assembly (GO:0051965),0.4733656991639547,1.584156737629234,0.033268101761252444,0.1709354654977757,0.999,10/28,8.62%,CLSTN2;NLGN1;EPHB1;PTPRD;DLG5;CUX2;GRID2;SEMA4D;WNT7A;EPHB2
gsea,Chloride Transport (GO:0006821),0.41340692513005484,1.5836433858222556,0.010822510822510822,0.16990652316447727,0.999,11/49,9.01%,GABRA2;GABRG3;ANO4;ANO3;ANO6;SLC6A1;ANO2;CLCN5;SLC1A1;GABRB1;ANO10
gsea,Protein Phosphorylation (GO:0006468),0.30629958215002245,1.5835138712240653,0.0021413276231263384,0.16829583627401096,0.999,97/394,14.42%,PRKG1;PAK3;SMG1;TAOK1;PRKAG2;CDK12;PRKCE;PKD1;EPHA10;MARK2;RB1CC1;PRKDC;CHUK;MAPK10;EPHB1;BIRC6;TGFBR1;ROCK1;CDK14;MAPK14;DAPK1;CSNK1G1;PRKCG;MAP4K4;STK10;CAMK2A;FLT3;CDK8;SIK2;NEK7;LIMK2;LCK;MAP3K7;ABL2;NTRK2;BRSK1;WNK2;COQ8B;CSNK2A2;DGKQ;PTK2;LMTK3;JAK2;CDKL1;WNK1;WNK3;SBK1;MAPKAPK2;GRK3;IKBKB;CDC42BPA;NEK10;AKT2;MAP3K5;EPHB2;IGF1R;RICTOR;TGFBR3;RELN;MAST2;NEK11;PIK3CD;MARK1;GRK5;FYN;ERBB4;EPHA6;ERC1;MTOR;STK26;CHEK2;MAP3K3;STK4;MAPK12;CAMK1G;TAF1;MAST1;GAS6;PRKG2;TAF6;CHEK1;MAP4K3;CDK20;STRADA;TTBK1;GRK4;GRK2;RPS6KA1;ULK3;ALK;TNIK;TAOK2;EPHA3;FAM20C;ACVR1B;DAB2IP;CSF2RA
gsea,Intracellular Protein Transport (GO:0006886),-0.317738272266623,-1.5829280173218543,0.0,0.10173171367059707,0.998,68/275,16.48%,RPL11;YWHAH;RAN;CALR;DNAJC19;TMED9;ARF1;APLP2;VPS29;STX7;ARF4;RAB6B;PDCD6;GABARAP;TMED2;CDC37;ARL1;RAB14;RAB6A;ARF3;SYNDIG1;STX16;VPS28;HIKESHI;NAPG;RAB24;ROMO1;PAM16;ARF5;NPM1;RAB1B;AKIRIN2;RAB22A;TMED4;SNX17;RAB18;BCS1L;TIMM23;NUP50;TMED7;TSG101;RAB31;ARL5B;CLIP3;SAR1A;TMED10;SURF4;ARL4C;LMAN1;STAM2;TIMM50;TIMM44;ERP29;LAPTM5;SEC13;RANBP3L;UBAP1;NUP107;COPB2;DNAJC15;IPO8;RAB32;OXA1L;LAMP2;GRPEL1;HSPA9;APEX1;NSF
gsea,Positive Regulation Of Intracellular Signal Transduction (GO:1902533),-0.31656306198437534,-1.5808469609139448,0.0,0.1029859535024768,0.999,98/341,22.64%,HSP90AB1;HMGB1;GAPDH;PPIA;RPL37;RACK1;RPS15;C1QTNF4;FKBP1A;RPL17;HSP90AA1;RPS3;PARK7;RPS20;FGFR2;CD81;LAMTOR2;NDFIP1;SPRY2;SEMA5A;P2RY12;PLK2;NEUROD2;BAX;RRAGA;SOD1;VAPA;IL18;GPRC5B;PRKD1;LAMTOR3;PDGFA;UBE2N;BOK;PINK1;ITGAV;RRAGD;FGFR1;RTN4;HRAS;TMED4;GSDME;AXL;C1QBP;PARP1;SOX9;CXXC5;UBE2V1;CX3CL1;ADRA2C;TSPYL5;GJA1;TEK;LYN;MTDH;NDFIP2;RASD2;MYDGF;TMEM9B;SEH1L;ILK;SHARPIN;WNT16;LAPTM5;SEC13;MUL1;TRIM44;TRIM32;GPR37;BMPR2;BCL10;IRAK4;ZDHHC17;NEK6;CD27;PDGFB;GPR37L1;DDX1;PHB2;BMP6;PDGFD;PELI2;GPR62;TBK1;TSPAN6;FIS1;TRAF3IP2;RHOA;JCAD;LURAP1;BBC3;CFLAR;JMJD8;GPR61;RNF13;DUSP19;MIB2;TGFB2
gsea,Regulation Of Protein Catabolic Process (GO:0042176),-0.3569361193193562,-1.5798240750990062,0.003703703703703704,0.10327536115762688,0.999,31/103,19.27%,UBB;EEF1A1;APOE;HSP90AA1;EEF1A2;OAZ1;PLK2;NDUFA13;USP14;PIN1;VPS28;RBX1;PINK1;SNX3;ODC1;GFAP;CHMP6;GSK3B;EZR;PSME3;ASB5;HMGCR;CDKN1B;TRIM32;ATP13A2;NSF;VPS35;RDX;VCP;TMF1;TNFSF12
gsea,Vesicle-Mediated Transport In Synapse (GO:0099003),-0.556805757985154,-1.5796000882603165,0.03787878787878788,0.10302784609373204,0.999,5/16,7.56%,RAB3A;CPLX2;VAMP2;SNCA;SNAP25
gsea,Mitochondrial Cytochrome C Oxidase Assembly (GO:0033617),-0.5289211459555964,-1.5787902595726617,0.02411873840445269,0.1033807514786511,0.999,15/20,30.38%,COX17;COA3;COX14;COX20;SCO2;COX19;SURF1;SMIM20;PET100;SCO1;STMP1;UQCC5;UQCC6;TMEM223;FASTKD3
gsea,Positive Regulation Of Cell Growth (GO:0030307),0.36829566965824767,1.5779238936337268,0.010141987829614604,0.17405602344126883,0.999,27/79,15.73%,MACF1;AKAP6;RPTOR;TGFBR1;SHTN1;SYT17;MAPT;RASAL1;INO80;LGI1;RNF157;RIMS1;PLAA;SEMA4D;ITSN2;NCBP1;UNC13A;USP47;RICTOR;MTOR;SYT1;RIMS2;L1CAM;RPS6KA1;KLHL22;LIMK1;NEDD4L
gsea,Negative Regulation Of Protein Binding (GO:0032091),-0.4055413775823866,-1.5745236176499835,0.019784172661870502,0.10638737222605911,0.999,10/48,7.48%,RACK1;PARK7;TLE5;BAX;CSNK1E;PPP1CA;TFIP11;LRPAP1;PIN1;TMBIM6
gsea,Negative Regulation Of Neuron Apoptotic Process (GO:0043524),-0.40321402903150183,-1.5727839401570431,0.009398496240601503,0.10738337564930187,1.0,11/56,10.86%,MT3;APOE;SET;PARK7;BDNF;MEF2C;SOD1;PINK1;CLU;RASA1;CX3CL1
gsea,Peptidyl-Serine Phosphorylation (GO:0018105),0.3457253711159726,1.5722757203025475,0.006134969325153374,0.17950169875424687,0.999,35/136,13.86%,SMG1;PRKCE;PKD1;MARK2;PRKDC;CHUK;TGFBR1;ROCK1;MAPK14;CSNK1G1;PRKCG;CAMK2A;NEK7;PIKFYVE;BRSK1;CSNK2A2;DGKQ;WNK1;SBK1;MAPKAPK2;IKBKB;AKT2;RICTOR;MAST2;MARK1;MTOR;STK4;MAPK12;CAMK1G;TAF1;MAST1;GAS6;TTBK1;GRK2;ULK3
gsea,Maintenance Of Protein Localization In Organelle (GO:0072595),-0.5190156961164004,-1.572124010629544,0.024193548387096774,0.10751007757100904,1.0,13/17,41.59%,CHCHD10;PINK1;PML;ARL2BP;HK1;ARL2;SKP1;HK2;TAF8;TOPORS;HSPA5;TAF3;KDELR2
gsea,Positive Regulation Of Protein Localization To Cell Periphery (GO:1904377),0.4079869909094529,1.5704277812556593,0.006369426751592357,0.1802068811276552,0.999,12/42,16.00%,SORBS1;DPP10;ATP2B4;PRKCE;PLS1;WNK3;ITGA3;EPHB2;SPTBN1;EPHA3;ZDHHC5;NUMA1
gsea,Positive Regulation Of Pattern Recognition Receptor Signaling Pathway (GO:0062208),-0.511375773515899,-1.5684362902096605,0.037383177570093455,0.10997347583312789,1.0,6/19,16.85%,HMGB1;NINJ1;RTN4;ZCCHC3;PJA2;PUM1
gsea,Regulation Of Endothelial Cell Proliferation (GO:0001936),-0.3868030972855915,-1.5677101853264892,0.012962962962962963,0.11010755094007861,1.0,19/62,19.27%,APOE;EMC10;NR2F2;SEMA5A;PDCD6;VEGFC;PRKD1;NELL2;VEGFB;SPARC;TEK;MYDGF;NRARP;EGR3;BMPR2;AIMP1;EGFL7;PDGFB;TNFSF12
gsea,Positive Regulation Of Binding (GO:0051099),-0.38326689161883143,-1.5675489386409653,0.009541984732824428,0.10982178442176828,1.0,14/65,13.79%,HMGB1;APOE;RPL11;FKBP1A;RAN;SUB1;STMN1;PIN1;VTN;ADD2;BAMBI;GSK3B;HIP1R;NME1
gsea,Innate Immune Response Activating Cell Surface Receptor Signaling Pathway (GO:0002220),0.5358802813498954,1.5659395243338248,0.028513238289205704,0.1842918574687741,0.999,5/15,10.19%,PAK3;MAP3K7;PLCG2;IKBKB;FYN
gsea,Plasma Membrane Repair (GO:0001778),-0.528648000228559,-1.5657687954768775,0.03932584269662921,0.1109639630594358,1.0,8/18,17.53%,RAB3A;ARL8B;CHMP2A;CHMP6;VPS4A;SYT11;CHMP4C;CHMP7
gsea,Cellular Response To Retinoic Acid (GO:0071300),-0.47783478533899804,-1.565169924812013,0.030710172744721688,0.11096936160719001,1.0,8/24,12.26%,SNW1;NDUFA13;BRINP3;RORB;SOX9;FZD4;GSK3B;LYN
gsea,Bone Development (GO:0060348),-0.475244729019838,-1.5648015051018491,0.027777777777777776,0.11084734448862636,1.0,10/25,20.38%,GNAS;RPL13;FGFR2;PPIB;GJA1;OGN;RANBP3L;VKORC1;BMP6;ATG9A
gsea,Positive Regulation Of Defense Response (GO:0031349),-0.39324661096855534,-1.5619843422360278,0.02394106813996317,0.11262502245275131,1.0,14/58,15.72%,CAMK2N1;MEF2C;CD47;IL18;NINJ1;GPRC5B;DDT;SNCA;PLA2G7;AKIRIN2;CX3CL1;CEBPA;POLR3D;RNF185
gsea,Regulation Of Protein Transport (GO:0051223),-0.48876864451387997,-1.561102500452072,0.02857142857142857,0.11294002380711338,1.0,9/23,18.71%,HSPA8;DNAJA1;NDFIP1;STXBP5L;SNX3;NDFIP2;ATP13A2;SIRT6;PTPN1
gsea,Regulation Of Histone Deacetylation (GO:0031063),0.4944663974083323,1.5604629722220529,0.022774327122153208,0.1901990484636134,0.999,3/20,3.08%,YEATS2;BAZ2A;NIPBL
gsea,Fc Receptor Signaling Pathway (GO:0038093),0.4876867864662941,1.5602430564382896,0.027426160337552744,0.18865762530987742,0.999,7/22,11.53%,MAPK10;LCK;MAP3K7;SOS1;PLCG2;IKBKB;PLCG1
gsea,Positive Regulation Of Transferase Activity (GO:0051347),-0.3622171893946287,-1.5593736623068204,0.015267175572519083,0.11390472165325843,1.0,27/97,20.31%,HSP90AB1;RPS2;SERINC1;APOE;HSP90AA1;FGFR2;HNRNPA2B1;CCT2;PTGES3;PIN1;UBE2N;PINK1;PCNA;FGFR1;AXL;GINS2;TEK;DKC1;MAPK3;ARRDC4;GINS4;CSF1R;MAPKAPK5;RFC3;FBXW7;MAPK1;RAD50
gsea,Cellular Response To Hormone Stimulus (GO:0032870),-0.38828598150883215,-1.5592445782719409,0.005791505791505791,0.113589748300111,1.0,16/56,14.52%,HSPA8;KLF9;ATP1A1;ATP1A3;WBP2;MEF2C;CTSB;RAMP2;SFR1;GPR22;ATP1A2;SOX9;TRIM24;XBP1;ZFP36L1;RAMP1
gsea,Regulation Of Reactive Oxygen Species Metabolic Process (GO:2000377),-0.4466522198693075,-1.5579954388639936,0.02247191011235955,0.11427691893142909,1.0,8/30,8.77%,MT3;RAC1;ARF4;SNCA;PINK1;MPV17;ROMO1;EIF6
gsea,Regulation Of Striated Muscle Contraction (GO:0006942),-0.5354948237877923,-1.5566587164831969,0.02895752895752896,0.11489667234719754,1.0,3/16,0.25%,CALM1;CALM2;CALM3
gsea,Regulation Of Protein Export From Nucleus (GO:0046825),-0.5106268078146032,-1.5559783962467801,0.03718199608610567,0.11502893388344212,1.0,6/19,15.81%,PARK7;YWHAE;RBM22;EMD;GSK3B;SIRT6
gsea,Cellular Response To Reactive Oxygen Species (GO:0034614),-0.39788231160216486,-1.555048421676537,0.014285714285714285,0.11542500537741568,1.0,13/53,13.82%,MT3;JUN;RPS3;PRDX5;SQSTM1;TPM1;MPV17;ROMO1;CLU;PEX12;MAPK3;OSER1;RHOB
gsea,Potassium Ion Transmembrane Transport (GO:0071805),-0.35359468083898626,-1.5550344483348453,0.005504587155963303,0.11500031301490632,1.0,18/95,10.01%,ATP1B1;KCNJ3;KCNA1;GHITM;ATP1A1;ATP1A3;KCND2;KCNT2;KCNK2;KCNJ2;ATP1B2;KCNK1;KCNA2;KCNJ4;KCNN1;KCNA4;KCNJ13;ATP1A2
gsea,Calcium-Ion Regulated Exocytosis (GO:0017156),-0.49963095016698145,-1.5546286861488006,0.0196078431372549,0.11492921388838521,1.0,7/20,16.62%,RAB3A;VAMP2;SYT5;PPP3CB;SDF4;SYT11;SYT6
gsea,Regulation Of Protein Sumoylation (GO:0033233),-0.5401751960803285,-1.5543001351932426,0.04119850187265917,0.11474516436271541,1.0,5/15,17.42%,PARK7;EGR1;RASD2;MUL1;UBA2
gsea,Activation Of Protein Kinase B Activity (GO:0032148),-0.4990041488973818,-1.5541676316623587,0.037109375,0.11443636506881696,1.0,6/19,11.01%,MT3;PPIA;PARK7;IL18;PINK1;ADRA2C
gsea,Regulation Of Neuron Death (GO:1901214),-0.4046923227421182,-1.5535547028586936,0.021400778210116732,0.11455007605052425,1.0,9/47,8.33%,UBB;PRNP;PARK7;FAIM2;SNCB;MEF2C;EGR1;SNCA;CLU
gsea,Eye Morphogenesis (GO:0048592),0.5298188888025495,1.5528475496279697,0.04665314401622718,0.1968048345616854,0.999,6/16,13.34%,NF1;NIPBL;FBN2;COL5A1;COL5A2;RARG
gsea,Regulation Of Endopeptidase Activity (GO:0052548),-0.44035528739126933,-1.5523660555784076,0.031598513011152414,0.11515073755225898,1.0,9/31,15.85%,GAPDH;TIMP3;PSENEN;PSMA3;VTN;APH1A;PSME3;ATP13A2;PRELID1
gsea,Porphyrin-Containing Compound Biosynthetic Process (GO:0006779),-0.5172579274329339,-1.550740135763145,0.0419047619047619,0.11598788352414206,1.0,8/18,27.59%,PGRMC1;ALAD;NFE2L1;FXN;ABCB6;SLC25A38;COX15;FECH
gsea,Cyclic-Nucleotide-Mediated Signaling (GO:0019935),0.4628992876025293,1.5449159060964768,0.03682170542635659,0.20614865709405075,0.999,9/27,8.29%,PDE2A;GUCY1A2;PDE9A;AKAP6;ADCY2;PDE7B;HTR2C;DGKQ;ATF1
gsea,Protein Localization To Plasma Membrane (GO:0072659),0.339862881876661,1.5447160894304215,0.0019646365422396855,0.20447639524895916,0.999,35/112,14.77%,ANK3;SPTBN4;DPP6;CACNB2;DPP10;FCHO2;TTC7B;ROCK1;RAB40C;PACS1;ACTN2;CCDC88A;TSPAN14;PACSIN1;C2CD5;MAP7;FLNA;SEC16A;WNK3;IKBKB;RAPGEF6;ZDHHC2;HYCC1;TSPAN15;RAB3B;GAS6;EPB41L3;MYO5A;KCNB2;PKP2;SPTBN1;TNIK;ANK2;CLASP2;INPP5K
gsea,Positive Regulation Of Endothelial Cell Migration (GO:0010595),-0.3951248171845267,-1.5444335061599663,0.023166023166023165,0.1210143324429219,1.0,16/59,18.98%,HMGB1;TMSB4X;RAC1;CALR;EMC10;SEMA5A;PDCD6;PRKD1;NELL2;FGFR1;SPARC;TEK;RHOB;BMPR2;PLPP3;PDGFB
gsea,Actomyosin Structure Organization (GO:0031032),0.3871618995701021,1.5440773062806252,0.015184381778741865,0.20351094458540084,0.999,16/55,16.89%,SORBS1;EPB41L4B;EPB41L4A;FRMD5;ROCK1;ACTN2;EPB41L1;TJP1;CDC42BPA;TTN;EPB41L3;MYH9;PHACTR1;PGM5;MYH7;TMOD1
gsea,Regulation Of Cell Morphogenesis (GO:0022604),0.4480224617980728,1.5433057572395656,0.04048582995951417,0.20257857227333032,0.999,10/27,11.45%,MACF1;NTNG2;MYO9A;FMNL2;MOV10;ZMYM4;CAMSAP1;SH3D19;ZMYM6;ZRANB1
gsea,Release Of Cytochrome C From Mitochondria (GO:0001836),-0.5318825139979722,-1.5432994623071037,0.03944773175542406,0.12157661213735556,1.0,6/15,21.80%,BAX;BOK;CLU;TIMM50;FIS1;BBC3
gsea,Positive Regulation Of Neuron Apoptotic Process (GO:0043525),-0.5302793749484309,-1.5404797168386093,0.050387596899224806,0.12357713296115584,1.0,4/17,7.28%,PRNP;EPHA7;BAX;CDK5R1
gsea,Cellular Response To Oxidative Stress (GO:0034599),-0.3510413668865826,-1.540440051726441,0.0019342359767891683,0.12318931484377238,1.0,21/97,15.59%,MT3;PPIA;JUN;RPS3;PARK7;PRDX5;CHCHD2;SQSTM1;TPM1;PRKD1;SNCA;SRXN1;PINK1;MPV17;ROMO1;PARP1;PEX12;MAPK3;WNT16;ATP13A2;SLC25A24
gsea,Regulation Of Postsynaptic Membrane Potential (GO:0060078),0.4508726100828566,1.5396022530241131,0.026694045174537988,0.2062804059989216,0.999,6/28,5.91%,GRIN2A;GRIN1;GABRA2;GABRG3;CHRNA4;GRID2
gsea,Positive Regulation Of Endocytosis (GO:0045807),-0.4083241443157066,-1.5395376403762562,0.029850746268656716,0.12345056063775178,1.0,14/50,12.50%,CALY;APOE;CALR;CDC42;CD47;VPS28;SNCA;VTN;CLU;LMAN2;AXL;HNRNPK;CLIP3;CD151
gsea,protein-DNA Complex Assembly (GO:0065004),-0.41953971873163254,-1.5393166101389344,0.015209125475285171,0.12319643563172951,1.0,20/41,25.78%,H4C9;CHRAC1;NAP1L2;NAP1L1;NPM1;SOX9;MACROH2A1;GTF2H5;SPTY2D1;ASF1A;BRD2;NAA60;H2AX;CENPV;RAD51;DAXX;SSRP1;NAP1L3;BAZ1A;RSF1
gsea,Positive Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032436),-0.36577982436835055,-1.5391621557467963,0.006024096385542169,0.12291055945944081,1.0,28/73,26.65%,RACK1;SUMO2;ELOB;COP1;CSNK1E;GABARAP;RBX1;TRIB2;UBQLN2;ZYG11B;CLU;STUB1;GSK3B;CEBPA;DNAJB2;NOP53;DDA1;SMAD7;SIRT6;VCP;CSNK1A1;NUB1;UBQLN1;SUMO1;DVL1;KEAP1;RNF144B;PSMD10
gsea,Blood Vessel Diameter Maintenance (GO:0097746),0.5114151933403575,1.5376147063059173,0.04791666666666667,0.2073687822831444,0.999,6/17,11.36%,ROCK1;ECE1;NOS1;KCNMB4;ADCY6;KCNMB2
gsea,Regulation Of Cytosolic Calcium Ion Concentration (GO:0051480),0.44756943165855456,1.5368922827811788,0.027196652719665274,0.20658761528326747,0.999,6/28,6.06%,RYR2;ATP2B4;ATP2B3;TRPC5;TRPC6;TRPC3
gsea,Positive Regulation Of Release Of Cytochrome C From Mitochondria (GO:0090200),-0.5247183548719339,-1.5354296902470665,0.030797101449275364,0.12566928022061516,1.0,6/17,21.80%,MLLT11;BAX;PINK1;FAM162A;CIDEB;BBC3
gsea,Coenzyme A Metabolic Process (GO:0015936),-0.5353982665222395,-1.5349806536934685,0.04220183486238532,0.1256640707323445,1.0,8/15,23.95%,PPCS;SLC25A16;ACLY;NUDT19;NUDT7;PANK4;PANK3;NUDT8
gsea,Mitochondrion Disassembly (GO:0061726),-0.43358228298561796,-1.534937545471058,0.03006012024048096,0.12528539468744493,1.0,15/33,21.12%,GABARAPL1;GABARAPL2;SQSTM1;GABARAP;MAP1LC3B;FUNDC2;ATG12;PINK1;MAP1LC3A;CISD2;ATG3;ATG9A;FUNDC1;USP30;FIS1
gsea,Positive Regulation Of Interleukin-8 Production (GO:0032757),-0.4765333781911179,-1.5349310350742607,0.030249110320284697,0.12485146939085387,1.0,12/25,37.05%,HMGB1;PARK7;BCL10;HYAL2;MAVS;RELA;LAMTOR5;EHHADH;MYD88;HSPA1A;STAT3;DDIT3
gsea,Organic Cation Transport (GO:0015695),0.5227658030860565,1.5333219171120291,0.029045643153526972,0.209972146551988,0.999,6/17,16.26%,SLC35F3;SLC44A5;SLC22A4;SLC29A4;SLC44A2;SLC7A6
gsea,Regulation Of T Cell Receptor Signaling Pathway (GO:0050856),-0.49152523727850184,-1.5324190142866632,0.03018867924528302,0.12676548211620503,1.0,4/21,2.79%,PRNP;RPS3;DUSP3;CD81
gsea,Negative Regulation Of Growth (GO:0045926),-0.35804412095489674,-1.5313529604636766,0.007462686567164179,0.12729453019054404,1.0,35/79,31.09%,MT3;RACK1;NDUFA13;PPP2CA;PPP2R1A;RTN4;PML;RBBP7;INHBA;GJA1;OSGIN2;DNAJB2;CDKN1B;MUL1;BMPR2;BTG1;CGRRF1;ENO1;NDRG3;HYAL2;TGFB2;CCAR2;CRLF3;HYAL1;SPHK2;SERTAD2;ING1;TSPYL2;CDKN2D;STK11;NDUFS3;CAPRIN2;CCDC85B;SIPA1;FLCN
gsea,Photoperiodism (GO:0009648),-0.485340408647131,-1.5304156431068017,0.02736842105263158,0.12779945405913679,1.0,7/20,19.34%,USP2;PPP1CA;PML;ID2;PPP1CC;RBM4B;FBXL3
gsea,Positive Regulation Of Protein Modification Process (GO:0031401),-0.32716058623885613,-1.530017145703339,0.007220216606498195,0.12772175120980664,1.0,28/151,14.52%,CALM1;CALM2;MT3;PPIA;CALM3;RACK1;DYNLL1;RAC1;HSP90AA1;RASGRP1;VEGFC;EGR1;KRAS;PIN1;PINK1;HRAS;SOX9;VEGFB;CLIP3;FMR1;PPP1R7;TEK;LYN;MYDGF;MAPK3;ILK;ERP29;RAMP1
gsea,Cell-Cell Adhesion Via Plasma-Membrane Adhesion Molecules (GO:0098742),0.34904241301317884,1.5288654509148627,0.016666666666666666,0.21413638452574393,0.999,15/110,3.85%,TENM4;DSCAML1;PTPRS;NLGN1;TENM2;CNTN4;PKD1;SDK2;CDH12;TENM1;IGSF21;PTPRD;DSCAM;PTPRF;NECTIN1
gsea,Plasma Membrane Bounded Cell Projection Morphogenesis (GO:0120039),0.3950004051047922,1.5276016854526273,0.018255578093306288,0.21409895579375346,0.999,17/45,14.52%,NLGN1;TRIO;MYO9B;SHTN1;CNTNAP2;MAP4K4;DICER1;PACSIN1;NTF3;GAS7;SRGAP3;DNM2;EPB41L3;ANKRD27;TNIK;DAB2IP;SNX1
gsea,Regulation Of Glucose Metabolic Process (GO:0010906),0.4829510128203024,1.5273996034434298,0.040983606557377046,0.21248897515836468,0.999,6/21,11.71%,PRKN;GPLD1;RORA;DGKQ;AKT2;ADIPOR1
gsea,Regulation Of Transport (GO:0051049),-0.43068550029803926,-1.526527649466467,0.03490759753593429,0.13026616353898204,1.0,11/34,15.40%,VAMP2;ACTG1;REEP5;DNAJA1;ARL6IP5;SNCA;RAB11A;PINK1;SURF4;MUL1;YRDC
gsea,Monoatomic Cation Transport (GO:0006812),0.44743482492904074,1.5257230803892146,0.03434343434343434,0.21322880339336955,0.999,11/26,9.25%,GRIN2A;GRIN1;ANO6;TMEM63C;LRP2;TRPM7;TRPM3;TRPC6;ATP10D;ANO10;SLC29A4
gsea,Cholesterol Metabolic Process (GO:0008203),-0.40588950779596383,-1.5252162020845899,0.011673151750972763,0.1309015427161094,1.0,17/43,23.16%,APOE;LCAT;MSMO1;HMGCS1;SQLE;SNX17;PIP4P1;ACLY;HMGCR;ANGPTL3;INSIG2;INSIG1;FDX1;HSD17B7;FDFT1;GBA2;OSBPL5
gsea,Proteasomal Protein Catabolic Process (GO:0010498),-0.3156579062482678,-1.523158101743302,0.002008032128514056,0.13240451701925596,1.0,56/198,21.07%,ENC1;PSMC3;PSMB5;PSMA7;PSMC2;COP1;PSMA5;PSMA4;CCDC47;KCTD13;RNF187;PSMD2;PSMD4;TBL1XR1;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;PSMB3;FBXO9;PML;UBXN1;ZFAND2B;PSMA1;PSMC6;STUB1;PSMD6;RNF5;UCHL1;XBP1;GSK3B;PSMC1;KCTD17;ATE1;PEX12;PSMC4;TBL1X;SHARPIN;KLHDC2;PSMB6;SIAH3;PJA2;RNF185;PSMB7;PSMA2;PCNP;PRPF19;VCP;FBXW7;RNF126;RNF139;MAEA;CSNK1A1;UBXN6;GID4
gsea,Chordate Embryonic Development (GO:0043009),0.42555909496396627,1.5220631860494727,0.041666666666666664,0.21681925175577557,0.999,12/36,14.08%,PCSK5;PKD1;PTPRR;TGFBR1;XYLT1;PKD2;INTU;NOG;TRIM71;DEAF1;SOX8;PROX1
gsea,Cytoskeleton Organization (GO:0007010),0.3510158172733949,1.5200421903273018,0.015968063872255488,0.21795622307710544,1.0,28/88,14.21%,DST;BIN1;PCLO;FGD4;SIPA1L3;FMNL2;MICAL2;BRWD1;MICAL3;PACSIN1;ZMYM4;PRPF40A;CAMSAP1;PLCE1;RICTOR;MAST2;FGD1;MARK1;SH3D19;MTOR;ZMYM6;ZRANB1;MAST1;EPB41L3;KLHL20;CECR2;TNIK;NCKIPSD
gsea,N-glycan Processing (GO:0006491),0.5222996650023699,1.5190820412157826,0.039014373716632446,0.21765627829692272,1.0,5/16,13.54%,MAN2A1;MAN1C1;MAN2A2;GNPTAB;MAN1A2
gsea,Positive Regulation Of Cell Differentiation (GO:0045597),-0.32340000686635806,-1.5182174546573888,0.00597609561752988,0.1366168100923838,1.0,49/180,21.21%,HSP90AB1;ACTB;PCP4;PPP3CA;OLFM1;MEF2C;NEUROD2;BRINP3;IL18;GPRC5B;PRKD1;MTCH2;FGFR1;AKIRIN1;BRD7;MMD;SOX9;WWTR1;ADRA2C;CEBPB;BAMBI;MACROH2A1;GJA1;XBP1;GSK3B;RAP1A;ZFP36L1;ID2;RANBP3L;SMARCE1;BLOC1S5;TRIM32;SMAD2;SIRT6;BMPR2;GPC1;BTG1;NBL1;SOX4;ACTL6B;CREB1;BMP6;BMPR1B;ASCL1;SMARCB1;LMO3;PLCB1;PA2G4;RHOA
gsea,Entrainment Of Circadian Clock By Photoperiod (GO:0043153),-0.4925979035029323,-1.5151657068562594,0.05,0.13919680306006996,1.0,7/19,19.34%,USP2;PPP1CA;PML;ID2;PPP1CC;RBM4B;FBXL3
gsea,Negative Regulation Of Binding (GO:0051100),-0.38280085535944364,-1.5148810701034492,0.0225140712945591,0.13901424193517997,1.0,11/56,7.48%,RACK1;JUN;PARK7;TLE5;BAX;CSNK1E;PPP1CA;TFIP11;LRPAP1;PIN1;TMBIM6
gsea,Receptor Metabolic Process (GO:0043112),-0.49465793304288497,-1.5148386450594837,0.057494866529774126,0.13859396879179137,1.0,6/18,21.00%,NSG1;SH3GLB1;EHD3;PLEKHA3;PHETA1;RAB11B
gsea,Regulation Of Transcription By RNA Polymerase III (GO:0006359),0.4666548282878455,1.5141421855752057,0.0536480686695279,0.22281534604092268,1.0,8/23,10.86%,CHD8;RPTOR;TENM1;SF3B1;POLR3G;ICE2;BAZ1B;MTOR
gsea,Regulation Of Exocytosis (GO:0017157),-0.3967000792989821,-1.5139521290380038,0.01904761904761905,0.13915288850892826,1.0,10/44,11.05%,RAB3A;CPLX2;VAMP2;STXBP6;SEPTIN5;STXBP5L;SNCA;IL1RAPL1;RALA;CHMP6
gsea,Positive Regulation Of Nervous System Development (GO:0051962),0.41312633733434395,1.512087567597084,0.027888446215139442,0.22407498591210243,1.0,10/38,8.62%,CLSTN2;NLGN1;EPHB1;PTPRD;DLG5;LRP2;CUX2;GRID2;WNT7A;EPHB2
gsea,Regulation Of Cardiac Muscle Cell Contraction (GO:0086004),0.48585133293199345,1.5119188311906515,0.05263157894736842,0.2224358183964091,1.0,2/18,0.11%,RYR2;CACNA1C
gsea,Positive Regulation Of Cell Cycle G1/S Phase Transition (GO:1902808),0.42569944529548326,1.5097055161484807,0.027659574468085105,0.2240273027624836,1.0,7/32,6.94%,UBE2E2;FGF10;RPTOR;ANKRD17;STXBP4;CCND2;PLCG2
gsea,Long-Chain fatty-acyl-CoA Biosynthetic Process (GO:0035338),-0.5338320929614832,-1.5087218664654183,0.06578947368421052,0.14357676242670261,1.0,2/15,1.54%,TECR;ACSL3
gsea,Polyol Metabolic Process (GO:0019751),0.5204413161593407,1.5071496687337471,0.05761316872427984,0.22614214718640369,1.0,9/16,19.04%,IPPK;OCRL;SYNJ1;INPP5A;PPIP5K1;SLC5A3;INPP5B;PPIP5K2;IP6K1
gsea,Cardiac Muscle Cell Action Potential Involved In Contraction (GO:0086002),0.4881294656323811,1.5058779413586394,0.04365904365904366,0.22619930673248842,1.0,3/20,0.48%,RYR2;CACNA1C;SCN1A
gsea,Digestive Tract Development (GO:0048565),0.4766808540741083,1.505092308480384,0.06967213114754098,0.22569579989167365,1.0,5/23,3.08%,PCSK5;CHD8;PKD1;RARB;NIPBL
gsea,Synapse Organization (GO:0050808),0.333329429421675,1.5034432655251924,0.008097165991902834,0.2264066469344917,1.0,17/111,4.42%,PTPRS;ANK3;NLGN1;SHANK2;PAK3;CACNB2;CYFIP1;SDK2;UNC13B;PTPRD;DSCAM;MAPT;CTNND2;DNM3;PTPRF;SLC6A1;SHANK3
gsea,ncRNA Metabolic Process (GO:0034660),0.5181016545931391,1.5032106502969818,0.05737704918032787,0.2249975412682455,1.0,7/16,13.06%,DICER1;MAPT;KHSRP;TUT4;XPO5;TRIM71;TENT4B
gsea,Regulation Of DNA Repair (GO:0006282),-0.3264115697418067,-1.502701518717378,0.0039447731755424065,0.14903168519497503,1.0,35/122,21.34%,ACTB;RPS3;MORF4L1;MORF4L2;DEK;BCL7B;EYA1;UBE2N;USP22;PCNA;TAF10;BRD7;PML;PARP1;PPP4C;UBE2V1;RUVBL1;MRGBP;RNF168;BABAM2;ENY2;TADA2B;SMARCE1;YY1;BCL7C;ACTL6B;H2AX;TADA3;TAF5;UIMC1;SMARCB1;DMAP1;ACTR8;DPF2;TAF7
gsea,Lipid Translocation (GO:0034204),0.4769534821674914,1.5016897702527567,0.045454545454545456,0.2254576942488552,1.0,14/19,29.15%,ATP8A2;ATP8A1;ATP10D;ABCA4;ATP11C;ATP10B;ATP11B;ATP9B;ATP11A;ATP8B2;ABCB4;TMEM30A;ATP9A;ATP8B1
gsea,Negative Regulation Of Response To Endoplasmic Reticulum Stress (GO:1903573),-0.4757441216930123,-1.5014420976866674,0.03718199608610567,0.1497900530053068,1.0,7/22,12.93%,RACK1;PARK7;TMBIM6;CLU;UBXN1;XBP1;AQP11
gsea,Regulation Of Cellular Component Biogenesis (GO:0044087),-0.42729507671710476,-1.5011047618624016,0.041176470588235294,0.14963478828684085,1.0,17/31,26.84%,APOE;HSPA8;HSP90AA1;PINK1;HJURP;BAG5;ANKRA2;GFAP;EZR;RAP1A;HCFC1;RDX;TRAF2;PTPN11;BBS10;METTL18;RAP1B
gsea,Positive Regulation Of Protein Phosphorylation (GO:0001934),-0.30540514468614444,-1.5007967514709843,0.0,0.14945712743062753,1.0,39/239,13.02%,CALM1;CALM2;HSP90AB1;MT3;PPIA;CALM3;RACK1;PRNP;PFN2;RAC1;HSP90AA1;PARK7;RASGRP1;CD81;BDNF;SPRY2;VEGFC;PRKD1;PDGFA;KRAS;PIN1;SNCA;VTN;PINK1;HRAS;INHBA;BANK1;CSNK2B;MMD;SOX9;VEGFB;CX3CL1;CLIP3;FMR1;TEK;LYN;MYDGF;RAP1A;MAPK3
gsea,Protein Heterooligomerization (GO:0051291),0.5199074245532048,1.4986149397885602,0.03420523138832998,0.22833590535273945,1.0,10/16,19.28%,GRIN1;PKD1;FARSA;PKD2;CBR4;CPSF7;NUDT21;GRIN2B;KCNC2;TMEM120B
gsea,Regulated Exocytosis (GO:0045055),-0.41057061756335017,-1.498308406270273,0.03409090909090909,0.15155277934202158,1.0,15/43,21.00%,RAB3A;CPLX2;VAMP2;PPP3CB;SNCA;SNAP25;RAB31;LYN;TMED10;SDF4;SYT11;SYT6;RAB11FIP2;SYNGR1;RAB11B
gsea,Fc-epsilon Receptor Signaling Pathway (GO:0038095),0.48585729866861976,1.496908254286092,0.04791666666666667,0.22906643637846555,1.0,7/20,16.13%,MAPK10;MAP3K7;SOS1;PLCG2;IKBKB;PLCG1;FER
gsea,Carboxylic Acid Metabolic Process (GO:0019752),-0.500808036829089,-1.4967562922469926,0.05325443786982249,0.15255275484216407,1.0,11/19,31.58%,CARNMT1;N6AMT1;GSTO1;GNE;ST6GAL1;TBXAS1;GRHPR;GLUD1;SLC2A1;GSTO2;PTGIS
gsea,Homophilic Cell Adhesion Via Plasma Membrane Adhesion Molecules (GO:0007156),0.4005325702736475,1.496515579682293,0.04132231404958678,0.2279133444265738,1.0,13/45,15.21%,DSCAML1;CNTN4;PKD1;SDK2;IGSF21;DSCAM;NECTIN1;PTK7;CNTN6;CADM1;L1CAM;CDH13;ROBO1
gsea,Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903320),-0.4248473756611077,-1.4949298698971165,0.046,0.15388633464587098,1.0,8/29,13.25%,HSP90AB1;HSP90AA1;COPS6;EGR1;PINK1;GPS1;COPS8;DNAJB2
gsea,Positive Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000060),-0.35406077588812473,-1.4943499755895226,0.020491803278688523,0.15396297192506891,1.0,31/73,29.35%,RACK1;SUMO2;ELOB;COP1;CSNK1E;GABARAP;RBX1;TRIB2;ZYG11B;CLU;STUB1;GSK3B;CEBPA;DNAJB2;LAPTM5;NOP53;DDA1;SMAD7;VCP;FBXW7;RNF139;CSNK1A1;NUB1;SUMO1;DVL1;KEAP1;RNF144B;PSMD10;PTEN;RCHY1;RNF19B
gsea,Integrated Stress Response Signaling (GO:0140467),-0.4622590641143698,-1.4932793477448243,0.06420233463035019,0.154603610584832,1.0,6/23,13.01%,JUN;CEBPD;JUNB;CEBPB;MAF;CEBPA
gsea,Keratinocyte Differentiation (GO:0030216),-0.5031839711232334,-1.492256104758319,0.06513409961685823,0.15513292706509133,1.0,7/17,21.91%,PPP3CA;KRT10;FGFR1;WNT16;JAG1;ADAM9;CFLAR
gsea,Endosome Transport Via Multivesicular Body Sorting Pathway (GO:0032509),-0.470251130909107,-1.4897463481780178,0.05046728971962617,0.15715063216869563,1.0,10/21,20.81%,LEPROT;CHMP2A;CHMP6;LEPROTL1;TMEM50A;TMEM50B;CHMP4C;CHMP7;VCP;UBXN6
gsea,Regulation Of Osteoblast Differentiation (GO:0045667),-0.3784586675573933,-1.4890123903201413,0.03571428571428571,0.15733368330350359,1.0,15/62,19.37%,DDX5;PPP3CA;FGFR2;MEF2C;PRKD1;RIOX1;RORB;SOX9;WWTR1;BAMBI;RANBP3L;BMPR2;LIMD1;BMP6;BMPR1B
gsea,Small GTPase Mediated Signal Transduction (GO:0007264),0.34406435026827303,1.4889862296173915,0.02301255230125523,0.23740954773994316,1.0,28/87,11.25%,RGL2;SHTN1;NF1;RALGPS1;TNK2;BCR;RGL1;DOK5;CCDC88A;RAPGEF4;RASGRF2;SOS1;RAPGEFL1;DOK6;RASGEF1B;KRIT1;CCDC88C;TIAM1;RAPGEF6;PLCE1;RALGPS2;USP8;RUNDC3A;ARHGAP18;RASGRF1;ARHGEF18;RIT1;ARL3
gsea,Positive Regulation Of Wound Healing (GO:0090303),0.49854833988886227,1.488413732439982,0.06517311608961303,0.23661016246362124,1.0,6/19,10.86%,SMOC2;PRKCE;RREB1;ARFGEF1;PTK2;MTOR
gsea,Negative Regulation Of Actin Filament Polymerization (GO:0030837),-0.4923677122553777,-1.4882231365394134,0.07086614173228346,0.15759896076748825,1.0,5/18,12.31%,TMSB4X;PFN2;PFN1;TWF1;HIP1R
gsea,Positive Regulation Of Apoptotic Signaling Pathway (GO:2001235),-0.41358183882552735,-1.4872572343975659,0.04021937842778794,0.15813461572401175,1.0,20/39,31.88%,RACK1;RPS3;BAX;BOK;PML;GSDME;BCL10;CTSH;TNFSF12;FIS1;HYAL2;BBC3;TRAF2;PAK2;SEPTIN4;CTSS;CTSL;STYXL1;DEDD2;CYLD
gsea,Heterotypic Cell-Cell Adhesion (GO:0034113),-0.5145523000584092,-1.4870019699506531,0.05410821643286573,0.15792480888816146,1.0,3/15,7.62%,CTNNA3;NINJ1;ITGAV
gsea,Negative Regulation Of Response To Stimulus (GO:0048585),-0.41258976370135614,-1.4859495786835175,0.03696498054474708,0.1584898215612813,1.0,13/35,19.60%,RPS3;TLE5;APLP2;KLF7;CLU;HHIP;LYN;AQP11;PIM3;EPHA4;UBASH3B;PTPN1;THY1
gsea,Embryonic Heart Tube Morphogenesis (GO:0003143),0.44798477623492333,1.4857715961828515,0.04878048780487805,0.23938777724945612,1.0,5/23,10.80%,RYR2;MICAL2;PKD2;NPHP3;SMO
gsea,Regulation Of AMPA Receptor Activity (GO:2000311),0.4529096001931557,1.4849287397631397,0.05172413793103448,0.23897876572388693,1.0,11/23,20.86%,NLGN1;SHISA9;SHANK3;SHANK1;CACNG3;RELN;SHISA7;CACNG8;SHISA6;CACNG2;CACNG4
gsea,Cell Morphogenesis Involved In Neuron Differentiation (GO:0048667),-0.35331084244983096,-1.484854490038812,0.01972386587771203,0.15910740186917882,1.0,14/70,6.84%,APLP1;PLPPR4;RAB3A;MAP1B;NTNG1;APLP2;FGFR2;MAP1A;BTBD3;MEF2C;TMEM106B;SLITRK2;KLF7;CCK
gsea,Central Nervous System Neuron Differentiation (GO:0021953),0.46349651560250354,1.4844903759042458,0.0497131931166348,0.23799624236912253,1.0,9/24,6.58%,TAOK1;KNDC1;MAPT;MDGA2;MAP2;MDGA1;GRID2;NTRK2;SPOCK1
gsea,"Retrograde Transport, Endosome To Golgi (GO:0042147)",-0.3543131361921383,-1.4840070213604286,0.021653543307086614,0.15956064831367286,1.0,24/72,23.27%,TMED9;VPS29;RAB6B;BET1L;ARL1;RAB6A;STX16;EHD3;VTI1B;SNX3;PLEKHA3;SURF4;LMAN1;GOSR1;SNX5;VAMP3;VPS35;PHETA1;RNF126;CLN5;TBC1D10B;VPS52;ARFRP1;VPS26B
gsea,Regulation Of Blood Vessel Endothelial Cell Migration (GO:0043535),-0.40158062215213086,-1.4828041913466086,0.02857142857142857,0.16037926184460838,1.0,8/37,11.99%,HMGB1;TMSB4X;APOE;MEF2C;PRKD1;FGFR1;CSNK2B;ANGPT2
gsea,miRNA-mediated Gene Silencing (GO:0035195),0.4487109533762523,1.4820438688077564,0.047151277013752456,0.23996911944041205,1.0,8/24,11.07%,TNRC6C;MOV10;AGO4;XPO5;TNRC6B;NCBP1;TRIM71;CNOT1
gsea,Response To Alcohol (GO:0097305),0.5058829707224711,1.4819721740309004,0.07231404958677685,0.23835842513361796,1.0,4/17,2.11%,GRIN2A;SLIT1;GRIN1;TGFBR1
gsea,Release Of Sequestered Calcium Ion Into Cytosol (GO:0051209),0.43929077398496885,1.4818303310241454,0.04516129032258064,0.23694448350916,1.0,9/29,11.53%,RYR2;FLNA;LCK;HTR2C;PLCG2;PLCH1;PKD2;PLCE1;PLCG1
gsea,Regulation Of Axonogenesis (GO:0050770),0.39795163071634565,1.4811489602570387,0.03792415169660679,0.23616541106570155,1.0,9/40,8.02%,PLXNA4;PAK3;MARK2;PLXNC1;PLXNA2;NTRK2;BRSK1;PLXNA3;TIAM1
gsea,"Regulation Of Alternative mRNA Splicing, Via Spliceosome (GO:0000381)",0.37389367143813057,1.4809138135755606,0.03468208092485549,0.23494678610270378,1.0,14/50,12.22%,RBFOX1;RBFOX3;CELF4;SRRM4;CELF5;RBM25;RBFOX2;RBM5;CELF3;TIA1;SMU1;YTHDC1;FAM172A;TRA2B
gsea,Cellular Response To Amino Acid Starvation (GO:0034198),-0.4027860874649164,-1.4796650455592266,0.0408997955010225,0.1633506309017305,1.0,11/37,19.64%,SESN1;RRAGA;PRKD1;SH3GLB1;RRAGD;ITFG2;MAPK3;SEH1L;KICS2;SESN3;MAPK1
gsea,Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903050),-0.45287353112829043,-1.479510244809868,0.04873294346978557,0.16301757415952223,1.0,9/22,22.35%,UBB;UBE3A;USP14;PINK1;PSME3;EPHA4;TMF1;NUB1;PRKACA
gsea,Mitotic G2 DNA Damage Checkpoint Signaling (GO:0007095),0.4621215232606561,1.4795099834212209,0.0546875,0.2355746902839394,1.0,10/21,20.21%,TAOK1;BRSK1;TOPBP1;FOXN3;DONSON;CHEK1;TAOK2;TRIM39;MRNIP;CDC14B
gsea,Negative Regulation Of Translation (GO:0017148),-0.33331977564120197,-1.4772828052042624,0.023529411764705882,0.1648162972115515,1.0,20/92,16.89%,GAPDH;ENC1;RACK1;RPS3;RPL13A;CALR;SERBP1;IGF2BP3;TOB1;BTG2;NCL;EIF6;DHFR;YBX1;FMR1;EIF4EBP2;IGFBP5;PARP16;PUM1;EPHA4
gsea,Regulation Of Peptidase Activity (GO:0052547),-0.5001045924448879,-1.4765015065215323,0.049429657794676805,0.16508315681905691,1.0,8/17,16.57%,CST3;NDUFA13;CTSB;PSMA3;PINK1;CSTB;ATP13A2;CTSH
gsea,Vesicle Coating (GO:0006901),-0.4458524485844608,-1.4762540311579,0.05389221556886228,0.16486134527822208,1.0,16/27,35.04%,TRAPPC6B;PDCD6;TMED2;TRAPPC2L;TRAPPC2;TRAPPC1;TMED10;AP3S2;AP3M2;PEF1;TRAPPC4;TRAPPC6A;TRAPPC12;TRAPPC10;TRAPPC3;PREB
gsea,ncRNA-mediated Post-Transcriptional Gene Silencing (GO:0035194),0.4969354921810264,1.476154081374243,0.06464646464646465,0.23877525792932758,1.0,6/16,11.07%,TNRC6C;MOV10;CELF1;TNRC6B;NCBP1;CNOT1
gsea,Regulation Of Apoptotic Signaling Pathway (GO:2001233),-0.40994735113043634,-1.4747462904483088,0.03896103896103896,0.16596968254292555,1.0,9/35,16.57%,PPIA;RPS3;FAIM2;GRINA;BDNF;TMBIM6;CX3CL1;NR4A2;CTSH
gsea,Regulation Of Anatomical Structure Morphogenesis (GO:0022603),0.33452292582226506,1.474103095338836,0.017716535433070866,0.24009390563935346,1.0,28/102,15.73%,TANC2;HECW1;PAK3;SRCIN1;MARK2;KNDC1;FMNL2;NF1;MAPT;ZMYM4;BCL6;CLASP1;SHANK3;LZTS3;BRSK1;SEMA4D;CAMSAP1;KRIT1;LZTS1;SH3D19;ZMYM6;ZRANB1;STAT2;TNIK;SIPA1L1;CLASP2;BMPER;NEDD4L
gsea,Cellular Response To Glucose Starvation (GO:0042149),-0.4197632577535601,-1.4739197489841802,0.06407766990291262,0.16626328330307,1.0,7/31,19.59%,SESN1;SH3GLB1;HNRNPA1;ITFG2;XBP1;KICS2;SESN3
gsea,Dendrite Morphogenesis (GO:0048813),0.42232113256683745,1.4734091644832137,0.05304518664047151,0.23950855829163561,1.0,15/33,14.48%,PAK3;DOCK10;EPHB1;CTNND2;SHANK3;SHANK1;MAP2;DIP2A;CHRNA7;WNT7A;EPHB2;DLG4;FARP1;TAOK2;PHACTR1
gsea,Fc-gamma Receptor Signaling Pathway (GO:0038094),0.47141331799348446,1.4732810343474665,0.05625,0.23803885224424196,1.0,7/19,16.45%,PRKCE;PLPP4;LCK;PTK2;FYN;LIMK1;PRKCD
gsea,Regulation Of Cation Channel Activity (GO:2001257),-0.3940879176737572,-1.4717197445472399,0.027559055118110236,0.1680244624152106,1.0,6/42,6.63%,CALM1;CALM2;VAMP2;FKBP1A;FGF13;JPH3
gsea,Synaptic Vesicle Exocytosis (GO:0016079),-0.41755668761094367,-1.471356640790314,0.04206500956022945,0.16787594340507897,1.0,7/35,7.56%,RAB3A;CPLX2;VAMP2;SYT5;SNAP47;SNCA;SNAP25
gsea,Positive Regulation Of Telomere Maintenance Via Telomere Lengthening (GO:1904358),-0.4195032464568773,-1.4709106107271837,0.047244094488188976,0.16795190046046232,1.0,10/31,19.64%,HNRNPA2B1;CCT2;CCT6A;HNRNPA1;CCT7;MAPK3;CCT5;CCT8;MAPKAPK5;MAPK1
gsea,Axon Extension (GO:0048675),-0.4594046210084128,-1.4704579696317452,0.051330798479087454,0.167815289898848,1.0,6/22,7.20%,HSP90AB1;HSP90AA1;MAP1B;SEMA5A;PPP3CB;NELL2
gsea,Mitotic G1 DNA Damage Checkpoint Signaling (GO:0031571),-0.4877919891343184,-1.4702240813287732,0.06469500924214418,0.16753614244822554,1.0,7/19,14.91%,RPL26;PLK2;TRIAP1;PML;RPS27L;SDE2;CDKN1B
gsea,Regulation Of Cell-Substrate Junction Assembly (GO:0090109),0.4690622711891168,1.4697906673053949,0.06439393939393939,0.24192886569172944,1.0,9/21,15.59%,MACF1;LIMCH1;ROCK1;CLASP1;PTK2;FYN;SLC9A1;EPHA3;PTPRA
gsea,Regulation Of Protein Localization To Nucleus (GO:1900180),-0.40852218978208055,-1.4683109366957023,0.048582995951417005,0.16909535410386783,1.0,17/39,34.60%,PARK7;YWHAZ;PPP3CB;GLUL;PIN1;WWTR1;CTNNA1;GSK3B;ATP13A2;JAK1;SIN3A;BYSL;LAMTOR5;LATS2;FLCN;TPR;SUMO3
gsea,Regulation Of Cell Cycle Process (GO:0010564),-0.33785587526700883,-1.4664472937816135,0.011583011583011582,0.1707235485717435,1.0,13/100,8.63%,CALM1;CALM2;CALM3;RPL17;CDC42;CETN2;KLHL9;BCL7B;SH3GLB1;PIN1;PDXP;RAB11A;BRD7
gsea,Phospholipid Translocation (GO:0045332),0.43466308452309604,1.4651296130716642,0.048,0.2473421893014192,1.0,16/24,29.15%,ANO6;ATP8A2;ATP8A1;ATP10D;PLSCR4;ABCA4;ATP11C;ATP10B;ATP11B;ATP9B;ATP11A;ATP8B2;ABCB4;TMEM30A;ATP9A;ATP8B1
gsea,Positive Regulation Of Peptidyl-Serine Phosphorylation (GO:0033138),-0.37363062690543847,-1.4649371180122994,0.03898635477582846,0.17189088150370246,1.0,9/49,7.41%,HSP90AB1;PFN2;HSP90AA1;PARK7;BDNF;SPRY2;PRKD1;SNCA;PINK1
gsea,Early Endosome To Late Endosome Transport (GO:0045022),0.44893292842182914,1.4648419012781788,0.05708661417322835,0.24611398193216813,1.0,10/21,21.74%,HOOK1;EEA1;PTPN23;HOOK2;ANKRD27;HOOK3;STX8;KIF16B;PXK;WDR81
gsea,Regulation Of NIK/NF-kappaB Signaling (GO:1901222),-0.39335090992022287,-1.463909507794548,0.03296703296703297,0.17246692688129153,1.0,14/47,21.21%,TMSB4X;C1QTNF4;RPS3;EZR;ILK;LAPTM5;TRIM44;NLRC3;CD27;PHB2;UACA;NFKBIA;TSPAN6;RHOA
gsea,Cortical Actin Cytoskeleton Organization (GO:0030866),0.4808134672501911,1.4639012982989437,0.04899777282850779,0.24606025790426797,1.0,4/18,7.96%,FMNL2;ROCK1;FMNL1;IKBKB
gsea,tRNA Processing (GO:0008033),-0.38266905762622205,-1.4629436596080236,0.03171641791044776,0.17302188004972494,1.0,13/45,20.70%,THUMPD1;FAM98B;RPP21;KTI12;WDR4;ZBTB8OS;RTCB;TRDMT1;FARS2;DDX1;RTRAF;PTCD1;LCMT2
gsea,Regulation Of Phagocytosis (GO:0050764),-0.44468090053298776,-1.4608309047068917,0.06427221172022685,0.1748830140588579,1.0,9/30,17.85%,RACK1;CALR;CD47;ITGAV;SNX3;LMAN2;SYT11;HCK;DOCK2
gsea,Signal Release From Synapse (GO:0099643),-0.41026380247024025,-1.460437680936608,0.06299212598425197,0.17478523414618388,1.0,7/36,8.98%,RAB3A;CPLX2;VAMP2;LIN7C;SNCA;SNAP25;LIN7B
gsea,Positive Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071902),-0.34450165701372254,-1.4604189225262996,0.017110266159695818,0.17429961167463176,1.0,11/81,8.80%,CALM1;CALM2;CALM3;RASGRP1;MEF2C;DIRAS2;PPP2CA;PDGFA;SNCA;FGFR1;HRAS
gsea,Ephrin Receptor Signaling Pathway (GO:0048013),0.4091955591860232,1.459711960597481,0.051181102362204724,0.25118954101733076,1.0,14/36,10.75%,ANKS1B;PAK3;KALRN;ARHGEF28;EPHA10;EPHB1;PTK2;EFNA1;TIAM1;EPHB2;EFNB2;ARHGEF7;FYN;EPHA6
gsea,Cytokine-Mediated Signaling Pathway (GO:0019221),-0.3284271272486686,-1.458264171847027,0.020484171322160148,0.17605677113995988,1.0,37/112,25.39%,MT3;TMSB4X;APLP2;EIF5A;RRAGA;IL18;EGR1;CSNK2B;TXNDC17;CX3CL1;P4HB;EPO;LYN;CEBPA;MAPK3;JAGN1;ILK;EPOR;ADIPOR2;IRAK4;HCK;COMMD7;CSF1R;PDGFB;CRLF2;NFKBIA;PLCB1;TRAF3IP2;CXCL12;PRKACA;IL13RA1;TRAF2;JAK1;PTPN11;AKT1;FOXO3;RELA
gsea,Autophagy Of Mitochondrion (GO:0000422),-0.38785671089026796,-1.4581684359180394,0.047244094488188976,0.1756433182715245,1.0,17/44,21.12%,GABARAPL1;GABARAPL2;SQSTM1;GABARAP;MAP1LC3B;FUNDC2;ATG12;PINK1;MAP1LC3A;RIMOC1;CISD2;ATG3;PHB2;ATG9A;FUNDC1;USP30;FIS1
gsea,Regulation Of Protein-Containing Complex Disassembly (GO:0043244),0.4923603836944853,1.4580168124748754,0.0728744939271255,0.25216663513626747,1.0,8/15,27.28%,GSPT1;IGF1R;TBC1D25;CLEC16A;HDAC6;OGFOD1;BNIP3;INSR
gsea,Mitotic DNA Damage Checkpoint Signaling (GO:0044773),0.3863780075433379,1.4579214812783674,0.035343035343035345,0.2507077204038563,1.0,18/42,20.21%,TAOK1;PRKDC;BRSK1;TOPBP1;NEK11;FOXN3;TIPIN;DONSON;CHEK2;HUS1;CHEK1;TAOK2;FANCD2;RAD17;TRIM39;STK33;MRNIP;CDC14B
gsea,Lipid Modification (GO:0030258),0.4138021401500374,1.455688624674972,0.04722792607802875,0.25263094284217924,1.0,8/28,7.61%,DGKG;DGKH;PLPP4;PLPPR1;DGKQ;DGKB;MBOAT2;DGKI
gsea,Muscle Cell Differentiation (GO:0042692),0.4442722966030247,1.455415566718319,0.06277056277056277,0.2514784218236843,1.0,9/23,11.10%,SYNE1;DMD;ACTN2;RORA;MRTFA;BVES;SGCZ;ACTN4;SPEG
gsea,Regulation Of Signal Transduction (GO:0009966),-0.308701536204868,-1.4547002705146737,0.021032504780114723,0.17913782584530785,1.0,35/146,19.72%,PPIA;PRNP;YWHAG;NUCKS1;FGFR2;RGS2;SNW1;NCK1;SEMA5A;FRRS1L;PPP2CA;PPP2R1A;RGS4;PRKD1;MTCH1;CLU;SNX3;HHIP;IGFBP7;ZFAND2B;CX3CL1;PIGBOS1;KCTD12;CD63;SLC8A2;ILK;SHARPIN;IGFBP5;CDC42SE2;ZDHHC17;UBASH3B;PTPN1;LURAP1L;KCTD16;NCAM1
gsea,Regulation Of Ubiquitin-Protein Transferase Activity (GO:0051438),-0.4446713909390986,-1.4533379828873594,0.06513409961685823,0.1801875858205874,1.0,8/26,15.55%,RPS2;PARK7;PIN1;UBE2N;PINK1;BAG5;ARRDC4;SMAD7
gsea,Cholesterol Homeostasis (GO:0042632),-0.40914585123317654,-1.45293156791659,0.05904059040590406,0.18008984423783733,1.0,13/37,19.03%,APOE;CNBP;IL18;LCAT;DGAT2;XBP1;FABP3;LDLR;ANGPTL3;MINAR2;RALY;INSIG1;EHD1
gsea,Regulation Of Protein Localization To Cell Surface (GO:2000008),-0.44021554914289973,-1.452064179176869,0.06431535269709543,0.18059436561754386,1.0,4/26,3.74%,HSP90AB1;MAP1A;BDNF;LEPROT
gsea,Negative Regulation Of Neuron Death (GO:1901215),-0.3588331000490217,-1.4520414698541002,0.038817005545286505,0.18010861487223612,1.0,11/67,9.84%,MT3;APOE;SET;PARK7;BDNF;MEF2C;SOD1;SNCA;PINK1;CLU;RASA1
gsea,Cellular Response To Starvation (GO:0009267),-0.32625142455496653,-1.4499092039375787,0.019569471624266144,0.18190915051297527,1.0,20/97,15.96%,GABARAPL1;HSPA8;SESN1;GABARAPL2;GABARAP;RRAGA;MAP1LC3B;PRKD1;SH3GLB1;HNRNPA1;RRAGD;ITFG2;MAP1LC3A;XBP1;MAPK3;SEH1L;KLF10;BMPR2;KICS2;LAMP2
gsea,Brain Development (GO:0007420),0.31511468030428863,1.4498347389834152,0.015717092337917484,0.25838824351798895,1.0,20/131,5.66%,CNTN5;DSCAML1;GRIN2A;GRIN1;FLNB;CHD8;CNTN4;NF1;CNTNAP2;SPEF2;NIPBL;ATXN1;ZFHX2;SHANK3;SYNJ1;EML1;NFASC;NCOA6;NFIB;MDGA1
gsea,Axon Development (GO:0061564),-0.3396274991060645,-1.4494729916220659,0.03088803088803089,0.1818518852410315,1.0,19/82,10.31%,APLP1;PLPPR4;RAB3A;MAP1B;NTNG1;APLP2;BHLHE22;FGFR2;MAP1A;SEMA5A;NEUROD2;SLITRK2;KLF7;CCK;CDK5R1;RTN4;DHFR;SLITRK5;SLITRK3
gsea,Inositol Lipid-Mediated Signaling (GO:0048017),0.4485657517404471,1.4479580585084502,0.07083333333333333,0.2598159915505023,1.0,10/26,11.53%,KCNH1;PITPNM2;OCRL;INPP5A;PLCG2;GAB2;PLCH1;IGF1R;PLCE1;PLCG1
gsea,intra-Golgi Vesicle-Mediated Transport (GO:0006891),-0.4233143389083246,-1.4461690874665025,0.0536480686695279,0.18532963372609174,1.0,10/29,16.48%,GABARAPL2;RAB6B;RAB6A;NAPG;VTI1B;COPG2;COPG1;GOSR1;COPB2;NSF
gsea,Regulation Of Nitric Oxide Biosynthetic Process (GO:0045428),-0.4519980353980874,-1.4461375318191076,0.07765151515151515,0.1848189372374049,1.0,5/23,8.33%,HSP90AB1;RAC1;HSP90AA1;CD47;CLU
gsea,Regulation Of Lamellipodium Assembly (GO:0010591),-0.43756972123447613,-1.445699139511318,0.07569721115537849,0.18484171129550034,1.0,8/27,12.71%,RAC1;BRK1;CDC42;ARPC2;ACTR2;AKIRIN1;TWF1;PIK3R1
gsea,Cellular Response To BMP Stimulus (GO:0071773),-0.4154841754191438,-1.445438371452315,0.06358381502890173,0.18459478068947044,1.0,12/31,26.47%,DDX5;INHBA;SOX9;MAPK3;BMPR2;BMP6;BMPR1B;SMAD9;TGFB2;VSTM2A;SMAD5;BMPR1A
gsea,Regulation Of Dendritic Spine Morphogenesis (GO:0061001),0.4210761654670666,1.4453017672122725,0.06611570247933884,0.26247783973890315,1.0,9/29,9.26%,NLGN1;TANC2;SRCIN1;SHANK3;CUX2;LRP8;LZTS3;EFNA1;RELN
gsea,Positive Regulation Of DNA Repair (GO:0045739),-0.33491093641142233,-1.4449672342199686,0.02091254752851711,0.18451053853402902,1.0,23/81,21.19%,ACTB;HMGB1;RPS3;BCL7B;EYA1;UBE2N;PCNA;BRD7;PARP1;RUVBL1;RNF168;BABAM2;SPIRE1;SMARCE1;SIRT6;YY1;BCL7C;ACTL6B;H2AX;UIMC1;SMARCB1;ACTR8;DPF2
gsea,Endoplasmic Reticulum To Golgi Vesicle-Mediated Transport (GO:0006888),-0.32520794106921097,-1.4443623710427083,0.012903225806451613,0.18464456231447066,1.0,38/98,28.31%,RAB2A;TRAPPC6B;TMED9;ARF4;PDCD6;VAPA;TMED2;IER3IP1;TRAPPC2L;TRAPPC2;RAB1B;TMED4;LMAN2;TMED7;TRAPPC1;SAR1A;TMED10;LMAN1;COPG2;COPG1;GOSR1;SEC13;YIPF4;COPB2;YIF1B;TMED1;USE1;COPE;MIA3;PEF1;TMED5;KDELR1;ARCN1;TRAPPC4;BCAP29;MPPE1;WHAMM;SAR1B
gsea,COPII Vesicle Coating (GO:0048208),-0.4860961804139773,-1.444137917478545,0.076171875,0.1838475266675019,1.0,12/18,35.04%,PDCD6;TMED2;TRAPPC2L;TRAPPC2;TRAPPC1;TMED10;PEF1;TRAPPC4;TRAPPC6A;TRAPPC12;TRAPPC3;PREB
gsea,"Vesicle Targeting, Rough ER To cis-Golgi (GO:0048207)",-0.4860961804139773,-1.444137917478545,0.076171875,0.1838475266675019,1.0,12/18,35.04%,PDCD6;TMED2;TRAPPC2L;TRAPPC2;TRAPPC1;TMED10;PEF1;TRAPPC4;TRAPPC6A;TRAPPC12;TRAPPC3;PREB
gsea,Response To Glucose (GO:0009749),-0.4089052785761282,-1.4429599098233652,0.05168986083499006,0.1847763272671521,1.0,10/33,19.56%,RACK1;VAMP2;SELENOT;ZBTB20;IRS2;PFKL;XBP1;EIF2B5;SOX4;UCP2
gsea,Sterol Homeostasis (GO:0055092),-0.4040480115101195,-1.4422206687671395,0.06343283582089553,0.18514001857284004,1.0,13/38,19.03%,APOE;CNBP;IL18;LCAT;DGAT2;XBP1;FABP3;LDLR;ANGPTL3;MINAR2;RALY;INSIG1;EHD1
gsea,Negative Regulation Of Secretion By Cell (GO:1903531),-0.45837443445792614,-1.4418526076296159,0.054901960784313725,0.1850589690847497,1.0,11/20,22.74%,APOE;STXBP6;SNCA;IL1RAPL1;CHGA;HMGCR;ERP29;SYT11;VAMP3;SLC30A1;DPH3
gsea,Neuron Projection Morphogenesis (GO:0048812),0.31446967292611716,1.4407682893432894,0.018218623481781375,0.26814107779048507,1.0,33/131,8.62%,DSCAML1;ANK3;NLGN1;SPTBN4;PAK3;CNTN4;TRIO;DOCK10;NTNG2;EPHB1;ROCK1;SHTN1;DOCK7;CNTNAP2;MAP4K4;DICER1;CTNND2;ADGRB1;PACSIN1;LRP2;SHANK3;DCC;TRIM46;NTF3;SHANK1;MAP2;BRSK1;GAS7;DIP2A;PLXNA3;SRGAP3;WNT7A;EPHB2
gsea,Associative Learning (GO:0008306),0.4898068215188274,1.4406458655734016,0.06832298136645963,0.2666511768181594,1.0,5/15,5.99%,GRIN1;NF1;SLC6A1;SHANK1;BRSK1
gsea,Lipid Droplet Organization (GO:0034389),-0.46238544632915335,-1.440488970422552,0.06716417910447761,0.186052409329578,1.0,8/21,21.93%,PPIA;SQLE;RAB18;CDS2;FAF2;CIDEA;CIDEB;FITM2
gsea,Macroautophagy (GO:0016236),-0.3318319581431976,-1.439969541279838,0.03909465020576132,0.18607112446358146,1.0,30/94,25.25%,GABARAPL1;CALR;ARL8B;GABARAPL2;SQSTM1;GABARAP;MAP1LC3B;VPS28;PIP4K2A;ATG12;VTI1B;CHMP2A;TSG101;CHMP6;MAP1LC3A;STAM2;VPS4A;ATP13A2;SNAP29;LAMP2;CHMP4C;CHMP7;VCP;YOD1;UBXN6;UBQLN1;ATG10;HDAC10;VPS36;STAM
gsea,Negative Regulation Of Protein Localization To Membrane (GO:1905476),-0.47100702726353255,-1.4395250488962128,0.07228915662650602,0.18609301225574104,1.0,3/18,5.64%,TMEM59;AP2M1;LRPAP1
gsea,Positive Regulation Of Protein Kinase Activity (GO:0045860),-0.3255037008375546,-1.4394889080212157,0.024029574861367836,0.18561488337792512,1.0,11/103,8.33%,CALM1;CALM2;HSP90AB1;CALM3;PRNP;HSP90AA1;PPP2CA;GPRC5B;EGR1;SNCA;CLU
gsea,Nucleosome Assembly (GO:0006334),-0.4036048665989369,-1.4389831380084896,0.045627376425855515,0.18572588131274614,1.0,19/36,29.74%,H4C9;CHRAC1;NAP1L2;NAP1L1;NPM1;SOX9;MACROH2A1;SPTY2D1;ASF1A;BRD2;NAA60;H2AX;DAXX;SSRP1;NAP1L3;BAZ1A;RSF1;GRWD1;ASF1B
gsea,Negative Regulation Of MAPK Cascade (GO:0043409),-0.35932239343312783,-1.4385343952382212,0.022988505747126436,0.18577128256317813,1.0,37/75,33.85%,PPIA;PEBP1;APOE;DUSP3;RGS2;SPRY2;TIMP3;DUSP7;GSTP1;PPP2R1A;PIN1;UCHL1;LYN;EZR;EPHA4;DUSP8;PTPN1;DUSP5;LMO3;HYAL2;CD300A;DUSP16;P2RX7;PIK3CB;PSMD10;PTEN;DUSP6;PIK3R2;DAG1;IGBP1;SMPD1;FLCN;DLG1;SIRPA;CNKSR3;SPRED1;SMAD4
gsea,Positive Regulation Of Cell Population Proliferation (GO:0008284),-0.28982443314144735,-1.437561063508413,0.008912655971479501,0.18627333679469832,1.0,72/290,19.94%,ACTB;GLP2R;RPL17;RPS6;RPS4X;CALR;RPS15A;COX17;SLC25A5;FGFR2;NME2;CNBP;CD81;RPS9;DNAJA2;MEF2C;COPS9;VEGFC;CD47;BCL7B;IL18;RNF187;FAM98B;PDGFA;KRAS;IRS2;ITGAV;ROMO1;FGFR1;NAP1L1;CDK4;BAD;NPM1;HRAS;EAPP;HMGN5;SOX9;WWTR1;CX3CL1;BAMBI;TSPYL5;EPO;GJA1;XBP1;GNAI2;EGR4;LYN;AQP11;DHPS;NME1;ID2;EPOR;POU3F3;SIRT6;CNOT8;HCK;SS18;CTSH;SSR1;EPHA4;CSF1R;SOX4;BCL7C;FXN;ACTL6B;PDGFB;PFDN1;BMP6;PDGFD;CNOT6L;SLC35F6;CRLF2
gsea,Fc-gamma Receptor Signaling Pathway Involved In Phagocytosis (GO:0038096),0.48526638118848825,1.436647246958087,0.0744466800804829,0.27156376019484474,1.0,6/16,16.45%,PRKCE;PLPP4;PTK2;FYN;LIMK1;PRKCD
gsea,Lipid Transport (GO:0006869),-0.3583217594910179,-1.4358269592735504,0.041353383458646614,0.18779705979101913,1.0,28/66,29.01%,PLPPR4;APOE;VAPA;TRIAP1;FABP5;GOT2;SCP2;PRELID3A;NME4;FABP3;LDLR;PLTP;FABP7;PRELID1;SLC10A3;LYPLA1;ABCA6;PITPNB;OSBPL5;ARID4A;SLCO1C1;MFSD2A;SLC25A17;GM2A;SLCO2B1;CLN8;TTPA;EHHADH
gsea,Nucleotide-Sugar Biosynthetic Process (GO:0009226),-0.493706771271882,-1.4348502927039863,0.051233396584440226,0.18837787323396674,1.0,7/15,32.19%,PMM1;GMPPB;GNPNAT1;GNPDA1;UAP1;PGM3;GFPT2
gsea,ERK1 And ERK2 Cascade (GO:0070371),-0.5084671125480311,-1.434078178039359,0.08935361216730038,0.1888366112916029,1.0,8/17,19.64%,MT3;DUSP7;ITGAV;SOX9;ZFP36L1;CTSH;DUSP5;MAPK1
gsea,Peptidyl-Proline Modification (GO:0018208),-0.4671825894699128,-1.4335186375770264,0.06042884990253411,0.18902041150528498,1.0,6/20,14.20%,PPIA;FKBP1A;PPIB;PIN1;FKBP7;PPIC
gsea,Positive Regulation Of Protein Localization To Plasma Membrane (GO:1903078),0.3756709416381864,1.4327074142916665,0.05010438413361169,0.27649016116635833,1.0,9/41,8.62%,SORBS1;DPP10;ATP2B4;PRKCE;PLS1;WNK3;ITGA3;ZDHHC2;EPHB2
gsea,Negative Regulation Of Blood Vessel Endothelial Cell Migration (GO:0043537),-0.4353290693651668,-1.4296915480978223,0.07086614173228346,0.19304878608122913,1.0,5/23,11.99%,HMGB1;APOE;MEF2C;CSNK2B;ANGPT2
gsea,Negative Regulation Of Response To Biotic Stimulus (GO:0002832),-0.4253943340232664,-1.4292310163739081,0.0697211155378486,0.1930831565124312,1.0,11/28,26.18%,BANF1;YWHAZ;ATG12;C1QBP;PARP1;MUL1;NLRC3;TRAF3IP1;AKT1;MAPKBP1;RNF26
gsea,Negative Regulation Of Cellular Component Organization (GO:0051129),-0.36017414804208764,-1.4290396520530786,0.04032258064516129,0.19274852456486835,1.0,19/54,19.28%,HSPA8;DNAJB6;CDC42;SPRY2;WASL;HSPA2;TFIP11;PRKD1;CLU;GSK3B;CRYAB;DNAJB2;LCMT1;SYT11;NOP53;TRAF3IP1;SVIP;RDX;BMP6
gsea,Glutamate Metabolic Process (GO:0006536),-0.4872178356685333,-1.4273534409884459,0.082,0.19426751466431716,1.0,10/16,38.78%,GLUL;GOT2;GCLM;ALDH5A1;DGLUCY;GLUD1;GLS;GCLC;GOT1;OAT
gsea,Glucose Metabolic Process (GO:0006006),-0.38004946138635765,-1.4265126779721955,0.06043956043956044,0.1947379326382908,1.0,9/42,10.62%,MDH2;PGAM1;MDH1;TPI1;PGK1;IRS2;ENO2;G6PC3;PGAM2
gsea,Positive Regulation Of Autophagy (GO:0010508),-0.3393396381995393,-1.4263385735863097,0.0390625,0.1943731787732753,1.0,15/81,12.39%,HMGB1;PARK7;SESN1;TMEM59;BNIP3L;SQSTM1;PLK2;PRKD1;SH3GLB1;PINK1;BAD;PAFAH1B2;SCOC;GSK3B;MTDH
gsea,Nervous System Development (GO:0007399),0.2802130639390602,1.4258429296631925,0.014314928425357873,0.2865417439617219,1.0,64/335,9.78%,DSCAML1;RBFOX1;RBFOX3;NLGN1;SHANK2;NAV2;ASIC2;KALRN;CNTN4;PRKN;MYT1L;NTN5;IL1RAPL2;SRRM4;PKD1;SDK2;SCN8A;APC;EPHB1;NRG1;TGFBR1;TENM1;NOTCH2;NF1;FGF14;DSCAM;RBFOX2;CHRM3;TRPC5;VPS13B;ADGRB1;KCNQ2;DNM3;PTPRZ1;ATXN1;PAX6;PLPPR1;SHANK3;NAV1;LGI1;MDGA2;NTF3;NFASC;DHX30;CDON;MDGA1;SPOCK1;RAPGEFL1;PKD2;ZDHHC2;IGF2BP2;GRIK1;ADGRB2;EPHB2;INTU;TRAK2;RPS6KA6;NOG;RELN;RBM45;FAT4;CNTN6;TRIM71;CABLES1
gsea,Positive Regulation Of Protein Transport (GO:0051222),-0.36665960005934384,-1.4255686832180137,0.040152963671128104,0.19486597860587201,1.0,18/54,23.80%,PPIA;RACK1;VAMP2;ACSL3;OAZ1;IER3IP1;VPS28;TMED10;EZR;RUFY3;ATP13A2;ZFAND1;ADAM9;BMP6;CNST;TGFB2;MYH10;ARF6
gsea,Positive Regulation Of Neuron Death (GO:1901216),-0.43273869089084394,-1.4250233963626648,0.07392996108949416,0.1949891007101777,1.0,6/26,8.33%,PRNP;EPHA7;BAX;SNCA;CDK5R1;CLU
gsea,Cell Junction Assembly (GO:0034329),0.3393581397021532,1.4249055488009494,0.03711340206185567,0.286403020487933,1.0,13/75,4.84%,NLGN1;SHANK2;SDK2;MYO9A;CDH12;DSCAM;PKP4;CTNND2;DNM3;TJP1;TLN2;SHANK3;SH3BP1
gsea,Neuron Development (GO:0048666),0.30625095731316254,1.424790236313261,0.023622047244094488,0.2848768347217311,1.0,28/125,8.22%,TENM4;NLGN1;TENM2;CNTN4;MYT1L;TAOK1;SRRM4;TMEM108;TENM1;TBCD;ROCK1;DMD;DOCK7;CNTNAP2;LAMB1;BICDL1;VPS13B;MAPT;ATP8A2;LGI1;MAP2;MICALL1;NTRK2;CAMSAP1;WNK1;PBX4;GPRIN3;FRYL
gsea,Response To Endoplasmic Reticulum Stress (GO:0034976),-0.33292460223399767,-1.4244701658233416,0.02490421455938697,0.19508341042567334,1.0,30/88,24.62%,JUN;SELENOK;NCK1;BAX;PDIA3;CCDC47;PDIA6;DNAJB9;RNF5;CEBPB;P4HB;XBP1;GSK3B;PIK3R1;RNF185;TMCO1;TMEM33;CREB3L2;EIF2B5;VCP;OS9;RNF139;UBXN6;BBC3;UBQLN1;ATG10;TRAF2;BRSK2;DERL1;HSP90B1
gsea,Response To Purine-Containing Compound (GO:0014074),0.4799818524982231,1.4239572038737762,0.0811965811965812,0.28458508809970295,1.0,4/16,8.29%,RYR2;TRPC3;DGKQ;ATF1
gsea,Positive Regulation Of Programmed Cell Death (GO:0043068),-0.3027998309132439,-1.4237299110915747,0.0186219739292365,0.19550489999900744,1.0,31/163,14.61%,HMGB1;RACK1;OLFM1;JUN;RPS6;DNAJA1;MLLT11;ARL6IP5;BNIP3L;SQSTM1;BAX;SOD1;TRIM35;SAP18;USP27X;MTCH1;MTCH2;SNCA;BOK;CLU;BAD;C1QBP;CTNNBL1;CLIP3;DDX20;HIP1R;UBE2Z;UTP11;RHOB;HSPD1;LAPTM5
gsea,Regulation Of Peptidyl-Serine Phosphorylation (GO:0033135),-0.34257514293151176,-1.4235794440883642,0.03861003861003861,0.19514292719179288,1.0,11/66,7.41%,HSP90AB1;RACK1;PFN2;HSP90AA1;PARK7;BDNF;NCK1;SPRY2;PRKD1;SNCA;PINK1
gsea,Regulation Of Gluconeogenesis (GO:0006111),0.42816123971861847,1.4233641766870297,0.054279749478079335,0.2838971227862852,1.0,4/24,8.75%,GCK;USP7;DGKQ;PTPN2
gsea,DNA Replication (GO:0006260),-0.3608070766744425,-1.4228490503201658,0.04013961605584642,0.19546891731162377,1.0,25/63,32.79%,PTMS;SET;CHRAC1;NAP1L1;RPA3;TOP1MT;RNASEH1;DUT;POLDIP2;RFC3;MCM6;TBRG1;BAZ1A;WDR18;RNASEH2A;POLD2;GRWD1;PCLAF;POLL;FAM111A;POLD3;FEN1;HELB;RFC5;TOP1
gsea,Signal Transduction By P53 Class Mediator (GO:0072331),-0.4480052696449731,-1.4226247940575354,0.07471264367816093,0.19526374534582727,1.0,3/22,7.22%,DDX5;TRIAP1;BOK
gsea,Histone Lysine Methylation (GO:0034968),0.4071679648179074,1.421684384230754,0.07551020408163266,0.28492635996082744,1.0,10/29,12.33%,KMT2A;NCOA6;SETDB1;KMT2C;HCFC2;EHMT2;KMT2B;PAXIP1;MLLT10;DPY30
gsea,Protein Homotetramerization (GO:0051289),-0.39480139555275795,-1.421481438553045,0.05046728971962617,0.1960787329062,1.0,19/35,34.58%,ALDOA;APLP2;KCNJ2;CLU;AQP4;ACOT13;SAMHD1;KCNJ12;HSD17B10;CBY1;B2M;TRPM4;RYR1;GLS;APIP;USP16;CRYZ;ALDH9A1;GOLGA2
gsea,Positive Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043123),-0.31988765099050553,-1.4214634955846221,0.028037383177570093,0.19558043162115676,1.0,41/113,26.32%,GAPDH;FKBP1A;NDFIP1;PLK2;VAPA;GPRC5B;PRKD1;UBE2N;PINK1;TMED4;PARP1;CXXC5;UBE2V1;CX3CL1;GJA1;MTDH;NDFIP2;TMEM9B;SHARPIN;MUL1;TRIM32;BCL10;IRAK4;ZDHHC17;NEK6;DDX1;PELI2;TBK1;TSPAN6;TRAF3IP2;RHOA;LURAP1;CFLAR;JMJD8;MIB2;TRAF2;MAVS;NUP62;RELA;GOLT1B;TRIM8
gsea,SMAD Protein Signal Transduction (GO:0060395),-0.4533859524659824,-1.420917804061071,0.08620689655172414,0.19570221172549535,1.0,8/23,25.58%,JUN;INHBA;SMAD2;SMAD7;BMP6;SMAD9;TGFB2;SMAD5
gsea,Cellular Response To Chemical Stress (GO:0062197),-0.3412035825709188,-1.4205656870831116,0.04436229205175601,0.19561499900379323,1.0,10/72,7.41%,MT3;PPIA;PARK7;PRDX5;CHCHD2;PRKD1;RBX1;SNCA;SRXN1;PINK1
gsea,Excitatory Postsynaptic Potential (GO:0060079),0.48337670040161934,1.4204953147609245,0.09033613445378151,0.28502972273638555,1.0,3/15,5.91%,GRIN2A;GRIN1;GRID2
gsea,Glycosphingolipid Biosynthetic Process (GO:0006688),0.4821803685242153,1.4198824012254638,0.09297520661157024,0.284417514112839,1.0,3/16,8.21%,ST6GALNAC3;ST6GALNAC5;LARGE1
gsea,Positive Regulation Of Tumor Necrosis Factor Production (GO:0032760),-0.406242087502841,-1.4197854859570689,0.07103825136612021,0.19608752654116643,1.0,5/37,8.33%,HMGB1;C1QTNF4;RASGRP1;DDT;CLU
gsea,mRNA Splice Site Recognition (GO:0006376),0.4149555545887542,1.419643177508399,0.07442748091603053,0.2830928816452476,1.0,11/28,13.92%,CELF4;SFSWAP;PRPF39;CELF5;CELF3;SETX;YTHDC1;KHDC4;SRSF1;SRSF5;SRSF6
gsea,Regulation Of T Cell Differentiation (GO:0045580),-0.40459028510806533,-1.419256762798356,0.064030131826742,0.19618267129980346,1.0,9/30,19.88%,ACTB;SOD1;BRD7;XBP1;CLPTM1;SMARCE1;PRELID1;ACTL6B;SMARCB1
gsea,Insulin Receptor Signaling Pathway (GO:0008286),0.3947343292319811,1.418700005209673,0.07370517928286853,0.28308820582466016,1.0,13/39,17.62%,SORBS1;GPLD1;STXBP4;C2CD5;IDE;PIK3R3;AKT2;IGF1R;PTPN2;AP3S1;FER;SLC39A14;SOGA1
gsea,Regulation Of Protein Kinase Activity (GO:0045859),-0.3247706885830516,-1.4181419123612995,0.029876977152899824,0.19694015888745184,1.0,28/92,24.81%,PPIA;CAMK2N1;YWHAG;PARK7;RAP2B;SOD1;GSTP1;TRIB2;SNCA;MMD;WWTR1;CAMK2N2;RAP1A;AKT1S1;UBASH3B;JTB;WARS1;THY1;RTRAF;TAF7;DBNDD1;DUSP19;XRCC6;DAXX;PAK2;DVL1;AKT1;DBNDD2
gsea,Negative Regulation Of Protein Polymerization (GO:0032272),-0.43494729755252565,-1.4175043386960355,0.068359375,0.19720549439043017,1.0,8/24,12.31%,PFN2;TUBB4A;STMN1;SNCA;PFN1;TWF1;CLIP3;HIP1R
gsea,Protein Localization To Cell Periphery (GO:1990778),0.3110042025538282,1.4167908993276637,0.013671875,0.2847525006472732,1.0,35/116,14.77%,ANK3;SPTBN4;DPP6;CACNB2;DPP10;FCHO2;TTC7B;ROCK1;RAB40C;PACS1;ACTN2;TSPAN14;PACSIN1;C2CD5;MAP7;FLNA;SEC16A;WNK3;IKBKB;RAPGEF6;ZDHHC2;HYCC1;ARL3;TSPAN15;RAB3B;GAS6;EPB41L3;MYO5A;KCNB2;PKP2;SPTBN1;TNIK;ANK2;CLASP2;INPP5K
gsea,Regulation Of Interleukin-10 Production (GO:0032653),-0.4864128018359032,-1.416433559734662,0.08208955223880597,0.1979776661744234,1.0,3/17,6.66%,HMGB1;CD47;TRIB2
gsea,Regulation Of Platelet Aggregation (GO:0090330),0.4920934210957425,1.4162449123917926,0.11666666666666667,0.28412360448692225,1.0,2/15,6.89%,PRKG1;JAK2
gsea,Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001242),-0.3956310096111462,-1.415206967328338,0.06839186691312385,0.19903857102751,1.0,16/35,33.39%,RACK1;NDUFA13;BOK;PINK1;GSDME;P4HB;NOL3;FIS1;BBC3;UBQLN1;SEPTIN4;STYXL1;NDUFS3;HERPUD1;CYLD;NOC2L
gsea,Regulation Of Vascular Endothelial Growth Factor Receptor Signaling Pathway (GO:0030947),-0.46623282063349447,-1.4146832107481466,0.06639839034205232,0.19919421631682288,1.0,3/17,7.32%,MT3;PDCD6;VTN
gsea,snRNA Metabolic Process (GO:0016073),0.44562613803668394,1.4146156922721076,0.06365503080082136,0.28539530914044675,1.0,10/21,29.61%,INTS11;INTS2;INTS6;TUT1;INTS4;INTS7;ZCCHC8;INTS14;INTS3;MEPCE
gsea,Regulation Of Myeloid Cell Differentiation (GO:0045637),-0.45963503589248145,-1.4145422785995503,0.07738095238095238,0.19882973788336064,1.0,6/20,17.72%,MEF2C;EIF6;PURB;LYN;HSPA9;SKIC8
gsea,Axonogenesis (GO:0007409),0.2983765966437417,1.4140300298548814,0.013888888888888888,0.2848018940699526,1.0,39/164,10.75%,CNTN5;DSCAML1;ANK3;SLIT1;SPTBN4;PAK3;KALRN;CNTN4;MYCBP2;TRIO;SEMA5B;CYFIP1;EPHA10;NTNG2;EPHB1;NOTCH2;SHTN1;DOCK7;DSCAM;TNR;SPG11;LGI1;DCC;TRIM46;NFASC;BRSK1;SOS1;SEMA4D;PTK2;EFNA1;PLXNA3;WNT7A;EPHB2;RELN;CNTN6;EFNB2;FYN;NEO1;EPHA6
gsea,Negative Regulation Of Endothelial Cell Proliferation (GO:0001937),-0.46217267691546826,-1.4103316072157113,0.0838095238095238,0.20372215189388507,1.0,3/19,3.63%,APOE;NR2F2;MEF2C
gsea,Positive Regulation Of Telomerase Activity (GO:0051973),-0.4184896387249858,-1.4078739943433574,0.07072691552062868,0.20620044287931066,1.0,8/27,19.64%,HSP90AB1;HSP90AA1;CCT2;PTGES3;DKC1;MAPK3;MAPKAPK5;MAPK1
gsea,Cellular Response To Organic Cyclic Compound (GO:0071407),-0.32300018429390065,-1.406925423674545,0.03488372093023256,0.20688466086804952,1.0,21/102,13.39%,ACTB;HSPA8;ATP1A1;H2AZ1;GABRG2;ATP1A3;GNG2;ARL6IP5;MEF2C;P2RY12;IL18;EGR1;PDXP;CLU;GNAI1;ATP1A2;CTNNA1;EZR;RAP1A;ZFP36L1;SSTR2
gsea,Microtubule Polymerization Or Depolymerization (GO:0031109),-0.45936774265440017,-1.406737414873056,0.08641975308641975,0.20661744963045092,1.0,5/18,6.48%,STMN3;FGF13;STMN4;STMN1;PIN1
gsea,Positive Regulation Of Blood Vessel Endothelial Cell Migration (GO:0043536),-0.4107529834902552,-1.4050152262082856,0.07183364839319471,0.20818945026543803,1.0,4/29,8.12%,HMGB1;TMSB4X;PRKD1;FGFR1
gsea,Neurotransmitter Secretion (GO:0007269),-0.3828174688199632,-1.4048717196610097,0.0703125,0.20785821821775805,1.0,7/41,8.98%,RAB3A;CPLX2;VAMP2;LIN7C;SNCA;SNAP25;LIN7B
gsea,Positive Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:1900087),0.40739605656730876,1.4032763986973482,0.06170212765957447,0.3018267021226384,1.0,5/26,6.87%,UBE2E2;FGF10;RPTOR;ANKRD17;CCND2
gsea,Regulation Of Adenylate Cyclase Activity (GO:0045761),0.4854683307781161,1.4032431885097467,0.10222222222222223,0.30019881962259864,1.0,3/15,2.70%,CACNA1C;GABBR2;NF1
gsea,Negative Regulation Of Protein Ubiquitination (GO:0031397),-0.3706463915924186,-1.4031243164213973,0.061452513966480445,0.20950777003981416,1.0,12/45,17.89%,RPS3;PARK7;DNAJA1;SPRY2;SQSTM1;VPS28;UBXN1;BAG5;IVNS1ABP;SMAD7;U2AF2;SOX4
gsea,Cellular Response To Calcium Ion (GO:0071277),0.34353727119645283,1.4015045438304485,0.04782608695652174,0.3016039067909183,1.0,15/57,14.88%,NLGN1;CACNA1A;ADCY8;GPLD1;RYR3;SYT17;KCNH1;PLCG2;ITPKB;PKD2;CPNE1;SYT1;ITPKC;CPNE8;IQGAP1
gsea,Regulation Of Inflammatory Response (GO:0050727),-0.3155289439435197,-1.4010570485012934,0.03571428571428571,0.2116669403497754,1.0,31/118,22.24%,TMSB4X;CAMK2N1;APOE;VAMP2;PARK7;CD47;IL18;NINJ1;GPRC5B;DDT;GPS2;SNCA;PLA2G7;OTULIN;SPATA2;CX3CL1;TEK;METRNL;CEBPA;SHARPIN;NLRC3;VAMP3;SEMA7A;HCK;VPS35;DAGLB;NFKBIA;SHPK;HYAL2;LETMD1;IL10RA
gsea,Eye Development (GO:0001654),0.39970414699114665,1.3991697209360785,0.06100217864923747,0.3039182591917832,1.0,10/38,12.12%,CACNA1C;SIPA1L3;NIPBL;FBN2;PAX6;ADAMTS18;PBX4;COL5A1;MEIS2;COL5A2
gsea,Regulation Of Cell Adhesion (GO:0030155),0.312753451318118,1.398674100614415,0.0371900826446281,0.3032255700985157,1.0,20/98,8.62%,PLXNA4;EPB41L4B;NRG1;RIPOR2;PLXNC1;FRMD5;ROCK1;DSCAM;LAMB1;PKP4;TNR;PLXNA2;LAMC1;ABL2;SEMA4D;PTK2;EFNA1;PLXNA3;ZDHHC2;EPHB2
gsea,Potassium Ion Transport (GO:0006813),0.3190895396750297,1.3973117131933384,0.041758241758241756,0.3041136239964346,1.0,37/89,19.10%,KCNAB1;KCND3;KCNN3;KCNK9;KCNK13;KCNJ6;KCNH1;KCNQ2;SLC9A7;SLC24A2;SLC24A3;KCNMA1;KCNQ3;KCNQ5;KCNG3;SLC24A4;SLC9A5;PKD2;KCNK12;KCNMB4;KCNMB2;SLC9A1;KCNH8;KCNB2;KCNA6;KCNG1;TMEM175;NALCN;KCNN2;SLC9A9;KCNH7;KCNIP2;HCN1;HPN;KCNC2;KCNK10;ABCC8
gsea,Positive Regulation Of Cell Adhesion (GO:0045785),-0.3541290387474613,-1.3958085555863233,0.06205673758865248,0.2177129264330471,1.0,19/55,22.64%,RAC1;PPP3CA;P2RY12;CD47;TPM1;CITED2;ITGAV;C1QBP;P4HB;SMAD7;EPHA4;RELL2;PLPP3;ADAM9;PDGFB;ARL2;CXCL12;MEGF10;TGFB2
gsea,Phosphatidic Acid Biosynthetic Process (GO:0006654),0.42601639893736887,1.3955150521085045,0.08829174664107485,0.3055545017099654,1.0,5/24,7.54%,DGKG;DGKH;DGKQ;DGKB;MBOAT2
gsea,DNA Methylation (GO:0006306),0.45943413123889637,1.3951346722802371,0.08091286307053942,0.30461070304377086,1.0,10/18,23.73%,BAZ2A;EHMT1;ATRX;EHMT2;KMT2E;PICK1;DNMT3B;ZDBF2;BEND3;DNMT3A
gsea,Positive Regulation Of Smooth Muscle Cell Proliferation (GO:0048661),-0.42618241634536125,-1.3903567286475806,0.09345794392523364,0.22422667787384618,1.0,13/26,31.47%,JUN;IL18;CX3CL1;GJA1;ID2;IGFBP5;PDGFB;AKT1;MFN2;BMPR1A;FOXP1;NOX1;NR4A3
gsea,Regulation Of Neuron Projection Development (GO:0010975),0.2985458362426518,1.3900894246099453,0.03219315895372234,0.31220641095081,1.0,32/151,10.03%,PTPRS;NLGN1;TANC2;LRRC7;PAK3;MYCBP2;SRCIN1;MARK2;NTNG2;KNDC1;NTRK3;CSMD3;TNR;CCDC88A;SHANK3;DCC;LZTS3;RTN4RL1;ABL2;NTRK2;BRSK1;SPOCK1;SETX;CAMK2G;ULK4;P3H1;ROR1;PTK7;RELN;ADCY6;EFNB2;MARK1
gsea,Regulation Of Double-Strand Break Repair Via Homologous Recombination (GO:0010569),-0.34472784180536375,-1.3894637677411636,0.047619047619047616,0.22490835872303225,1.0,22/60,31.66%,ACTB;MORF4L1;MORF4L2;POLQ;ACTR2;PARP1;PPP4C;RUVBL1;MRGBP;SIRT6;SHLD1;DMAP1;KMT5A;MAD2L2;RAD51;UBQLN4;EPC2;KAT5;USP51;YEATS4;ACTL6A;HELB
gsea,Negative Regulation Of Catabolic Process (GO:0009895),-0.35975984669209843,-1.3866913789781634,0.054924242424242424,0.22808620853832365,1.0,8/52,8.67%,RPS7;RPL5;RPL11;CST3;RPL17;PIN1;SNX3;PML
gsea,Regulation Of Epidermal Growth Factor Receptor Signaling Pathway (GO:0042058),0.38440123788367925,1.3863532206686264,0.07855626326963906,0.31708287954684355,1.0,14/34,16.18%,SHKBP1;ZFYVE28;CCDC88A;CBL;RHBDF1;PDE6H;PTPN2;MVB12B;HIP1;CDH13;DAB2IP;PTPN3;FER;MVP
gsea,Morphogenesis Of An Epithelium (GO:0002009),-0.47378272722763476,-1.3860982386861211,0.09406952965235174,0.2283772710227074,1.0,6/18,17.46%,ACTG1;LIN7C;FGFR2;SOX9;VCL;TRAF3IP1
gsea,Positive Regulation Of Response To Endoplasmic Reticulum Stress (GO:1905898),-0.48783428381669325,-1.3859450134687363,0.11242603550295859,0.22800885161068665,1.0,6/15,15.72%,NCK1;BAX;BOK;XBP1;PIK3R1;RNF185
gsea,Peptidyl-Tyrosine Dephosphorylation (GO:0035335),0.408657200574685,1.3852049939566418,0.0944206008583691,0.317533325802624,1.0,6/26,8.75%,PTPRS;PTPRR;PTPRZ1;PTPRF;PTPN5;PTPN2
gsea,Response To Amyloid-Beta (GO:1904645),0.4158138256763959,1.3838970007814617,0.08048289738430583,0.31822281914631706,1.0,7/25,10.19%,GRIN2A;GRIN1;CACNA1A;CACNA1B;CHRNA7;IGF1R;FYN
gsea,Multivesicular Body Organization (GO:0036257),-0.3915356582450549,-1.3816817532738956,0.07648183556405354,0.2330268275595667,1.0,10/28,17.53%,VPS28;RAB11A;CHMP2A;TSG101;CHMP6;STAM2;VPS4A;UBAP1;CHMP4C;CHMP7
gsea,Receptor Recycling (GO:0001881),-0.4791039029365396,-1.381269736587554,0.10396975425330812,0.23298638421141835,1.0,8/16,31.39%,NSG1;EHD3;PLEKHA3;PEX12;PHETA1;RAB11B;PEX5;PLEKHJ1
gsea,Regulation Of NLRP3 Inflammasome Complex Assembly (GO:1900225),-0.44664301045873755,-1.3809572190500574,0.08840864440078586,0.2328166384128769,1.0,4/20,5.73%,USP50;HSPA8;PPP2CA;PRKD1
gsea,Fc Receptor Mediated Stimulatory Signaling Pathway (GO:0002431),0.4536065732558848,1.3808380185524516,0.10973084886128365,0.3221007046076391,1.0,6/18,16.45%,PRKCE;PLPP4;PTK2;FYN;LIMK1;PRKCD
gsea,Regulation Of Vascular Endothelial Growth Factor Signaling Pathway (GO:1900746),0.44574165402081534,1.3807306104797759,0.08113590263691683,0.3206213129949301,1.0,3/17,2.00%,SMOC2;CCBE1;NRG1
gsea,Regulation Of Vesicle-Mediated Transport (GO:0060627),-0.32505166955039627,-1.3804237329119762,0.045364891518737675,0.23294627736503062,1.0,21/77,21.11%,RAB3A;CPLX2;VAMP2;SEPTIN5;BET1L;STXBP5L;RAB11A;SNX17;RALA;HIP1R;MAPK3;PACSIN2;RUFY1;APEX1;NSF;AP2S1;PTPN1;MAPK1;RNF139;RAB11B;RAB5B
gsea,Myeloid Cell Differentiation (GO:0030099),-0.3763437910194606,-1.3803387811418415,0.0807899461400359,0.23246815755512,1.0,11/41,16.40%,RPS14;SLC25A5;INHBA;CEBPB;EPO;MAF;LYN;CEBPA;RPS19;KAT6A;HSPA9
gsea,Sulfur Compound Catabolic Process (GO:0044273),-0.45997139770129847,-1.380000437107701,0.09922178988326848,0.23244373894781473,1.0,7/17,23.95%,TST;SUCLG1;GPC1;NUDT19;NUDT7;FITM2;NUDT8
gsea,Long-Chain Fatty Acid Transport (GO:0015909),-0.4603340873483436,-1.3798899291250124,0.09879032258064516,0.2320346848122949,1.0,4/18,11.91%,APOE;ACSL3;FABP5;FABP3
gsea,Regulation Of Androgen Receptor Signaling Pathway (GO:0060765),-0.4477322184203101,-1.3793559397090585,0.08817635270541083,0.23221613404164848,1.0,3/20,6.95%,DDX5;PARK7;RNF6
gsea,Golgi Vesicle Transport (GO:0048193),-0.29003704525076474,-1.379295999629769,0.011928429423459244,0.23173867874693743,1.0,42/171,19.10%,RAB2A;TRAPPC6B;TMED9;ARF4;GABARAPL2;RAB6B;PDCD6;VAPA;TMED2;IER3IP1;PRKD1;RAB6A;ARF3;TRAPPC2L;NAPG;EHD3;VTI1B;ARF5;TRAPPC2;SNX3;RAB1B;TMED4;LMAN2;TMED7;TRAPPC1;SAR1A;TMED10;SURF4;LMAN1;COPG2;COPG1;GOSR1;SPIRE1;RER1;YIPF4;COPB2;YIF1B;NSF;TMED1;PLPP3;SCAMP3;USE1
gsea,Response To Retinoic Acid (GO:0032526),-0.3904060875863916,-1.3785353143999335,0.08778625954198473,0.23220858398961922,1.0,17/35,31.07%,SNW1;NDUFA13;BRINP3;RORB;SOX9;FZD4;GSK3B;LYN;CTSH;CREB1;ASCL1;HTRA2;LTK;RXRB;CDKN2D;TESC;POLR2D
gsea,Plasma Membrane Bounded Cell Projection Assembly (GO:0120031),0.2748810636219716,1.3781502155224654,0.019823788546255508,0.32385232795542723,1.0,72/235,20.45%,DYNC2H1;CYFIP1;ABLIM3;ABLIM2;FGD4;CPLANE1;ANO6;SHTN1;ACTN2;CCDC57;MAP4K4;DNM3;CCDC88A;CFAP47;OCRL;IFT140;DISC1;RAB3IP;IFT88;IQCB1;FLNA;GBF1;DNAH5;RILPL1;CARMIL1;TMEM67;TTC21B;MTSS1;BBS9;SRGAP3;RAPGEF6;NPHP3;PARVB;INTU;BBS1;DYNLT2B;CC2D2A;FGD1;FBXW8;ARHGEF7;PTPN23;STK26;ARL3;FBF1;C2CD3;IQUB;CDH13;UBXN10;TNIK;CIBAR1;INPP5K;TCTN2;RAP2C;ARMC9;RPGR;CENPJ;SPATA13;CLUAP1;RAB23;DNMBP;PLA2G3;CEP162;SNX10;TTC39C;WDPCP;ARHGEF4;PARVA;OFD1;DMTN;CDC14B;CEP164;HDAC6
gsea,Cell-Substrate Junction Assembly (GO:0007044),0.41279819025933273,1.377539978747096,0.08316430020283976,0.32330074994118646,1.0,9/24,16.50%,SORBS1;DST;ACTN2;BCR;LAMC1;ARHGEF7;CDH11;TAOK2;THSD1
gsea,Negative Regulation Of Mitochondrion Organization (GO:0010823),-0.4048954347517635,-1.3773569450212249,0.07569721115537849,0.23322951816438833,1.0,15/30,26.65%,SLC25A4;GHITM;SLC25A5;TRIAP1;PINK1;CLU;TMEM14A;MUL1;PRELID1;FXN;SLC35F6;NOL3;AKT1;MPV17L;PSMD10
gsea,Response To Amino Acid Starvation (GO:1990928),-0.37968184863904525,-1.377011269929172,0.08436213991769548,0.2330881757396456,1.0,10/36,19.64%,SESN1;RRAGA;PRKD1;SH3GLB1;ITFG2;MAPK3;SEH1L;KICS2;SESN3;MAPK1
gsea,Neuron Projection Development (GO:0031175),0.28973890732334034,1.3768595122212577,0.01867219917012448,0.3228548970223518,1.0,41/159,10.15%,NLGN1;PAK3;CNTN4;TRIO;DOCK10;MARK2;EPHB1;TMEM108;ROCK1;SHTN1;DOCK7;CNTNAP2;LAMB1;MAP4K4;BICDL1;DICER1;VPS13B;MAPT;CTNND2;PACSIN1;SHANK3;LGI1;IFT88;NTF3;SHANK1;MAP2;MICALL1;GRM7;CAMSAP1;GAS7;DIP2A;GPRIN3;PLXNA3;SRGAP3;FRYL;WNT7A;EPHB2;NMNAT2;UNC5A;DNM2;RASGRF1
gsea,Lysosome Organization (GO:0007040),0.3740147246363735,1.374933149889348,0.06947368421052631,0.32480978165690594,1.0,12/37,17.78%,CLVS2;HOOK1;SPG11;ZKSCAN3;MTOR;GNPTAB;VPS33A;HOOK2;TMEM175;HOOK3;GRN;ATP10B
gsea,Negative Regulation Of Gene Expression (GO:0010629),-0.27750571820988157,-1.3739936175270997,0.01486988847583643,0.23661377940820078,1.0,52/244,19.86%,GAPDH;ENC1;RACK1;APOE;OLFM1;RPS3;PARK7;RPL13A;TLE5;CALR;SERBP1;IGF2BP3;NDFIP1;MEF2C;TOB1;CNPY2;BTG2;PPM1D;RPS26;CITED2;TCEAL1;PINK1;TMBIM6;NCL;HRAS;SFMBT2;LSM2;DHFR;YBX1;RPS13;PABPC1;PPP1R11;FMR1;MACROH2A1;GSK3B;ATP2B1;NDFIP2;ID2;ERP29;SYT11;SIRT6;IGFBP5;PUM1;EPHA4;PTRH2;YY1;PDGFB;SH3GL2;FBXW7;LSM5;RNF139;CIDEA
gsea,Regulation Of Stress Fiber Assembly (GO:0051492),-0.3508320295707093,-1.3734411711276493,0.057971014492753624,0.23682944457994465,1.0,9/56,7.35%,DYNLL1;PFN2;RAC1;ACTG1;CDC42;CD47;TPM1;STMN1;PFN1
gsea,Artery Development (GO:0060840),0.46354362521167514,1.3721510081097779,0.10284463894967177,0.32821699612777455,1.0,4/16,7.94%,PDE2A;TGFBR1;NF1;PKD2
gsea,Regulation Of Telomerase Activity (GO:0051972),-0.3803204601331167,-1.3712235082769686,0.09161793372319688,0.23916355099366002,1.0,10/36,20.27%,HSP90AB1;HSP90AA1;CCT2;PTGES3;TERF1;DKC1;MAPK3;MAPKAPK5;MAPK1;PARP4
gsea,Phagocytosis (GO:0006909),-0.38999155167476285,-1.3705538085724422,0.07564575645756458,0.23954234647124667,1.0,18/41,34.54%,HMGB1;CDC42;MESD;ITGAV;AXL;LDLR;CD302;RAB11FIP2;GULP1;MEGF10;ADORA1;PLD4;CORO1A;ANXA11;CORO1C;PECAM1;MYD88;MERTK
gsea,Regulation Of Release Of Sequestered Calcium Ion Into Cytosol By Sarcoplasmic Reticulum (GO:0010880),-0.45827582501964337,-1.3704112418580083,0.10103092783505155,0.2391623930699455,1.0,3/17,0.25%,CALM1;CALM2;CALM3
gsea,Anterograde Axonal Transport (GO:0008089),-0.38008615356335274,-1.370025979072018,0.08678500986193294,0.23912572457446002,1.0,9/36,16.47%,NEFL;ARL8A;ARL8B;MAP1A;SOD1;BLOC1S4;BLOC1S5;AP3S2;APEX1
gsea,Negative Regulation Of Protein Localization (GO:1903828),-0.3838329681885122,-1.3695510541041682,0.0989247311827957,0.23927758302893715,1.0,13/35,24.08%,MAP1A;LEPROT;BTF3;YWHAZ;MACROH2A1;CTNNA1;GSK3B;COMMD1;SIRT6;VCP;SNX33;SIN3A;TTBK2
gsea,Intrinsic Apoptotic Signaling Pathway (GO:0097193),-0.33138942389733983,-1.3689192143243973,0.04380952380952381,0.2396055931523033,1.0,10/70,11.12%,DDX5;MLLT11;SELENOK;ARL6IP5;BAX;CYCS;BOK;BAD;PML;CEBPB
gsea,Gonad Development (GO:0008406),-0.4135721603845045,-1.3686704640769751,0.08695652173913043,0.23936964282770704,1.0,9/24,24.74%,BASP1;NR2F2;INHBA;SOX9;NUP107;ADAM21;MAMLD1;TGFB2;SALL1
gsea,"Chemical Synaptic Transmission, Postsynaptic (GO:0099565)",0.4263525260208614,1.3679916283013283,0.08958333333333333,0.33438377074203557,1.0,4/20,5.91%,GRIN2A;GRIN1;CHRNA4;GRID2
gsea,Learning (GO:0007612),0.3850505445929949,1.366056398634831,0.08264462809917356,0.33625444580053737,1.0,12/36,10.85%,SHANK2;CNTNAP2;ATXN1;SLC6A1;SHANK3;SYNJ1;SHANK1;NTRK2;BRSK1;EPHB2;FYN;DLG4
gsea,Positive Regulation Of Peptidyl-Lysine Acetylation (GO:2000758),0.48020853825689575,1.3658149102928314,0.09876543209876543,0.3349826825379536,1.0,5/15,8.83%,NOS1;SF3B1;DIP2A;DIP2B;BAZ1B
gsea,Apoptotic Mitochondrial Changes (GO:0008637),-0.4031772373455516,-1.365772774369931,0.10285714285714286,0.2427215779943101,1.0,11/27,23.35%,BAX;BOK;CLU;BAD;TIMM50;HSPD1;VPS35;ATG3;FIS1;BBC3;CCAR2
gsea,DNA Duplex Unwinding (GO:0032508),-0.3834938071588924,-1.3656044270271745,0.09262759924385633,0.24238344511895582,1.0,13/33,24.68%,PURA;GINS2;GINS4;CDC45;RECQL;DDX1;RAD50;MCM6;DTD1;ERCC3;RAD51;HMGA1;ASCC1
gsea,Negative Regulation Of Protein Kinase Activity (GO:0006469),-0.333928433883565,-1.365600995321556,0.0670391061452514,0.24182511019938044,1.0,27/71,24.81%,PPIA;CAMK2N1;YWHAG;PARK7;DUSP3;GSTP1;TRIB2;SNCA;NPM1;WWTR1;MACROH2A1;CAMK2N2;CDKN1B;AKT1S1;UBASH3B;WARS1;PTPN1;THY1;RTRAF;TAF7;HYAL2;DBNDD1;DUSP19;PAK2;DVL1;AKT1;DBNDD2
gsea,Positive Regulation Of Peptidase Activity (GO:0010952),-0.4340208160794346,-1.3633088006174066,0.10357815442561205,0.24420576724727985,1.0,7/20,18.97%,NDUFA13;PSENEN;PINK1;PSME3;PRELID1;CTSH;VCP
gsea,Cortical Cytoskeleton Organization (GO:0030865),0.40534245181960255,1.362230866634171,0.09534368070953436,0.3398545239863208,1.0,5/25,7.96%,NLGN1;FMNL2;ROCK1;FMNL1;IKBKB
gsea,Cellular Response To Organonitrogen Compound (GO:0071417),-0.3281313089580343,-1.362033325385982,0.05,0.2454417482194807,1.0,17/76,13.10%,ACTB;GABRG2;LAMTOR2;MEF2C;P2RY12;RRAGA;EGR1;LAMTOR3;PDXP;RRAGD;CLU;SOX9;CTNNA1;XBP1;EZR;RAP1A;ZFP36L1
gsea,Negative Regulation Of Protein Catabolic Process (GO:0042177),-0.35959538766257176,-1.3619098166086745,0.09375,0.24505424854784014,1.0,7/41,8.44%,HSP90AB1;CST3;GABARAPL2;TIMP3;PIN1;SNCA;SNX3
gsea,Phosphatidic Acid Metabolic Process (GO:0046473),0.4020304339205498,1.3615758216821834,0.10586011342155009,0.3395103976890377,1.0,5/26,7.54%,DGKG;DGKH;DGKQ;DGKB;MBOAT2
gsea,Regulation Of Myelination (GO:0031641),0.4761912491252016,1.3606163983434674,0.12627291242362526,0.33961782990116135,1.0,5/18,11.30%,TENM4;DICER1;PTPRZ1;TNFRSF21;SIRT2
gsea,Regulation Of Cell Cycle Phase Transition (GO:1901987),0.4565640184534828,1.360363051976171,0.14285714285714285,0.3384222833135645,1.0,5/16,11.62%,ATP2B4;ERCC2;NEK10;NEK11;TAF1
gsea,T Cell Receptor Signaling Pathway (GO:0050852),0.3492206626970277,1.3599942905723144,0.07399577167019028,0.3373137893114598,1.0,12/53,11.53%,DENND1B;RFTN1;LCK;MAP3K7;PLCG2;WNK1;TNFRSF21;IKBKB;GNAO1;PIK3CD;FYN;PLCG1
gsea,Positive Regulation Of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903557),-0.3850935135468884,-1.3599002668590043,0.10211267605633803,0.24744909717505476,1.0,5/39,8.33%,HMGB1;C1QTNF4;RASGRP1;DDT;CLU
gsea,RNA Destabilization (GO:0050779),0.4447591983641216,1.3598326931989526,0.11003861003861004,0.3359441401587306,1.0,6/19,19.08%,LIN28B;ROCK1;GIGYF2;FXR1;YTHDF3;FTO
gsea,Regulation Of Reactive Oxygen Species Biosynthetic Process (GO:1903426),0.4519507016299431,1.358138066976458,0.1014799154334038,0.3374831215444953,1.0,6/16,9.07%,GRIN1;RAB27A;ADGRB1;PIKFYVE;PLCG2;SLC5A3
gsea,Mesenchymal Cell Differentiation (GO:0048762),-0.380436940245813,-1.3580575512377784,0.08884297520661157,0.24950278699113218,1.0,8/36,14.89%,DDX5;FGFR2;MEF2C;HNRNPAB;FGFR1;SOX9;GSK3B;RANBP3L
gsea,Negative Regulation Of TOR Signaling (GO:0032007),-0.3669986237283513,-1.3578135462371097,0.07522935779816514,0.2493246988474256,1.0,12/43,22.42%,SESN1;PDCD6;ITFG2;TMEM127;SEH1L;SEC13;KICS2;TBC1D7;MAPKAPK5;SESN3;ENDOG;DDIT4
gsea,Negative Regulation Of Mitotic Cell Cycle (GO:0045930),-0.40433614702113607,-1.357571024967925,0.08966861598440545,0.24911239725970138,1.0,9/27,16.55%,AURKAIP1;BRINP3;TRIM35;BTG2;FZD3;ZWINT;ZFP36L1;CDKN1B;BTG1
gsea,Positive Regulation Of Supramolecular Fiber Organization (GO:1902905),-0.3350908309686049,-1.3573018178535328,0.06692160611854685,0.24890374876979046,1.0,14/70,10.86%,APOE;PFN2;RAC1;RPS3;NAV3;NCK1;SEMA5A;CFL2;PDXP;CDK5R1;PFN1;CLU;MYLK3;CX3CL1
gsea,Adenine Nucleotide Transport (GO:0051503),-0.4687936366898535,-1.3569381410406645,0.10943396226415095,0.24898033801773428,1.0,5/15,18.85%,SLC25A4;SLC25A5;SLC35B3;SLC25A24;SLC25A23
gsea,Cellular Response To Nerve Growth Factor Stimulus (GO:1990090),0.4317152244490394,1.3563946746994837,0.10916179337231968,0.33921798185668955,1.0,5/18,5.98%,TMEM108;NTRK3;MAPT;NTF3;NTRK2
gsea,T Cell Activation (GO:0042110),-0.37946225498177394,-1.3561246862712064,0.10669077757685352,0.24952754391112184,1.0,11/43,17.89%,PPP3CA;FKBP1A;RASGRP1;NCK1;PPP3CB;DDOST;PIK3R1;HSPD1;NLRC3;CD247;SOX4
gsea,Positive Regulation Of Telomere Maintenance Via Telomerase (GO:0032212),-0.3986565728943101,-1.3559903405640104,0.09784735812133072,0.24919121669756128,1.0,9/28,19.64%,CCT2;CCT6A;HNRNPA1;CCT7;MAPK3;CCT5;CCT8;MAPKAPK5;MAPK1
gsea,Sodium Ion Transport (GO:0006814),0.348385398958655,1.3558877672152887,0.06431535269709543,0.33863991349749434,1.0,12/54,7.94%,SCN1A;ASIC2;SLC8A1;SCN8A;SLC6A1;SLC24A2;SLC24A3;SCN7A;SLC24A4;ASIC4;SLC9A5;PKD2
gsea,Protein Destabilization (GO:0031648),-0.3894681369362147,-1.3553495858573084,0.09568480300187618,0.249447784402648,1.0,12/29,23.70%,PRNP;SERF2;SNCA;MUL1;SIRT6;CTSH;FBXL3;CAPN3;RNF139;CDC73;SUMO1;DERL1
gsea,Positive Regulation Of Amide Metabolic Process (GO:0034250),-0.3296564932779118,-1.3544262300998755,0.06626506024096386,0.2502108554747185,1.0,16/71,17.99%,RPL5;RPS4X;EIF3C;RPL26;EEF2;CLU;NPM1;EIF6;CIRBP;FMR1;RPS27L;POLDIP3;UPF3A;EPHA4;SOX4;EIF3D
gsea,Lamellipodium Organization (GO:0097581),0.38667141114153153,1.3543888028548063,0.09036144578313253,0.34002387472523865,1.0,13/29,20.11%,CYFIP1;ABLIM3;ABLIM2;MYO9B;CCDC88A;CARMIL1;PARVB;ARHGEF7;CDH13;SNX1;SPATA13;ARHGEF4;DMTN
gsea,Positive Regulation Of Response To External Stimulus (GO:0032103),-0.32987775339214565,-1.3541125742595417,0.06319702602230483,0.2501139319779581,1.0,19/74,21.44%,CAMK2N1;P2RY12;CD47;IL18;NINJ1;GPRC5B;DDT;SNCA;VTN;PLA2G7;AKIRIN2;CX3CL1;CEBPA;POLR3D;RNF185;PDGFB;BMP6;NFKBIA;HYAL2
gsea,Dicarboxylic Acid Metabolic Process (GO:0043648),-0.3620954217432465,-1.3533686471172037,0.07739307535641547,0.25071069289046327,1.0,15/40,28.05%,MDH2;MDH1;NIT2;GOT2;GCLM;DHFR;MRPS36;ACLY;SDHA;MTHFD2;IDH2;ADHFE1;ALDH5A1;DGLUCY;MTRR
gsea,"Regulation Of Synaptic Transmission, Glutamatergic (GO:0051966)",0.3493009873715179,1.3528137903307358,0.07992202729044834,0.3411867979430714,1.0,18/47,18.71%,GRIN2A;NLGN1;GRIN1;GRM8;SHANK3;CACNG3;GRM7;DGKI;GRIK1;UNC13A;RELN;SYT1;GRIK3;CACNG8;GRIN2B;FXR1;HCN1;CACNG2
gsea,Peptidyl-Threonine Modification (GO:0018210),0.3396877034194904,1.3522796057174864,0.06823027718550106,0.3405616557519655,1.0,18/61,17.24%,MARK2;PRKDC;TGFBR1;ROCK1;GALNTL6;GALNT16;CSNK2A2;WNK1;WNK3;SBK1;CDC42BPA;TAF1;CHEK1;TTBK1;GALNT3;ACVR1B;PRKCD;CDK10
gsea,Negative Regulation Of Endothelial Cell Migration (GO:0010596),-0.40696353956679676,-1.3521234205506283,0.10687022900763359,0.2518644885552078,1.0,6/27,11.99%,HMGB1;APOE;NR2F2;MEF2C;CSNK2B;ANGPT2
gsea,Positive Regulation Of Cell-Substrate Adhesion (GO:0010811),-0.3446463859148648,-1.3518629158774693,0.0759493670886076,0.25171974817592857,1.0,14/55,21.66%,ENC1;RAC1;CALR;CDC42;PLEKHA2;C1QBP;CX3CL1;P4HB;GSK3B;ILK;RELL2;PDGFB;ARL2;EMP2
gsea,Cellular Response To Light Stimulus (GO:0071482),-0.3562583459524987,-1.351736540824215,0.0973630831643002,0.2513390991147444,1.0,10/47,12.91%,RPL26;COPS9;TRIAP1;NSMCE3;RBX1;PCNA;NPM1;PARP1;SDE2;DDB2
gsea,Cellular Response To Epidermal Growth Factor Stimulus (GO:0071364),-0.42571084322946073,-1.350963183173228,0.11262135922330097,0.2518675325602386,1.0,4/21,13.10%,EEF1A1;DUSP3;SOX9;ZFP36L1
gsea,Transcription Initiation At RNA Polymerase II Promoter (GO:0006367),-0.3359103641179447,-1.3505603862590547,0.07954545454545454,0.2518833663595856,1.0,32/62,37.07%,ELOB;POLR2I;MED10;MED4;POLR2G;TAF10;MED19;TAF11;MED31;GTF2B;MED9;MED21;MED22;TAF5;ELOC;MED7;TAF7;ERCC3;TAF7L;TAF12;MED11;MED30;TAF6L;POLR2D;GTF2E1;MED6;ELOA;TAF8;MED28;GTF2F2;MED8;TAF13
gsea,Protein Localization (GO:0008104),-0.27235950285249333,-1.350541799156998,0.01764705882352941,0.2513534419274981,1.0,95/287,26.88%,ACTB;YWHAH;DNAJC19;TMED9;ARF1;VPS29;CD81;LAMTOR2;STX7;ARF4;CPE;RAB6B;SQSTM1;PDCD6;RRAGA;TMED2;ARL1;RAB14;TM9SF3;RAB6A;LAMTOR3;ARF3;SYNDIG1;STX16;SPTSSA;ABHD17A;MESD;NAPG;RAB24;RRAGD;ROMO1;CUTA;PAM16;ARF5;NPM1;RAB1B;RAB22A;TMED4;SNX17;RAB18;TIMM23;TMED7;RAB31;ARL5B;GJA1;ERBIN;SAR1A;TMED10;VCL;ARL4C;TIMM50;TIMM44;ERP29;LAPTM5;SEC13;BBS2;COPB2;DNAJC15;RAB32;GRPEL1;HSPA9;APEX1;NSF;VPS35;TMED1;PRPF19;SLU7;EHD1;CAPN3;RAB5A;ATG9A;RAB5B;EMP2;VANGL2;RAB5C;ARFRP1;ERCC3;UNC50;VPS26B;REEP1;SUMO1;RAB35;ARF6;TMED5;MYO7A;CBY1;STX1B;LAMTOR1;ARCN1;MFN2;RNF26;ARL4D;ZDHHC15;RAB28;PEX5
gsea,Cellular Response To Salt (GO:1902075),0.3081898033201907,1.3496197022590783,0.0654627539503386,0.3441122959906102,1.0,22/81,14.88%,NLGN1;CACNA1A;ATP2B4;ADCY8;GPLD1;RYR3;SYT17;KCNH1;NEK7;PLCG2;ITPKB;PKD2;CACNA1H;FYN;DLG4;CPNE1;TAF1;SYT1;SSH1;ITPKC;CPNE8;IQGAP1
gsea,Positive Regulation Of Macroautophagy (GO:0016239),-0.34636901064918213,-1.349319401166227,0.06060606060606061,0.2524280486941744,1.0,9/55,10.91%,SLC25A4;SESN1;SLC25A5;BNIP3L;SH3GLB1;PIP4K2A;PINK1;PAFAH1B2;SCOC
gsea,Axonal Transport (GO:0098930),-0.37633640973571664,-1.3487097044789569,0.10404624277456648,0.2528090717749853,1.0,10/37,16.47%,NEFL;HSBP1;ARL8A;ARL8B;SOD1;PAFAH1B1;BLOC1S4;BLOC1S5;AP3S2;APEX1
gsea,"Regulation Of mRNA Splicing, Via Spliceosome (GO:0048024)",0.3095521711688152,1.3487032025849819,0.061752988047808766,0.34432522248245734,1.0,21/85,12.22%,RBFOX1;RBFOX3;CELF4;SRRM4;SFSWAP;CELF5;RBM25;RBFOX2;RBM5;CELF3;CELF1;TRA2A;TIA1;NCBP1;SMU1;YTHDC1;DAZAP1;NUP98;FAM172A;WDR77;TRA2B
gsea,Protein Peptidyl-Prolyl Isomerization (GO:0000413),-0.4679589647143261,-1.3483263517950743,0.12195121951219512,0.2527760140130707,1.0,3/15,6.48%,PPIA;PPIB;PIN1
gsea,Protein K48-linked Ubiquitination (GO:0070936),0.3368612311843082,1.3478144869712207,0.08108108108108109,0.3442680692841761,1.0,9/59,5.91%,UBE2E2;UBR5;PRKN;MYCBP2;HACE1;UBE3C;ZNRF2;RNF216;KLHL3
gsea,DNA Metabolic Process (GO:0006259),-0.27513941887030335,-1.3471099381686449,0.014084507042253521,0.2539155084025564,1.0,91/244,32.79%,HMGB1;PTMS;RAN;SET;RPS3;PARK7;CNBP;MRPL36;CSNK1E;POLQ;SMC1A;PTGES3;BTG2;NSMCE3;UBE2N;INIP;NAP1L1;RAD21;NPM1;ORC1;PURA;RPA3;PARP1;FBXO6;RUVBL1;TOP1MT;FMR1;TERF1;MACROH2A1;DUT;HPF1;DDB2;ADPRS;ASF1A;NOP53;CDC45;RECQL;APEX1;NOC3L;YY1;TDG;DFFB;RFC3;SAMHD1;VCP;XRCC2;RRM1;SMARCB1;PARP4;RAD50;RRM2B;ACTR8;ENDOG;RAD9B;MCM6;TSN;RBBP8;XRCC6;ERCC3;RAD51;ORC4;LONP1;SUMO1;TBRG1;GTF2H4;FSCN1;RNASEH2A;LIG4;DCTPP1;POLD2;GRWD1;PCLAF;POLL;ZBTB1;NABP2;FAM111A;POLD3;MUS81;GTF2H3;UBE2A;FEN1;ACTL6A;HELB;XPA;KPNA2;RFC5;NUDT1;POLI;MSH6;DCLRE1B;TOP1
gsea,Positive Regulation Of Stress Fiber Assembly (GO:0051496),-0.3838054829319659,-1.3470854716006881,0.10317460317460317,0.25339209707056126,1.0,5/32,5.41%,PFN2;RAC1;CDC42;CD47;TPM1
gsea,cAMP-mediated Signaling (GO:0019933),0.4512121197698009,1.3459102466007473,0.11290322580645161,0.346176955446452,1.0,6/19,8.29%,PDE2A;AKAP6;ADCY2;PDE7B;DGKQ;ATF1
gsea,Regulation Of Chromosome Organization (GO:0033044),0.35784004770607425,1.3458401086413918,0.09221311475409837,0.34472767830049,1.0,11/38,16.17%,SMG1;YLPM1;MAPT;INO80;TERF2;NFRKB;HDAC8;NSMCE2;XRCC5;SETMAR;SMG6
gsea,Response To Epidermal Growth Factor (GO:0070849),-0.41178153643181975,-1.3452539133066026,0.09381237524950099,0.25539624889284424,1.0,5/24,13.10%,EEF1A1;DUSP3;SOX9;MAPK3;ZFP36L1
gsea,Synapse Assembly (GO:0007416),0.33296645710297584,1.3450847579172704,0.07531380753138076,0.34452052213061296,1.0,12/58,8.40%,NLGN1;SHANK2;GABRA2;SDK2;PTPRD;DSCAM;DNM3;SHANK3;GRID2;SRGAP3;ZDHHC2;WNT7A
gsea,Establishment Of Protein Localization To Vacuole (GO:0072666),0.4069471886062703,1.34451960331422,0.10256410256410256,0.3440113684435684,1.0,7/26,10.28%,VPS13A;VPS13C;VPS13D;CACNG3;HGS;VPS41;PTPN23
gsea,Organophosphate Ester Transport (GO:0015748),-0.4192302249431457,-1.344409527994309,0.09090909090909091,0.2560237995185182,1.0,9/22,23.16%,VAPA;TRIAP1;SCP2;PRELID3A;LDLR;PLTP;PRELID1;PITPNB;OSBPL5
gsea,DNA Unwinding Involved In DNA Replication (GO:0006268),-0.46135197326193755,-1.343714733906239,0.11560693641618497,0.2564254169353421,1.0,8/17,24.06%,PURA;GINS2;GINS4;CDC45;RECQL;MCM6;RAD51;HMGA1
gsea,Positive Regulation Of Protein Localization To Nucleus (GO:1900182),-0.3465588984786405,-1.3431623794329628,0.0703125,0.25667169057169514,1.0,12/56,14.31%,RAN;PARK7;CCT2;CCT6A;PPP3CB;RBM22;WWTR1;CCT7;DKC1;PIK3R1;CCT5;CCT8
gsea,Regulation Of Endocytosis (GO:0030100),-0.3403362254866517,-1.342625502419778,0.068762278978389,0.2568326000120832,1.0,19/57,22.03%,CALY;APOE;LRPAP1;PRKD1;SNCA;ITGAV;SNX17;CLIP3;HIP1R;CD151;PACSIN2;SYT11;RUFY1;HCK;AP2S1;PTPN1;RAB5B;CBLL1;LETMD1
gsea,Negative Regulation Of Protein Kinase B Signaling (GO:0051898),-0.4047275399376968,-1.342624783342976,0.1053639846743295,0.25628163052900194,1.0,7/27,15.03%,RACK1;PDCD6;PPP2CA;PPP2R1A;BANK1;NOP53;MUL1
gsea,Superoxide Metabolic Process (GO:0006801),-0.4751456938724735,-1.3424207696543597,0.1225296442687747,0.25599501847558337,1.0,4/15,10.37%,MT3;SOD1;PRDX1;NCF2
gsea,Protein Neddylation (GO:0045116),-0.4139068539595167,-1.3417308480122851,0.11812627291242363,0.2564888366836731,1.0,11/21,28.85%,COPS6;NEDD8;RBX1;RNF7;GPS1;COPS8;UBA3;DCUN1D5;COPS7A;UBE2M;COPS5
gsea,Vesicle Cytoskeletal Trafficking (GO:0099518),0.37301925846085454,1.3414301531589068,0.11578947368421053,0.3484171838670522,1.0,9/33,12.26%,TANC2;MYO1B;BICDL1;MYO5B;MYO1D;DYNC1I1;TRAK2;HTT;MYO5A
gsea,Ubiquitin-Dependent ERAD Pathway (GO:0030433),-0.32716260829743915,-1.3412032413365296,0.07262569832402235,0.2567703279003385,1.0,29/67,30.60%,CALR;CANX;UBE2J1;JKAMP;DNAJB9;UBQLN2;PSMC6;STUB1;RNF5;FBXO6;DNAJB2;FAF2;UBXN4;RNF185;VCP;OS9;CALR3;YOD1;UBQLN1;SEC61B;DERL1;DERL2;RNF103;HSP90B1;FAM8A1;TMUB2;EDEM1;HERPUD1;TMUB1
gsea,Positive Regulation Of Catabolic Process (GO:0009896),-0.32941788017171025,-1.3407386854735546,0.07170542635658915,0.25687623490132283,1.0,21/62,19.82%,HSP90AA1;OAZ1;PLK2;NDUFA13;VPS28;RBX1;CLU;GSK3B;EZR;ASB5;ANGPTL3;LAPTM5;CDKN1B;TRIM32;NSF;VPS35;RDX;VCP;FBXW7;TNFSF12;RNF139
gsea,Regulation Of Interleukin-2 Production (GO:0032663),-0.413318477128573,-1.3398779780335193,0.11026615969581749,0.25751632799362123,1.0,3/26,2.77%,PRNP;RPS3;NAV3
gsea,Regulation Of Tubulin Deacetylation (GO:0090043),0.44443913197040485,1.339796045257697,0.13291139240506328,0.34994772170273686,1.0,2/17,3.21%,YEATS2;MAPT
gsea,Positive Regulation Of Response To Stimulus (GO:0048584),-0.3318499602837027,-1.3397476055670394,0.08102766798418973,0.2571873573128446,1.0,16/55,23.94%,RPS3;VDAC1;EYA1;UBE2N;IER5;PCNA;RUVBL1;RNF168;BABAM2;ILK;YY1;H2AX;UIMC1;ACTR8;TGFB2;MAVS
gsea,Cell Cycle G2/M Phase Transition (GO:0044839),0.3860383865796007,1.3374188201147035,0.11180124223602485,0.3528388667809615,1.0,7/27,10.95%,CDK14;CCDC57;AKAP8L;BRSK1;AKAP8;DNM2;CHEK2
gsea,Granulocyte Chemotaxis (GO:0071621),-0.4649613627434018,-1.3366814340938462,0.12127236580516898,0.26105594432087464,1.0,4/17,10.86%,PPIA;BSG;PPIB;CX3CL1
gsea,Regulation Of Macromolecule Metabolic Process (GO:0060255),-0.3019355459360281,-1.336001114675814,0.04990757855822551,0.26149768101801657,1.0,17/101,13.10%,ATP1B1;ATXN7L3B;APOE;IGF2BP3;CGGBP1;TOB1;PIN1;HNRNPAB;C1D;CDK4;HMG20B;YBX1;ANKRA2;RASA1;SLC8A2;LDLR;ZFP36L1
gsea,Cellular Response To Gamma Radiation (GO:0071480),-0.467595823061991,-1.3357102746431826,0.13195876288659794,0.2613274158550754,1.0,6/15,22.96%,RPL26;HRAS;TSPYL5;CRYAB;TMEM109;XRCC6
gsea,Phosphatidylinositol Dephosphorylation (GO:0046856),0.45359971647583464,1.3354696883724229,0.14171656686626746,0.35497238851300944,1.0,9/16,24.33%,OCRL;SYNJ1;MTMR1;INPP5B;INPP5K;PIP4P2;MTM1;INPP5J;SYNJ2
gsea,Supramolecular Fiber Organization (GO:0097435),-0.28030278745015236,-1.3352818793138943,0.039792387543252594,0.2614148823295875,1.0,23/195,7.14%,HSP90AB1;ALDOA;NEFL;CST3;RAC1;FKBP1A;TAGLN3;STMN3;INA;DNAJB6;CDC42;KRT10;BAX;MARCKSL1;FGF13;MARCKS;TPM1;STMN4;HNRNPA1;STMN1;PIN1;WDR73;SNCA
gsea,Positive Regulation Of Cellular Process (GO:0048522),-0.25923159462875167,-1.3347812770115932,0.016100178890876567,0.2615766811470951,1.0,87/364,19.94%,HSP90AB1;ACTB;PPP3CA;GLP2R;RPL17;RPS6;RPS4X;CALR;RPS15A;COX17;SLC25A5;FGFR2;CNBP;CDC42;CD81;MAP1A;RPS9;MTPN;DNAJA2;COPS9;VEGFC;CD47;BCL7B;TPM1;RNF187;FAM98B;PDGFA;KRAS;CITED2;IRS2;ITGAV;ROMO1;IER5;FGFR1;NAP1L1;CDK4;CFAP20;NPM1;BRD7;HRAS;EAPP;MTLN;C1QBP;HMGN5;SOX9;WWTR1;CX3CL1;BAMBI;P4HB;TSPYL5;EPO;XBP1;GSK3B;GNAI2;EGR4;LYN;RNF10;EXOSC4;AQP11;ZFP36L1;DHPS;EPOR;SMARCE1;TRIM32;POU3F3;EIF4G2;N6AMT1;CNOT8;HCK;SS18;HCFC1;CTSH;SSR1;EPHA4;CSF1R;SOX4;BCL7C;FXN;ACTL6B;PDGFB;PFDN1;BMP6;PDGFD;CNOT6L;SLC35F6;SMARCB1;CRLF2
gsea,Negative Regulation Of Oxidative Stress-Induced Cell Death (GO:1903202),-0.4309731112671942,-1.334649187948151,0.13193116634799235,0.26120108557823113,1.0,8/19,23.43%,PPIA;PARK7;PINK1;BAG5;GPR37;GPR37L1;NOL3;HTRA2
gsea,Neuron Differentiation (GO:0030182),0.2991365562691883,1.334196980447553,0.05296610169491525,0.35597089531305887,1.0,19/106,7.31%,LHX9;TENM4;TENM2;MYT1L;TGFBR1;TENM1;DMD;PTPRD;ATP8A2;DTNB;MYEF2;PAX6;ERCC2;NRBP2;NTRK2;BRSK1;SPOCK1;WNK1;PBX4
gsea,Protein Depolymerization (GO:0051261),-0.4244622376193683,-1.3335520926152091,0.1165644171779141,0.2622627418992328,1.0,7/21,14.01%,STMN3;DSTN;CFL2;STMN4;STMN1;TWF1;VPS4A
gsea,Positive Regulation Of Reactive Oxygen Species Metabolic Process (GO:2000379),0.4041187963497953,1.3332183429567985,0.11561866125760649,0.3562824319421882,1.0,7/27,9.07%,GRIN1;RAB27A;MAPK14;MAPT;ADGRB1;PLCG2;SLC5A3
gsea,Ameboidal-Type Cell Migration (GO:0001667),0.4472351034101812,1.3327898435295824,0.13402061855670103,0.3555715241190277,1.0,8/16,19.60%,SRGAP3;GPC3;CCN3;IQGAP1;AMOTL2;ITGA4;PDLIM1;MEGF8
gsea,DNA-templated Transcription (GO:0006351),-0.2789967836356402,-1.3327438171315014,0.033073929961089495,0.26293147643981946,1.0,37/163,15.40%,DDX5;PTMA;KLF13;CEBPD;DEK;CCDC124;DRAP1;POLR2F;NAT14;POLR2I;MED4;POLR2G;TAF10;POLR2E;NFKBIB;TCEA1;TAF11;TBPL1;PARP1;NFIC;POLR2C;POLR3H;TRIM24;GTF2H5;MAF;XBP1;MRPL12;ZFP36L1;ETV1;PIR;SPTY2D1;CBFB;IVNS1ABP;NR4A2;GTF2B;TFAM;SMAD2
gsea,Long-Chain fatty-acyl-CoA Metabolic Process (GO:0035336),-0.43592266652174627,-1.3324627723400382,0.11727078891257996,0.2627751660884236,1.0,6/20,20.47%,TECR;ACSL3;DGAT2;ACSBG1;FAR2;HSD17B12
gsea,Positive Regulation Of Interleukin-1 Production (GO:0032732),-0.4171662213614383,-1.3315369565688384,0.12595419847328243,0.26356078675398337,1.0,3/24,5.58%,HMGB1;USP50;EGR1
gsea,Branching Morphogenesis Of An Epithelial Tube (GO:0048754),0.4277355580167549,1.331377756301511,0.11868131868131868,0.3567792421896513,1.0,4/20,12.86%,PKD1;FGF10;PKD2;COL4A1
gsea,Neuromuscular Junction Development (GO:0007528),0.4181611290534462,1.331156963340526,0.13636363636363635,0.35566674815109506,1.0,10/22,24.92%,CACNB2;UNC13B;UNC13A;ZC4H2;PDZRN3;CACNB1;LRRK2;KY;DOK7;CACNB4
gsea,Phosphatidylinositol Phosphate Biosynthetic Process (GO:0046854),0.36240969696194103,1.3310663370164892,0.11290322580645161,0.3542699940833361,1.0,13/36,19.81%,SMG1;TTC7B;ITPKB;PIK3R3;SOCS2;PIK3CD;HYCC1;SOCS7;ITPKC;EFR3B;IP6K1;PI4KA;PIK3CA
gsea,Positive Regulation Of Lamellipodium Organization (GO:1902745),-0.4029922502852665,-1.3305288193671636,0.12692307692307692,0.264581659946199,1.0,7/26,12.71%,RAC1;BRK1;CDC42;ARPC2;ACTR2;AKIRIN1;PIK3R1
gsea,Lamellipodium Assembly (GO:0030032),0.40706735272058064,1.3304925233720477,0.11614173228346457,0.35380260933489865,1.0,8/24,10.07%,CYFIP1;ABLIM3;ABLIM2;CCDC88A;CARMIL1;SRGAP3;PARVB;ARHGEF7
gsea,"mRNA Cis Splicing, Via Spliceosome (GO:0045292)",-0.43836649265304645,-1.3287693502594673,0.1452513966480447,0.26663873321159337,1.0,10/17,21.65%,PSIP1;WBP4;RBM22;SNRNP200;SDE2;HNRNPC;CLNS1A;CWC15;SART1;NCBP2
gsea,Positive Regulation Of Epithelial Cell Proliferation (GO:0050679),-0.31803175514652265,-1.3284650054429028,0.07330827067669173,0.266542158886944,1.0,24/77,19.28%,EMC10;FGFR2;NME2;SEMA5A;PDCD6;VEGFC;PRKD1;NELL2;BAD;RTN4;HRAS;SOX9;VEGFB;XBP1;TEK;MYDGF;NME1;NRARP;EGR3;BMPR2;EGFL7;PDGFB;TNFSF12;BMP6
gsea,Protein Localization To Nucleus (GO:0034504),-0.29487164811964384,-1.328117042480059,0.047337278106508875,0.2665461760974343,1.0,30/105,26.33%,RPL11;RAN;CALR;APLP2;YWHAE;CHCHD10;HIKESHI;RPF2;PML;AKIRIN2;NUP50;TOR1AIP2;CTDNEP1;NOP53;SEC13;NUP107;ARL2BP;IPO8;PHB2;RPAIN;ARL2;TOR1A;DVL1;TBRG1;AKT1;NUP62;RRP7A;SKP1;KPNA3;NUP85
gsea,Regulation Of Primary Metabolic Process (GO:0080090),-0.39078836767252495,-1.3281123522934206,0.11068702290076336,0.26600147371316085,1.0,9/31,17.43%,APOE;PSAP;IRS2;GPS2;MACROH2A1;LDLR;ID2;SIRT6;VPS35
gsea,Negative Regulation Of Small Molecule Metabolic Process (GO:0062014),0.4132120000899608,1.327048171764368,0.1193058568329718,0.3588706593752435,1.0,7/22,17.62%,GCK;USP7;CBFA2T3;HDAC4;PPARA;BCKDK;SOGA1
gsea,Gamma-Aminobutyric Acid Signaling Pathway (GO:0007214),0.46600463818811144,1.326544662778876,0.15694164989939638,0.35828243493104006,1.0,3/15,1.10%,GABRA2;GABRG3;GABBR2
gsea,snRNA 3'-End Processing (GO:0034472),0.4202782058590628,1.326110592164196,0.12951167728237792,0.35766100614197516,1.0,6/19,11.51%,INTS6L;INTS2;EXOSC8;INTS1;INTS6;TUT1
gsea,Response To Hexose (GO:0009746),-0.45950793647567,-1.3261002260255152,0.1388888888888889,0.2682771938091857,1.0,5/17,17.28%,VAMP2;SELENOT;IRS2;PFKL;EIF2B5
gsea,Positive Regulation Of Phospholipase C Activity (GO:0010863),-0.45016865752448104,-1.3259403348988,0.13142857142857142,0.26796189712097906,1.0,5/17,19.22%,P2RY12;FGFR1;HRAS;HTR2A;PHB2
gsea,Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0007178),-0.3186833767851046,-1.3248247134823532,0.06786427145708583,0.2690390896835771,1.0,16/76,19.37%,DDX5;FKBP1A;JUN;APLP2;INHBA;STUB1;BAMBI;MAPK3;SMAD2;SMAD7;BMPR2;COL1A2;ADAM9;EID2;BMP6;BMPR1B
gsea,Positive Regulation Of Cell Projection Organization (GO:0031346),0.2986595063262907,1.3243229409271668,0.04771784232365145,0.35954432183681656,1.0,26/102,15.21%,NLGN1;PLXNA4;LRRC7;MARK2;PLXNC1;NTRK3;PTPRD;PLXNA2;CUX2;CARMIL1;NTRK2;SETX;NCOA2;P3H1;PLXNA3;TIAM1;ROR1;PTK7;RELN;FBXW8;DLG4;DPYSL3;EPHA3;DAB2IP;CAPRIN1;ROBO1
gsea,Cellular Response To Tumor Necrosis Factor (GO:0071356),-0.3302026981201963,-1.3243079286796249,0.08159392789373814,0.2692362956299928,1.0,20/59,25.44%,TMSB4X;RPS3;EIF5A;RRAGA;GSDME;TXNDC17;BAG4;CX3CL1;ERBIN;ZFP36L1;ILK;COMMD7;ZFAND6;NFKBIA;HYAL2;TRAF2;AKT1;FOXO3;RELA;HYAL1
gsea,Regulation Of Multicellular Organismal Development (GO:2000026),0.341322953263251,1.3226897421194335,0.08016032064128256,0.3612216294022728,1.0,8/46,7.16%,YEATS2;KAT6B;TRIP12;EHMT1;NIPBL;INO80;NFRKB;MYSM1
gsea,Plasma Membrane Bounded Cell Projection Organization (GO:0120036),-0.29657381637570635,-1.3203363149395215,0.072265625,0.27446063296718687,1.0,18/106,7.40%,HMGB1;NCDN;APOE;RAC1;GPM6A;MAP1B;STMN3;RAB6B;MANF;VAPA;ATP1B2;TPM1;STMN4;BTG2;RAB6A;STMN1;CDK5R1;RAB11A
gsea,Regulation Of Intracellular Signal Transduction (GO:1902531),0.2705367993015103,1.3201605052716658,0.049145299145299144,0.3644793355758937,1.0,51/228,12.56%,NLGN1;PDE2A;PAK3;KALRN;TRIO;DOCK3;FGD4;ARHGEF28;ARHGAP15;MYO9A;AKAP6;MYO9B;NTRK3;USP7;ITSN1;MAP4K4;BCR;MAPT;TRAF3;PEX5L;SGMS1;PIP5K1B;SEZ6L;SH3BP1;RASGRF2;GMIP;NTRK2;GNA12;PLCG2;ULK4;PREX2;SRGAP3;TIAM1;TNFRSF25;PPP1R16B;RICTOR;PRDM11;WWC1;FGD1;ARHGAP18;ARHGEF17;ARHGEF3;MTOR;CHEK2;STK4;ARAP1;CPNE1;TAF1;CHN2;CHEK1;RRAGB
gsea,Regulation Of Neuron Differentiation (GO:0045664),-0.32686550167400713,-1.3189391368202283,0.07827788649706457,0.27615395239361173,1.0,13/63,11.01%,PCP4;YWHAG;YWHAH;CALR;BDNF;MEF2C;NEUROD2;BRINP3;GPRC5B;CDK5R1;FGFR1;MMD;ADRA2C
gsea,Negative Regulation Of Cellular Biosynthetic Process (GO:0031327),-0.2985279250381314,-1.3187363250518258,0.07269155206286837,0.2758402741688828,1.0,14/100,9.35%,GAPDH;ENC1;RACK1;RPS3;RPL13A;CALR;SERBP1;IGF2BP3;TOB1;BTG2;PDGFA;NCL;DHFR;YBX1
gsea,Regulation Of T Cell Activation (GO:0050863),-0.39910275413932206,-1.3170613853903685,0.13257575757575757,0.2778741953394364,1.0,10/24,25.01%,DUSP3;CD47;MYDGF;HSPD1;LAPTM5;PRELID1;THY1;CCDC88B;B2M;GPNMB
gsea,Negative Regulation Of Cell Growth (GO:0030308),-0.30150779153617935,-1.3161126454618042,0.07818181818181819,0.2787290934025942,1.0,39/88,31.09%,MT3;RACK1;NDUFA13;FGF13;PPP2CA;PPP2R1A;RNF6;RTN4;PML;RBBP7;INHBA;RTN4R;GJA1;OSGIN2;DNAJB2;CDKN1B;MUL1;BMPR2;BTG1;CGRRF1;ENO1;NDRG3;HYAL2;TGFB2;CCAR2;CRLF3;CDKL3;HYAL1;SPHK2;SERTAD2;ING1;TSPYL2;CDKN2D;STK11;NDUFS3;CAPRIN2;CCDC85B;SIPA1;FLCN
gsea,Lytic Vacuole Organization (GO:0080171),0.3696101384215741,1.315864461419411,0.10660980810234541,0.37145331577482504,1.0,9/32,15.68%,CLVS2;HOOK1;SPG11;ZKSCAN3;MTOR;GNPTAB;HOOK2;HOOK3;GRN
gsea,Regulation Of MAP Kinase Activity (GO:0043405),-0.31590042631812937,-1.31496349373268,0.0912621359223301,0.27986965640963846,1.0,23/74,22.51%,APOE;RASGRP1;RGS2;SPRY2;MEF2C;DUSP7;DIRAS2;GSTP1;PDGFA;TRIB2;FGFR1;HRAS;TSG101;UCHL1;LYN;ERP29;ADAM9;PTPN1;PDGFB;PDGFD;HYAL2;DUSP19;CD300A
gsea,Cardiac Conduction (GO:0061337),0.38497655230354755,1.3148022476904646,0.09014675052410902,0.37174683623886656,1.0,5/31,1.43%,CACNA1C;SPTBN4;CACNB2;BIN1;KCND3
gsea,Regulation Of Establishment Of Cell Polarity (GO:2000114),0.4457744868574242,1.3136052620112468,0.13995943204868155,0.3724993852018661,1.0,6/16,7.62%,RIPOR2;ROCK1;SHTN1;BCAS3;ARFGEF1;KRIT1
gsea,Regulation Of Neural Precursor Cell Proliferation (GO:2000177),0.46058793994388525,1.3132762968702683,0.15711252653927812,0.3715931988039689,1.0,7/15,18.96%,PTPRZ1;KDM2B;DISP3;TRIM71;SLC16A2;PROX1;SHCBP1
gsea,Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0017015),-0.30889393376490404,-1.313182050131841,0.06870229007633588,0.2820906117783296,1.0,35/85,36.11%,HSP90AB1;FKBP1A;SNW1;SPRY2;ZEB2;PIN1;CITED2;RBBP7;STUB1;BAMBI;SMAD2;SMAD7;BRMS1;EID2;CIDEA;ARID4A;SIN3A;CAPN5;STRAP;ING1;DKK3;STK11;GIPC1;LATS2;FLCN;HDAC2;NREP;SPRED1;SMAD4;DAB2;HTRA4;ADAMTSL2;HSPA1A;IL17RD;SDCBP
gsea,Positive Regulation Of Cell Death (GO:0010942),-0.37401128623033986,-1.3118325781347417,0.10805860805860806,0.28350777699656154,1.0,4/32,8.33%,MT3;PRNP;SNCA;CLU
gsea,ERAD Pathway (GO:0036503),-0.30934135566162096,-1.3116070878802466,0.0847457627118644,0.2832804871234465,1.0,36/82,30.60%,CALR;CANX;UBE2J1;CCDC47;JKAMP;DNAJB9;UBQLN2;PSMC6;STUB1;RNF5;FBXO6;XBP1;DNAJB2;FAF2;UBXN4;RNF185;VCP;OS9;RNF139;CALR3;YOD1;UBXN6;UBQLN1;SEC61B;TOR1A;BRSK2;DERL1;DERL2;RNF103;HSP90B1;FAM8A1;UGGT1;TMUB2;EDEM1;HERPUD1;TMUB1
gsea,Peptidyl-Threonine Phosphorylation (GO:0018107),0.33662379094747985,1.3112503984432842,0.10515463917525773,0.37381060934915383,1.0,16/53,17.24%,MARK2;PRKDC;TGFBR1;ROCK1;CAMK2A;CSNK2A2;WNK1;WNK3;SBK1;CDC42BPA;TAF1;CHEK1;TTBK1;ACVR1B;PRKCD;CDK10
gsea,Semaphorin-Plexin Signaling Pathway (GO:0071526),0.3893804151625245,1.311144322240832,0.130879345603272,0.3724842844715808,1.0,7/30,7.93%,PLXNA4;SEMA5B;PLXNA2;SH3BP1;FLNA;SEMA4D;PLXNA3
gsea,Positive Regulation Of Cellular Biosynthetic Process (GO:0031328),-0.2944253158694704,-1.3098280129942947,0.05870841487279843,0.28551206810614815,1.0,28/123,19.12%,HSP90AB1;RPL5;HSP90AA1;RPS4X;PARK7;EIF3C;RPL26;EEF2;EGR1;ZEB2;IRS2;SNCA;CLU;NPM1;EIF6;CIRBP;FMR1;RPS27L;PAOX;POLDIP3;LDLR;CTDNEP1;UPF3A;SOX4;EIF3D;MID1IP1;PDGFB;HTR2A
gsea,Regulation Of Necroptotic Process (GO:0060544),-0.435846427053051,-1.3089063735425173,0.16393442622950818,0.2863816454823362,1.0,3/16,10.74%,SLC25A4;PARP1;SPATA2
gsea,Muscle Contraction (GO:0006936),0.3256184691336841,1.308479893733007,0.0876068376068376,0.3763448088035699,1.0,12/52,9.44%,RYR2;SLC8A1;ROCK1;RYR3;NOS1;PABPN1;SCN7A;MYOF;TRDN;TAFAZZIN;GNAO1;CACNA1H
gsea,Action Potential (GO:0001508),-0.4169941805577152,-1.3075379177626574,0.1323251417769376,0.287958351728443,1.0,7/21,12.97%,KCNA1;YWHAH;KCND2;KCNJ2;KCNA2;SRI;GNA11
gsea,Skeletal System Morphogenesis (GO:0048705),0.42137701926896665,1.3071627291836592,0.1364522417153996,0.3773353208086578,1.0,4/20,3.15%,DSCAML1;TGFBR1;SPEF2;FBN2
gsea,Positive Regulation Of Ubiquitin-Protein Transferase Activity (GO:0051443),-0.4115315708838918,-1.3064631928344437,0.1394422310756972,0.2890057231101185,1.0,5/21,7.75%,RPS2;PIN1;UBE2N;PINK1;UBE2S
gsea,Protein Localization To Chromatin (GO:0071168),-0.4032685168995418,-1.3055415621378599,0.13498098859315588,0.2899548735429685,1.0,5/23,11.39%,H4C9;WBP2;RAD21;PARP1;MACROH2A1
gsea,Regulation Of Oxidative Stress-Induced Intrinsic Apoptotic Signaling Pathway (GO:1902175),-0.46783952986225424,-1.3047810964653217,0.14821763602251406,0.2905435521505206,1.0,5/15,11.24%,PPIA;PARK7;SOD1;BAG5;P4HB
gsea,Positive Regulation Of Neurogenesis (GO:0050769),0.3241344401127942,1.3039316350063972,0.08134920634920635,0.3822429067613195,1.0,16/61,16.34%,PLXNA4;PLXNC1;PTPRD;PLXNA2;LRP2;SHANK3;CUX2;DISC1;NTRK2;PLXNA3;TIAM1;FBXW8;SOX8;CAPRIN1;ROBO1;VCAN
gsea,Protein O-linked Mannosylation (GO:0035269),-0.4582180729899877,-1.3034600988846674,0.16314779270633398,0.2921768174932739,1.0,7/15,24.63%,DPM3;DPM2;FKRP;TMTC4;DPM1;RXYLT1;POMT1
gsea,Spliceosomal Complex Assembly (GO:0000245),-0.32302430301450913,-1.3017974751332169,0.1028225806451613,0.29410983582276357,1.0,23/61,21.67%,CELF2;SNRPG;SNRPF;SNRPD2;SF3B2;SF3B4;ZRSR2;PUF60;SCAF11;LUC7L3;SNRNP200;SNRPD1;RBMX2;TXNL4A;SNRPE;PHF5A;SF3B6;SNIP1;PRPF19;DDX1;DDX39B;NOL3;SNRPB
gsea,Proteasome-Mediated Ubiquitin-Dependent Protein Catabolic Process (GO:0043161),-0.25762758057574603,-1.3014696998833142,0.033932135728542916,0.2940522980976241,1.0,83/286,25.33%,CALR;PSMC3;PSMB5;PSMA7;PSMC2;COP1;FBXL16;CANX;PSMA5;PSMA4;UBE2J1;KCTD13;ANAPC13;RNF187;PSMD2;PSMD4;TBL1XR1;PSMA3;PSMC5;PSMD7;JKAMP;RBX1;DNAJB9;UBQLN2;PSMB1;UBE2S;PSMB3;FBXO9;PML;AKIRIN2;UBXN1;ZFAND2B;PSMA1;PSMC6;STUB1;PSMD6;RNF5;FBXO6;UCHL1;ANAPC11;GSK3B;PSMC1;KCTD17;RNF10;PEX12;DNAJB2;PSMC4;TBL1X;SHARPIN;KLHDC2;PSMB6;SIAH3;PJA2;FAF2;UBXN4;RNF185;PSMB7;KLHDC1;PSMA2;PCNP;VCP;FBXW7;OS9;FBXL3;RNF126;MAEA;CALR3;YOD1;CSNK1A1;DCAF12;GID4;UBQLN1;SEC61B;KBTBD7;DERL1;DERL2;RNF103;HSP90B1;RNF34;PSMD11;CDC26;SKP1;CDC16
gsea,Positive Regulation Of Microtubule Polymerization Or Depolymerization (GO:0031112),-0.4173507598709849,-1.301208990376083,0.1271186440677966,0.2938995279336894,1.0,4/21,7.28%,RAC1;RPS3;NAV3;CDK5R1
gsea,Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167),0.32074000571904193,1.3000235263160762,0.09871244635193133,0.38855064929893257,1.0,29/76,22.65%,TRIO;NTRK3;PTPRD;FLT3;DOK5;PTPRF;IL31RA;NTF3;LCK;NTRK2;JAK2;DOK6;MTSS1;ROR1;GUCA1B;FYN;ERBB4;EFS;ALK;ACVR1B;SHC3;GFRA2;FRS2;DOK3;LIFR;NEDD9;SHC4;PTPRU;SAMD12
gsea,Negative Chemotaxis (GO:0050919),-0.37947401656325463,-1.2999111628513358,0.12295081967213115,0.29529261405427776,1.0,7/26,15.74%,EPHA7;LRTM1;PDGFA;ITGAV;LRTM2;UNC5C;SEMA7A
gsea,Regulation Of Telomere Maintenance (GO:0032204),0.3610986469713005,1.299839048910005,0.12883435582822086,0.3873159682899207,1.0,10/33,16.17%,SMG1;YLPM1;ATRX;USP7;TERF2;HDAC8;ERCC4;NSMCE2;XRCC5;SMG6
gsea,Regulation Of Transcription By RNA Polymerase I (GO:0006356),0.3747700459779932,1.2995391873170175,0.11627906976744186,0.3863463286265144,1.0,6/29,8.83%,ASIC2;BAZ2A;FLNA;SF3B1;HEATR1;BAZ1B
gsea,Histone Deubiquitination (GO:0016578),-0.3811167157177338,-1.2992337557813498,0.136986301369863,0.29576881625689866,1.0,10/29,21.34%,USP22;TAF10;BABAM2;ENY2;TADA2B;MPND;TADA3;TAF5;UIMC1;TAF7
gsea,Purine Nucleotide Biosynthetic Process (GO:0006164),0.4441554704706214,1.2987155025875607,0.1517094017094017,0.3864492643981126,1.0,4/16,11.33%,PFAS;NMNAT2;SLC4A7;MTHFD1
gsea,DNA-templated Transcription Initiation (GO:0006352),-0.32208759845610935,-1.2985921540523542,0.09302325581395349,0.2960950203468019,1.0,19/55,23.01%,ELOB;NAT14;POLR2I;POLR2G;TAF10;TAF11;TBPL1;POLR3H;ZFP36L1;GTF2B;TFAM;TAF1C;TFB2M;TAF5;ELOC;MED7;TAF7;RRN3;ERCC3
gsea,Positive Regulation Of Filopodium Assembly (GO:0051491),0.4091478912537099,1.2981022292419089,0.1475054229934924,0.3860746625919861,1.0,6/22,4.80%,NLGN1;TENM2;DOCK11;RIPOR2;TENM1;BCAS3
gsea,Negative Regulation Of Viral Process (GO:0048525),-0.39855660516755465,-1.2969005893496746,0.13409961685823754,0.29797232252137584,1.0,2/24,2.81%,PPIA;BANF1
gsea,Negative Regulation Of Macromolecule Metabolic Process (GO:0010605),-0.2855151783863433,-1.2967754357624117,0.08378870673952642,0.2976197316906858,1.0,16/125,8.83%,HSP90AB1;RACK1;APOE;OLFM1;PARK7;TLE5;SUB1;AP1AR;NDFIP1;MEF2C;CNPY2;CITED2;TCEAL1;PINK1;HRAS;SFMBT2
gsea,Regulation Of Calcium-Mediated Signaling (GO:0050848),-0.42901561528354015,-1.2952588964009892,0.14705882352941177,0.2993970203432237,1.0,2/18,4.04%,CALM2;NEUROD2
gsea,Negative Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071901),-0.32696897696729854,-1.295150463350052,0.10139165009940358,0.29893738782354184,1.0,18/62,22.51%,APOE;NR2F2;RGS2;SPRY2;DUSP7;GSTP1;UCHL1;MACROH2A1;PRKAR1B;PKIG;LYN;CEBPA;CDKN1B;PTPN1;HEXIM2;HYAL2;PRKAR1A;CD300A
gsea,ERBB Signaling Pathway (GO:0038127),0.35177064128599045,1.2944701454438008,0.1111111111111111,0.3917655620924455,1.0,17/41,19.81%,PTPRR;NRG1;CBL;SOS1;PTK2;PLCE1;NCK2;CUL5;ERBB4;PLCG1;IQGAP1;MVP;EGF;SHC3;KIF16B;BRAF;PIK3CA
gsea,Synaptic Vesicle Endocytosis (GO:0048488),0.35687394190849503,1.2932132331857673,0.1303501945525292,0.3927913732827811,1.0,13/35,11.99%,NLGN1;FCHO2;DNM1;ITSN1;DNM3;STON2;PACSIN1;SYNJ1;ITSN2;STX1A;DNM2;SNAP91;SYT1
gsea,protein-DNA Complex Organization (GO:0071824),-0.34695699202173536,-1.2931368284967089,0.1001926782273603,0.30158084320863393,1.0,8/44,8.29%,RPL17;NUCKS1;BANF1;CBX3;HMGN1;HMGN3;GATAD1;HMGN2
gsea,Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060338),-0.4107709542609498,-1.2931143394247584,0.12598425196850394,0.30103640621531114,1.0,8/19,24.17%,CDC37;USP27X;MUL1;RNF185;PTPN1;SAMHD1;MAVS;PTPN11
gsea,Positive Regulation Of Multicellular Organismal Process (GO:0051240),-0.26468183379880145,-1.2927344150440871,0.04864864864864865,0.3010146683003925,1.0,62/232,25.25%,ACTB;GAPDH;GNAS;APOE;OLFM1;CFL1;APLP2;NME2;PPIB;SOD1;BCL7B;IL18;LRPAP1;FABP5;BAD;RTN4;RBBP7;INHBA;C1QBP;ADRB1;SOX9;WWTR1;CEBPB;BAMBI;MACROH2A1;GJA1;XBP1;DIO2;RPS19;SMARCE1;SMAD2;RBM19;SIRT6;BMPR2;ADIPOR2;APEX1;SS18;GPR3;ENO1;BCL7C;THRA;ACTL6B;PDGFB;BRMS1;BMPR1B;UCP2;SMARCB1;CCDC88B;PLCB1;AGPAT1;DPF2;CNKSR2;LURAP1;TGFB2;ARID4A;STRA6;SIN3A;PTPN11;FST;MC4R;TRPM4;GRB10
gsea,Negative Regulation Of Endocytosis (GO:0045806),-0.4186113977647323,-1.292622904679293,0.1442687747035573,0.3006033187079397,1.0,4/20,8.44%,RACK1;RAC1;PRKD1;SNX3
gsea,Regulation Of Cardiac Muscle Cell Action Potential (GO:0098901),-0.3983202422020111,-1.292447093840981,0.14231499051233396,0.30030727813915004,1.0,4/22,4.51%,CALM1;CALM3;CTNNA3;FGF13
gsea,Negative Regulation Of Epithelial Cell Proliferation (GO:0050680),-0.3525624985838037,-1.291895181084229,0.1111111111111111,0.30060261884744466,1.0,11/40,20.09%,APOE;KLF9;FGFR2;MAGED1;NR2F2;SOX9;SPARC;AQP11;NLRC3;FBXW7;CDC73
gsea,Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043122),-0.27883441047058116,-1.2913568137504285,0.06297709923664122,0.30086510645326786,1.0,54/152,28.93%,GAPDH;FKBP1A;NDFIP1;SQSTM1;PLK2;VAPA;GSTP1;GPRC5B;PRKD1;UBE2N;PINK1;TMED4;PARP1;CXXC5;UBE2V1;CX3CL1;GJA1;MTDH;NDFIP2;TMEM9B;SHARPIN;TLE1;MUL1;NLRC3;TRIM32;BCL10;IRAK4;ZDHHC17;ZFAND6;NEK6;DDX1;CAPN3;PELI2;TBK1;TSPAN6;TRAF3IP2;RHOA;LURAP1;CFLAR;JMJD8;MIB2;USP20;TRAF2;MAVS;NUP62;RELA;GOLT1B;MAPKBP1;TRIM8;SPHK2;LPAR1;MIER1;NLRX1;LAMTOR5
gsea,Regulation Of Cyclin-Dependent Protein Kinase Activity (GO:1904029),-0.37086519985879696,-1.2904233567383347,0.12284069097888675,0.3017145779768955,1.0,10/34,25.59%,HSP90AB1;CDK5R2;CDC37;CDK5R1;CDKN1B;CCND3;CCNG2;GTPBP4;CCNI;BCCIP
gsea,Negative Regulation Of Signal Transduction (GO:0009968),-0.2788637810793193,-1.2898647174926632,0.06715063520871144,0.3019852275387699,1.0,33/170,19.15%,RACK1;YWHAB;CALR;FAIM2;GRINA;RGS2;BDNF;NCK1;SPRY2;LEPROT;PDCD6;CD47;LRPAP1;GPS2;PIP4K2A;SNCA;TMBIM6;HHIP;CX3CL1;LEPROTL1;LYN;NR4A2;TLE1;NRARP;IGFBP5;GPC1;GPR108;HEY1;UBASH3B;EGFL7;PTPN1;VCP;FBXW7
gsea,Positive Regulation Of Protein Polymerization (GO:0032273),-0.3432367510393577,-1.2898572313323577,0.1194331983805668,0.3014212819611951,1.0,9/51,7.41%,PFN2;RAC1;HSP90AA1;RPS3;NAV3;NCK1;CDK5R1;PFN1;PINK1
gsea,Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage (GO:0008630),-0.3651201040096588,-1.2890433653536613,0.12404580152671756,0.3021119469055036,1.0,13/35,27.17%,SNW1;BAX;BOK;PML;RPS27L;CDIP1;HIPK1;TMEM109;CIDEB;DDIT4;HTRA2;FNIP2;CRIP1
gsea,Ventricular Cardiac Muscle Tissue Morphogenesis (GO:0055010),0.40210731661680255,1.2887366777514446,0.12424849699398798,0.40050888408877006,1.0,11/22,18.00%,RYR2;NRG1;TGFBR1;LRP2;NOG;TGFBR3;TNNC1;PKP2;PROX1;MYH7;ZFPM2
gsea,Positive Regulation Of NIK/NF-kappaB Signaling (GO:1901224),-0.38376594488596316,-1.2879559452127234,0.1442125237191651,0.3033049641062653,1.0,8/30,21.21%,C1QTNF4;RPS3;ILK;LAPTM5;TRIM44;CD27;PHB2;RHOA
gsea,RNA Polymerase II Preinitiation Complex Assembly (GO:0051123),-0.3440526636516394,-1.2879487734938877,0.12244897959183673,0.30275292364133666,1.0,23/44,37.07%,MED10;MED4;TAF10;MED19;TAF11;MED31;GTF2B;MED9;MED21;MED22;TAF5;MED7;TAF7;TAF7L;TAF12;MED11;MED30;TAF6L;MED6;TAF8;MED28;MED8;TAF13
gsea,Peptidyl-Threonine Dephosphorylation (GO:0035970),-0.4436315375469416,-1.2872374586712954,0.1576923076923077,0.3032493438503816,1.0,5/16,18.92%,PPP1CA;PPP2CA;PPM1D;PPM1K;DUSP5
gsea,Ceramide Biosynthetic Process (GO:0046513),0.3701314298992452,1.2864601289994007,0.1656441717791411,0.4036269269417134,1.0,7/31,13.52%,ST6GALNAC3;ST6GALNAC5;CERS4;SGMS1;CERS6;ALOXE3;CERS5
gsea,Regulation Of Microtubule Polymerization (GO:0031113),-0.36000574712534505,-1.285460346809958,0.14285714285714285,0.3054845562334869,1.0,8/35,10.90%,RAC1;RPS3;NAV3;TUBB4A;STMN1;SNCA;CDK5R1;CLIP3
gsea,Phosphatidylinositol Biosynthetic Process (GO:0006661),0.2949920512044702,1.2854483030326707,0.08456659619450317,0.4040405770373422,1.0,33/85,24.33%,SMG1;TTC7B;PITPNM2;OCRL;PIP5K1B;SYNJ1;PIKFYVE;PIGO;PLCG2;MTMR7;ITPKB;PIK3R3;MTMR1;SOCS2;HYCC1;SOCS7;PIGQ;PGAP2;ITPKC;INPP5K;CDS1;EFR3B;IP6K1;PI4KA;PIK3CA;PIGL;PIGA;VAC14;MTM1;INPP5J;EFR3A;PI4KB;SYNJ2
gsea,Protein Tetramerization (GO:0051262),-0.334879267319186,-1.2853383618569327,0.13360323886639677,0.30509858642570975,1.0,20/52,25.20%,ALDOA;APLP2;KRT10;KCNJ2;HSD17B8;SNCA;CUTC;CLU;AQP4;ACOT13;FKRP;OXA1L;KCNC3;SAMHD1;KCNJ12;HSD17B10;CBY1;B2M;TRPM4;RYR1
gsea,Neuron Migration (GO:0001764),-0.3360784020779729,-1.2848362778520788,0.12240663900414937,0.3052431970443727,1.0,10/49,8.12%,RAC1;GPM6A;MAP1B;MEF2C;FGF13;TUBB2B;PAFAH1B1;CCK;CDK5R1;FGFR1
gsea,Hexose Metabolic Process (GO:0019318),-0.3608874969862401,-1.2839098626969696,0.1261595547309833,0.3060929266405312,1.0,5/35,8.40%,ALDOA;PMM1;ALDOC;IRS2;FUCA1
gsea,Translesion Synthesis (GO:0019985),-0.4170698301308583,-1.2827894853881434,0.14869888475836432,0.30740017419958565,1.0,10/19,32.18%,PCNA;POLDIP2;VCP;MAD2L2;POLD2;RCHY1;PCLAF;ZBTB1;POLD3;POLI
gsea,Maintenance Of Protein Location In Nucleus (GO:0051457),-0.4284999600091941,-1.282160659613507,0.1717171717171717,0.30774085159927356,1.0,7/16,25.29%,PARK7;CHCHD10;PML;ARL2BP;SUN1;SUN2;SKP1
gsea,Positive Regulation Of Osteoblast Differentiation (GO:0045669),-0.3758644463939776,-1.2811238707459014,0.14340344168260039,0.30886582220085357,1.0,7/30,19.37%,PPP3CA;MEF2C;PRKD1;WWTR1;BMPR2;BMP6;BMPR1B
gsea,Positive Regulation Of Intracellular Protein Transport (GO:0090316),-0.28926488906236525,-1.2811194644111386,0.08986615678776291,0.30829065307198794,1.0,29/104,21.80%,PRNP;VAMP2;RAN;YWHAE;CD81;OAZ1;LEPROT;TOMM7;SH3GLB1;ANP32B;PIN1;PINK1;RBM22;HRAS;EMD;MTCL1;GSK3B;SAR1A;PIK3R1;RUFY3;SIRT6;NMT1;ZFAND1;PDZK1;FBXW7;DMAP1;FIS1;HYAL2;BBC3
gsea,Positive Regulation Of Dendrite Morphogenesis (GO:0050775),0.4401453298451034,1.2807198454803468,0.15495867768595042,0.41207226306323214,1.0,6/16,15.08%,PTPRD;CUX2;LRP8;RELN;FBXW8;CAPRIN1
gsea,Negative Regulation Of Protein Tyrosine Kinase Activity (GO:0061099),0.4141106141950024,1.280677689291537,0.13191489361702127,0.4105130633670574,1.0,6/18,16.18%,SRCIN1;ZFYVE28;CBL;SH3BP5;SNX6;MVP
gsea,Negative Regulation Of Cell Projection Organization (GO:0031345),-0.3506951855244477,-1.2804333781299155,0.12598425196850394,0.3088124444444824,1.0,5/42,3.46%,MT3;PRNP;APOE;YWHAH;SPRY2
gsea,Protein Methylation (GO:0006479),-0.3784529239308854,-1.2800293516087493,0.1619047619047619,0.308910982614147,1.0,14/28,33.01%,TRMT112;RAB6A;FAM98B;EEF1AKMT1;LCMT1;N6AMT1;PRMT7;SNRPB;PRMT1;ETF1;METTL22;PCMT1;ETFBKMT;EEF1AKMT2
gsea,Positive Regulation Of Axon Extension (GO:0045773),0.42383444368403733,1.2794217847366467,0.17049808429118773,0.4117211991399544,1.0,4/17,3.21%,MACF1;SHTN1;DSCAM;MAPT
gsea,Glycosaminoglycan Biosynthetic Process (GO:0006024),0.33558591909936336,1.279367759997397,0.1285140562248996,0.410191146015845,1.0,18/44,25.06%,CHST11;EXT2;ST3GAL3;XYLT1;HEXA;GCNT2;HS3ST2;CHST9;EXT1;XYLT2;UST;ST3GAL2;UGDH;SLC10A7;ST3GAL4;GLCE;B3GNT2;CHPF
gsea,Purine Ribonucleotide Metabolic Process (GO:0009150),-0.32414915187126525,-1.2784883133689608,0.11088709677419355,0.3108424336143439,1.0,7/52,12.84%,ATP1B1;HSPA8;RAN;OLA1;BAD;ATP1A2;ACLY
gsea,Regulation Of MAPK Cascade (GO:0043408),-0.28328946774659236,-1.2782947169818666,0.08377896613190731,0.31060017310689486,1.0,36/135,19.69%,HMGB1;PPIA;PEBP1;EPHA7;RASGRP1;FGFR2;DUSP3;CD81;DUSP7;SOD1;GSTP1;YWHAZ;PPP2R1A;PDGFA;ATP6AP2;FGFR1;HRAS;GSDME;CX3CL1;ADRA2C;TEK;LYN;MYDGF;MAPK3;LAPTM5;WDR54;GPR37;ZDHHC17;DUSP8;CSF1R;DUSP5;PDGFB;GPR37L1;PHB2;MAPK1;PELI2
gsea,Regulation Of Actin Polymerization Or Depolymerization (GO:0008064),-0.41622334905035563,-1.2781119938434853,0.15257731958762888,0.3103544421221213,1.0,8/19,22.34%,PFN2;BRK1;PFN1;RASA1;COTL1;FCHSD1;CXCL12;GBA2
gsea,COPII-coated Vesicle Budding (GO:0090114),-0.3598405179642803,-1.2772295401362124,0.13733075435203096,0.3112248520425359,1.0,19/33,35.42%,PDCD6;VAPA;TMED2;TRAPPC2L;TRAPPC2;TRAPPC1;SAR1A;TMED10;SEC13;MIA3;PEF1;TRAPPC4;TRAPPC6A;TBC1D20;TRAPPC12;SEC23A;TRAPPC3;PREB;VAPB
gsea,fatty-acyl-CoA Metabolic Process (GO:0035337),-0.4412536764837256,-1.2771249741942707,0.1640625,0.31085929567283965,1.0,6/15,21.93%,ACSL3;DGAT2;NUDT19;NUDT7;FAR2;FITM2
gsea,Organophosphate Biosynthetic Process (GO:0090407),0.36171187414403067,1.276722779830006,0.14455445544554454,0.41410937450498325,1.0,11/28,20.27%,GCK;IPPK;PCYT2;PPIP5K1;ITPKB;ITPKC;GK5;PPIP5K2;IP6K1;DCK;MBOAT1
gsea,Endosome To Lysosome Transport (GO:0008333),0.3200724609603912,1.2765695374481707,0.13141683778234087,0.41275891086319966,1.0,18/49,23.41%,BIN1;LYST;HOOK1;CACNG3;VPS41;VPS33A;HOOK2;HOOK3;CACNG8;VPS11;GPRASP1;CLEC16A;CACNG2;HMGXB4;PXK;CACNG4;MTM1;SORT1
gsea,DNA Recombination (GO:0006310),-0.36491928040585636,-1.2764197552918448,0.1169811320754717,0.3114608204985678,1.0,12/33,26.99%,HMGB1;MRPL36;RAD21;XRCC2;RAD50;ENDOG;TSN;RBBP8;XRCC6;RAD51;HDAC10;LIG4
gsea,Negative Regulation Of MAP Kinase Activity (GO:0043407),-0.35560359050122653,-1.2757723140754806,0.13793103448275862,0.31194749814023726,1.0,13/38,23.39%,APOE;DNAJA1;RGS2;SPRY2;DUSP7;GSTP1;UCHL1;LYN;PTPN1;HYAL2;DUSP19;CD300A;DUSP16
gsea,Sensory Perception Of Mechanical Stimulus (GO:0050954),0.3311046749698311,1.2751325029252896,0.13274336283185842,0.4142182132211184,1.0,12/49,9.38%,SPTBN4;RIPOR2;COL11A1;NIPBL;LRP2;SPNS2;PCDH15;GRM7;TIMM9;LHFPL3;ROR1;SLC26A4
gsea,"Regulation Of DNA Damage Response, Signal Transduction By P53 Class Mediator (GO:0043516)",-0.415024405381743,-1.274433463620523,0.1460446247464503,0.3134227144687343,1.0,1/19,0.09%,DDX5
gsea,Negative Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050732),0.4054163237706212,1.2737881897038754,0.14855875831485588,0.4156047055118471,1.0,6/20,8.75%,SRCIN1;OCRL;NTF3;SEMA4D;SH3BP5;PTPN2
gsea,Positive Regulation Of Lipid Kinase Activity (GO:0090218),-0.4024519572518043,-1.272706466429329,0.16377649325626203,0.315637167512323,1.0,5/20,11.97%,EEF1A2;CD81;P2RY12;PRKD1;TEK
gsea,Mitotic G2/M Transition Checkpoint (GO:0044818),0.35805752217397635,1.272579304298709,0.1446028513238289,0.41646798690511494,1.0,14/32,20.21%,TAOK1;BRSK1;TOPBP1;NABP1;FOXN3;DONSON;CHFR;HUS1;CHEK1;TAOK2;RAD17;TRIM39;MRNIP;CDC14B
gsea,Second-Messenger-Mediated Signaling (GO:0019932),0.32498334840987086,1.2721147133501087,0.1013215859030837,0.41592721976514807,1.0,9/45,8.94%,RYR2;MCTP1;CHRM3;NOS1;MCU;RILPL1;INPP5A;PLCG2;PLCE1
gsea,Regulation Of Voltage-Gated Calcium Channel Activity (GO:1901385),0.39201438288775126,1.2712947902768197,0.14915966386554622,0.41595412741825666,1.0,4/22,2.51%,CACNA1A;CACNB2;NOS1AP;DMD
gsea,Metal Ion Transport (GO:0030001),0.2791134097132093,1.2712347460498619,0.09401709401709402,0.4145119538352579,1.0,21/115,7.97%,RYR2;SCN1A;KCNAB1;KCND3;PKD1;SCN8A;KCNK9;CHRNA4;RYR3;KCNJ6;KCNH1;TRPC5;CAMK2A;LRP2;TRPM7;KCNMA1;CACNG3;TRPC3;SCN7A;PKD2;CHRNA7
gsea,Regulation Of Cell Population Proliferation (GO:0042127),-0.2423011359381535,-1.2704806724179336,0.03985507246376811,0.3186859196453658,1.0,106/478,20.09%,FTH1;ACTB;DYNLL1;PPP3CA;GLP2R;RPL17;JUN;RPS6;RPS4X;CALR;RPS15A;COX17;SLC25A5;FGFR2;CNBP;CD81;JUND;RPS9;DNAJA2;COPS9;TOB1;VEGFC;CD47;BCL7B;JUNB;BTG2;RNF187;FAM98B;PPM1D;PDGFA;KRAS;IRS2;SQLE;BOK;ITGAV;ROMO1;IER5;FGFR1;NAP1L1;CLU;CDK4;NPM1;PML;HRAS;IGFBP7;GSDME;INHBA;EAPP;CSNK2B;DNAJA3;HMGN5;SOX9;WWTR1;CX3CL1;BAMBI;TSPYL5;EPO;TMEM127;XBP1;FABP3;GNAI2;EGR4;FOXO4;LYN;AQP11;CEBPA;ZFP36L1;COPS8;DNAJB2;DHPS;NME1;ID2;JAG1;EPOR;CDKN1B;FABP7;GAS8;KLF10;POU3F3;BMPR2;CNOT8;HCK;SS18;BTG1;CTSH;SSR1;EPHA4;OPRM1;CGRRF1;CSF1R;SOX4;BCL7C;WARS1;FXN;ACTL6B;PDGFB;EID2;PFDN1;BMP6;PDGFD;CNOT6L;RNF126;SLC35F6;RNF139;CRLF2;CDC73
gsea,Positive Regulation Of Substrate Adhesion-Dependent Cell Spreading (GO:1900026),-0.3818812093027415,-1.2700628556475555,0.1464354527938343,0.31876023433359035,1.0,6/29,14.16%,RAC1;CALR;CDC42;C1QBP;P4HB;ILK
gsea,Regulation Of Cell Migration (GO:0030334),0.25286881558180996,1.26971368289365,0.05870020964360587,0.4162794474491907,1.0,54/297,11.01%,DACH1;PLXNA4;MACF1;MCTP1;SEMA5B;ADARB1;DOCK10;SRCIN1;HACE1;NTNG2;APC;LIMCH1;TGFBR1;PLXNC1;FRMD5;NTRK3;ROCK1;TCAF1;NF1;LAMB1;MAP4K4;TNR;CAMK2A;TJP1;DLG5;PLXNA2;SCAI;NTF3;FLNA;CARMIL1;HDAC1;SEMA4D;PTK2;ARID2;GNA12;ULK4;ACTN4;PIK3R3;PLXNA3;SRGAP3;TIAM1;AKT2;GCNT2;EPHB2;IGF1R;NOG;RELN;TMEFF2;PIK3CD;FYN;ERBB4;SMO;STK26;TMSB10
gsea,Protein N-linked Glycosylation (GO:0006487),-0.3193150929317235,-1.269554851229828,0.11886792452830189,0.319014591125381,1.0,26/56,35.30%,TMEM258;PMM1;KRTCAP2;PDCD6;UBE2J1;DAD1;PSMD2;DDOST;ALG14;OST4;ST6GAL1;DPM1;B4GALT7;STT3A;ALG5;TUSC3;ALG11;UGGT1;MOGS;PGM3;GFPT2;ALG3;STT3B;ALG6;SRD5A3;OSTC
gsea,Endoplasmic Reticulum Calcium Ion Homeostasis (GO:0032469),-0.4110516734585343,-1.2694512027599465,0.1821705426356589,0.31864236350883174,1.0,7/19,21.12%,SELENOK;BAX;CCDC47;PML;KCTD17;TMCO1;FIS1
gsea,Membrane Fission (GO:0090148),-0.34679472055666205,-1.269382989469992,0.12625250501002003,0.31816881940374364,1.0,19/36,34.02%,SH3GLB1;VPS28;CHMP2A;TSG101;CHMP6;STAM2;VPS4A;UBAP1;CHMP4C;CHMP7;EXOC3;VPS36;STAM;CHMP3;EXOC8;CORO1C;VPS37C;EXOC7;CHMP5
gsea,Negative Regulation Of Carbohydrate Metabolic Process (GO:0045912),0.39844275117001493,1.2687026502951517,0.16701902748414377,0.41688607641157593,1.0,6/22,17.62%,GCK;USP7;CBFA2T3;HDAC4;PPARA;SOGA1
gsea,Nucleosome Organization (GO:0034728),-0.3219376485435246,-1.2680431869109048,0.1285444234404537,0.319763612184957,1.0,22/54,25.78%,SET;H4C9;CHRAC1;NAP1L2;H2AC25;NAP1L1;NPM1;SOX9;MACROH2A1;SPTY2D1;ASF1A;BRD2;SMARCE1;NAA60;H2AX;SMARCB1;DAXX;HMGA1;SSRP1;NAP1L3;BAZ1A;RSF1
gsea,Synaptic Vesicle Cycle (GO:0099504),-0.3620376230176681,-1.2674644897736522,0.16129032258064516,0.3201549804108013,1.0,6/33,7.56%,RAB3A;CPLX2;VAMP2;SYNDIG1;SNCA;SNAP25
gsea,Regulation Of JNK Cascade (GO:0046328),0.2966832821953589,1.2664332806662872,0.08225108225108226,0.42024900608974436,1.0,20/81,14.38%,ANKS1B;PRKN;TAOK1;EPHB1;MAP4K4;TRAF3;AXIN1;ULK4;MTURN;MAP3K5;WNT7A;SH3RF3;IGF1R;TGFBR3;ANKRD6;TNFRSF19;SH3RF1;TNIK;TAOK2;DAB2IP
gsea,Positive Regulation Of Myeloid Leukocyte Differentiation (GO:0002763),-0.4139399656198745,-1.2651508704274574,0.17590822179732313,0.32346142244041437,1.0,11/19,39.62%,PPP3CA;ZFP36L1;ID2;EEIG1;HAX1;EVI2B;TESC;CTNNBIP1;CASP8;IL34;RUNX1
gsea,Carbohydrate Biosynthetic Process (GO:0016051),0.4272202128249898,1.2643897896069607,0.16030534351145037,0.42290826068102827,1.0,3/15,4.93%,ST6GALNAC5;EXT2;ST3GAL3
gsea,DNA Synthesis Involved In DNA Repair (GO:0000731),-0.4002432824055281,-1.264125963527013,0.16,0.32452849646335896,1.0,11/21,32.89%,PCNA;POLDIP2;RFC3;VCP;RRM1;RRM2B;PCLAF;ZBTB1;POLD3;POLI;FAAP20
gsea,Positive Regulation Of Gene Expression (GO:0010628),-0.25224185319788334,-1.2640371666813728,0.04595588235294118,0.3240889201449311,1.0,68/305,19.99%,MT3;GAPDH;RPS7;RPL5;RPL11;OLFM1;ACTG1;RPL17;RPS3;RPS4X;PARK7;EIF3C;RPL26;WBP2;SPRY2;EEF2;MEF2C;SOD1;TRMT112;RAMP2;EGR1;FAM98B;KRAS;CITED2;SLC38A2;RBM22;CLU;NPM1;BRD7;EIF6;INHBA;CIRBP;HMGN5;SOX9;FMR1;RPS27L;MACROH2A1;GJA1;GSK3B;EZR;POLDIP3;PIK3R1;ATF2;WNT16;ID2;ERP29;TLE1;UPF3A;POU3F1;ATP13A2;POU3F3;BMPR2;N6AMT1;HCFC1;CTSH;VPS35;U2AF2;SOX4;EIF3D;WARS1;RDX;PDGFB;TADA3;BMP6;BMPR1B;MBIP;SMARCB1;CCDC88B
gsea,Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169),0.2623063068230272,1.2633211025259385,0.07306889352818371,0.42358785164273693,1.0,49/199,14.23%,ANKS1B;SORBS1;PAK3;KALRN;ARHGEF28;EPHA10;EPHB1;NRG1;NTRK3;GPLD1;MAPK14;FLT3;DOK5;IL31RA;STXBP4;NTF3;LCK;NTRK2;IDE;SETX;PTK2;JAK2;DOK6;MTSS1;PIK3R3;MAPKAPK2;PLAT;EFNA1;TIAM1;AKT2;SOCS2;EPHB2;IGF1R;PTPN2;ROR1;TRIM71;EFNB2;ARHGEF7;FYN;ERBB4;EPHA6;KL;EFS;AP3S1;GIGYF2;GALNT3;ALK;EPHA3;SIPA1L1
gsea,Glycoprotein Metabolic Process (GO:0009100),0.3282822548424096,1.2632479624878818,0.09690721649484536,0.4221909868909118,1.0,18/43,26.38%,ST6GALNAC3;MAN2A1;MAN1C1;MAN2A2;LARGE1;FBXO44;MANBA;PCSK6;MAN1A2;ST3GAL2;TNIP1;ADAMTS13;ST3GAL4;OGA;NEU4;MAN1B1;MGAT4A;GANAB
gsea,Regulation Of Type I Interferon Production (GO:0032479),-0.34558901321568974,-1.262451475396813,0.13178294573643412,0.32606721666280913,1.0,14/42,26.18%,GAPDH;BANF1;RBX1;ATG12;ZCCHC3;IRF8;G3BP1;TRAF3IP1;PQBP1;TBK1;IRF3;MAVS;PTPN11;RNF26
gsea,Erythrocyte Differentiation (GO:0030218),-0.3488660597852356,-1.2624300871012835,0.13092979127134724,0.3255229710572026,1.0,11/39,22.85%,RPS14;SLC25A5;INHBA;EPO;LYN;RPS19;ID2;HSPA9;HSCB;CFLAR;SLC25A38
gsea,Protein N-linked Glycosylation Via Asparagine (GO:0018279),-0.40449108970123815,-1.2614527741422625,0.18837675350701402,0.3265682204027487,1.0,10/20,27.17%,UBE2J1;DAD1;PSMD2;DDOST;OST4;ST6GAL1;DPM1;STT3A;TUSC3;UGGT1
gsea,Regulation Of Ras Protein Signal Transduction (GO:0046578),0.30040613661677323,1.2611201014617917,0.11717171717171718,0.4251449299499208,1.0,25/64,20.04%,ARHGEF28;FGF10;MYO9B;SYNGAP1;LZTR1;NOTCH2;RAF1;RALGPS1;BCR;SH3BP1;EPHB2;PLCE1;RASGRF1;ARHGEF18;EPS8;DAB2IP;RABL3;ARHGEF2;SGSM3;KANK1;DENND4C;ARFGAP3;STARD13;GIT2;SYDE2
gsea,Ventricular Septum Development (GO:0003281),0.36173289227168326,1.2610114750051047,0.156312625250501,0.42377910850016814,1.0,10/30,19.06%,SLIT1;PDE2A;TGFBR1;NOG;TGFBR3;PROX1;ROBO1;MATR3;ZFPM2;HEY2
gsea,Monoatomic Cation Transmembrane Transport (GO:0098655),0.25456439274355397,1.2597034889737853,0.061946902654867256,0.42497393374552933,1.0,60/188,17.80%,CACNA1C;GRIN2A;GRIN1;CACNA1A;ASIC2;SLC8A1;ATP2B4;PKD1;KCNN3;KCNK9;KCNK13;ANO6;RYR3;KCNH1;TRPC5;KCNQ2;SLC6A1;SLC9A7;SLC24A2;SLC24A3;TRPM7;TRPM3;KCNQ3;TRPC6;KCNQ5;SLC39A11;TRPC3;KCNG3;SLC24A4;ABCB8;ASIC4;NNT;SLC9A5;PKD2;KCNK12;SLC29A4;SLC6A7;SLC9A1;ORAI1;GAS6;TRPC1;KCNH8;KCNB2;KCNA6;TRPC4AP;DMAC2L;KCNG1;ATP6V0A1;TMEM175;ASIC1;ATP6V0A2;NALCN;KCNN2;GRIN2B;SLC39A14;SLC9A9;KCNH7;HCN1;SLC8A3;HPN
gsea,Positive Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903052),-0.3796917151989746,-1.2596758037671365,0.1653061224489796,0.3289566651455251,1.0,9/24,19.82%,PSMC3;PSMC2;PSMC5;CLU;PSMC6;FMR1;LAPTM5;FBXW7;RNF139
gsea,Cellular Response To Hypoxia (GO:0071456),-0.3211054461121001,-1.2594309670297306,0.12572533849129594,0.3287967376625034,1.0,12/56,17.05%,MT3;KCND2;BNIP3L;PGK1;PINK1;BAD;STUB1;ADO;P4HB;ZFP36L1;NOP53;FAM162A
gsea,Positive Regulation Of DNA Binding (GO:0043388),-0.4373437723651864,-1.2590139373809073,0.16929133858267717,0.32884289230976715,1.0,2/16,1.50%,HMGB1;PARK7
gsea,Phospholipid Metabolic Process (GO:0006644),-0.3352683691344913,-1.2588983241933565,0.13320463320463322,0.3284283399145142,1.0,13/46,22.85%,PLPPR4;GDE1;GPX4;LCAT;PIP4P1;PLPPR5;ANGPTL3;AGPAT5;PLPP3;AGPAT1;FITM2;FDFT1;PLPPR3
gsea,Protein Localization To Organelle (GO:0033365),-0.2876908895494777,-1.258865955165223,0.11238095238095239,0.3279086786001944,1.0,29/107,24.33%,ATP6V1D;RPL11;CALR;DNAJA1;YWHAE;GABARAPL2;VAPA;CCDC47;ARL1;RAB6A;LAMP1;MTCH2;RAB11A;WDR83OS;YBX1;IFT20;PACSIN2;CTDNEP1;BBS2;VPS35;SYS1;EHD1;DDX1;ARFRP1;TOR1A;RAB35;ARF6;MAVS;DVL1
gsea,Positive Regulation Of ERK1 And ERK2 Cascade (GO:0070374),-0.2941166230612393,-1.258632595342228,0.10052910052910052,0.3277183517144902,1.0,21/96,19.30%,MT3;HMGB1;APOE;RASGRP1;FGFR2;SPRY2;DDT;PDGFA;HRAS;CX3CL1;TEK;RAP1A;MAPK3;SEMA7A;OPRM1;CSF1R;PDGFB;HTR2A;FBXW7;PHB2;PDGFD
gsea,Positive Regulation Of Chemotaxis (GO:0050921),-0.3840524593530582,-1.2584121443291938,0.16570327552986513,0.3275078717568626,1.0,4/25,5.73%,TMSB4X;SEMA5A;P2RY12;PRKD1
gsea,Postreplication Repair (GO:0006301),-0.42289007232428777,-1.2560900596316986,0.172147001934236,0.3306177581615623,1.0,11/18,39.71%,UBE2N;PCNA;UBE2V1;VCP;PCLAF;ZBTB1;UBE2A;POLI;FAAP20;UBE2V2;MSH2
gsea,Regulation Of Axon Extension (GO:0030516),-0.3568453280627337,-1.2554380479893912,0.14256198347107438,0.3310586355196992,1.0,9/31,12.75%,MT3;APOE;OLFM1;ISLR2;RNF6;RTN4;RTN4R;GSK3B;RUFY3
gsea,Positive Regulation Of B Cell Proliferation (GO:0030890),-0.44096247365549013,-1.2553313244329978,0.18552875695732837,0.3306507728805737,1.0,3/16,6.74%,CD81;MEF2C;IRS2
gsea,Protein Targeting (GO:0006605),-0.2807636606074308,-1.25474234974956,0.1067193675889328,0.331077644419463,1.0,27/109,18.11%,RPL11;NACA;DNAJC19;SRP14;TIMM8B;SPCS2;TOMM5;GABARAP;TOMM7;CDC37;TIMM13;SEC61G;ZFAND2B;TOMM20;TIMM23;TIMM10;PEX12;SPCS1;AQP11;TIMM44;LAMP2;YIF1B;APEX1;ZFAND6;SRPRB;ATG3;PEX19
gsea,Cell Junction Organization (GO:0034330),0.3228490600528341,1.2546084799570993,0.14031620553359683,0.43436040447808627,1.0,12/49,12.66%,PAK3;MYO9A;TJP2;MAPT;CTNND2;TJP1;SLC6A1;SH3BP1;CHRNA7;PTK7;ELFN1;L1CAM
gsea,Regulation Of Proteolysis (GO:0030162),-0.35119383369535584,-1.254091486175684,0.15778688524590165,0.3315670147588,1.0,18/35,38.45%,CST3;AURKAIP1;NEDD8;BAD;STUB1;CSTB;TRIM32;CAPN3;RNF139;DNAJC1;PARL;CLN8;HDAC2;SPOPL;CASP8;CLN6;BAG6;FBXW11
gsea,Positive Regulation Of Cysteine-Type Endopeptidase Activity (GO:2001056),-0.34408654240652037,-1.253926593055573,0.14849624060150377,0.3312593048758998,1.0,6/42,4.82%,HMGB1;USP50;ARL6IP5;PDCD6;NDUFA13;CYCS
gsea,Negative Regulation Of Proteolysis (GO:0045861),-0.37976734416196445,-1.2528587592383291,0.17408906882591094,0.3325468198853891,1.0,4/24,4.71%,PRNP;CST3;TIMP3;CTSB
gsea,Chromatin Remodeling (GO:0006338),0.2549179228830485,1.2525291535120016,0.07407407407407407,0.43737605445147826,1.0,38/197,12.49%,SFPQ;UBR5;CHD8;CHD2;YEATS2;TRIP12;BAZ2A;ATRX;SATB1;BRD9;MTA2;INO80;KDM2B;NFAT5;SMARCA4;HDAC1;MTF2;SETDB1;BICRA;NFRKB;ARID2;SF3B1;MYSM1;DPF3;SMARCA2;HCFC2;BAZ1B;KDM5B;MTA3;PAXIP1;BPTF;CHD1;USP3;SIRT2;BICRAL;CHEK1;HIRA;CHD4
gsea,Negative Regulation Of Transport (GO:0051051),-0.36768431072753316,-1.2517365880449287,0.14484126984126985,0.33377852929317886,1.0,10/29,15.40%,ARL6IP5;NDFIP1;PRKD1;SNCA;ITGAV;SNX3;CRYAB;NDFIP2;SYT11;YRDC
gsea,Negative Regulation Of DNA Biosynthetic Process (GO:2000279),0.3967041211505585,1.2511540016225564,0.1859504132231405,0.43890081158258926,1.0,7/22,13.06%,DACH1;TENM1;TERF2;ERCC4;NIBAN2;EXOSC10;TENT4B
gsea,Positive Regulation Of Insulin Secretion (GO:0032024),0.37500210995454886,1.250804599893769,0.17659137577002054,0.4380741996584425,1.0,5/26,4.76%,GCK;ADCY8;GPLD1;MYRIP;MCU
gsea,Protein Exit From Endoplasmic Reticulum (GO:0032527),-0.3874303337212654,-1.2506092719835928,0.1657250470809793,0.33499776996913994,1.0,11/23,24.62%,TMED9;SURF4;LMAN1;SEC13;FAF2;VCP;OS9;SEC61B;DERL1;DERL2;HSP90B1
gsea,Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001959),-0.38471729597928184,-1.2496535726634364,0.16310679611650486,0.3359610972464387,1.0,12/26,27.45%,CDC37;AXL;OTULIN;SPATA2;HIPK1;SHARPIN;TRIM44;PTPN1;TBK1;MIB2;PTPN11;VRK2
gsea,Regulation Of Osteoclast Differentiation (GO:0045670),-0.4013590400634576,-1.2487270309670164,0.16923076923076924,0.336778103548051,1.0,6/21,23.19%,PPP3CA;CEBPB;PRXL2A;UBASH3B;EEIG1;TCTA
gsea,Canonical Wnt Signaling Pathway (GO:0060070),-0.35505878635111204,-1.2484445747136104,0.1586998087954111,0.3366889087606196,1.0,16/39,35.64%,CSNK1E;PPP1CA;FZD3;FZD2;FZD4;GSK3B;NR4A2;WNT16;RAB5A;DVL1;TCF7L1;PTEN;FZD6;WNT5B;FZD8;DIXDC1
gsea,protein-DNA Complex Disassembly (GO:0032986),-0.4360009658087798,-1.247179657742844,0.1935483870967742,0.3383242853897555,1.0,8/15,28.29%,RPL17;SET;H2AC25;SMARCE1;SMARCB1;HMGA1;SSRP1;GRWD1
gsea,Sensory Perception Of Sound (GO:0007605),0.3206220996443439,1.247064919868455,0.14512471655328799,0.4446819341296444,1.0,12/51,9.38%,SPTBN4;RIPOR2;COL11A1;NIPBL;LRP2;SPNS2;PCDH15;GRM7;TIMM9;LHFPL3;ROR1;SLC26A4
gsea,Cell Projection Organization (GO:0030030),-0.4104599627901565,-1.2463675956731364,0.1791044776119403,0.33915537442579774,1.0,3/17,14.02%,P2RY12;PDGFA;PACSIN2
gsea,Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0033209),-0.36072608033267545,-1.2463543702967115,0.17870722433460076,0.33859392026490276,1.0,10/28,25.39%,TMSB4X;EIF5A;RRAGA;TXNDC17;ILK;COMMD7;NFKBIA;TRAF2;FOXO3;RELA
gsea,Regulation Of Interleukin-12 Production (GO:0032655),-0.4110090908251413,-1.2446250299633446,0.19557195571955718,0.3411067291512319,1.0,5/18,14.61%,HMGB1;CD47;C1QBP;HSPD1;LAPTM5
gsea,Toll-Like Receptor Signaling Pathway (GO:0002224),0.43400399738247547,1.244618445053437,0.21120689655172414,0.4487723012785793,1.0,4/15,7.64%,TRAF3;MAP3K7;PLCG2;MAPKAPK2
gsea,Negative Regulation Of Epithelial Cell Migration (GO:0010633),-0.3848117633996422,-1.2443621342644557,0.2052313883299799,0.3409502430004878,1.0,3/24,2.54%,APOE;PFN2;NR2F2
gsea,Cholesterol Biosynthetic Process (GO:0006695),-0.39007179813659354,-1.2440190157355304,0.17425742574257425,0.34094364968612406,1.0,8/21,21.94%,MSMO1;HMGCS1;ACLY;HMGCR;INSIG2;INSIG1;HSD17B7;FDFT1
gsea,Establishment Of Vesicle Localization (GO:0051650),0.4266738143029576,1.243587323886783,0.2049808429118774,0.4494677633878055,1.0,5/17,10.13%,RAB27A;SPG11;SYNJ1;LIMK2;DNM2
gsea,Cell Morphogenesis Involved In Differentiation (GO:0000904),0.3919622033686146,1.2435093232909364,0.16865079365079366,0.44804787312615835,1.0,5/18,14.08%,SIPA1L3;TBCD;RILPL1;RELN;PROX1
gsea,Myelination (GO:0042552),0.3570530597607496,1.2433500925460084,0.17573221757322174,0.4467801094990523,1.0,16/39,26.26%,SCN8A;NF1;NFASC;TNFRSF21;SBF2;HYCC1;SIRT2;EPB41L3;GAL3ST1;MARVELD1;SLC8A3;PLLP;MYRF;SKI;LGI4;ACER3
gsea,Protein K11-linked Ubiquitination (GO:0070979),0.3627559770695907,1.243330925114909,0.17190388170055454,0.44524092211945165,1.0,3/26,1.99%,UBE2E2;PRKN;CDC27
gsea,Membrane Fusion (GO:0061025),-0.37839507223860236,-1.2420366955421702,0.16024340770791076,0.3437962547216256,1.0,7/23,16.48%,VAMP2;VAPA;NAPG;VTI1B;SNAP29;VAMP3;NSF
gsea,Negative Regulation Of Signaling Receptor Activity (GO:2000272),0.4079720839201675,1.2415302402812167,0.19607843137254902,0.4476519066965097,1.0,6/17,15.97%,ZFYVE28;CBL;EPHB2;PPARG;SNX6;PPARA
gsea,Regulation Of Glycogen Biosynthetic Process (GO:0005979),0.4042411438534988,1.2409195279685707,0.18049792531120332,0.4473521046222804,1.0,5/18,15.07%,SORBS1;GCK;AKT2;INPP5K;PASK
gsea,Regulation Of Microtubule Polymerization Or Depolymerization (GO:0031110),-0.3857518025367155,-1.2407903845503188,0.17623762376237623,0.3454181787255858,1.0,10/23,22.34%,MAP1B;STMN3;MAP1A;STMN4;STMN1;PRUNE1;FKBP4;ARL2;MAP1S;GBA2
gsea,Regulation Of Sodium Ion Transmembrane Transporter Activity (GO:2000649),0.3440374560781514,1.2402502827657869,0.15702479338842976,0.44730098834791093,1.0,6/31,7.38%,HECW1;PRKCE;DMD;FGF14;WNK2;WNK3
gsea,Positive Regulation Of Calcium Ion Transport (GO:0051928),0.40802790876530204,1.2394079367732163,0.19507186858316222,0.44754064745971045,1.0,5/18,11.90%,CACNB2;CAMK2A;TRPC6;WNK3;ORAI1
gsea,Regulation Of calcineurin-NFAT Signaling Cascade (GO:0070884),-0.38099538057824234,-1.2389366983777794,0.16733067729083664,0.34803863597774776,1.0,4/23,5.45%,PRNP;PPP3CA;PPP3R1;PPP3CB
gsea,Regulation Of Interleukin-1 Beta Production (GO:0032651),-0.36790660235138734,-1.2377333818998963,0.17884615384615385,0.3495536516040863,1.0,16/30,37.12%,USP50;GSTP1;EGR1;CX3CL1;P2RX7;STMP1;FOXP1;RIPK2;CD33;SIRPA;GIT1;MYD88;STAT3;CASP8;NLRC4;APP
gsea,Positive Regulation Of Cell Development (GO:0010720),-0.40542343571028083,-1.2374707984932054,0.1958568738229755,0.34944850269538674,1.0,5/19,16.95%,SNW1;NAP1L1;BAD;TRIM32;OPRM1
gsea,DNA-templated DNA Replication (GO:0006261),-0.30928106888748846,-1.2367490190626136,0.13443830570902393,0.3500929234593501,1.0,24/62,33.33%,CHRAC1;ORC1;PURA;GINS2;POLDIP2;GINS4;CDC45;RECQL;NOC3L;RFC3;RRM1;RRM2B;TEFM;MCM6;RAD51;ORC4;HMGA1;WDR18;POLD2;POLD3;HELB;RFC5;MGME1;CDC34
gsea,Mitotic Cell Cycle Phase Transition (GO:0044772),0.2824381607383157,1.2364905061708222,0.1290983606557377,0.4525400895268448,1.0,24/83,20.21%,CDC27;CCNJL;CDK14;CCDC57;CAMK2A;CLASP1;BRSK1;CCND2;GSPT1;USP29;TRIM71;CUL5;DNM2;SPAST;CHEK2;EPS8;ACVR1B;CLASP2;CTDP1;ANAPC1;PLK3;CUL4A;CUL2;CDC25B
gsea,Regulation Of ERK1 And ERK2 Cascade (GO:0070372),-0.27338569070465185,-1.2363907722330543,0.1233644859813084,0.3500570285492105,1.0,32/143,19.30%,MT3;HMGB1;APOE;EPHA7;RASGRP1;FGFR2;DUSP3;SPRY2;TIMP3;GSTP1;YWHAZ;DDT;PDGFA;PIN1;HRAS;CX3CL1;TEK;LYN;EZR;RAP1A;MAPK3;SEMA7A;EPHA4;OPRM1;ZDHHC17;CSF1R;PTPN1;PDGFB;HTR2A;FBXW7;PHB2;PDGFD
gsea,Inorganic Anion Transport (GO:0015698),0.3548404009963262,1.2363565985702323,0.1752808988764045,0.4512763437081007,1.0,9/30,15.42%,ANO4;ANO6;CLCN5;ANO10;SLC26A4;SLC25A10;SLC26A8;PACC1;SLC26A11
gsea,Vesicle Transport Along Microtubule (GO:0047496),0.3923641966994895,1.235923552275175,0.19367588932806323,0.4506983936666476,1.0,5/21,11.60%,BICDL1;DYNC1I1;TRAK2;KIF1C;HTT
gsea,Regulation Of Dendrite Morphogenesis (GO:0048814),0.3647463272287949,1.2357396477999714,0.18290258449304175,0.4496066030963171,1.0,10/30,15.73%,HECW1;KNDC1;PTPRD;CUX2;SEMA4D;FBXW8;LZTS1;TNIK;CAPRIN1;NEDD4L
gsea,Skeletal Muscle Organ Development (GO:0060538),-0.40901568258781573,-1.234722278164915,0.20306513409961685,0.35228920648939266,1.0,4/17,5.38%,MYL6;ZBTB18;MEF2C;IGSF8
gsea,Monoatomic Anion Transport (GO:0006820),0.34917092651816023,1.2338231833965532,0.2,0.4523211378513681,1.0,10/31,13.53%,ANO4;ANO6;CLCN5;ANO10;SLC26A4;LRRC8C;LRRC8D;SLC26A8;SLC17A5;PACC1
gsea,Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046425),-0.3677733779303609,-1.2337176218442671,0.1348747591522158,0.35339075639909584,1.0,3/27,8.06%,CALM1;LEPROT;OCIAD1
gsea,Cellular Response To Lipid (GO:0071396),-0.2771383132891905,-1.233239859356049,0.12921348314606743,0.3536094779214474,1.0,30/121,21.21%,HMGB1;HSPA8;ATP1A1;H2AZ1;ATP1A3;SNW1;MEF2C;NDUFA13;BRINP3;GSTP1;NFKBIB;RORB;AXL;GNAI1;ATP1A2;SOX9;FZD4;XBP1;GSK3B;LYN;SSTR2;BCL10;INSIG1;SSTR1;ADAM9;CREB1;CDC73;SHPK;VIM;RHOA
gsea,Central Nervous System Neuron Development (GO:0021954),-0.4198690672415599,-1.2329757342343473,0.17416829745596868,0.3534292510763172,1.0,2/16,1.14%,HSP90AB1;HSP90AA1
gsea,Positive Regulation Of Phosphorylation (GO:0042327),-0.26761706310300404,-1.232746710681162,0.12411347517730496,0.35322787054423693,1.0,25/147,14.42%,MT3;PPIA;RACK1;RAC1;HSP90AA1;RASGRP1;FGFR2;VEGFC;PTGES3;KRAS;PIN1;PINK1;FGFR1;HRAS;AXL;SOX9;VEGFB;CLIP3;FMR1;TEK;LYN;MYDGF;MAPK3;ILK;ERP29
gsea,Modulation By Host Of Symbiont Process (GO:0051851),-0.35964424192209765,-1.2324269085784705,0.17325800376647835,0.3531140429253614,1.0,4/29,3.15%,JUN;NUCKS1;CDC42;SNW1
gsea,Ubiquitin-Dependent Protein Catabolic Process (GO:0006511),-0.2423894927747342,-1.2324164149576495,0.07042253521126761,0.3525511459841712,1.0,78/322,21.07%,PSMC3;PSMB5;PSMA7;NDFIP1;PSMC2;COP1;SQSTM1;PSMA5;PSMA4;KCTD13;NEDD8;RNF187;PSMD2;PSMD4;TBL1XR1;PSMA3;PSMC5;PSMD7;VPS28;RBX1;RNF6;PSMB1;PINK1;UBA1;UBE2S;PSMB3;FBXO9;RNF11;PML;RNF7;UBXN1;ZFAND2B;PSMA1;PSMC6;STUB1;PSMD6;CHMP2A;RNF5;TSG101;PPP1R11;CHMP6;UCHL1;ANAPC11;RNF168;XBP1;GSK3B;PSMC1;KCTD17;ATE1;PEX12;NDFIP2;PSMC4;TBL1X;RNF114;VPS4A;SHARPIN;KLHDC2;PSMB6;UBAP1;SIAH3;PJA2;TRIM32;RNF185;PSMB7;CHMP4C;PSMA2;CHMP7;PCNP;VCP;FBXW7;OS9;ELOC;RNF126;MAEA;UBE2H;CSNK1A1;NUB1;GID4
gsea,Positive Regulation Of Actin Filament Bundle Assembly (GO:0032233),-0.3319650756705207,-1.2322369883996813,0.1695906432748538,0.3522498964568225,1.0,7/38,10.86%,PFN2;RAC1;CDC42;CD47;TPM1;PFN1;CX3CL1
gsea,Negative Regulation Of Transcription By RNA Polymerase II (GO:0000122),-0.23712482912686264,-1.2319106132556308,0.07115384615384615,0.3522718614086897,1.0,97/466,18.44%,DDX5;HMGB1;HSBP1;RPL17;JUN;EID1;TLE5;CALR;RPS14;FGFR2;MAGED1;CNBP;NR2F2;ZBTB18;NDN;JUND;SNW1;ZBTB20;ETS2;USP2;MEF2C;CGGBP1;HSF4;DRAP1;CBX3;MLIP;YWHAZ;SIN3B;NSMCE3;TBL1XR1;KLF7;ZEB2;CITED2;GPS2;RPL10;MAGEH1;SNCA;TRO;METTL13;NIF3L1;CHD3;ZBTB39;RBBP7;DNAJA3;C1QBP;PURA;PARP1;NFIC;IRF8;SOX9;CXXC5;UBE2V1;CEBPB;KDM1B;EPO;MAGED2;MACROH2A1;CBX6;MAF;DDX20;THAP7;MTDH;EZR;ZBTB21;ATF2;CEBPA;CRYM;HDGF;TBL1X;CBX5;KLF12;CBFB;NR4A2;NFIL3;ID4;ID2;ZBTB33;NOP53;ELK4;ZBTB6;SMAD7;KLF10;SIRT6;HEY1;CBX4;RTF1;HCFC1;FLYWCH1;ID3;UBA2;ENO1;MED9;YY1;SOX4;CBX7;ZBTB12;THRA
gsea,Double-Strand Break Repair (GO:0006302),-0.26249989430096715,-1.2319102504921922,0.10931899641577061,0.3516896240926925,1.0,38/146,23.03%,HMGB1;MORF4L1;NUCKS1;MRPL36;SEM1;POLQ;SWI5;EYA1;NSMCE3;SFR1;UBE2N;INIP;RAD21;RPA3;PARP1;PPP4C;RNF168;BABAM2;HPF1;MPND;SIRT6;RECQL;IFFO1;YY1;PRPF19;SAMHD1;H2AX;VCP;DDX1;XRCC2;UIMC1;RAD50;ACTR8;RNF138;MAD2L2;RBBP8;XRCC6;RAD51
gsea,Wound Healing (GO:0042060),0.31544686664119215,1.2318924408959628,0.15466101694915255,0.45494881853146657,1.0,14/53,12.63%,MACF1;EPB41L4B;DST;FGF10;NRG1;TGFBR1;NF1;RAF1;MYOF;WNT7A;NOG;ANXA6;MYH9;FUT10
gsea,Zinc Ion Transport (GO:0006829),-0.3953628968530695,-1.2317292914778226,0.21301775147928995,0.3514147957388908,1.0,6/19,26.79%,MT3;SLC39A3;SLC30A6;SLC30A1;SLC39A13;SLC39A7
gsea,Secondary Alcohol Biosynthetic Process (GO:1902653),-0.3947999343723696,-1.231693931407742,0.17682926829268292,0.35091605378596813,1.0,8/20,21.94%,MSMO1;HMGCS1;ACLY;HMGCR;INSIG2;INSIG1;HSD17B7;FDFT1
gsea,Negative Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043154),-0.3680723500757458,-1.231454488376099,0.18773946360153257,0.3507370929245911,1.0,5/29,7.14%,ARL6IP1;PARK7;DNAJB6;TRIAP1;SNCA
gsea,"Maturation Of 5.8S rRNA From Tricistronic rRNA Transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.39121217193355007,-1.2314203043701126,0.19883040935672514,0.3502138312824537,1.0,6/20,22.26%,RPS21;EXOSC3;NOP14;ERI2;PES1;EXOSC9
gsea,Secretory Granule Organization (GO:0033363),0.3693263279903236,1.23135054255513,0.18004338394793926,0.45459253404950023,1.0,5/23,13.31%,LYST;HPS5;AP1B1;AP3B1;AP3S1
gsea,Positive Regulation Of Ion Transmembrane Transporter Activity (GO:0032414),0.35778081646657356,1.2291599287508628,0.18875502008032127,0.45770830533128043,1.0,10/26,9.26%,ANK3;DMD;TCAF1;ACTN2;SHANK3;TRPC6;WNK2;WNK3;EPHB2;RELN
gsea,rRNA Methylation (GO:0031167),-0.4029727245722057,-1.2290535291614713,0.18214936247723132,0.3535012445315313,1.0,6/19,28.14%,TRMT112;EMG1;FBLL1;TFB2M;FBL;MRM1
gsea,Regulation Of Nervous System Development (GO:0051960),0.3583809793209484,1.2279166745005328,0.1858974358974359,0.458718025363355,1.0,13/31,26.34%,TENM4;DOCK7;PTPRZ1;NPHP3;SIRT2;FXR1;HLTF;HEY2;NSUN5;PER2;BHLHE40;LGI4;ZPR1
gsea,Regulation Of TORC1 Signaling (GO:1903432),-0.3230596497622434,-1.2277169934053946,0.160075329566855,0.35527853390496184,1.0,15/45,32.77%,SESN1;RRAGA;RRAGD;ITFG2;PIP4P1;SEH1L;SEC13;KICS2;SESN3;RRAGC;LAMTOR5;STK11;FLCN;PIH1D1;SIK3
gsea,Regulation Of Chemokine Production (GO:0032642),-0.43396126607966845,-1.227048484951657,0.1988527724665392,0.3558207014234629,1.0,3/15,17.62%,IL18;EGR1;CSF1R
gsea,Cellular Response To Oxygen-Containing Compound (GO:1901701),-0.24989517005129078,-1.2254534797247512,0.08839779005524862,0.35788455090050725,1.0,62/260,20.78%,ACTB;MT3;HMGB1;JUN;RPS3;PRDX5;H2AZ1;GNG2;LAMTOR2;SNW1;MEF2C;SQSTM1;P2RY12;NEUROD2;NDUFA13;RRAGA;BRINP3;SYT5;GSTP1;TPM1;EGR1;PRKD1;LAMTOR3;PDXP;MPV17;RRAGD;ROMO1;CLU;NFKBIB;RORB;AXL;ITPKA;SOX9;FZD4;XBP1;GSK3B;LYN;PEX12;EZR;RAP1A;MAPK3;ZFP36L1;SSTR2;SYT11;CDKN1B;SLC25A24;IGFBP5;BCL10;SYT6;ZFAND1;INSIG1;SSTR1;ADAM9;VCP;PDGFB;CREB1;CAPN3;MAPK1;RASGRP2;CDC73;SHPK;VIM
gsea,Cellular Response To Catecholamine Stimulus (GO:0071870),0.39926271271002517,1.2249729983426658,0.20833333333333334,0.4635397647729602,1.0,6/17,11.75%,RYR2;PRKN;ATP2B4;ADCY6;SIRT2;SLC9A1
gsea,BMP Signaling Pathway (GO:0030509),-0.35337765291356416,-1.224850653771324,0.15913555992141454,0.3583549795507827,1.0,10/30,26.47%,DDX5;INHBA;MAPK3;BMPR2;BMP6;BMPR1B;SMAD9;TGFB2;SMAD5;BMPR1A
gsea,Inorganic Cation Transmembrane Transport (GO:0098662),-0.2560375464675231,-1.224684981551163,0.09782608695652174,0.3580520887846477,1.0,27/182,10.01%,ATP1B1;ATP6V0C;KCNA1;RNASEK;ATP6V1D;ATP6V1A;FKBP1A;ATP1A1;ATP6V0E2;ATP1A3;ATP6V0B;KCND2;KCNK2;KCNJ2;ATP6V1F;KCNK1;KCNA2;SLC39A3;KCNN1;ATP6V1E1;ITGAV;ATP6AP2;CLU;KCNA4;SLC24A5;SCN1B;ATP1A2
gsea,Positive Regulation Of Biosynthetic Process (GO:0009891),0.3650747971634525,1.2243560618886282,0.18461538461538463,0.46336393687428895,1.0,7/26,10.86%,SORBS1;GRIN1;RPTOR;RAB27A;PLCG2;SLC5A3;MTOR
gsea,Autophagosome Organization (GO:1905037),-0.32064865668216164,-1.2242415617262479,0.17227722772277226,0.3582510275718608,1.0,14/49,23.66%,GABARAPL1;GABARAPL2;GABARAP;MAP1LC3B;UBQLN2;ATG12;RAB1B;MAP1LC3A;EMC6;ATP13A2;ATG3;ATG9A;UBQLN1;RAB35
gsea,Muscle Organ Development (GO:0007517),0.34977087082919817,1.2235383386859613,0.18087318087318088,0.46367450665003473,1.0,10/32,14.06%,CHD2;DMD;BVES;SGCD;LARGE1;CACNA1H;SPEG;MAPK12;MEF2D;EVC
gsea,Negative Regulation Of Actin Filament Bundle Assembly (GO:0032232),0.38943638972450095,1.2229981960049563,0.1921641791044776,0.4633283979569908,1.0,9/20,14.77%,PRKN;TJP1;CLASP1;SHANK3;SHANK1;TMEFF2;ARHGEF18;CLASP2;INPP5K
gsea,Cellular Response To Decreased Oxygen Levels (GO:0036294),-0.3104097879828444,-1.2229888908478745,0.1485148514851485,0.3599224804680529,1.0,12/57,17.05%,MT3;KCND2;BNIP3L;PGK1;PINK1;BAD;STUB1;ADO;P4HB;ZFP36L1;NOP53;FAM162A
gsea,Regulation Of Ossification (GO:0030278),-0.39319906988679953,-1.2216797263738346,0.21146245059288538,0.36161730753980276,1.0,6/23,16.56%,MEF2C;CCDC134;SOX9;S1PR1;BMPR2;BMP2K
gsea,Cellular Response To Amyloid-Beta (GO:1904646),0.3750785300097704,1.2215015146534707,0.17613636363636365,0.4650324669289934,1.0,3/22,0.55%,GRIN2A;GRIN1;CACNA1A
gsea,Epithelial To Mesenchymal Transition (GO:0001837),-0.3554780322972505,-1.2213558475004476,0.20404040404040405,0.3616216393551653,1.0,6/30,11.74%,DDX5;OLFM1;HNRNPAB;FGFR1;SOX9;GSK3B
gsea,Positive Regulation Of Protein Targeting To Mitochondrion (GO:1903955),-0.3684056266793998,-1.220307852168673,0.202,0.3628202001195656,1.0,5/25,7.41%,LEPROT;TOMM7;SH3GLB1;PIN1;PINK1
gsea,Stem Cell Differentiation (GO:0048863),-0.36500554325552714,-1.2196425060763685,0.1803921568627451,0.3633040859399584,1.0,3/27,3.63%,GPM6A;FGFR2;MEF2C
gsea,Negative Regulation Of Ras Protein Signal Transduction (GO:0046580),-0.35123487419313104,-1.21827844575533,0.1828793774319066,0.36515993842048905,1.0,5/28,6.39%,DYNLL1;STMN3;SPRY2;KCTD13;STMN1
gsea,Positive Regulation Of Endopeptidase Activity (GO:0010950),-0.37245239578102945,-1.2174861001550275,0.18467583497053044,0.36587466918934486,1.0,7/23,16.89%,USP50;PSENEN;APH1A;LYN;PSME3;PRELID1;EPHA4
gsea,Regulation Of Protein Phosphorylation (GO:0001932),-0.2581035492971835,-1.2167637615927827,0.11029411764705882,0.36650723697466625,1.0,31/184,14.84%,MT3;PPIA;RACK1;PRNP;EPHA7;RAC1;HSP90AA1;PARK7;RASGRP1;VEGFC;SOD1;PPP2CA;PDGFA;KRAS;PIN1;PINK1;NPM1;HRAS;TWF1;SOX9;VEGFB;WWTR1;CLIP3;FMR1;TEK;LYN;MYDGF;MAPK3;ILK;ERP29;NOP53
gsea,Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001236),-0.3381766831035561,-1.2167539734570039,0.18908382066276802,0.3659360292728796,1.0,15/39,27.28%,PARK7;GSTP1;ITGAV;FGFR1;PML;PSME3;BCL10;TNFSF12;NOL3;HYAL2;CFLAR;TRAF2;PAK2;RELA;ITGA6
gsea,Negative Regulation Of Intracellular Protein Transport (GO:0090317),-0.39732874892961983,-1.2159249436560613,0.21176470588235294,0.3667692842531087,1.0,8/18,27.86%,PARK7;BAG4;LMAN1;SIAH3;SIRT6;INSIG1;SUMO1;CHP1
gsea,DNA Geometric Change (GO:0032392),-0.37126154047671744,-1.2157564695538319,0.22328244274809161,0.3664871323388573,1.0,2/23,3.77%,HMGB1;HNRNPA2B1
gsea,Regulation Of Protein Metabolic Process (GO:0051246),-0.2841448486269854,-1.2140230942258492,0.13857677902621723,0.3689700634637693,1.0,11/76,12.74%,HSP90AB1;APOE;FKBP1A;MTPN;NEDD8;NOLC1;RPL10;ODC1;INHBA;CHMP6;LDLR
gsea,Regulation Of Microtubule Cytoskeleton Organization (GO:0070507),0.3433237167193157,1.2133125871382433,0.19961612284069097,0.4815679165040932,1.0,14/35,20.23%,TAOK1;MARK2;ROCK1;MAPT;CLASP1;PATJ;MPDZ;MAPRE1;EPHA3;CLASP2;PHLDB1;MID1;MAP6;PHLDB2
gsea,Protein Targeting To Vacuole (GO:0006623),0.3423447113829578,1.2131221802687897,0.2028397565922921,0.4803700589056965,1.0,5/31,8.54%,VPS13A;VPS13C;VPS13D;HGS;VPS41
gsea,Regulation Of Innate Immune Response (GO:0045088),-0.3156365917832959,-1.2121268073828628,0.1835564053537285,0.37162239421358645,1.0,17/52,26.42%,APLP2;BANF1;YWHAZ;CDC37;ATG12;AKIRIN2;PARP1;POLR3D;MUL1;NLRC3;RNF185;PTPN1;SAMHD1;TKFC;PTPN11;AKT1;CFH
gsea,Negative Regulation Of Blood Vessel Morphogenesis (GO:2000181),0.3259815683875955,1.2119623255816283,0.1936842105263158,0.48145566301193016,1.0,12/42,14.38%,ATP2B4;NRG1;ROCK1;ADGRB1;AGO1;HGS;KRIT1;MECP2;SYNJ2BP;NIBAN2;PPARG;DAB2IP
gsea,fatty-acyl-CoA Biosynthetic Process (GO:0046949),-0.37587295558078715,-1.2118452856524977,0.2109704641350211,0.37149206582516897,1.0,2/22,1.54%,TECR;ACSL3
gsea,Sterol Metabolic Process (GO:0016125),-0.3547791328578272,-1.2115877625572933,0.2019607843137255,0.37140163984356733,1.0,12/29,27.70%,APOE;LCAT;MSMO1;SQLE;PIP4P1;HMGCR;ANGPTL3;FDX1;GBA2;OSBPL5;CYP46A1;CLN8
gsea,Determination Of Left/Right Symmetry (GO:0007368),0.36656240380611804,1.2114063991834214,0.2076271186440678,0.48116223089648374,1.0,11/24,23.34%,DNAH5;PKD2;NPHP3;SMO;ODAD4;DNAAF4;MEGF8;OFD1;GALNT11;CCDC40;CCDC39
gsea,Regulation Of Cytokine Production (GO:0001817),-0.29099374651778426,-1.2110651023376513,0.1592920353982301,0.3717639535108563,1.0,36/82,35.93%,GAPDH;IGF2BP3;ZBTB20;SOD1;CD47;ZBTB39;IRF8;PPP1R11;ATP2B1;LYN;ZBTB33;SYT11;ZBTB6;ZBTB12;CIDEA;CCDC88B;TBK1;AGPAT1;LURAP1;LITAFD;GPNMB;RNF26;PLD4;ZBTB45;MOG;FOXP1;FLOT1;ZBTB1;PATZ1;SIRPA;LITAF;PTGER4;ASB1;PLD3;CASP8;CD276
gsea,Regulation Of Heart Contraction (GO:0008016),-0.3254392215571103,-1.210481038954395,0.18346774193548387,0.3721438630122013,1.0,12/43,15.55%,CALM1;CALM2;CALM3;CELF2;TPM1;SCN1B;ATP1A2;ATP2B1;SRI;SLC8A2;FXYD1;SMAD7
gsea,Positive Regulation Of Establishment Of Protein Localization To Mitochondrion (GO:1903749),-0.35625035405037986,-1.2103793912392096,0.21686746987951808,0.37174030187828544,1.0,11/27,28.15%,LEPROT;TOMM7;SH3GLB1;PIN1;PINK1;NMT1;FBXW7;BBC3;HTRA2;USP36;SREBF2
gsea,Negative Regulation Of Receptor-Mediated Endocytosis (GO:0048261),-0.40182613082282187,-1.209763535677643,0.21584158415841584,0.3722087363496541,1.0,4/17,7.62%,RAC1;LRPAP1;UBQLN2;ITGAV
gsea,Regulation Of DNA Damage Checkpoint (GO:2000001),-0.42844462853360776,-1.2096977405876121,0.21495327102803738,0.3717485138485396,1.0,9/15,40.62%,TTI2;TTI1;DDX39B;RAD51;CCAR2;ETAA1;WDR76;THOC1;CRY1
gsea,Fatty Acid Transport (GO:0015908),-0.3997287914171349,-1.2090449619536294,0.2151639344262295,0.372366331733989,1.0,9/18,25.28%,APOE;FABP5;GOT2;FABP3;FABP7;LYPLA1;ARID4A;MFSD2A;SLC25A17
gsea,Positive Regulation Of Lymphocyte Proliferation (GO:0050671),-0.35963822165278436,-1.2087833577350908,0.2209737827715356,0.3722085777035133,1.0,5/30,6.74%,CD81;NCK1;MEF2C;IL18;IRS2
gsea,Positive Regulation Of Cell-Matrix Adhesion (GO:0001954),-0.34484710677648167,-1.2085005311272603,0.21484375,0.3721293031428674,1.0,6/33,11.97%,ENC1;RAC1;PLEKHA2;CX3CL1;GSK3B;TEK
gsea,Negative Regulation Of Ion Transmembrane Transporter Activity (GO:0032413),-0.4212995840818845,-1.207716776982953,0.2332657200811359,0.37281035788113126,1.0,2/15,2.64%,CALM2;YWHAE
gsea,Regulation Of Mitotic Spindle Organization (GO:0060236),-0.3482190813989014,-1.2076742055470133,0.21161048689138576,0.3722991173126686,1.0,16/34,34.92%,GNAI1;CHMP2A;CHMP6;CHMP4C;CHMP7;CCSAP;MAP9;NUP62;SASS6;DRG1;CHMP3;TPR;CHMP5;FSD1;DCTN1;HSPA1A
gsea,Cellular Response To Organic Substance (GO:0071310),0.3232094993782479,1.2075838317614964,0.16865079365079366,0.48843634040822814,1.0,11/41,9.44%,SLIT1;AKAP6;KHSRP;FLT3;NFAT5;PLCG2;NCOA2;SLC1A1;SOCS2;NCOA1;CACNA1H
gsea,Heart Contraction (GO:0060047),0.3672767379638598,1.2057500151331466,0.20491803278688525,0.4909657160506538,1.0,10/25,13.31%,RYR2;SLC8A1;DMD;SGCZ;SGCD;TRDN;TAFAZZIN;TTN;TNNC1;GRK2
gsea,Response To Calcium Ion (GO:0051592),-0.28904288396439687,-1.205690913469398,0.16129032258064516,0.3751418593559657,1.0,8/81,4.72%,CALM1;CALM2;CALM3;PPP3CA;MEF2C;PDCD6;NEUROD2;SYT5
gsea,miRNA Processing (GO:0035196),0.3361905015496458,1.2038169693050438,0.1895551257253385,0.49383008781850085,1.0,10/30,10.41%,LIN28B;ZC3H7A;DICER1;TUT4;AGO4;AGO1;NCBP1;TRIM71;PUS10;DGCR8
gsea,Negative Regulation Of Fat Cell Differentiation (GO:0045599),0.39776144000434255,1.203721343566354,0.21965317919075145,0.4924524166149125,1.0,6/21,11.89%,TRIO;RORA;RUNX1T1;ANKRD26;SIRT2;ASXL1
gsea,Oligosaccharide Metabolic Process (GO:0009311),0.33683603517256583,1.2035552691145552,0.19959677419354838,0.4912775538614367,1.0,4/32,9.40%,ST6GALNAC3;ST6GALNAC5;ST3GAL3;MANBA
gsea,Epidermal Cell Differentiation (GO:0009913),-0.3821817808426636,-1.2032039777841386,0.20662768031189083,0.3788798694936282,1.0,8/22,23.01%,PPP3CA;KRT10;FGFR1;WNT16;JAG1;ADAM9;CFLAR;ERCC3
gsea,TOR Signaling (GO:0031929),-0.36243384732953793,-1.202958878147392,0.19111969111969113,0.37865633264491094,1.0,5/25,12.15%,RPS6;LAMTOR2;LAMTOR3;PINK1;EIF4EBP2
gsea,Cardiac Muscle Cell Action Potential (GO:0086001),0.3748145738748222,1.2024386788079706,0.226,0.4922316660585408,1.0,5/23,2.51%,CACNA1C;SCN1A;SLC8A1;KCND3;DMD
gsea,Regulation Of DNA Binding (GO:0051101),-0.34785110369395045,-1.2017972204139198,0.2035225048923679,0.3801552068458074,1.0,5/30,9.59%,HMGB1;JUN;RNF220;HJURP;CSNK2B
gsea,Transcription By RNA Polymerase II (GO:0006366),-0.25119906063603503,-1.201613402831928,0.1266540642722117,0.3799395667915889,1.0,45/161,21.65%,KLF13;CEBPD;ELOB;SUB1;DEK;CCDC124;DRAP1;POLR2F;POLR2I;MED4;POLR2G;TAF10;POLR2E;TCEA1;ADRM1;TAF11;TBPL1;PARP1;NFIC;POLR2C;SNAPC5;TRIM24;GTF2H5;MAF;XBP1;ETV1;PIR;CBFB;GTF2B;RTF1;TAF1C;SKIC8;THRA;POLR2J;CREB1;TAF5;SNAPC1;ELOC;SNAPC2;CDC73;SSU72;POLR2B;MED7;TAF7;NCBP2
gsea,Inositol Phosphate Metabolic Process (GO:0043647),0.38590422978957045,1.2009768914272279,0.24596774193548387,0.49404558988547076,1.0,9/21,15.88%,IPPK;OCRL;SYNJ1;INPP5A;PPIP5K1;ITPKB;INPP5B;ITPKC;PPIP5K2
gsea,Positive Regulation Of Cell Cycle G2/M Phase Transition (GO:1902751),-0.40745798472186884,-1.200231076327892,0.22674418604651161,0.3817930498457315,1.0,6/18,22.00%,RAB11A;CDK4;NPM1;RRM1;RRM2B;RCC2
gsea,Positive Regulation Of Double-Strand Break Repair Via Homologous Recombination (GO:1905168),-0.3343194313120548,-1.199879112866345,0.2043222003929273,0.38186116207578946,1.0,6/32,11.26%,MORF4L1;MORF4L2;ACTR2;PARP1;RUVBL1;MRGBP
gsea,Negative Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120033),0.36464431191813024,1.1988848503235556,0.216,0.49724129502791226,1.0,10/26,17.51%,NRG1;MPHOSPH9;LIMK2;ODF2L;TBC1D30;EVI5L;PRKCD;RAP1GAP;CDK10;KANK1
gsea,Cellular Response To Glucose Stimulus (GO:0071333),-0.3699745109790695,-1.1986017248254883,0.20883534136546184,0.38360357385684596,1.0,9/23,22.35%,RACK1;SELENOT;ZBTB20;XBP1;SOX4;RAB11FIP2;UCP2;RAB11B;PRKACA
gsea,Establishment Of Epithelial Cell Polarity (GO:0090162),0.4133948689661695,1.1985844861756974,0.2135523613963039,0.49632146302587976,1.0,5/16,11.35%,SIPA1L3;MYO9A;SH3BP1;MSN;FBF1
gsea,Cellular Response To Misfolded Protein (GO:0071218),-0.39317012725818823,-1.1985666160670627,0.23260437375745527,0.3830572242005236,1.0,9/19,27.17%,STUB1;RNF5;DNAJC18;RNF185;VCP;RNF126;TOR1A;DERL1;UGGT1
gsea,Sensory Perception Of Light Stimulus (GO:0050953),0.30213107934050754,1.198453772282911,0.17899761336515513,0.49507659404811694,1.0,16/49,20.60%,MYO9A;COL11A1;GRM8;PAX6;ATXN7;PCDH15;GUCA1B;DRAM2;IMPG2;RPGR;KRT12;RABGGTA;OPA3;PITPNA;EML2;WFS1
gsea,Regulation Of Synapse Organization (GO:0050807),-0.36941941807294787,-1.1982440071092213,0.21544715447154472,0.38306657823831763,1.0,7/22,20.52%,MEF2C;SLITRK2;YWHAZ;IL1RAPL1;CAMK2B;EPHA4;CHRNB2
gsea,Heparan Sulfate Proteoglycan Biosynthetic Process (GO:0015012),0.389578642493448,1.1978624806531726,0.2366255144032922,0.49488991298942386,1.0,11/19,24.16%,EXT2;XYLT1;HS6ST3;HS3ST2;EXTL3;EXT1;XYLT2;HS2ST1;UGDH;GLCE;HS6ST2
gsea,Protein Homooligomerization (GO:0051260),-0.27762544667303013,-1.1975650559198603,0.1491395793499044,0.3836217926617173,1.0,32/87,31.24%,ALDOA;APLP2;KCNJ2;POLQ;NINJ1;G3BP2;EHD3;CLU;AQP4;ACOT13;CHMP2A;AQP11;ALAD;BCL10;TMEM70;SAMHD1;EHD1;NOL3;KCNJ12;HSD17B10;CBY1;B2M;TRPM4;RYR1;PRMT1;GLS;EHD4;ZBTB1;APIP;ALOX5AP;USP16;CRYZ
gsea,Autophagosome Assembly (GO:0000045),-0.30477203360856436,-1.196253957120796,0.18962075848303392,0.3854598040035015,1.0,9/53,11.95%,GABARAPL1;GABARAPL2;GABARAP;MAP1LC3B;UBQLN2;ATG12;RAB1B;MAP1LC3A;EMC6
gsea,mRNA Methylation (GO:0080009),0.4142781533925654,1.1953660175006637,0.24803149606299213,0.49907462203711567,1.0,3/15,11.08%,VIRMA;CMTR1;NSUN2
gsea,Cytoplasmic Microtubule Organization (GO:0031122),0.3169715072444841,1.1953027930582423,0.19715447154471544,0.4976790406402893,1.0,15/46,16.00%,HOOK1;MAPT;CLIP2;CCDC88A;CLASP1;LIMK2;CCDC88C;CLIP1;TRDN;FYN;HOOK2;TUBGCP5;KATNB1;HOOK3;NUMA1
gsea,Regulation Of Developmental Growth (GO:0048638),-0.3693838775827765,-1.1950415465725335,0.22532188841201717,0.38712709882663265,1.0,3/22,4.48%,APOE;OLFM1;SOD1
gsea,Establishment Of Endothelial Barrier (GO:0061028),0.3668415164810679,1.1945663479866258,0.22633744855967078,0.49783783257012487,1.0,6/22,9.56%,PDE2A;TJP2;TJP1;RAPGEF6;PPP1R16B;MSN
gsea,Calcium-Mediated Signaling (GO:0019722),-0.30243263762612893,-1.1944453887374824,0.18928571428571428,0.3876318850100726,1.0,7/57,5.45%,ATP1B1;PRNP;PPP3CA;NCALD;P2RY12;PPP3R1;PPP3CB
gsea,Regulation Of Monoatomic Ion Transmembrane Transporter Activity (GO:0032412),0.29198706271289077,1.194409016713192,0.1670103092783505,0.4966251681510282,1.0,19/60,18.71%,NLGN1;SHISA9;DAPK1;CHRM3;SHANK1;TRPC6;CACNG3;WNK3;RELN;DLG4;SHISA7;ANK2;PTPN3;NEDD4L;CACNG8;SHISA6;HCN1;CAPN1;CACNG2
gsea,Cilium Organization (GO:0044782),0.24444163980757946,1.193979195037448,0.1211453744493392,0.49603445605967517,1.0,68/188,24.88%,DYNC2H1;ABLIM3;TTC17;CPLANE1;CCDC57;CFAP47;OCRL;IFT140;DISC1;RAB3IP;IFT88;IQCB1;FLNA;GBF1;DNAH5;RILPL1;TMEM67;TTC21B;BBS9;PKD2;NPHP3;INTU;BBS1;DYNLT2B;CC2D2A;FBXW8;PTPN23;ARL3;FBF1;C2CD3;IQUB;UBXN10;CIBAR1;CFAP61;TCTN2;ARMC9;RPGR;CENPJ;FAM161B;CLUAP1;RAB23;DNMBP;PLA2G3;CEP162;SNX10;TTC39C;WDPCP;MARK4;PARVA;OFD1;CDC14B;CEP164;HDAC6;NEDD9;KIF27;FNBP1L;GALNT11;CEP89;CDC14A;IFT172;CEP131;SCLT1;IFT81;PHIP;BBS5;CFAP54;TCTN3;TTC8
gsea,Defense Response To Bacterium (GO:0042742),-0.32075762033369853,-1.1936919605711849,0.2068345323741007,0.3883304456472925,1.0,11/51,14.29%,FAU;RPL30;RPL39;IL18;ROMO1;AKIRIN2;PPP1R11;CEBPB;CHGA;RPS19;SHARPIN
gsea,Response To Transforming Growth Factor Beta (GO:0071559),0.3730998704616638,1.1928785084450875,0.23588709677419356,0.49703098480387203,1.0,5/27,8.40%,PDE2A;TGFBR1;ROCK1;SOX5;WNT7A
gsea,Neuron Apoptotic Process (GO:0051402),-0.41465616607796174,-1.1926667432117544,0.2419047619047619,0.3896606881019585,1.0,1/15,0.19%,GAPDH
gsea,Regulation Of Histone Acetylation (GO:0035065),-0.3998398500687318,-1.1923651958291346,0.24366471734892786,0.3895805446151923,1.0,4/18,11.73%,SET;DEK;NFYB;THAP7
gsea,Regulation Of Endoplasmic Reticulum Stress-Induced Intrinsic Apoptotic Signaling Pathway (GO:1902235),-0.38784349974154675,-1.1916362704835963,0.208984375,0.3902171419384836,1.0,5/19,11.66%,PARK7;NCK1;BOK;TMBIM6;XBP1
gsea,Positive Regulation Of Signal Transduction (GO:0009967),0.24494379463733126,1.1915935163785754,0.1271186440677966,0.49836887374021976,1.0,48/195,16.34%,GRIN2A;NLGN1;SORBS1;GRIN1;MACF1;SMOC2;CCBE1;TMEM108;TGFBR1;LAMB1;ADAMTS3;DLG5;TSPAN14;SHANK3;CUX2;DISC1;RIMS1;FLNA;SHANK1;SMARCA4;LAMC1;JAK2;PKD2;CHRNA7;WNT7A;PDE6H;THRB;RELN;NECAB2;RSPO3;DLG4;CCN3;ZRANB1;HTT;ASXL1;GAS6;RIMS2;ARNT;ULK3;EVC;DAB2IP;CIBAR1;ROBO1;ATP6V1C2;ZDHHC5;NEPRO;ASXL2;ARMC9
gsea,"Retrograde Vesicle-Mediated Transport, Golgi To Endoplasmic Reticulum (GO:0006890)",-0.30584780341045115,-1.189537226160481,0.16938775510204082,0.3933179844541198,1.0,16/43,26.82%,ARF4;RAB6B;RAB6A;ARF3;ARF5;LMAN2;TMED10;COPG2;RER1;COPB2;PLPP3;USE1;PITPNB;KDELR1;TMEM115;BICD2
gsea,Positive Regulation Of Hydrolase Activity (GO:0051345),0.2631501452730103,1.1891110261851299,0.13911290322580644,0.502742272909194,1.0,33/120,11.55%,DOCK9;DOCK10;DOCK11;ROCK1;DOCK7;NF1;RALGPS1;PKP4;MAP4K4;RGL1;BCAS3;SH3BP1;RGS8;RAPGEF4;RASGRF2;SOS1;RGS11;SEMA4D;RAP1GDS1;SNX13;RGS7;RAPGEFL1;RASGEF1B;PREX2;SRGAP3;RAPGEF6;WRN;RALGPS2;ARHGEF7;RASGRF1;RSU1;MAPK12;ARAP1
gsea,Glycosphingolipid Metabolic Process (GO:0006687),0.3488338528005732,1.1885633119220693,0.2222222222222222,0.5024780233329618,1.0,2/26,1.32%,ST6GALNAC3;ST6GALNAC5
gsea,Regulation Of Vacuole Organization (GO:0044088),0.40162701994386,1.187524568266643,0.23880597014925373,0.5035115217092657,1.0,5/16,9.05%,ELAPOR1;IFT88;PIKFYVE;EPHB2;TBC1D12
gsea,"Wound Healing, Spreading Of Cells (GO:0044319)",0.3874086140350931,1.1871664368110595,0.2170212765957447,0.5027365315629619,1.0,8/18,22.75%,MRTFA;FLNA;WNT7A;TMEFF2;COL5A1;ADAM17;CD44;ARHGAP24
gsea,Vitamin Transport (GO:0051180),0.37743594923053325,1.1859639340137973,0.2336065573770492,0.5039976337221139,1.0,6/21,18.89%,SLC35F3;LRP2;SLC5A6;SLC2A6;ABCD4;SLC25A32
gsea,Regulation Of Tumor Necrosis Factor Production (GO:0032680),-0.3028385561942113,-1.1858805356646527,0.22847100175746923,0.3994677209310524,1.0,11/65,15.21%,HMGB1;C1QTNF4;RASGRP1;CD47;GSTP1;DDT;CLU;CX3CL1;ARG2;SYT11;NLRC3
gsea,Negative Regulation Of miRNA Metabolic Process (GO:2000629),0.3969043792795896,1.185485948765851,0.2389558232931727,0.5035524380642309,1.0,6/16,15.97%,NFIB;PPARD;PPARG;POU5F1;TENT2;PPARA
gsea,Protein Localization To Membrane (GO:0072657),0.2536375885984331,1.1854775761256013,0.147117296222664,0.502040850530998,1.0,40/157,14.77%,ANK3;NLGN1;SPTBN4;DPP6;CACNB2;DPP10;FCHO2;TTC7B;ROCK1;RAB40C;PACS1;ACTN2;RFTN1;TSPAN14;PACSIN1;C2CD5;SHANK3;MAP7;FLNA;SEC16A;WNK3;HGS;IKBKB;RAPGEF6;ZDHHC2;HYCC1;ARL3;TSPAN15;RAB3B;TM9SF1;GAS6;EPB41L3;MYO5A;KCNB2;PKP2;SPTBN1;TNIK;ANK2;CLASP2;INPP5K
gsea,Histone Deacetylation (GO:0016575),-0.3382874661855483,-1.1854395880667836,0.21765913757700206,0.3996366369001807,1.0,8/34,15.81%,MORF4L1;MORF4L2;TBL1XR1;CHD3;RBBP7;TBL1X;ELK4;SIRT6
gsea,RNA Methylation (GO:0001510),-0.29512452622573654,-1.184669825983,0.18864468864468864,0.40043489271745686,1.0,16/61,23.75%,SNRPG;SNRPF;SNRPD2;TRMT112;FBLL1;SNRPD1;TRMT12;SNRPE;HENMT1;TRDMT1;TFB2M;LCMT2;CBLL1;SNRPB;DIMT1;TGS1
gsea,Sulfur Compound Transport (GO:0072348),0.4025112430890182,1.182759649822682,0.2360248447204969,0.5067106774629168,1.0,6/16,15.42%,SLC35F3;SLC26A4;SLC25A10;SLC26A8;SLC5A6;SLC26A11
gsea,Positive Regulation Of Carbohydrate Metabolic Process (GO:0045913),0.34963882905711263,1.1825739266732236,0.20743639921722112,0.5056189184408201,1.0,10/25,18.41%,PRKCE;RPTOR;GPLD1;AKT2;MTOR;ARNT;PRXL2C;EGF;PTH1R;NFKB1
gsea,Positive Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001961),-0.3762387258292106,-1.182238504022012,0.2222222222222222,0.40413225050587986,1.0,8/21,23.94%,C1QTNF4;USP27X;AXL;LAPTM5;TRIM44;RNF185;AGPAT1;MAVS
gsea,Negative Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001960),0.3347602625402854,1.1821795956882382,0.1963927855711423,0.504967120267319,1.0,13/31,21.09%,SLIT1;CCDC3;PTPN2;STAT2;GAS6;PPARG;PELI3;ROBO1;OTUD4;YTHDF3;PPP2CB;RFFL;TRAIP
gsea,Positive Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120034),-0.28983373494057035,-1.1800864477212218,0.18613138686131386,0.40747772013548716,1.0,19/72,13.33%,RAC1;GPM6A;BRK1;CDC42;WASL;P2RY12;ARPC2;ACTR2;PFN1;AKIRIN1;HRAS;RALA;FMR1;EPS8L1;GSK3B;IFT20;KCTD17;PIK3R1;PLPPR5
gsea,Negative Regulation Of Stress-Activated MAPK Cascade (GO:0032873),-0.3476304538270424,-1.179495854627147,0.2407766990291262,0.40790608880923285,1.0,5/29,7.41%,PPIA;DUSP3;GSTP1;GPS2;PINK1
gsea,Ubiquitin-Dependent Protein Catabolic Process Via The Multivesicular Body Sorting Pathway (GO:0043162),-0.33783173335345945,-1.1791503276551296,0.2350597609561753,0.4079543302829211,1.0,13/31,27.50%,VPS28;CHMP2A;TSG101;CHMP6;STAM2;VPS4A;UBAP1;CHMP4C;CHMP7;RNF126;VPS36;STAM;CHMP3
gsea,Regulation Of Protein Secretion (GO:0050708),-0.2981034609691697,-1.179016780633192,0.18809980806142035,0.4075886385270508,1.0,21/60,23.80%,PPIA;APOE;UQCC2;PPP3CB;IER3IP1;STXBP5L;ENSA;SNAP25;TMED10;EZR;HMGCR;ERP29;ATP13A2;SIRT6;ADAM9;BMP6;TGFB2;MYH10;DPH3;DNAJC1;ARF6
gsea,Positive Regulation Of Focal Adhesion Assembly (GO:0051894),0.3974478389629523,1.1787070904830315,0.23732251521298176,0.5114277448250402,1.0,4/16,7.36%,NRG1;ROCK1;MAP4K4;COL16A1
gsea,Proteolysis Involved In Protein Catabolic Process (GO:0051603),-0.2868276188092544,-1.1778319033077642,0.164,0.409346627339099,1.0,14/61,18.97%,UBB;RPS27A;UBA52;CTSB;NEDD8;ZYG11B;STUB1;ATE1;PEX12;VPS4A;CHMP4C;CTSH;PRPF19;VCP
gsea,Neural Crest Cell Differentiation (GO:0014033),-0.407207035693031,-1.176726502588526,0.24660194174757283,0.41073460940073103,1.0,3/15,6.15%,MEF2C;PDCD6;NOLC1
gsea,Fatty Acid Biosynthetic Process (GO:0006633),-0.3265943371921346,-1.1766497240314255,0.22957198443579765,0.41026562838326597,1.0,10/38,22.07%,TECR;HSD17B8;GPX4;HACD4;XBP1;ACLY;ACSBG1;NDUFAB1;OXSM;FASN
gsea,Negative Regulation Of Phosphorylation (GO:0042326),-0.2980918963660155,-1.176231835433685,0.20662768031189083,0.41043179475779445,1.0,12/62,19.07%,PPIA;PRNP;DYNLL1;PARK7;IRS2;INHBA;WWTR1;LYN;CDKN1B;TRAF3IP1;PLPP3;SH3GL2
gsea,Regulation Of Microtubule Depolymerization (GO:0031114),-0.37639950851327475,-1.1744038711066138,0.23293172690763053,0.41319742233096296,1.0,4/20,4.51%,MAP1B;NAV3;MAP1A;FGF13
gsea,Positive Regulation Of Transcription By RNA Polymerase I (GO:0045943),0.3410094065096619,1.1742244712373455,0.24329896907216494,0.5205378978121359,1.0,8/30,13.56%,ASIC2;IPPK;SMARCA4;SF3B1;HEATR1;BAZ1B;MTOR;UBTF
gsea,Negative Regulation Of Small GTPase Mediated Signal Transduction (GO:0051058),0.4048955507256627,1.1739404227626196,0.24242424242424243,0.5196161442216275,1.0,5/16,14.38%,SYNGAP1;LZTR1;SH3BP1;EPHB2;DAB2IP
gsea,Regulation Of Cell Growth (GO:0001558),-0.2430486515341606,-1.1735449767821275,0.14471243042671614,0.4142422811522576,1.0,61/165,31.32%,MT3;RACK1;CDC42;LAMTOR2;MTPN;NDUFA13;NRG3;PPP2CA;PPP2R1A;RTN4;PML;RBBP7;INHBA;GJA1;EXOSC4;OSGIN2;DNAJB2;CDKN1B;MUL1;TRIM32;EIF4G2;BMPR2;N6AMT1;IL17RB;BTG1;CGRRF1;ENO1;PAPPA2;FXN;FAM107A;RASGRP2;NDRG3;HYAL2;EXOSC9;TGFB2;MAD2L2;EBAG9;CCAR2;CRLF3;DERL2;DCUN1D5;AKT1;CSNK2A1;MFSD2A;LAMTOR1;HYAL1;PSMD10;SPHK2;SERTAD2;TMEM97;JADE2;ING1;TSPYL2;CDKN2D;STK11;NDUFS3;CAPRIN2;CCDC85B;SIPA1;FLCN;MLST8
gsea,Cellular Response To UV (GO:0034644),-0.29346350783211594,-1.1733761317306157,0.20703125,0.41393783273396956,1.0,11/61,12.91%,RPL26;COPS9;H2AC25;TRIAP1;NSMCE3;RBX1;PCNA;NPM1;PARP1;SDE2;DDB2
gsea,Regulation Of Endothelial Cell Migration (GO:0010594),-0.29502402025303737,-1.1730397868557776,0.2138728323699422,0.4138904938657506,1.0,9/66,7.20%,APOE;RAC1;CALR;EMC10;NR2F2;PDCD6;GLUL;PRKD1;NELL2
gsea,Central Nervous System Development (GO:0007417),0.24601371976033387,1.172791213613465,0.16470588235294117,0.5207865888200867,1.0,41/217,12.88%,CNTN5;DSCAML1;GRIN2A;GRIN1;ASIC2;FLNB;CHD8;CNTN4;PRKN;IL1RAPL2;PKD1;NF1;CNTNAP2;NIPBL;VPS13B;PTPRZ1;ATXN1;ZFHX2;PAX6;SYNJ1;EML1;NFASC;NCOA6;DHX30;NFIB;MDGA1;SPOCK1;PBX4;PKD2;GRIK1;RPS6KA6;RELN;CNTN6;BPTF;SMO;ADAM22;MAST1;SOX8;MEIS2;COL4A1;DCX
gsea,Positive Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090100),-0.3023478202438196,-1.1723896329594259,0.2101313320825516,0.41448461394178937,1.0,6/52,9.59%,HSP90AB1;SNW1;ZEB2;CITED2;INHBA;CSNK2B
gsea,Regulation Of Secretion By Cell (GO:1903530),-0.30891315982203366,-1.1718284803921073,0.229126213592233,0.4148985124999042,1.0,12/51,16.48%,RAB3A;CPLX2;VAMP2;MEF2C;SEPTIN5;STXBP5L;RALA;FMR1;VAMP3;SIRT6;APEX1;NSF
gsea,Long-Term Synaptic Potentiation (GO:0060291),0.3903845816253286,1.171123358829621,0.2357563850687623,0.5231980067252977,1.0,3/16,4.41%,GRIN2A;SHANK2;SLC24A2
gsea,Phosphatidylinositol Metabolic Process (GO:0046488),0.2900168024543789,1.1709981362445467,0.20647773279352227,0.5219264809670976,1.0,21/57,24.33%,PITPNM2;PLA2G4E;OCRL;PIP5K1B;SYNJ1;PIKFYVE;PLCG2;MTMR7;MTMR1;PLCG1;INPP5B;INPP5K;CDS1;PIP4P2;PLA2G3;PI4KA;VAC14;MTM1;INPP5J;PI4KB;SYNJ2
gsea,Glycosaminoglycan Metabolic Process (GO:0030203),0.3528469390370036,1.1702670729236868,0.23721881390593047,0.5222166501164053,1.0,9/24,17.88%,EXT2;XYLT1;HEXA;HEXB;GCNT2;HS3ST2;CHST9;EXT1;XYLT2
gsea,Regulation Of Sodium Ion Transmembrane Transport (GO:1902305),-0.3723694580686778,-1.1676498180058366,0.24206349206349206,0.4221474354959004,1.0,6/21,17.91%,YWHAH;SCN1B;FXYD1;COMMD1;SCN2B;GPD1L
gsea,Cellular Response To Osmotic Stress (GO:0071470),0.37790654208062685,1.1676086349150152,0.23700623700623702,0.5269778318737686,1.0,6/19,10.97%,RPTOR;NFAT5;WNK3;PKD2;MTOR;LRRC8D
gsea,Focal Adhesion Assembly (GO:0048041),0.3752530520954394,1.1670659344665295,0.23640167364016737,0.5267169844943246,1.0,9/19,21.27%,SORBS1;ACTN2;BCR;ARHGEF7;CDH11;TAOK2;THSD1;TRIP6;TESK2
gsea,Neutrophil Chemotaxis (GO:0030593),-0.4142915734450506,-1.1666855685510427,0.2813688212927757,0.4232466044467714,1.0,3/15,10.86%,PPIA;PPIB;CX3CL1
gsea,Monocarboxylic Acid Transport (GO:0015718),-0.33547439069482315,-1.1658090548521882,0.24285714285714285,0.42429202026964347,1.0,14/36,27.02%,FABP5;GOT2;SLC16A11;SLC16A1;FABP7;SLC16A4;SLC10A3;LYPLA1;ARID4A;SLCO1C1;MFSD2A;SLC25A17;SLC6A13;SLCO2B1
gsea,Regulation Of Smooth Muscle Cell Proliferation (GO:0048660),-0.34551569806568116,-1.1652870924244056,0.26582278481012656,0.424593397073358,1.0,15/31,31.47%,APOE;IL18;CX3CL1;OGN;ID2;IGFBP5;BMPR2;PDGFB;XRCC6;AKT1;MFN2;NDRG4;FOXP1;NOX1;NR4A3
gsea,Cellular Response To Hexose Stimulus (GO:0071331),-0.38110485266830324,-1.1634094853717927,0.2379110251450677,0.427516454697356,1.0,6/19,22.35%,RACK1;ZBTB20;XBP1;SOX4;UCP2;PRKACA
gsea,Heart Development (GO:0007507),0.2591892193429998,1.1631016347996053,0.19230769230769232,0.5342241916651304,1.0,19/104,9.16%,CACNA1C;PCSK5;PKD1;MICAL2;TGFBR1;NTRK3;NF1;NIPBL;ECE1;NCOA6;BVES;SGCZ;PTK2;SGCD;PKD2;TAFAZZIN;GPC3;PLCE1;TGFBR3
gsea,Golgi To Plasma Membrane Transport (GO:0006893),0.29949454351092214,1.1626603090497314,0.2198019801980198,0.5337317193324489,1.0,16/45,22.21%,ANK3;MACF1;SEC16A;EXOC6B;VPS35L;BBS1;CCDC93;ARL3;GGA3;SPTBN1;PREPL;EXOC6;RABEP1;GOLGA4;EXOC2;EXOC5
gsea,Negative Regulation Of Protein Localization To Nucleus (GO:1900181),-0.3781992876905789,-1.1622161323699616,0.2494802494802495,0.4290643497307127,1.0,9/18,31.09%,YWHAZ;CTNNA1;GSK3B;SIRT6;SUMO1;SIN3A;CHP1;LATS2;FLCN
gsea,Histone H4 Acetylation (GO:0043967),-0.30968657701028246,-1.1611104221258284,0.24571428571428572,0.43049341908180727,1.0,13/38,31.64%,MORF4L1;MORF4L2;PHF20;RUVBL1;MRGBP;HCFC1;ACTL6B;DMAP1;EPC2;JADE2;KAT5;YEATS4;ACTL6A
gsea,Intracellular Glucose Homeostasis (GO:0001678),-0.331829246938928,-1.1607762941468782,0.23874755381604695,0.43056090271552727,1.0,10/32,22.35%,RACK1;NUCKS1;ZBTB20;XBP1;PIK3R1;SOX4;FOXK1;HK1;UCP2;PRKACA
gsea,Histone H2A Acetylation (GO:0043968),-0.3641337471989123,-1.1607337097539132,0.2821011673151751,0.4300065928927062,1.0,9/20,31.64%,MORF4L1;MORF4L2;RUVBL1;MRGBP;DMAP1;EPC2;KAT5;YEATS4;ACTL6A
gsea,Regulation Of Defense Response (GO:0031347),-0.3005328031678661,-1.1602960070076773,0.22286821705426357,0.430271141370792,1.0,13/53,22.03%,TMSB4X;APOE;PARK7;APLP2;ELMOD2;SPATA2;SEMA7A;HCK;DAGLB;SAMHD1;SHPK;TKFC;LETMD1
gsea,Skin Development (GO:0043588),-0.3281024058329921,-1.160166709866843,0.2303370786516854,0.4299202977559635,1.0,12/35,21.91%,PPP3CA;KRT10;PDGFA;FGFR1;ASCL4;DACT2;WNT16;JAG1;COL1A2;ADAM9;ABCB6;CFLAR
gsea,mRNA Transport (GO:0051028),-0.2934377843239462,-1.16004760254206,0.24060150375939848,0.4295120236933271,1.0,16/53,21.65%,HNRNPA2B1;RBM8A;ALKBH5;MAGOH;CHTOP;FMR1;MAGOHB;SRSF3;ZFP36L1;NUP107;SLBP;DDX39B;UPF2;NOL3;THOC7;NCBP2
gsea,Regulation Of Heart Rate By Cardiac Conduction (GO:0086091),0.35863479984115043,1.1599277382640738,0.2346723044397463,0.5386788567499189,1.0,4/26,1.43%,CACNA1C;CACNB2;BIN1;KCND3
gsea,Protein Localization To Cilium (GO:0061512),0.3235503686260339,1.1593715034737742,0.23306772908366533,0.5383363063720277,1.0,13/30,21.47%,IFT140;TTC21B;BBS9;BBS1;CC2D2B;NPHP4;CC2D2A;ODAD4;TCTN2;SNX10;TUB;RABEP1;TULP3
gsea,Positive Regulation Of Establishment Of Protein Localization (GO:1904951),-0.38743573808588816,-1.1591691001544098,0.2720156555772994,0.4305640724625677,1.0,5/17,14.31%,CCT6A;CCT7;DKC1;CCT5;CCT8
gsea,Regulation Of Extrinsic Apoptotic Signaling Pathway In Absence Of Ligand (GO:2001239),-0.3935506549433955,-1.159076680032041,0.259047619047619,0.4301063385990749,1.0,3/17,9.07%,EYA1;FGFR1;INHBA
gsea,Positive Regulation Of MAPK Cascade (GO:0043410),-0.2451298328319973,-1.1584504600711598,0.17253521126760563,0.4306871979980133,1.0,37/175,19.69%,MT3;HMGB1;PPIA;APOE;RASGRP1;FGFR2;CD81;ARL6IP5;SPRY2;MEF2C;SOD1;DIRAS2;DDT;PDGFA;FGFR1;HRAS;GSDME;CX3CL1;ADRA2C;TEK;MYDGF;RAP1A;MAPK3;ERP29;LAPTM5;SEMA7A;GPR37;OPRM1;CSF1R;ADAM9;PDGFB;HTR2A;GPR37L1;FBXW7;PHB2;PDGFD;PELI2
gsea,Positive Regulation Of RNA Splicing (GO:0033120),-0.3307781074437112,-1.1582270999240345,0.23563218390804597,0.4304989520544454,1.0,11/31,17.58%,SNW1;SF3B4;SLC38A2;RBM22;NCL;CIRBP;PRDX6;PIK3R1;RBMXL1;CLNS1A;U2AF2
gsea,Negative Regulation Of Double-Strand Break Repair Via Homologous Recombination (GO:2000042),-0.39953633594037613,-1.1577267743341277,0.26356589147286824,0.4308488675084855,1.0,7/16,31.66%,POLQ;SHLD1;KMT5A;MAD2L2;UBQLN4;KAT5;HELB
gsea,Regulation Of Nitric-Oxide Synthase Activity (GO:0050999),0.3705840320243743,1.1574670303385342,0.26229508196721313,0.5413421073532694,1.0,5/20,6.10%,ATP2B4;NOS1AP;NPR3;TERF2;ZDHHC21
gsea,Regulation Of Receptor-Mediated Endocytosis (GO:0048259),-0.3441496265444251,-1.1569634636718924,0.25680933852140075,0.4316562218271897,1.0,7/25,12.31%,RAC1;ARF1;LRPAP1;VTN;CLU;HNRNPK;HIP1R
gsea,Positive Regulation Of Myeloid Cell Differentiation (GO:0045639),0.34040063139356835,1.1565181447775696,0.2462526766595289,0.5420009186624437,1.0,7/26,15.79%,PRKDC;MAPK14;MTURN;BRD1;ARNT;ACVR1B;MAPK11
gsea,Cellular Response To Molecule Of Bacterial Origin (GO:0071219),-0.3024136615405628,-1.1563213178317802,0.24593128390596744,0.4322570352939153,1.0,25/52,36.17%,HMGB1;MEF2C;GSTP1;NFKBIB;AXL;XBP1;BCL10;ADAM9;CDC73;SHPK;VIM;RHOA;RELA;CCR5;EHHADH;UXT;CACTIN;LY96;SIRPA;GIT1;MYD88;CHMP5;AHR;CYRIB;CD68
gsea,Protein Localization To Centrosome (GO:0071539),0.40604998649037266,1.156315726200887,0.2682445759368836,0.5410268025670064,1.0,6/15,23.20%,CEP192;SPAG5;C2CD3;HOOK3;SNX10;CEP131
gsea,Negative Regulation Of Protein Depolymerization (GO:1901880),0.36846288235884933,1.155030951777512,0.2631578947368421,0.5425603205405263,1.0,9/20,20.46%,TAOK1;LIMA1;CLASP1;ATXN7;KATNB1;CLASP2;ARHGEF2;PIK3CA;APC2
gsea,Proteoglycan Biosynthetic Process (GO:0030166),0.33714471443928073,1.1542861019823722,0.2573099415204678,0.5427348227461478,1.0,8/27,17.88%,CHST11;EXT2;XYLT1;CHST10;CHST9;EXTL3;EXT1;XYLT2
gsea,Negative Regulation Of Immune Response (GO:0050777),-0.3209783029504065,-1.1541347261041095,0.2401500938086304,0.43585040802876046,1.0,9/38,16.45%,BANF1;PLK2;YWHAZ;ATG12;PARP1;LYN;MUL1;NLRC3;HCK
gsea,Regulation Of Muscle Cell Differentiation (GO:0051147),0.40748250112802065,1.1540920998823891,0.2851485148514851,0.5416393212124796,1.0,10/15,26.21%,MAPK14;LAMB1;ZBED6;LAMC1;MAPK12;MAPK11;CDK9;PTBP1;RBM4;HDAC9
gsea,Negative Regulation Of Developmental Process (GO:0051093),0.2753004696212992,1.1530256453942915,0.22587268993839835,0.5426764770547398,1.0,17/76,12.11%,PTPRS;PRKN;HUWE1;ROCK1;BRD9;MAPT;DCC;NFIB;SMARCA4;HDAC1;BICRA;SMARCA2;RPS6KA6;ADCK1;BCL11A;GAS6;BICRAL
gsea,"Wnt Signaling Pathway, Planar Cell Polarity Pathway (GO:0060071)",-0.35346077797376807,-1.152759186646438,0.2538167938931298,0.4378892639483236,1.0,4/25,7.58%,RAC1;CDC42;FZD3;FZD2
gsea,Negative Regulation Of Multicellular Organismal Process (GO:0051241),-0.250985243770952,-1.1525236320084977,0.18840579710144928,0.4377041795072597,1.0,26/138,16.89%,PFN2;CALR;RGS2;PLCL1;SPRY2;MEF2C;PPP2CA;LRPAP1;KLF7;RBBP7;ACOT11;ACOT13;PARP1;SOX9;PPP1R11;GJA1;GSK3B;ATP2B1;RPS19;HMGCR;SYT11;BBS2;SMAD7;BMPR2;ALDH1A1;EPHA4
gsea,Regulation Of Interleukin-6 Production (GO:0032675),-0.3046114642422042,-1.1522061867070155,0.2158273381294964,0.4377006765742913,1.0,10/54,16.15%,HMGB1;C1QTNF4;CD47;AKIRIN2;CX3CL1;XBP1;HSPD1;SYT11;NLRC3;BCL10
gsea,Presynaptic Endocytosis (GO:0140238),0.3354759878358143,1.152165382390236,0.26653696498054474,0.5431980594648363,1.0,10/26,11.99%,NLGN1;FCHO2;DNM1;DNM3;STON2;PACSIN1;SYNJ1;STX1A;DNM2;SYT1
gsea,Glucose Homeostasis (GO:0042593),-0.29216672575936187,-1.1517005105388216,0.23564356435643563,0.4380824254334551,1.0,13/55,19.39%,RPS6;PARK7;NUCKS1;SELENOT;APLP2;KLF7;BAD;PIK3R1;CEBPA;ADIPOR2;SOX4;FOXK1;HK1
gsea,Nuclear Membrane Organization (GO:0071763),-0.35958323218491517,-1.1516616418556624,0.27626459143968873,0.4375249760312618,1.0,18/23,46.10%,EMD;CHMP2A;CHMP6;VPS4A;CHMP4C;CHMP7;TOR1A;CHMP3;NEMP1;NSFL1C;CHMP5;DCTN1;UBXN2A;TOR1AIP1;CHMP1B;CHMP2B;VPS4B;UBXN2B
gsea,Response To Gamma Radiation (GO:0010332),-0.36421943388277767,-1.1506525403634886,0.2737864077669903,0.43878200598910294,1.0,7/20,26.99%,RPL26;HRAS;TSPYL5;CRYAB;TMEM109;XRCC6;LIG4
gsea,Negative Regulation Of Peptidyl-Serine Phosphorylation (GO:0033137),-0.3958239434300141,-1.15021007080808,0.27037773359840955,0.4390478636864276,1.0,2/15,3.38%,RACK1;NCK1
gsea,Positive Regulation Of Response To Wounding (GO:1903036),0.4038811069558385,1.1494630968316961,0.28629856850715746,0.5482801023807641,1.0,6/15,20.11%,PRKCE;ARFGEF1;PTK2;GRN;KANK1;DMTN
gsea,Positive Regulation Of Cytokine Production (GO:0001819),-0.25084663836474674,-1.1488901882186189,0.19538188277087035,0.4409342207471316,1.0,29/147,21.47%,HMGB1;GAPDH;C1QTNF4;RPS3;PARK7;RASGRP1;SOD1;IL18;EGR1;ZCCHC3;AKIRIN2;CEBPB;XBP1;TMED10;MYDGF;HSPD1;LAPTM5;G3BP1;BCL10;CSF1R;PQBP1;CRLF2;CCDC88B;TBK1;IRF3;PLCB1;AGPAT1;HYAL2;LURAP1
gsea,Positive Regulation Of Cholesterol Transport (GO:0032376),-0.38171869088872296,-1.148163614626561,0.2826510721247563,0.4417096395618194,1.0,4/19,13.31%,APOE;GPS2;SCP2;PLTP
gsea,Negative Regulation Of Cellular Catabolic Process (GO:0031330),0.2946743913973937,1.1467722283365192,0.22747747747747749,0.5531534523635968,1.0,15/51,19.29%,ATP2B4;RPTOR;GPLD1;ROCK1;ZKSCAN3;MTOR;SIRT2;RRAGB;KLHL22;EIF4G3;PTPN3;WDR6;KDM4A;TIMP2;PTPN22
gsea,Regulation Of Cellular Response To Stress (GO:0080135),-0.2631736870197461,-1.146759073423395,0.20634920634920634,0.4438096971490136,1.0,25/97,21.34%,CHCHD2;DNAJB6;MANF;SLC38A2;UBE2N;USP22;PINK1;TAF10;NPM1;CHORDC1;UBE2V1;RUVBL1;GSK3B;BABAM2;ENY2;TADA2B;OPRM1;YY1;SOX4;TADA3;TAF5;UIMC1;ACTR8;KMT5A;TAF7
gsea,Positive Regulation Of Cholesterol Efflux (GO:0010875),-0.40815256078316103,-1.1463644840489609,0.3044315992292871,0.4439147029801043,1.0,4/15,19.97%,APOE;GPS2;PLTP;NFKBIA
gsea,Positive Regulation Of Receptor-Mediated Endocytosis (GO:0048260),-0.33854106313940446,-1.145220625234611,0.26045627376425856,0.4453892753020197,1.0,7/29,12.20%,ATAD1;WASL;VTN;CLU;HNRNPK;FMR1;CD63
gsea,Epidermal Growth Factor Receptor Signaling Pathway (GO:0007173),0.33077890058566806,1.145056186410673,0.2702702702702703,0.5558227342860074,1.0,12/32,19.81%,CBL;SOS1;PTK2;PLCE1;NCK2;PLCG1;IQGAP1;EGF;SHC3;KIF16B;BRAF;PIK3CA
gsea,Integrin-Mediated Signaling Pathway (GO:0007229),-0.29257031621188834,-1.144999735426664,0.22753346080305928,0.44521983903524587,1.0,15/61,19.60%,NME2;CDC42;CD47;PRKD1;ITGAV;PRAM1;ERBIN;ILK;ANGPTL3;SEMA7A;HCK;ITGA2B;PLPP3;ADAM9;THY1
gsea,Maintenance Of Blood-Brain Barrier (GO:0035633),0.3806760690689261,1.1439472979279093,0.278,0.556900026439239,1.0,6/20,8.35%,TJP2;DMD;TJP1;LAMC1;WNK3;SLC1A1
gsea,Regulation Of Protein Targeting To Mitochondrion (GO:1903214),-0.32485626219653324,-1.1439387371792138,0.2633663366336634,0.4467600513478431,1.0,14/32,28.15%,LEPROT;TOMM7;SH3GLB1;PIN1;PINK1;BAG4;LMAN1;SIAH3;FBXW7;HTRA2;PARL;USP36;HAX1;SREBF2
gsea,Cellular Response To Vascular Endothelial Growth Factor Stimulus (GO:0035924),-0.35433223323388163,-1.1434339846319637,0.26883910386965376,0.44710984424199496,1.0,6/24,15.79%,SPRY2;VEGFC;RAMP2;PRKD1;VEGFB;EGR3
gsea,Muscle Tissue Development (GO:0060537),-0.356363545747118,-1.1408762367818954,0.27223230490018147,0.4514886762378158,1.0,9/22,23.79%,MYL6;ZBTB18;MEF2C;IGSF8;CSRP2;SVIL;CSRP1;CFLAR;STRA6
gsea,"DNA Damage Response, Signal Transduction By P53 Class Mediator (GO:0030330)",-0.3538294035796854,-1.1396868746168352,0.2658959537572254,0.45321267776408397,1.0,6/25,14.91%,RPL26;PLK2;TRIAP1;PML;RPS27L;CDKN1B
gsea,Positive Regulation Of Epidermal Growth Factor Receptor Signaling Pathway (GO:0045742),0.36572156941468253,1.1390974031477166,0.2800829875518672,0.5670011744473805,1.0,7/19,19.75%,SHKBP1;CCDC88A;CBL;PDE6H;HIP1;EGF;AFAP1L2
gsea,Regulation Of miRNA Transcription (GO:1902893),-0.3156307286935745,-1.1380916795755558,0.2573099415204678,0.4559025746353276,1.0,5/37,12.05%,DDX5;JUN;EGR1;SOX9;MRTFB
gsea,Nuclear Membrane Reassembly (GO:0031468),-0.3646111477987427,-1.1378443595764685,0.2994011976047904,0.45574466944016667,1.0,10/21,34.02%,BANF1;CHMP2A;CHMP6;VPS4A;CHMP4C;CHMP7;BROX;CHMP3;NSFL1C;CHMP5
gsea,Positive Regulation Of TORC1 Signaling (GO:1904263),-0.3442191501294961,-1.1377927101126277,0.2900763358778626,0.45521222419141094,1.0,5/25,14.87%,RRAGA;RRAGD;PIP4P1;SEH1L;SEC13
gsea,Substrate Adhesion-Dependent Cell Spreading (GO:0034446),0.31664863760984574,1.1359014784681345,0.2860169491525424,0.5732858090425366,1.0,8/30,8.59%,SRCIN1;LAMB1;LAMC1;BVES;ITGA8;EFNA1;SRGAP3;PARVB
gsea,Positive Regulation Of CREB Transcription Factor Activity (GO:0032793),-0.3912124942263573,-1.135488734046451,0.3194444444444444,0.4591104276470278,1.0,2/15,5.73%,EPHA5;PRKD1
gsea,Negative Regulation Of Myeloid Cell Differentiation (GO:0045638),-0.3949496730285897,-1.1353662541942224,0.279467680608365,0.45870656167582424,1.0,6/16,30.53%,H4C9;ZFP36L1;HSPA9;SKIC8;PRMT1;LDB1
gsea,Positive Regulation Of Catalytic Activity (GO:0043085),-0.31959315031036606,-1.1353144471580123,0.2653846153846154,0.4581738635805775,1.0,9/31,18.38%,YWHAB;PSENEN;SOD1;APH1A;CHTOP;FDX2;MAPK3;MID1IP1;FXN
gsea,Cellular Response To Virus (GO:0098586),-0.34330122488653103,-1.135050781538786,0.2613861386138614,0.4580155431033236,1.0,7/23,11.06%,HSP90AA1;EIF5A;BAX;IFNGR2;GSDME;LGALS8;FMR1
gsea,Plasma Membrane Organization (GO:0007009),0.28917447794113504,1.1347806735452681,0.2494802494802495,0.5743903559254454,1.0,15/54,14.11%,ANK3;BIN1;ANO6;PACSIN1;MICALL1;MYOF;STX2;ANXA6;EPB41L3;COL5A1;MYH9;PLSCR4;SPTBN1;OSBPL2;ANK2
gsea,Hepaticobiliary System Development (GO:0061008),0.3947327431372172,1.1345312419560516,0.29774127310061604,0.5734394423421679,1.0,5/15,14.08%,NF1;NIPBL;PKD2;TGFBR3;PROX1
gsea,Monocarboxylic Acid Metabolic Process (GO:0032787),-0.27855519425703124,-1.1338433637085683,0.24763705103969755,0.45973432931613517,1.0,20/59,28.10%,ACSL3;VDAC1;MSMO1;LDHA;SCP2;ACOT11;LDHB;HYI;ANGPTL3;DSEL;PNPLA8;GPAM;HSD17B10;FASN;GBA2;GNPAT;GRHPR;GAMT;CPT1C;ACOT6
gsea,Negative Regulation Of Defense Response (GO:0031348),-0.2713913094530878,-1.133333737893799,0.2490566037735849,0.4600198687527194,1.0,15/70,17.46%,APOE;BANF1;YWHAZ;GPS2;ATG12;C1QBP;PARP1;OTULIN;TEK;METRNL;SHARPIN;MUL1;NLRC3;VPS35;TRAF3IP1
gsea,Metaphase Plate Congression (GO:0051310),-0.3107876599415683,-1.1330918082325563,0.2589928057553957,0.4598841905357635,1.0,13/39,27.50%,RAB11A;BOD1;CHMP2A;CHMP6;VPS4A;SEH1L;NUDC;CHMP4C;CHMP7;MAP1S;NUP62;KIF18A;CHMP3
gsea,Regulation Of Substrate Adhesion-Dependent Cell Spreading (GO:1900024),-0.31303259620666113,-1.1329871503907136,0.2625482625482625,0.45945646444735017,1.0,7/41,14.16%,RAC1;CALR;AP1AR;CDC42;C1QBP;P4HB;ILK
gsea,Striated Muscle Contraction (GO:0006941),0.3183706821194976,1.132165609211267,0.2716049382716049,0.5777544627808058,1.0,9/32,13.31%,RYR2;SLC8A1;RYR3;DMD;NOS1;TAFAZZIN;TTN;TNNC1;GRK2
gsea,Negative Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001237),-0.30089326629092683,-1.1321510402282304,0.25918762088974856,0.4604524929136783,1.0,14/45,27.28%,PARK7;FAIM2;GSTP1;EYA1;ITGAV;GSK3B;PSME3;NOL3;CFLAR;RNF34;AKT1;RELA;TMBIM1;ITGA6
gsea,Artery Morphogenesis (GO:0048844),0.36386913766277335,1.1317071868594033,0.30785123966942146,0.5773019182399057,1.0,5/21,9.15%,TGFBR1;NF1;LRP2;PKD2;NOG
gsea,"Negative Regulation Of DNA-templated Transcription, Elongation (GO:0032785)",-0.3886792533536574,-1.1315376828232009,0.28875968992248063,0.46100916642125267,1.0,4/16,15.81%,WDR82;PARP1;RNF168;SIRT6
gsea,Positive Regulation Of Erythrocyte Differentiation (GO:0045648),0.35212071747125556,1.1310190711544623,0.2946236559139785,0.5774385471245218,1.0,6/22,15.79%,PRKDC;MAPK14;BRD1;ARNT;ACVR1B;MAPK11
gsea,Epithelium Development (GO:0060429),-0.28013692443143046,-1.1309409725685329,0.26838235294117646,0.46151712826029245,1.0,12/71,13.08%,PTER;FGFR2;VDAC1;KRT10;ALDOC;CTSB;TST;PGK1;PCNA;SOX9;TAGLN2;VCL
gsea,Negative Regulation Of Cellular Process (GO:0048523),-0.21757388630692565,-1.1305731603010898,0.15625,0.4616012803632038,1.0,70/351,18.27%,FTH1;ACTB;MT3;RACK1;DYNLL1;PARK7;APLP2;SEMA5A;TOB1;NDUFA13;BRINP3;BCL7B;PPP2CA;PPP2R1A;BTG2;ANP32B;PPM1D;PIN1;CLU;RTN4;NPM1;PML;HRAS;IGFBP7;RBBP7;GSDME;INHBA;CSNK2B;DNAJA3;RASA1;CHMP2A;CHMP6;GJA1;TMEM127;CRYAB;FABP3;FOXO4;LYN;AQP11;CEBPA;COPS8;OSGIN2;DNAJB2;DACT2;NME1;RHOB;JAM2;VPS4A;WNT16;CDKN1B;FABP7;MUL1;GAS8;VAMP3;KLF10;HOPX;BMPR2;CHMP4C;SS18;BTG1;EPHA4;OPRM1;VPS35;CGRRF1;CHMP7;TMEM109;ENO1;SOX4;BCL7C;WARS1
gsea,Regulation Of DNA-templated Transcription Elongation (GO:0032784),0.30593929700713707,1.1298896573416735,0.2685370741482966,0.5786065774251038,1.0,7/38,10.32%,SRCAP;INTS11;SETD5;INTS2;SCAF8;INTS1;INTS6
gsea,Cellular Response To Insulin Stimulus (GO:0032869),0.2727229194946188,1.1292154039790576,0.24151696606786427,0.5786886534205938,1.0,22/79,17.62%,SORBS1;GCK;PRKDC;GPLD1;STXBP4;C2CD5;IDE;PIK3R3;AKT2;CPEB1;IGF1R;PTPN2;LPIN1;MYO5A;AP3S1;PPARG;INPP5K;LPIN2;FER;SLC39A14;DENND4C;SOGA1
gsea,Regulation Of Telomere Capping (GO:1904353),0.3598053339616691,1.1291446920111532,0.29878048780487804,0.5772903936796192,1.0,6/19,16.17%,USP7;NEK7;TERF2;MAP3K4;PNKP;SMG6
gsea,Positive Regulation Of mRNA Catabolic Process (GO:0061014),0.30325551085633706,1.129121581370286,0.2854251012145749,0.5757975317382477,1.0,13/41,21.68%,TNRC6C;MOV10;ROCK1;KHSRP;CELF1;TNRC6B;CNOT1;GIGYF2;FXR1;YTHDF3;FTO;GTPBP1;DHX36
gsea,Negative Regulation Of Hydrolase Activity (GO:0051346),0.32670574716321704,1.1289629298147024,0.274468085106383,0.5747462707459066,1.0,9/31,7.24%,CAMK2A;ECM1;NOS1;BCAS3;ARFGEF1;GMIP;TERF2;WNK1;RRP1B
gsea,Positive Regulation Of Immunoglobulin Production (GO:0002639),-0.37708833295850447,-1.1289014600370082,0.30844793713163066,0.46418700640796867,1.0,7/17,22.65%,DNAJB9;HMCES;XBP1;VAMP3;SHLD1;PHB2;MAD2L2
gsea,Monocarboxylic Acid Biosynthetic Process (GO:0072330),-0.3092577276754754,-1.1285241185051258,0.27052238805970147,0.46429319409368125,1.0,21/41,36.61%,PARK7;HSD17B8;SCP2;XBP1;ACLY;DSEL;NDUFAB1;OSBPL9;OXSM;HSD17B10;HSD3B7;FASN;OSBPL3;GAMT;CYP46A1;CHST12;CYP27A1;MCAT;ELOVL4;SRR;CYP7B1
gsea,Generation Of Neurons (GO:0048699),0.2512961154026112,1.1283858077064655,0.22365591397849463,0.574625971394288,1.0,23/116,10.64%,LHX9;MYT1L;MARK2;PTPRD;MAPT;DTNB;MYEF2;NAV1;DISC1;DCC;TRIM46;EML1;SDCCAG8;MDGA1;NRBP2;NTRK2;BRSK1;SPOCK1;WNT7A;RELN;RUNX2;MARK1;NEO1
gsea,Cellular Response To Acid Chemical (GO:0071229),-0.34713101956438186,-1.128373781666748,0.2584493041749503,0.4639104544827925,1.0,5/23,11.66%,LAMTOR2;RRAGA;LAMTOR3;RRAGD;XBP1
gsea,Monoatomic Cation Homeostasis (GO:0055080),0.2959099189826467,1.1277105919352568,0.26875,0.5747025260441109,1.0,4/46,0.85%,ANK3;UNC80;GRIN1;SLC8A1
gsea,Cellular Response To Ionizing Radiation (GO:0071479),-0.2980835388012701,-1.127460752470079,0.2676864244741874,0.46496519984033724,1.0,12/41,23.03%,NUCKS1;RPL26;SWI5;HRAS;TSPYL5;CRYAB;BABAM2;RHOB;TMEM109;RAD9B;XRCC6;RAD51
gsea,Intracellular Steroid Hormone Receptor Signaling Pathway (GO:0030518),-0.32621506712281734,-1.1269729936958601,0.280561122244489,0.46525222669107213,1.0,3/31,3.44%,DDX5;UBE3A;WBP2
gsea,Regulation Of Insulin Secretion (GO:0050796),-0.2867929941959668,-1.126913121001574,0.24,0.46474405644935,1.0,8/52,8.39%,EPHA5;UQCC2;PPP3CB;ENSA;IRS2;NNAT;SNAP25;BAD
gsea,Sulfur Compound Biosynthetic Process (GO:0044272),0.2846908819351538,1.1267646464472287,0.2759295499021526,0.5754302356576632,1.0,19/49,25.06%,CHST11;EXT2;LIAS;ST3GAL3;XYLT1;CBS;CHST9;EXTL3;EXT1;PAPSS1;XYLT2;UST;ST3GAL2;UGDH;SLC10A7;ST3GAL4;GLCE;B3GNT2;CHPF
gsea,Regulation Of Mitotic Spindle Assembly (GO:1901673),-0.3825872652751697,-1.126154344376571,0.2938856015779093,0.4654763507444029,1.0,9/18,34.92%,CHMP2A;CHMP6;CHMP4C;CHMP7;DRG1;CHMP3;TPR;CHMP5;HSPA1A
gsea,Regulation Of Filopodium Assembly (GO:0051489),0.3144741090389661,1.1260177932916728,0.2909090909090909,0.5756736641116965,1.0,6/36,4.80%,NLGN1;TENM2;DOCK11;RIPOR2;TENM1;BCAS3
gsea,Ras Protein Signal Transduction (GO:0007265),0.24941657141045082,1.125967561906746,0.24145299145299146,0.5742837871201986,1.0,26/117,11.14%,CYFIP1;HACE1;RGL2;MYO9B;ROCK1;SHTN1;NF1;RALGPS1;RGL1;DOK5;RAPGEF4;RASGRF2;SOS1;RAPGEFL1;GNA12;DOK6;RASGEF1B;TIAM1;RAPGEF6;TNFRSF25;PLCE1;RALGPS2;USP8;RASGRF1;ARHGEF3;RIT1
gsea,Transcription Preinitiation Complex Assembly (GO:0070897),-0.2983210945975591,-1.1257188403599414,0.26752767527675275,0.4657020537549679,1.0,23/47,37.07%,MED10;MED4;TAF10;MED19;TAF11;MED31;GTF2B;MED9;MED21;MED22;TAF5;MED7;TAF7;TAF7L;TAF12;MED11;MED30;TAF6L;MED6;TAF8;MED28;MED8;TAF13
gsea,Regulation Of Angiogenesis (GO:0045765),-0.2524848888443891,-1.125138451593368,0.2338403041825095,0.46623848133443946,1.0,24/114,16.57%,EMC10;SPRY2;SEMA5A;PDCD6;VEGFC;RAMP2;GLUL;NINJ1;PRKD1;PGK1;PML;VEGFB;SPARC;XBP1;TEK;FOXO4;MTDH;MYDGF;ATF2;HIPK1;RHOB;ANGPTL3;BTG1;CTSH
gsea,Regulation Of Epithelial Cell Migration (GO:0010632),0.3131449630133936,1.1247584620294118,0.2975206611570248,0.5756339967484678,1.0,13/41,15.00%,MACF1;PRKCE;FGF10;PTPRR;CLASP1;RREB1;PTK2;PLCG2;PTPN23;PLCG1;DAB2IP;CLASP2;BMPER
gsea,Response To Hydrogen Peroxide (GO:0042542),-0.3250270875383028,-1.1247517418302293,0.2795031055900621,0.46643048687365074,1.0,7/28,18.50%,RPS3;SOD1;CLU;OSER1;RHOB;FXN;ADAM9
gsea,Cellular Lipid Catabolic Process (GO:0044242),0.3829421794443634,1.1246518676511983,0.3107569721115538,0.574394129222038,1.0,6/16,15.48%,SMPDL3B;FAAH;LPIN1;PPARD;SIRT2;LPIN2
gsea,Calcium Ion Homeostasis (GO:0055074),0.2802256020380774,1.1245738108655936,0.266384778012685,0.5730759242006515,1.0,10/53,7.97%,RYR2;GRIN1;SLC8A1;ATP2B4;SLC24A2;SLC24A3;SLC24A4;HTR2C;TRDN;CHRNA7
gsea,Positive Regulation Of Type I Interferon Production (GO:0032481),-0.30455597358559794,-1.1237497624237445,0.26452905811623245,0.4677663209521528,1.0,18/40,34.66%,GAPDH;HSP90AA1;ZCCHC3;POLR3D;HSPD1;G3BP1;PQBP1;TBK1;IRF3;MAVS;PTPN11;POLR3A;FLOT1;RIPK2;DHX33;MYD88;RAB2B;IRF1
gsea,Regulation Of Small Molecule Metabolic Process (GO:0062012),0.30610520594026164,1.1227870665965605,0.25313807531380755,0.5758197255905039,1.0,9/34,16.71%,PRKN;PRKAG2;GCK;RORA;DGKQ;ADIPOR1;SLC2A6;PPARA;BCKDK
gsea,Sterol Biosynthetic Process (GO:0016126),-0.34730308763551637,-1.122522010108009,0.2905811623246493,0.4695620586684094,1.0,9/22,21.94%,MSMO1;HMGCS1;SQLE;ACLY;HMGCR;INSIG2;INSIG1;HSD17B7;FDFT1
gsea,Cardiac Muscle Contraction (GO:0060048),0.3548421267336676,1.122454561280037,0.31752577319587627,0.575184398419743,1.0,7/20,13.31%,RYR2;SLC8A1;DMD;TAFAZZIN;TTN;TNNC1;GRK2
gsea,Positive Regulation Of mRNA Processing (GO:0050685),0.3434257196937167,1.1223351599136415,0.29583333333333334,0.573960796101626,1.0,8/23,12.22%,CELF4;CELF3;TRA2A;NCBP1;DAZAP1;NUP98;WDR77;TRA2B
gsea,Regulation Of Ruffle Assembly (GO:1900027),-0.35909143917507585,-1.1216150679404144,0.2980392156862745,0.47067298238086847,1.0,5/20,11.45%,PFN2;P2RY12;PFN1;HRAS;EPS8L1
gsea,Cellular Response To Lipopolysaccharide (GO:0071222),-0.288393765881188,-1.1213222905427178,0.2846441947565543,0.4706411902590429,1.0,26/57,34.02%,HMGB1;MEF2C;GSTP1;IL18;NFKBIB;AXL;XBP1;LYN;MTDH;BCL10;HCK;ADAM9;CDC73;SHPK;VIM;RHOA;RELA;CCR5;EHHADH;UXT;CACTIN;LY96;SIRPA;GIT1;MYD88;CHMP5
gsea,RNA Metabolic Process (GO:0016070),0.25212601761191955,1.12097742413437,0.2578740157480315,0.5757232652815995,1.0,27/92,18.19%,ADARB1;RBFOX2;ATXN2;DICER1;ATXN1;RBM5;RBM6;PABPN1;XRN2;AGO4;SETX;AGO1;NCBP1;SNRNP40;EXOSC8;BICD1;PAPOLA;TBRG4;EXOSC10;TENT2;NUFIP1;RNGTT;RBMS1;SUPV3L1;DHX9;SIDT2;ELAVL4
gsea,Cilium Movement (GO:0003341),0.3087027210638846,1.1208569954457028,0.2534562211981567,0.5745109157270176,1.0,14/34,24.75%,SPEF2;DNAH5;NME5;ODAD4;CFAP61;CABYR;DNAAF4;DNAI4;DNAH9;DNAAF5;CCDC40;RSPH9;CCDC39;CFAP54
gsea,Regulation Of Cell Differentiation (GO:0045595),-0.24490933957583808,-1.1201975903631696,0.22960151802656548,0.47226343727756026,1.0,19/144,8.94%,HSP90AB1;DDX5;YWHAG;YWHAH;UQCC2;CEBPD;FGFR2;BDNF;BCL7B;PPP2CA;PPP2R1A;ANP32B;GPS2;CDK5R1;CHD3;OCIAD1;FGFR1;BRD7;RBBP7
gsea,Positive Regulation Of DNA-binding Transcription Factor Activity (GO:0051091),-0.24090090995667243,-1.1195766259775892,0.22264150943396227,0.47281779337943636,1.0,21/157,12.95%,EPHA5;PPIA;RPS3;PARK7;MTPN;RNF220;NEUROD2;IL18;USP14;PRKD1;BEX1;UBE2N;FZD2;BUD31;CLU;NPM1;UBE2V1;CX3CL1;FZD4;MTDH;ATF2
gsea,Negative Regulation Of Catalytic Activity (GO:0043086),-0.3870852400224568,-1.1184640837965698,0.31285988483685223,0.474378785455029,1.0,1/15,0.11%,MT3
gsea,Phosphatidylcholine Metabolic Process (GO:0046470),0.3207705182515273,1.1178696371456818,0.29098360655737704,0.5802046264008941,1.0,10/33,21.59%,SLC44A5;GPLD1;CHKA;MBOAT2;ABHD4;SLC44A2;PLA2G3;MBOAT1;PLA2G4A;ENPP2
gsea,Negative Regulation Of Cellular Response To Insulin Stimulus (GO:1900077),-0.3516304915454595,-1.1174830712200148,0.30538922155688625,0.47573899441119993,1.0,3/23,7.10%,APLP2;NCK1;PIP4K2A
gsea,Negative Regulation Of Cell-Substrate Adhesion (GO:0010812),0.3239166641103522,1.1174461619656662,0.3038229376257545,0.5797349346380799,1.0,7/29,8.86%,TBCD;MAP4K4;CASK;SPOCK1;ACTN4;GCNT2;NEXMIF
gsea,Phosphatidylinositol-Mediated Signaling (GO:0048015),0.30082692644362224,1.1174200721285852,0.2754237288135593,0.5783075683955922,1.0,12/48,11.53%,NF1;KCNH1;PITPNM2;OCRL;INPP5A;PLCG2;GAB2;PLCH1;IGF1R;PLCE1;PIK3CD;PLCG1
gsea,Negative Regulation Of Double-Strand Break Repair (GO:2000780),-0.3367208032338048,-1.1170546961153525,0.29699248120300753,0.4759967190803345,1.0,9/25,31.66%,POLQ;TFIP11;OTUB1;SHLD1;KMT5A;MAD2L2;UBQLN4;KAT5;HELB
gsea,Positive Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010971),-0.3952012753403344,-1.1167605307098116,0.30326295585412666,0.47595490222095105,1.0,5/15,22.00%,RAB11A;CDK4;RRM1;RRM2B;RCC2
gsea,Regulation Of Cellular Metabolic Process (GO:0031323),-0.30424258976444796,-1.1162584056578209,0.2892249527410208,0.47631745139426795,1.0,14/37,25.09%,PGAM1;ARF4;PINK1;MPV17;EIF6;STUB1;NEK6;COQ7;ARL2;CIDEB;JMJD8;RNF34;PARL;RSL1D1
gsea,Positive Regulation Of Developmental Process (GO:0051094),-0.2334157778298448,-1.1160901564109542,0.22873345935727787,0.47603561240464504,1.0,44/185,21.19%,HSP90AB1;APOE;CFL1;BASP1;KRT10;NEUROD2;BCL7B;LLPH;PINK1;FGFR1;RTN4;BRD7;HMCES;RBBP7;C1QBP;SOX9;RALA;FMR1;CEBPB;FZD4;GJA1;XBP1;GSK3B;ADGRL1;SPIRE1;MUL1;SMARCE1;RBM19;SIRT6;BMPR2;CAMK2B;SS18;SHLD1;VPS35;BCL7C;ACTL6B;PDGFB;BRMS1;BMPR1B;SMARCB1;PLCB1;PA2G4;FIS1;DPF2
gsea,Microtubule Bundle Formation (GO:0001578),0.31621856438506746,1.1160819479067676,0.279826464208243,0.5799905210206773,1.0,8/33,11.03%,CLASP1;NAV1;TRIM46;NCKAP5L;CFAP74;CLIP1;SPAST;CCSER2
gsea,Circulatory System Development (GO:0072359),0.25996666108676614,1.115210994344293,0.2591792656587473,0.5806104173805198,1.0,15/87,11.33%,CACNA1C;PCSK5;PKD1;MICAL2;TGFBR1;NTRK3;NF1;ECE1;NCOA6;BVES;PKD2;TAFAZZIN;PLCE1;ERBB4;MTHFD1
gsea,Reticulophagy (GO:0061709),0.3713380117938041,1.1140751285233492,0.3218390804597701,0.5817777306427658,1.0,5/15,22.16%,RB1CC1;ULK3;ATG2B;ULK2;ULK1
gsea,Positive Regulation Of ERBB Signaling Pathway (GO:1901186),0.37226886131892195,1.114008491510538,0.30879345603271985,0.5804379036133845,1.0,5/16,12.70%,SHKBP1;CCDC88A;CBL;PDE6H;HIP1
gsea,Regulation Of DNA Biosynthetic Process (GO:2000278),0.33048724903138,1.1137320571683669,0.3047808764940239,0.5796157696915981,1.0,3/27,5.95%,DACH1;SMOC2;TERF2
gsea,Actin Filament-Based Transport (GO:0099515),0.38291835474124497,1.112523087627464,0.31196581196581197,0.5810775260979528,1.0,3/16,4.26%,MYO1B;MYO5B;MYO1D
gsea,Cellular Response To Peptide Hormone Stimulus (GO:0071375),0.2725190586643951,1.112160585537201,0.2648870636550308,0.5804783939238595,1.0,19/65,18.41%,SORBS1;GCK;ADCY8;PRKDC;GPLD1;C2CD5;AKT2;CPEB1;LPIN1;MYO5A;PPARG;INPP5K;LPIN2;FER;PRKCD;CRHR1;SLC39A14;DENND4C;NFKB1
gsea,In Utero Embryonic Development (GO:0001701),0.3613514550588365,1.1112876364366897,0.29979879275653926,0.5810652424264522,1.0,5/19,11.80%,PKD1;PTPRR;TGFBR1;PKD2;SOX8
gsea,Regulation Of Cell Cycle (GO:0051726),-0.22327386297303883,-1.1110460932934116,0.21611721611721613,0.48555363432290116,1.0,41/224,20.43%,HSP90AB1;ACTB;RACK1;JUN;MORF4L1;CALR;RPS15A;RPRM;FGFR2;YWHAE;JUND;MORF4L2;BRINP3;JUNB;ANAPC13;BEX1;CITED2;CDK4;BRD7;HRAS;SOX9;RUVBL1;MRGBP;ANAPC11;CKS2;RHOB;PIM3;NOP53;CDKN1B;TRIM32;EIF4G2;HCFC1;PUM1;NEK6;YY1;TADA3;MBIP;PES1;MAEA;DMAP1;ACTR8
gsea,Regulation Of Receptor Internalization (GO:0002090),-0.3276074707627934,-1.1097506245449125,0.2888015717092338,0.487578597902726,1.0,6/26,15.22%,ARF1;ATAD1;LRPAP1;FMR1;CD63;WDR54
gsea,Actin Polymerization Or Depolymerization (GO:0008154),-0.3018872272566977,-1.1093385449908875,0.27755905511811024,0.48780597990199925,1.0,10/42,19.24%,RAC1;CFL1;WASL;DSTN;CFL2;TWF1;PSTPIP2;SPIRE1;SVIL;FAM107A
gsea,Regulation Of Intracellular Protein Transport (GO:0033157),-0.3220700418840155,-1.1093234247282537,0.3176691729323308,0.4871841207214904,1.0,7/33,18.71%,VAMP2;OAZ1;GSK3B;RUFY3;ATP13A2;ZFAND1;PTPN1
gsea,Protein O-linked Glycosylation (GO:0006493),0.26212556922357366,1.108342925811378,0.2776617954070981,0.5867487470102075,1.0,24/75,23.63%,GALNT18;GALNT14;MGAT5B;GALNTL6;GALNT10;ST3GAL3;GALNT16;LARGE1;GALNT9;GALNT7;B3GALNT2;GALNT3;XXYLT1;POGLUT3;ST3GAL2;POFUT2;GALNT11;FKTN;ST3GAL4;TET3;GALNT12;OGA;POMGNT1;B3GNTL1
gsea,Regulation Of Neuronal Synaptic Plasticity (GO:0048168),0.3248120907792334,1.1079309582751709,0.3081510934393638,0.5863363593355867,1.0,10/32,12.64%,GRIN2A;GRIN1;MCTP1;SHISA9;CAMK2A;GRIK2;ZDHHC2;EPHB2;DLG4;SHISA7
gsea,Regulation Of Cellular Response To Heat (GO:1900034),-0.38105196779380623,-1.1075465017267851,0.3319755600814664,0.4900683244953452,1.0,4/15,11.74%,DNAJB6;IER5;CHORDC1;GSK3B
gsea,Neurotransmitter Transport (GO:0006836),0.30518474754768654,1.107201677101117,0.3069306930693069,0.586647436140111,1.0,8/39,9.25%,GABRA2;PTPRN2;SYNJ1;BRSK1;SYN2;SLC1A1;UNC13A;SLC29A4
gsea,Regulation Of Bone Mineralization (GO:0030500),0.3075048344515011,1.107183233942367,0.31634819532908703,0.5852053608013502,1.0,5/37,3.90%,SLC8A1;ANO6;FBN2;TXLNG;ECM1
gsea,Endosomal Transport (GO:0016197),-0.2357700489518759,-1.1066440486417315,0.22745098039215686,0.4911629358210272,1.0,40/150,23.80%,CALY;NSG1;NSG2;VPS29;RAB6B;SQSTM1;BET1L;ARL1;RAB14;RAB6A;STX16;EHD3;VTI1B;SNX3;SNX17;CHMP2A;DCLK1;PLEKHA3;ACAP2;ANKRD50;ARL4C;VPS4A;GOSR1;SNX5;VAMP3;VPS35;PHETA1;EHD1;RNF126;SNX4;EPS15;CLN5;RAB11B;TBC1D10B;VPS52;ARFRP1;VPS26B;SNX33;RAB35;ARF6
gsea,Positive Regulation Of Fat Cell Differentiation (GO:0045600),-0.32001198457109686,-1.1059307157115872,0.31717171717171716,0.491968730399721,1.0,13/31,28.60%,CEBPB;XBP1;METRNL;ZFP36L1;ID2;SIRT6;CREB1;LMO3;AKT1;TRPM4;VSTM2A;FNDC5;NAPEPLD
gsea,Mitotic Cell Cycle Checkpoint Signaling (GO:0007093),-0.36698187862483134,-1.105094953330022,0.32558139534883723,0.49301737683756913,1.0,8/19,22.93%,INIP;ZWINT;BABAM2;VPS4A;CHMP4C;UIMC1;RAD50;RBBP8
gsea,Heart Morphogenesis (GO:0003007),0.31388236353448074,1.104627968835375,0.3125,0.5899008239368424,1.0,9/31,11.28%,RYR2;APC;TGFBR1;NIPBL;PTK2;TAFAZZIN;NOG;TGFBR3;TTN
gsea,Cell-Cell Junction Organization (GO:0045216),0.28783655882035175,1.1038937817149839,0.2839756592292089,0.5902688745662555,1.0,6/46,4.36%,CDH12;TJP2;PKP4;CTNND2;TJP1;TLN2
gsea,Positive Regulation Of B Cell Activation (GO:0050871),-0.32606776707190305,-1.1036691642597882,0.32771535580524347,0.49519147893747284,1.0,18/33,40.42%,CD81;MEF2C;IRS2;HMCES;XBP1;SHLD1;CD27;CHRNB2;MAD2L2;CD38;BTK;MMP14;INPP5D;NCKAP1L;TFRC;SH3KBP1;GPR183;VAV3
gsea,Peptidyl-Tyrosine Modification (GO:0018212),0.2964980441498792,1.1033323739743615,0.3025210084033613,0.5901009339371716,1.0,13/40,16.13%,FLT3;LCK;ABL2;PTK2;JAK2;TPST2;EPHB2;RELN;FYN;ERBB4;TTBK1;EPHA3;FER
gsea,Positive Regulation Of Interferon-Beta Production (GO:0032728),-0.35261656514134865,-1.1030238045661531,0.3436293436293436,0.49583472199875883,1.0,9/20,30.61%,HSP90AA1;POLR3D;TBK1;IRF3;MAVS;PTPN11;POLR3A;FLOT1;RIPK2
gsea,Response To Amino Acid (GO:0043200),-0.32484495961145143,-1.1023024885617632,0.3048327137546468,0.4965897324501006,1.0,6/25,11.66%,LAMTOR2;RRAGA;LAMTOR3;TMBIM6;RRAGD;XBP1
gsea,Positive Regulation Of Monooxygenase Activity (GO:0032770),-0.38098645358607286,-1.1020712818994196,0.31843575418994413,0.4963959324854775,1.0,4/16,10.93%,APOE;PARK7;DHFR;GCH1
gsea,Positive Regulation Of Interleukin-6 Production (GO:0032755),-0.3121385601497151,-1.1017672537538303,0.315884476534296,0.496362305346223,1.0,12/37,30.90%,HMGB1;C1QTNF4;AKIRIN2;XBP1;HSPD1;BCL10;HYAL2;MAVS;PTPN11;SPHK2;EHHADH;SETD4
gsea,Neuropeptide Signaling Pathway (GO:0007218),-0.3276750783569247,-1.1017153832824436,0.3176691729323308,0.49582562886010884,1.0,19/30,42.68%,CPE;AGRP;SSTR2;GPR37;OPRM1;SSTR1;NPY;PDYN;OPRD1;RELA;GLRB;OPRL1;HCRTR2;GRP;PENK;GPR83;NTSR2;SORL1;RAPGEF2
gsea,Negative Regulation Of DNA Binding (GO:0043392),-0.3562770078202778,-1.100437985902441,0.3326848249027237,0.4977965694849996,1.0,7/18,25.78%,JUN;HEY1;NFKBIA;MAD2L2;SUMO1;SIN3A;RSF1
gsea,Negative Regulation Of mRNA Catabolic Process (GO:1902373),-0.33184907457514157,-1.1001588563711346,0.30754352030947774,0.49771183520321444,1.0,5/26,11.06%,HNRNPAB;YBX1;CIRBP;PABPC1;FMR1
gsea,Regulation Of Mitotic Cell Cycle (GO:0007346),-0.2512366773943444,-1.0999940252605565,0.2787524366471735,0.49740680732070003,1.0,20/97,17.49%,RPRM;YWHAE;DUSP3;USP2;BRINP3;TRIM35;BTG2;ANAPC13;PIN1;PDXP;USP22;BRD7;SOX9;ANAPC11;CKS2;PIM3;CDKN1B;MKI67;BTG1;NEK6
gsea,Positive Regulation Of Macromolecule Metabolic Process (GO:0010604),-0.22740042622914633,-1.0998906316724235,0.26508226691042047,0.4969716693697757,1.0,50/215,19.97%,MT3;RPS7;RPL5;RPL11;OLFM1;ACTG1;RPL17;RPS3;PARK7;MTPN;SPRY2;MEF2C;RAMP2;EGR1;FAM98B;KRAS;CITED2;SLC38A2;SNCA;CLU;INHBA;HMGN5;SOX9;GJA1;GSK3B;EZR;ATF2;WNT16;ID2;ERP29;LAPTM5;TLE1;POU3F1;ATP13A2;VAMP3;POU3F3;BMPR2;NSF;HCFC1;CTSH;VPS35;WARS1;PTPN1;RDX;PDGFB;TADA3;BMP6;BMPR1B;MBIP;NFKBIA
gsea,Cellular Response To Metal Ion (GO:0071248),0.24582100571096394,1.099722239773971,0.2570806100217865,0.5976369801211481,1.0,14/92,7.94%,ANK3;NLGN1;CACNA1A;PRKN;ADCY8;CHUK;GPLD1;RYR3;SYT17;KCNH1;NEK7;PLCG2;ITPKB;PKD2
gsea,Organic Hydroxy Compound Biosynthetic Process (GO:1901617),-0.32867453057439106,-1.0996688784543547,0.3320964749536178,0.49675606610852935,1.0,11/27,26.60%,PARK7;MSMO1;SQLE;SCP2;HMGCR;OSBPL9;PSAT1;HSD17B10;HSD3B7;OSBPL3;CYP46A1
gsea,DNA Biosynthetic Process (GO:0071897),-0.38856180681724545,-1.0990125785702378,0.30111524163568776,0.4974749423315172,1.0,7/15,30.43%,POLDIP2;RFC3;RRM1;RRM2B;POLD2;POLL;POLD3
gsea,Regulation Of Long-Term Synaptic Potentiation (GO:1900271),-0.3251244148925513,-1.0988715460447753,0.3016194331983806,0.49708436281767343,1.0,4/27,3.91%,APOE;NSG1;SQSTM1;CALB1
gsea,Myotube Differentiation (GO:0014902),0.36195859803138386,1.0973839279213966,0.32696390658174096,0.6018968569268174,1.0,4/17,9.44%,KCNH1;MYEF2;NOS1;CACNA1H
gsea,RNA Transport (GO:0050658),0.30707162947542566,1.096868638440755,0.3037190082644628,0.6017272643825732,1.0,8/32,11.80%,RBFOX1;ATXN2;RFTN1;NUP188;CKAP5;XPO5;DDX39A;NUP98
gsea,Visual Perception (GO:0007601),0.2768022584180186,1.0968229727065508,0.29906542056074764,0.6003323366629256,1.0,15/49,20.60%,MYO9A;COL11A1;GRM8;PAX6;ATXN7;GUCA1B;DRAM2;IMPG2;RPGR;KRT12;RABGGTA;OPA3;PITPNA;EML2;WFS1
gsea,Positive Regulation Of Proteolysis (GO:0045862),-0.30078214751177657,-1.0958062852840453,0.32251908396946566,0.5027709941500689,1.0,10/38,19.48%,APOE;AURKAIP1;NDUFA13;PINK1;BAD;STUB1;TRIM32;CTSH;ADAM9;CAPN3
gsea,Positive Regulation Of Type II Interferon Production (GO:0032729),-0.35001386844690474,-1.095687210768609,0.33661417322834647,0.5023210207319887,1.0,4/21,14.55%,RASGRP1;IL18;MYDGF;HSPD1
gsea,Golgi To Vacuole Transport (GO:0006896),-0.36657954424933736,-1.095489964392587,0.32142857142857145,0.5020678085661346,1.0,4/16,14.61%,LAMP1;EHD3;VTI1B;LAPTM5
gsea,Actin Filament Organization (GO:0007015),-0.254564911973793,-1.0952361039408365,0.2680221811460259,0.5019236059158445,1.0,10/100,6.01%,ALDOA;RAC1;TAGLN3;CDC42;WASL;DSTN;MARCKSL1;MARCKS;TPM1;RFLNB
gsea,RNA Processing (GO:0006396),-0.22909861290550643,-1.0950450199045432,0.2547892720306513,0.5016608892655975,1.0,51/171,23.49%,CELF2;PRPF4B;SNRPG;PABPC4;HNRNPA2B1;SNRPF;SNRPD2;SF3B2;WBP4;SF3B4;PPP2CA;PPP2R1A;TFIP11;ZCRB1;RBM8A;ALKBH5;ZRSR2;MAGOH;LSM4;HNRNPF;SCAF11;U2AF1;LUC7L3;HNRNPK;SNRPD1;DDX20;MAGOHB;EXOSC4;EXOSC3;DKC1;IVNS1ABP;PDCD7;LSM1;HNRNPC;MBNL1;U2AF2;SNRPN;MPHOSPH10;SLU7;LSM5;DDX39B;NOL3;NCBP2;SNRPB;RP9;HNRNPH3;EXOSC9;PRKACA;FASTK;CCAR2;BCAS2
gsea,Positive Regulation Of Reproductive Process (GO:2000243),0.36494261576916,1.094952386029167,0.3333333333333333,0.603487139259457,1.0,6/16,19.48%,ASIC2;CACNA1H;SMURF2;SIRT2;CFAP69;ANKRD31
gsea,Antiviral Innate Immune Response (GO:0140374),-0.342931765806715,-1.0947873650154705,0.3441682600382409,0.5015282369932196,1.0,7/23,28.58%,NCK1;UBE2N;PHB2;TBK1;USP20;MAVS;DHX16
gsea,Stress-Activated MAPK Cascade (GO:0051403),0.2985419140423144,1.094761716691235,0.30505050505050507,0.6024929142139565,1.0,9/35,15.79%,MAPK10;MAPK14;MAP3K7;IKBKB;MAP3K5;TNFRSF19;MAP4K3;TAOK2;MAPK11
gsea,Regulation Of Transcription Initiation By RNA Polymerase II (GO:0060260),-0.27883200492776977,-1.0947078718405792,0.3037974683544304,0.5010523476715396,1.0,19/53,29.56%,PPM1D;MED10;MED4;CDK4;TAF10;MED19;TAF11;MED31;MED9;MED21;MED22;TAF5;MED7;TAF7;PCID2;ZNHIT1;TAF12;MED11;MED30
gsea,Synaptic Vesicle Recycling (GO:0036465),-0.3017156285292027,-1.0944940403259167,0.3073852295409182,0.5008661581605128,1.0,7/38,7.14%,RAB3A;VAMP2;SNCB;AP2M1;CANX;SYT5;SNCA
gsea,Regulation Of Cellular Catabolic Process (GO:0031329),0.27339378848941587,1.0940183982503062,0.30155210643015523,0.6028052810644412,1.0,20/56,24.95%,PRKN;RPTOR;ROCK1;DAPK1;MAPT;ABL2;DRAM2;OSBPL7;ULK3;SOGA1;USP13;USP10;HDAC6;ABL1;TYSND1;RMC1;LRRK2;EP300;ATM;WAC
gsea,Regulation Of Plasma Membrane Bounded Cell Projection Organization (GO:0120035),0.32834411850180106,1.0937899623672438,0.3188976377952756,0.6019391859190146,1.0,6/23,10.03%,NTNG2;CCDC88A;BRSK1;CAMK2G;ULK4;MARK1
gsea,Cellular Response To Interleukin-1 (GO:0071347),-0.2974573416306019,-1.093545047607759,0.2948960302457467,0.5022043866504241,1.0,17/39,33.49%,CD47;EGR1;SOX9;MYLK3;CX3CL1;MAPK3;IRAK4;PLCB1;HYAL2;RELA;HYAL1;CACTIN;IL1RAP;PTGIS;SIRPA;ST18;MYD88
gsea,Negative Regulation Of Cell Motility (GO:2000146),0.249959591948022,1.0932347868422534,0.27566539923954375,0.6018463242497891,1.0,24/92,15.84%,DACH1;MCTP1;ADARB1;LIMCH1;FRMD5;TCAF1;NF1;DLG5;SCAI;HDAC1;ARID2;SRGAP3;NOG;TMEFF2;STK26;RNF20;RECK;CDH11;RNF41;DPYSL3;ROBO1;RAP2C;SPOCK3;ARID4B
gsea,Positive Regulation Of T Cell Activation (GO:0050870),-0.28690466491639655,-1.0917939943939718,0.3161904761904762,0.505032403574835,1.0,12/54,19.99%,ACTB;CD81;NCK1;CD47;BRD7;XBP1;HSPD1;SMARCE1;ACTL6B;THY1;SMARCB1;CCDC88B
gsea,Positive Regulation Of Viral Process (GO:0048524),-0.30998269971576486,-1.0912047242357072,0.3007662835249042,0.5056600907878324,1.0,4/29,10.54%,PPIA;ATG12;AXL;PABPC1
gsea,Positive Regulation Of Macromolecule Biosynthetic Process (GO:0010557),-0.25389458200182596,-1.0907587460770216,0.3065134099616858,0.5058843686804929,1.0,15/91,12.63%,RPL5;RPS4X;EIF3C;RPL26;MTPN;EEF2;IRS2;NPM1;EIF6;CIRBP;FMR1;RPS27L;XBP1;HSPH1;POLDIP3
gsea,Regulation Of Cellular Senescence (GO:2000772),-0.32628809750203214,-1.0898761708958782,0.3162878787878788,0.5070494547343152,1.0,10/26,31.46%,YPEL3;YBX1;ARG2;SIRT6;NEK6;B2M;RSL1D1;PTEN;AKT3;EEF1E1
gsea,Epidermis Development (GO:0008544),-0.331156459783917,-1.0894023628467067,0.31393298059964725,0.5074265814755046,1.0,4/25,9.35%,PPP3CA;FGFR2;FABP5;YBX1
gsea,Epithelial Cilium Movement Involved In Extracellular Fluid Movement (GO:0003351),0.37980746161850176,1.0890064201378509,0.3304535637149028,0.6108367629509197,1.0,8/16,23.34%,SPEF2;NEK10;NPHP3;ODAD4;CABYR;OFD1;CCDC40;CCDC39
gsea,Negative Regulation Of Axonogenesis (GO:0050771),-0.34915338059524886,-1.08815869213501,0.3522504892367906,0.5093556852198898,1.0,8/20,19.60%,MT3;FGF13;RNF6;RTN4;RTN4R;RUFY3;EFNB3;THY1
gsea,Negative Regulation Of NF-kappaB Transcription Factor Activity (GO:0032088),-0.28563383060304093,-1.0876244739962182,0.3019230769230769,0.50984614713935,1.0,11/49,19.97%,TMSB4X;G3BP2;NFKBIB;OTULIN;ERBIN;COMMD6;NLRC3;COMMD1;COMMD7;BRMS1;NFKBIA
gsea,Blood Vessel Morphogenesis (GO:0048514),0.31972587325461954,1.0875368601682407,0.2957446808510638,0.6129641668982581,1.0,10/28,21.28%,CCBE1;TGFBR1;NF1;SLC1A1;EFNB2;COL4A1;PROX1;ITGB8;HEY2;RBPJ
gsea,Regulation Of Defense Response To Virus By Host (GO:0050691),-0.3536487122117095,-1.087443307528342,0.3460764587525151,0.5095758762996576,1.0,7/19,24.01%,HSP90AA1;MUL1;TRIM44;PQBP1;TRAF3IP2;MAVS;SIN3A
gsea,Exocytosis (GO:0006887),-0.27013538435578477,-1.0873081622648841,0.31021194605009633,0.5092193449652382,1.0,23/64,25.75%,RAB3A;VAMP2;SNAP47;RAB11A;SNAP25;RAB31;TMED10;JAGN1;ANK1;SNAP29;VAMP3;NSF;RAB11FIP2;SYNGR1;RAB11B;PIK3C2A;EXOC3;STEAP2;MIA3;TMEM167B;SYNGR3;STX1B;SCRN1
gsea,Regulation Of Insulin Secretion Involved In Cellular Response To Glucose Stimulus (GO:0061178),-0.35786495694057574,-1.0866551174036865,0.3301707779886148,0.5099102341453564,1.0,3/18,6.33%,EPHA5;PPP3CB;KLF7
gsea,Phosphate-Containing Compound Metabolic Process (GO:0006796),-0.23858270967935888,-1.0864610207824026,0.298372513562387,0.5097007181982166,1.0,37/140,21.31%,ALDOA;PLPPR4;EPHA7;PPP3CA;DUSP3;ALDOC;GDE1;GPX4;PPP1CA;PPP3CB;LCAT;PGK1;PDXP;G6PC3;INPP4B;PFKL;PIP4P1;MAPK3;IMPA1;PLPPR5;ANGPTL3;NANP;ACYP1;DUSP8;LIMD1;PFKFB3;PLPP3;DUSP5;FRA10AC1;HK1;MINPP1;SHPK;INPP1;PPA1;PSPH;AGPAT1;PANK3
gsea,Establishment Of Protein Localization To Plasma Membrane (GO:0061951),0.2979045055972184,1.0860099259559681,0.3360323886639676,0.6153280051862176,1.0,7/33,14.97%,ANK3;MACF1;RILPL1;BBS1;GGA3;SPTBN1;PREPL
gsea,Negative Regulation Of Angiogenesis (GO:0016525),0.28493812549284125,1.0853362673052334,0.316008316008316,0.6156223693335556,1.0,12/47,14.38%,ATP2B4;NRG1;ROCK1;ADGRB1;AGO1;HGS;KRIT1;MECP2;SYNJ2BP;NIBAN2;PPARG;DAB2IP
gsea,Nucleotide Biosynthetic Process (GO:0009165),0.36300106591005854,1.0852664395961222,0.3145631067961165,0.6143165023464398,1.0,4/16,11.33%,PFAS;NMNAT2;SLC4A7;MTHFD1
gsea,Myoblast Differentiation (GO:0045445),-0.3819179380473007,-1.083904580183226,0.35728542914171657,0.5139927896969867,1.0,1/15,0.09%,DDX5
gsea,Antigen Receptor-Mediated Signaling Pathway (GO:0050851),0.2690466726634166,1.0838551391802485,0.32762312633832974,0.6163611530392605,1.0,12/67,11.53%,DENND1B;RFTN1;LCK;MAP3K7;PLCG2;WNK1;TNFRSF21;IKBKB;GNAO1;PIK3CD;FYN;PLCG1
gsea,Regulation Of Catecholamine Secretion (GO:0050433),0.34104914004479203,1.0837340036984289,0.3438155136268344,0.615169436040919,1.0,6/21,13.31%,PRKN;CHRNA4;SYT17;STX1A;SYT1;GRK2
gsea,T Cell Differentiation (GO:0030217),0.3434558358191133,1.0832689416483952,0.35344827586206895,0.6148298760287214,1.0,9/23,19.33%,LCK;PIK3R3;PTPN2;PIK3CD;LMBR1L;RABL3;CHD7;PTPN22;NHEJ1
gsea,Endomembrane System Organization (GO:0010256),0.22518563485801202,1.0827200033154938,0.28094302554027506,0.6147849065274837,1.0,36/156,15.82%,ANK3;DYNC2H1;DYM;HACE1;SYNE1;DOP1B;DNM1;HOOK1;VPS13B;TRIP11;CLASP1;TRAPPC8;BCAS3;ARFGEF1;GBF1;NPLOC4;SEC16A;TANGO2;COG4;USP8;FBXW8;COG3;ARHGEF7;TMCC1;DNAJC13;TOR1B;HTT;HOOK2;BNIP1;PLEKHM2;SPTBN1;OSBPL2;CLASP2;COG7;HOOK3;LNPK
gsea,Positive Regulation Of Cell Migration (GO:0030335),0.22800474504861906,1.0826873227676188,0.2752688172043011,0.6134182151008408,1.0,32/181,11.53%,SEMA5B;PRKCE;FGF10;APC;TGFBR1;NTRK3;SHTN1;LAMB1;MAP4K4;NIPBL;TJP1;CLASP1;RREB1;NTF3;PLAA;CARMIL1;SEMA4D;PTK2;PLCG2;ACTN4;PIK3R3;TIAM1;AKT2;GCNT2;EPHB2;IGF1R;PIK3CD;ARHGEF7;SMO;MTOR;SMURF2;PLCG1
gsea,Purine Ribonucleotide Biosynthetic Process (GO:0009152),0.2815597751607244,1.0819749102343554,0.3354978354978355,0.6138380037893223,1.0,8/39,10.63%,AK5;PRKAG2;ADCY8;ADCY2;PFAS;ADCY9;ADCY6;AMPD3
gsea,Regulation Of Cholesterol Efflux (GO:0010874),-0.35020522229418566,-1.0816735268018356,0.36811023622047245,0.5179802107091366,1.0,9/22,31.09%,APOE;GPS2;PLTP;NFKBIA;NAXE;LAMTOR1;SREBF2;ZDHHC8;NR1H2
gsea,Regulation Of RNA Splicing (GO:0043484),-0.25398638048292166,-1.0810816975045472,0.3352941176470588,0.5185627393177241,1.0,24/84,24.14%,HNRNPA1;RPS26;SLC38A2;USP22;RBM22;TMBIM6;TAF10;HNRNPF;RPS13;PRDX6;HNRNPK;SRSF3;PIK3R1;ENY2;TADA2B;MBNL1;U2AF2;PQBP1;TADA3;GRSF1;ZC3H10;HNRNPH3;FASTK;QKI
gsea,Regulation Of Cellular Biosynthetic Process (GO:0031326),-0.26339452018650267,-1.081067441118066,0.3076923076923077,0.5179312876180459,1.0,8/59,8.77%,RAC1;MTPN;CD47;NOLC1;PDGFA;RPL10;MFSD12;EIF6
gsea,Negative Regulation Of Cell Junction Assembly (GO:1901889),0.3494331831888681,1.080901176382657,0.36062378167641324,0.614894637503836,1.0,4/19,7.96%,SLIT1;ROCK1;BCAS3;IKBKB
gsea,Negative Regulation Of Stress Fiber Assembly (GO:0051497),-0.35266989255057507,-1.080830866376157,0.35306553911205074,0.5177605591606796,1.0,4/17,12.71%,DYNLL1;STMN1;PFN1;PIK3R1
gsea,Protein Polymerization (GO:0051258),-0.2885909527173078,-1.0805386338393856,0.33201581027667987,0.5177267885003713,1.0,17/45,27.50%,RAC1;WASL;GPX4;FGF13;PIN1;UBE2S;CHMP2A;PSTPIP2;SPIRE1;TRIM32;MID1IP1;FAM107A;HDGFL3;MAP4;WASF1;WASHC3;CHMP3
gsea,Protein Quality Control For Misfolded Or Incompletely Synthesized Proteins (GO:0006515),-0.3181653308870938,-1.0804174939347542,0.3319838056680162,0.5173166350534361,1.0,10/27,27.17%,ZYG11B;STUB1;RNF5;PEX12;RNF185;VCP;LONP1;TOR1A;DERL1;UGGT1
gsea,Cellular Response To Low-Density Lipoprotein Particle Stimulus (GO:0071404),-0.386754077567245,-1.0802183528773495,0.36462093862815886,0.5170614594945899,1.0,8/15,36.33%,CD81;LDLR;MIA3;AKT1;SREBF2;MYD88;CD68;CD9
gsea,Regulation Of B Cell Proliferation (GO:0030888),-0.34755829384623704,-1.0801091414901711,0.33815551537070526,0.5166339432447652,1.0,7/22,25.48%,CD81;MEF2C;IRS2;LYN;CHRNB2;CD300A;CD38
gsea,"Positive Regulation Of DNA-templated Transcription, Elongation (GO:0032786)",-0.27596156278087197,-1.079936055515275,0.33460076045627374,0.5163315291933688,1.0,14/50,21.65%,HMGN1;MED10;MED4;EAPP;MED19;PARP1;MED31;MED9;MED21;MED22;DDX39B;CDC73;MED7;NCBP2
gsea,DNA Repair (GO:0006281),-0.22033431984530144,-1.0795030977619289,0.27387387387387385,0.5165401372622871,1.0,91/251,33.43%,RPS3;PARK7;NUCKS1;MRPL36;CETN2;CSNK1E;H2AC25;POLQ;CENPX;SMC1A;EYA1;BTG2;NSMCE3;UBE2N;INIP;PCNA;RAD21;MPG;NPM1;RPA3;PARP1;FBXO6;UBE2V1;FMR1;MACROH2A1;GTF2H5;RNF168;VCPIP1;BABAM2;HPF1;DDB2;ADPRS;POLDIP2;ASF1A;NOP53;MPND;COMMD1;SIRT6;RNASEH2C;RECQL;APEX1;TDG;RFC3;H2AX;VCP;DDX1;XRCC2;UIMC1;RRM1;PARP4;RAD50;RRM2B;ACTR8;RAD9B;MAD2L2;RBBP8;XRCC6;ERCC3;RAD51;SUMO1;ASCC1;GTF2H4;FSCN1;RNASEH2A;LIG4;ZGRF1;FANCE;MLH1;PRMT6;CDKN2D;KAT5;POLL;MLH3;ZBTB1;NABP2;FAM111A;POLD3;MUS81;GTF2H3;UBE2A;FEN1;XPA;RFC5;NUDT1;POLI;MSH6;DCLRE1B;MGME1;FAAP20;RAD23B;XRCC3
gsea,Cell Surface Receptor Signaling Pathway Involved In Cell-Cell Signaling (GO:1905114),-0.3375816096610893,-1.0779322121180994,0.3416030534351145,0.5190680847672433,1.0,7/24,25.18%,CPE;FZD2;FZD4;VPS35;CSNK1A1;P2RX7;NDP
gsea,Negative Regulation Of Phosphatase Activity (GO:0010923),-0.36554044943090547,-1.0778058412740057,0.3485148514851485,0.5186637371710567,1.0,4/16,12.17%,FKBP1A;PPP1R11;GSK3B;PPP1R1B
gsea,Negative Regulation Of Neuron Projection Development (GO:0010977),0.284752071372942,1.0774255151759748,0.3389121338912134,0.621849113585048,1.0,10/44,10.40%,PTPRS;NLGN1;TNR;DCC;RTN4RL1;SPOCK1;EFNA1;ADCY6;EFNB2;BCL11A
gsea,Neutrophil Migration (GO:1990266),-0.3590318412305471,-1.0769694781234702,0.3559633027522936,0.5198148785557508,1.0,6/19,22.64%,PPIA;PPIB;CX3CL1;IRAK4;EMP2;TGFB2
gsea,Cellular Response To Amino Acid Stimulus (GO:0071230),-0.3114242406489328,-1.0766570620733595,0.32741617357001973,0.5198391014077329,1.0,6/29,11.66%,SESN1;LAMTOR2;RRAGA;LAMTOR3;RRAGD;XBP1
gsea,Protein Catabolic Process (GO:0030163),-0.2536966293193603,-1.0763448824699533,0.31417624521072796,0.5198427454694083,1.0,34/75,36.01%,APOE;HSPA8;HSP90AA1;BNIP3L;SQSTM1;CTSB;RNF5;FBXO6;TRIM24;ATE1;LAMP2;CTSH;PRPF19;VCP;USE1;CAPN3;CLN5;LONP1;HTRA2;CTSD;UCHL3;CTSS;CLN8;CTSL;CTSZ;RAB12;CTSF;CAPN2;STT3B;LGMN;NGLY1;TPP1;CASP8;CLN6
gsea,Negative Regulation Of Cytoskeleton Organization (GO:0051494),0.3268814949976703,1.0750435474364368,0.35177865612648224,0.6262332453785099,1.0,7/25,7.87%,PRKN;LIMA1;CLASP1;SHANK3;SHANK1;SSH3;SSH2
gsea,Cartilage Development (GO:0051216),0.32291771822316184,1.0747391615372368,0.36403508771929827,0.6255183702870464,1.0,7/32,11.18%,PKD1;GPLD1;TRIP11;NFIB;SOX5;WNT7A;CCN3
gsea,Regulation Of Establishment Of Planar Polarity (GO:0090175),-0.3266932059907628,-1.074626315564286,0.36742424242424243,0.5228325564013409,1.0,4/26,7.58%,RAC1;CDC42;FZD3;FZD2
gsea,Vesicle-Mediated Transport (GO:0016192),-0.2113631834146814,-1.0742153543286181,0.2803180914512923,0.5230927276723979,1.0,59/337,16.51%,CALY;RAB3A;VAMP2;RAB2A;NSG1;ARF1;NSG2;NECAP1;CDC42;STX7;AP2M1;ARF4;WASL;SQSTM1;NCALD;CSNK1E;SYP;TMED2;SNAP47;DPYSL2;ARL1;PRKD1;RAB14;ARF3;STX16;CYTH2;PIP4K2A;RAB11A;SNAP25;OCIAD1;EHD3;VTI1B;ARF5;EPN1;RAB22A;SNX17;CHMP2A;TSG101;ARL5B;CHMP6;DCLK1;AP2B1;HIP1R;TMED10;LDLR;RHOB;VPS4A;JAGN1;GOSR1;SYT11;ANK1;SPIRE1;SNAP29;COMMD1;VAMP3;AP3S2;CHMP4C;NSF;CACFD1
gsea,Regulation Of Autophagosome Assembly (GO:2000785),-0.29242364255619335,-1.0734712943682991,0.3422680412371134,0.5239465568711756,1.0,12/37,23.62%,SH3GLB1;UBQLN2;PIP4K2A;PINK1;RAB1B;IFT20;FEZ2;FEZ1;SNX4;RAB5A;PHF23;SNX33
gsea,Regulation Of Actin Cytoskeleton Organization (GO:0032956),-0.25904224492791067,-1.073327529697883,0.3435114503816794,0.523570310283842,1.0,12/76,12.57%,EPHA5;DYNLL1;RAC1;ARHGDIA;CDC42;PDGFA;CLU;HRAS;TWF1;RALA;HIP1R;EZR
gsea,Amide Biosynthetic Process (GO:0043604),0.29777862240186687,1.0730630103670988,0.3285123966942149,0.6281895533676825,1.0,7/33,13.52%,PCSK5;DMD;CERS4;SGMS1;CERS6;ALOXE3;CERS5
gsea,Regulation Of Establishment Or Maintenance Of Cell Polarity (GO:0032878),0.35200142981448257,1.0726532072889896,0.3598326359832636,0.6277064524437013,1.0,5/17,7.62%,RIPOR2;ROCK1;SHTN1;BCAS3;KRIT1
gsea,Protein Targeting To Membrane (GO:0006612),-0.26574957217765693,-1.0723387765592245,0.3517110266159696,0.5248263833258925,1.0,4/59,1.73%,NACA;ARL6IP1;SEC62;SRP14
gsea,ncRNA Catabolic Process (GO:0034661),0.31165926009787825,1.0709764694832462,0.3496932515337423,0.6304181973589624,1.0,6/26,14.04%,LIN28B;DICER1;TUT4;EXOSC10;TENT4B;DIS3L2
gsea,Regulation Of Cellular Component Organization (GO:0051128),-0.2333907857806201,-1.0708427771237894,0.3359840954274354,0.5272024790834251,1.0,39/126,27.00%,APOE;HSPA8;HSP90AA1;PARK7;LAMTOR2;SLITRK2;NRG3;PINK1;HJURP;SNX17;BAG5;ANKRA2;GFAP;HIP1R;RAP1A;PACSIN2;RUFY1;IL17RB;MKI67;HCFC1;AP2S1;PAPPA2;PTPN1;FAM107A;RASGRP2;RAB5B;MAD2L2;EBAG9;TRAF2;PTPN11;BBS10;DCUN1D5;SSRP1;ERMN;LAMTOR1;ALKBH4;TMEM97;RAP1B;JADE2
gsea,Regulation Of Cell-Cell Adhesion (GO:0022407),-0.3196447694222649,-1.0706839450112533,0.34024896265560167,0.5269035354567567,1.0,8/27,23.83%,EPHA7;CD47;CITED2;JAG1;SMAD7;PLPP3;MEGF10;GTPBP4
gsea,Cellular Response To Cytokine Stimulus (GO:0071345),-0.2329212018891213,-1.0699683043165196,0.30939226519337015,0.5276952059944001,1.0,40/145,25.44%,CALM1;GAPDH;RPS3;RPL13A;NDUFA13;CD47;EGR1;SELPLG;GSDME;AQP4;AXL;BAG4;IRF8;SOX9;MYLK3;CX3CL1;ERBIN;XBP1;GSK3B;CEBPA;ZFP36L1;EPOR;IRAK4;HCK;ZFAND6;CSF1R;CRLF2;NFKBIA;SHPK;RHOA;CXCL12;HYAL2;PRKACA;IL13RA1;HTRA2;JAK1;PTPN11;AKT1;RELA;HYAL1
gsea,Negative Regulation Of DNA Metabolic Process (GO:0051053),0.31183235139038956,1.06991671311516,0.3480083857442348,0.6315874010109698,1.0,10/27,17.73%,DACH1;KMT2A;TERF2;GMNC;MSH3;ERCC4;NIBAN2;XRCC5;PDS5A;RAD17
gsea,Positive Regulation Of Cell Cycle (GO:0045787),-0.2747192796079243,-1.0696280624671768,0.3504950495049505,0.5277384639460017,1.0,7/50,7.26%,CALR;RPS15A;FGFR2;DUSP3;USP2;CITED2;USP22
gsea,Positive Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0045737),0.3648374362961374,1.0682566466770456,0.34518828451882844,0.6342439701050328,1.0,4/15,14.08%,PKD1;CCND2;PKD2;PROX1
gsea,Endoplasmic Reticulum Organization (GO:0007029),-0.27360783430927005,-1.067695129403114,0.33904761904761904,0.5310244337407702,1.0,10/46,16.81%,REEP5;VAPA;CCDC47;WDR83OS;RTN4;RAB18;VCPIP1;TOR1AIP2;JAGN1;TMEM33
gsea,Response To Interleukin-1 (GO:0070555),-0.29726331553387214,-1.0675659483661166,0.34307992202729043,0.5306239572891708,1.0,15/38,33.49%,TLE5;CD47;SNCA;SOX9;MYLK3;CX3CL1;HYAL2;RELA;HYAL1;IGBP1;SMPD1;CACTIN;PTGIS;SIRPA;MYD88
gsea,Intracellular Calcium Ion Homeostasis (GO:0006874),-0.24846730057779587,-1.0673325761344332,0.328125,0.5304266399751034,1.0,15/88,12.64%,ATP1B1;TPT1;CALR;YWHAE;SELENOK;SMDT1;BAX;CCDC47;PML;SLC24A5;ATP13A5;TMEM203;ATP2B1;KCTD17;SLC8A2
gsea,Organelle Organization (GO:0006996),0.20622461119811464,1.0666249270680699,0.27054108216432865,0.6367951568027069,1.0,59/328,12.18%,DYNC2H1;PRKN;DST;VPS13C;BIN1;TTC17;PCLO;FGD4;SIPA1L3;DYM;HACE1;SYNE1;FMNL2;VPS13D;MICAL2;BRWD1;MICAL3;DOP1B;VPS13B;TRIP11;PACSIN1;ZMYM4;CLASP1;TRAPPC8;ATXN7;BCAS3;ARFGEF1;GBF1;PIKFYVE;NPLOC4;PRPF40A;SEC16A;CAMSAP1;TANGO2;COG4;PKD2;PEX1;TAFAZZIN;PLCE1;RICTOR;MAST2;ADCK1;FGD1;FBXW8;MARK1;COG3;ARHGEF7;CLUH;SLC25A36;TMCC1;SH3D19;MTOR;ZMYM6;TOR1B;ZRANB1;HTT;MAST1;BNIP1;KLHL20
gsea,Regulation Of Chemotaxis (GO:0050920),-0.3507112385752924,-1.0665569412765477,0.3694390715667311,0.5313995822744905,1.0,3/18,5.55%,DUSP3;P2RY12;USP14
gsea,Negative Regulation Of Canonical Wnt Signaling Pathway (GO:0090090),0.2528822667041699,1.0652670000744215,0.33460803059273425,0.6386361886679895,1.0,16/85,11.37%,HECW1;CHD8;PRKN;RBMS3;APC;ZNRF3;HDAC1;AXIN1;CCDC88C;NPHP3;NPHP4;NOG;TLE3;LMBR1L;ANKRD6;STK4
gsea,Cellular Response To Fibroblast Growth Factor Stimulus (GO:0044344),-0.2982081415568921,-1.0641603489535991,0.3378640776699029,0.5356288667470136,1.0,14/36,30.34%,FGFR2;FLRT2;RAB14;FGFR1;FIBP;ZFP36L1;FLRT3;EGR3;HYAL2;PTPN11;HYAL1;FGF5;CHURC1;NR4A1
gsea,Neurogenesis (GO:0022008),0.2949047215510609,1.0633401759656074,0.3747412008281574,0.6419475024844644,1.0,7/38,10.37%,NTN5;EPHB1;MAPT;SPOCK1;TRAK2;FAT4;ERBB4
gsea,Positive Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050731),0.2593232131696144,1.0625336817612965,0.3568181818181818,0.6424648000650487,1.0,16/71,12.01%,SRCIN1;FGF10;TNK2;FLT3;IL31RA;LRP8;NTF3;SEMA4D;DGKQ;JAK2;PLCG2;EFNA1;RELN;ERBB4;DLG4;GAS6
gsea,Regulation Of Smoothened Signaling Pathway (GO:0008589),-0.2829528700877476,-1.062417619676519,0.3553875236294896,0.5384881188121027,1.0,5/40,9.14%,RACK1;FGFR2;TTC23;HHIP;PDCL
gsea,Regulation Of Postsynapse Organization (GO:0099175),0.3221220506879739,1.0621394593135451,0.37777777777777777,0.6419947137821574,1.0,5/24,6.22%,TANC2;SRCIN1;SHANK3;LZTS3;TANC1
gsea,Transcription Initiation-Coupled Chromatin Remodeling (GO:0045815),-0.3013228339710498,-1.0621271018404368,0.3634538152610442,0.5384474752427608,1.0,7/30,19.88%,WBP2;TRMT112;BRD7;MACROH2A1;ATF2;N6AMT1;SMARCB1
gsea,Regulation Of Interferon-Beta Production (GO:0032648),0.2965717202816075,1.0613043343061612,0.3582995951417004,0.6425813102140953,1.0,5/33,8.33%,PTPRS;RIOK3;TRAF3;RNF216;POLR3G
gsea,Fatty Acid Metabolic Process (GO:0006631),-0.256280834746562,-1.0605742328901042,0.34545454545454546,0.5410408676377859,1.0,19/75,22.78%,ACSL3;HSD17B8;GPX4;MSMO1;ACOT11;XBP1;ACLY;ANGPTL3;ACOX1;ACSBG1;ADIPOR2;NUDT19;NDUFAB1;PNPLA8;OXSM;GPAM;HSD17B10;FASN;GNPAT
gsea,Unsaturated Fatty Acid Metabolic Process (GO:0033559),-0.32271088223345656,-1.0604590174228221,0.3546511627906977,0.540615877904705,1.0,6/24,20.59%,GPX4;GSTP1;SCP2;DAGLB;PNPLA8;PTGR1
gsea,Mitochondrial RNA Metabolic Process (GO:0000959),-0.3461649221571048,-1.0599300708450667,0.37640449438202245,0.5410439052389276,1.0,9/19,34.31%,MRPL12;TFAM;TFB2M;TEFM;FASTK;FOXO3;MTERF4;FASTKD3;SLC25A33
gsea,Negative Regulation Of JNK Cascade (GO:0046329),-0.3250042925800485,-1.0586008000584834,0.3617886178861789,0.5431628018144417,1.0,5/27,7.41%,DNAJA1;DUSP3;GSTP1;GPS2;PINK1
gsea,Regulation Of Focal Adhesion Assembly (GO:0051893),0.27304373128711784,1.0581285710194042,0.37524557956778,0.6491529686735673,1.0,14/50,15.59%,MACF1;NRG1;LIMCH1;ROCK1;MAP4K4;CLASP1;BCAS3;PTK2;COL16A1;FYN;SLC9A1;EPHA3;CLASP2;PTPRA
gsea,Nucleic Acid Phosphodiester Bond Hydrolysis (GO:0090305),0.3563176403566889,1.0580881929127202,0.38427947598253276,0.6478061631917474,1.0,5/16,18.52%,DICER1;EDC4;SETMAR;MEI4;EXD2
gsea,Regulation Of Canonical Wnt Signaling Pathway (GO:0060828),0.22998014971923708,1.0580539887703444,0.3372093023255814,0.6463960223635737,1.0,30/163,11.37%,UBR5;HECW1;CHD8;PRKN;FGF10;RBMS3;APC;CDK14;CSNK1G1;CTNND2;USP34;ZNRF3;PRDM15;HDAC1;WNK2;WNK1;AXIN1;CCDC88C;NPHP3;GPC3;USP47;NPHP4;NOG;PTK7;USP8;TLE3;LMBR1L;ANKRD6;SMURF2;STK4
gsea,Aortic Valve Morphogenesis (GO:0003180),0.33469672419759383,1.05802078540125,0.3665254237288136,0.6450123371685241,1.0,8/21,21.73%,SLIT1;ROCK1;EFNA1;CDH11;ROBO1;ELN;HEY2;AXIN2
gsea,Regulation Of Golgi Organization (GO:1903358),0.3546654044825216,1.0578107509172208,0.38065843621399176,0.6440661463644609,1.0,2/15,2.98%,PDE4DIP;ARMH3
gsea,Cholesterol Transport (GO:0030301),-0.33147430045023873,-1.0573640833054692,0.3832684824902724,0.5450723113688518,1.0,5/24,14.01%,APOE;LCAT;CLU;LDLR;VPS4A
gsea,Regulation Of Embryonic Development (GO:0045995),0.26526348226417745,1.0571683733291426,0.36363636363636365,0.6442062311849273,1.0,9/53,9.11%,YEATS2;TRIP12;EHMT1;NIPBL;INO80;CLASP1;NFRKB;NPHP3;RPS6KA6
gsea,Negative Regulation Of RNA Splicing (GO:0033119),-0.3429312677772669,-1.057043362207283,0.3684210526315789,0.5451495719451678,1.0,4/19,9.55%,SAP18;RPS26;TMBIM6;RPS13
gsea,Monoubiquitinated Histone Deubiquitination (GO:0035521),-0.3229782056552903,-1.0566221118398407,0.3824091778202677,0.5447327931359714,1.0,7/25,21.34%,USP22;TAF10;ENY2;TADA2B;TADA3;TAF5;TAF7
gsea,Monoubiquitinated Histone H2A Deubiquitination (GO:0035522),-0.3229782056552903,-1.0566221118398407,0.3824091778202677,0.5447327931359714,1.0,7/25,21.34%,USP22;TAF10;ENY2;TADA2B;TADA3;TAF5;TAF7
gsea,G1/S Transition Of Mitotic Cell Cycle (GO:0000082),0.274137145653764,1.0560986917762956,0.34297520661157027,0.6454777811934737,1.0,22/48,29.76%,CDK14;CAMK2A;CCND2;GSPT1;USP29;TRIM71;CUL5;NPAT;PLK3;CUL4A;CUL2;BACH1;BRD4;CUL3;KHDRBS1;CUL4B;HINFP;TFDP1;CDC25A;BCAT1;USP37;E2F3
gsea,Blood Vessel Endothelial Cell Migration (GO:0043534),0.34602188556508223,1.0553772623105828,0.35368421052631577,0.6458887712925194,1.0,5/17,15.21%,GPLD1;PIK3R3;EFNB2;MYH9;ROBO1
gsea,Positive Regulation Of Production Of Molecular Mediator Of Immune Response (GO:0002702),-0.3777754687853051,-1.0553726559784151,0.36804308797127466,0.5465956956878587,1.0,7/15,31.07%,DNAJB9;XBP1;LAPTM5;VAMP3;PHB2;SPHK2;POLR2D
gsea,Very Long-Chain Fatty Acid Metabolic Process (GO:0000038),-0.3186094886519598,-1.0553451910099012,0.35860655737704916,0.5459792750161411,1.0,4/25,15.65%,TECR;HACD4;ACOX1;ACSBG1
gsea,Regulation Of Protein Polymerization (GO:0032271),-0.3116973485698407,-1.054509015869229,0.36381709741550694,0.5470817452733289,1.0,9/26,22.34%,PFN2;HSP90AA1;PFN1;RASA1;COTL1;PRUNE1;FCHSD1;ARL2;GBA2
gsea,Autophagy Of Nucleus (GO:0044804),0.35868688041147334,1.0542799490480628,0.3855932203389831,0.6472500244908246,1.0,7/17,22.16%,RB1CC1;ULK3;ATG2A;ATG2B;WDR45;ULK2;ULK1
gsea,Positive Regulation Of Nucleocytoplasmic Transport (GO:0046824),-0.2963129102187759,-1.0537095218558288,0.3772819472616633,0.5481560782634055,1.0,11/35,23.94%,RAN;YWHAE;RBM22;EMD;GSK3B;PIK3R1;SIRT6;DMAP1;HYAL2;NCBP2;MAVS
gsea,Nucleic Acid Metabolic Process (GO:0090304),0.3225475553763291,1.05345769308549,0.3796680497925311,0.6478225362959574,1.0,6/24,8.12%,RBFOX2;ATXN2;XRN2;TOPBP1;RECQL5;WRN
gsea,Regulation Of Glucose Import (GO:0046324),0.32064467713766504,1.053178462978933,0.37549407114624506,0.647083805209513,1.0,2/25,1.04%,SORBS1;PRKAG2
gsea,Positive Regulation Of DNA Metabolic Process (GO:0051054),-0.24054032839610356,-1.0529895386078645,0.3521400778210117,0.5489958164168636,1.0,20/92,20.43%,HMGB1;RPS3;EYA1;HNRNPAB;UBE2N;PCNA;PML;RUVBL1;TERF1;GINS2;RNF168;BABAM2;GINS4;SIRT6;YY1;H2AX;PDGFB;UIMC1;RAD50;ACTR8
gsea,Regulation Of Actin Filament Bundle Assembly (GO:0032231),-0.3255755046630876,-1.0528541782940142,0.3747534516765286,0.5486380703171612,1.0,5/21,10.86%,PFN2;RAC1;CDC42;PFN1;CX3CL1
gsea,Ventricular Septum Morphogenesis (GO:0060412),0.3186901018923918,1.0525945100642167,0.3682092555331992,0.647068420227456,1.0,8/24,19.06%,SLIT1;TGFBR1;NOG;TGFBR3;PROX1;ROBO1;ZFPM2;HEY2
gsea,Regulation Of Organelle Organization (GO:0033043),0.23907632893814035,1.0522208340809236,0.34475806451612906,0.6466116645967942,1.0,13/90,6.95%,PDE2A;PRKN;PDE4DIP;TAOK1;MARK2;ARMH3;MAPT;TJP1;INO80;RAP1GDS1;PTK2;NFRKB;SFI1
gsea,Stress Granule Assembly (GO:0034063),-0.324267524322469,-1.0520582641002196,0.3667334669338677,0.5496714148578656,1.0,5/22,15.00%,RPS23;G3BP2;CIRBP;FMR1;G3BP1
gsea,Gland Development (GO:0048732),0.2943369353366472,1.0519944317596244,0.35833333333333334,0.6457664049780486,1.0,7/34,9.56%,FGF10;NRG1;TGFBR1;NF1;PKD2;TGFBR3;MSN
gsea,Regulation Of Wnt Signaling Pathway (GO:0030111),-0.2558183562726628,-1.0514906602525749,0.37547892720306514,0.5502145310297133,1.0,10/72,10.66%,ATP6V0C;RACK1;FGFR2;PPP1CA;PPP2CA;PPP2R1A;ATP6AP2;SNX3;EMD;OTULIN
gsea,Golgi Organization (GO:0007030),0.23797301430531828,1.0514899116348353,0.3588709677419355,0.6455743279604448,1.0,19/100,11.60%,DYNC2H1;DYM;HACE1;SYNE1;VPS13B;TRIP11;CLASP1;TRAPPC8;BCAS3;GBF1;NPLOC4;SEC16A;TANGO2;COG4;FBXW8;COG3;ARHGEF7;VTI1A;HTT
gsea,Regulation Of Autophagy Of Mitochondrion (GO:1903146),-0.33878334284941514,-1.051132991076325,0.3840155945419103,0.5503170432617849,1.0,9/18,30.52%,PARK7;VDAC1;PINK1;FBXW7;HTRA2;USP36;HAX1;SREBF2;CAMKK2
gsea,MAPK Cascade (GO:0000165),-0.2545193846413156,-1.0509464239301451,0.3726235741444867,0.5500494355553611,1.0,14/76,13.10%,MT3;YWHAE;MEF2C;DUSP7;FGF13;IL18;KRAS;RBX1;ITGAV;FGFR1;HRAS;SOX9;MAPK3;ZFP36L1
gsea,Regulation Of cAMP-mediated Signaling (GO:0043949),0.3621455496314139,1.050782348374655,0.3974358974358974,0.6458074116199785,1.0,2/15,3.98%,PDE2A;PEX5L
gsea,Adenylate Cyclase-Inhibiting G Protein-Coupled Receptor Signaling Pathway (GO:0007193),0.30283511973438765,1.0505587128518066,0.3626609442060086,0.6449500228807075,1.0,6/30,6.09%,PDE2A;GABBR2;CHRM3;GRM8;FLNA;GRM7
gsea,"Positive Regulation Of mRNA Splicing, Via Spliceosome (GO:0048026)",0.3380241203976641,1.0496058189193143,0.3722772277227723,0.6457649823054323,1.0,7/18,12.22%,CELF4;TRA2A;NCBP1;DAZAP1;NUP98;WDR77;TRA2B
gsea,Regulation Of Actin Filament-Based Process (GO:0032970),-0.2671984489609568,-1.0495030118113169,0.36363636363636365,0.5524261144005349,1.0,11/57,16.45%,EPHA5;DYNLL1;RAC1;CDC42;PDGFA;HRAS;RALA;HIP1R;EZR;ARHGEF19;HCK
gsea,Regulation Of Stress-Activated MAPK Cascade (GO:0032872),-0.28247924952420755,-1.0490980023399676,0.3856589147286822,0.552614029659017,1.0,4/40,4.97%,PPIA;RASGRP1;ARL6IP5;GSTP1
gsea,Negative Regulation Of Cell Cycle Process (GO:0010948),-0.34654897078209834,-1.049072005448575,0.39444444444444443,0.552009723172509,1.0,6/20,16.46%,AURKAIP1;CHMP2A;TERF1;FOXO4;VPS4A;CHMP4C
gsea,Glial Cell Differentiation (GO:0010001),0.33607823345320664,1.0490670683120213,0.3784355179704017,0.6456592502560585,1.0,9/27,18.39%,FGF10;PTPRZ1;NFIB;RELN;SOX8;PICK1;VCAN;SLC8A3;MMP24
gsea,Positive Regulation Of Cyclin-Dependent Protein Kinase Activity (GO:1904031),-0.34334271888139567,-1.0487807641980114,0.3824626865671642,0.5520185228077061,1.0,1/18,0.06%,HSP90AB1
gsea,Epigenetic Regulation Of Gene Expression (GO:0040029),-0.2593671619107956,-1.0487395180465369,0.38493723849372385,0.5514415139539967,1.0,15/65,20.93%,WBP2;CGGBP1;TRMT112;PPM1D;BRD7;KDM1B;MACROH2A1;RNF168;ATF2;SIRT6;N6AMT1;PRMT7;TDG;SMARCB1;CTCF
gsea,Chondroitin Sulfate Proteoglycan Biosynthetic Process (GO:0050650),0.3486022600941732,1.0481543221483651,0.39183673469387753,0.6465500432612273,1.0,8/17,29.22%,CHST11;XYLT1;CHST9;XYLT2;UGDH;CHPF;PXYLP1;CSGALNACT1
gsea,Positive Regulation Of Phagocytosis (GO:0050766),-0.3286503627179833,-1.0479128278489198,0.39065420560747666,0.552549938880404,1.0,5/27,10.57%,CALR;APLP2;CD47;LMAN2;RAB31
gsea,Regulation Of Protein Localization To Plasma Membrane (GO:1903076),-0.2583683986948845,-1.0477518471117169,0.3667953667953668,0.552247037968516,1.0,11/61,15.81%,ACTB;TMEM59;STX7;AP2M1;SQSTM1;LRPAP1;VTI1B;CLIP3;PIK3R1;VPS4A;SIRT6
gsea,Golgi To Plasma Membrane Protein Transport (GO:0043001),0.3068481462780772,1.047528913136004,0.4036885245901639,0.646701188615512,1.0,6/26,14.97%,ANK3;MACF1;BBS1;GGA3;SPTBN1;PREPL
gsea,Regulation Of Cytoskeleton Organization (GO:0051493),0.24789752423864517,1.04712311230729,0.34475806451612906,0.6462699584806175,1.0,19/95,10.86%,PAK3;TAOK1;IQGAP2;MARK2;NRG1;ROCK1;MAPT;TJP1;CCDC88A;CLASP1;SH3BP1;PTK2;PLXNA3;PATJ;RICTOR;MPDZ;BICD1;ARHGAP18;MTOR
gsea,Heterochromatin Formation (GO:0031507),0.3088940393866375,1.0470709920488073,0.3878787878787879,0.6449961500612637,1.0,7/26,13.49%,UBR5;TRIP12;BAZ2A;SCMH1;SIRT2;FAM172A;UBR2
gsea,Positive Regulation Of Growth (GO:0045927),0.2573360344287994,1.0469239038870533,0.34439834024896265,0.6439267475137471,1.0,12/54,13.77%,AKAP6;RPTOR;TGFBR1;INO80;RFTN1;LGI1;NCBP1;USP47;RICTOR;MTOR;RPS6KA1;KLHL22
gsea,Cilium Assembly (GO:0060271),0.20975594719255597,1.0467880897476738,0.35129310344827586,0.642858492851107,1.0,70/201,24.88%,DYNC2H1;ABLIM3;CPLANE1;CCDC57;CFAP47;OCRL;IFT140;DISC1;RAB3IP;IFT88;IQCB1;FLNA;GBF1;DNAH5;RILPL1;TMEM67;TTC21B;CFAP74;BBS9;NPHP3;INTU;BBS1;CC2D2B;DYNLT2B;CC2D2A;FBXW8;PTPN23;ARL3;FBF1;C2CD3;IQUB;BBOF1;UBXN10;CIBAR1;TCTN2;ARMC9;RPGR;CENPJ;CLUAP1;RAB23;DNMBP;PLA2G3;CEP162;SNX10;TTC39C;WDPCP;PARVA;OFD1;CDC14B;CEP164;HDAC6;KIF27;RSPH1;FNBP1L;GALNT11;CEP89;CDC14A;RPGRIP1L;CCDC40;IFT172;RSPH9;CEP131;SCLT1;CCDC39;IFT81;PHIP;BBS5;CFAP54;TCTN3;TTC8
gsea,Positive Regulation Of Microtubule Polymerization (GO:0031116),-0.31686353776349274,-1.0467134768304305,0.3943089430894309,0.5538269572873972,1.0,4/25,7.28%,RAC1;RPS3;NAV3;CDK5R1
gsea,Histone Acetylation (GO:0016573),-0.261558419182471,-1.046378147692494,0.3816793893129771,0.5538627883635584,1.0,15/56,21.34%,MORF4L1;MORF4L2;USP22;TAF10;RUVBL1;MRGBP;ENY2;TADA2B;NAA60;ACTL6B;TADA3;TAF5;MBIP;DMAP1;TAF7
gsea,Regulation Of TOR Signaling (GO:0032006),-0.25788125333907175,-1.0455022687136073,0.3754646840148699,0.5551104818813862,1.0,22/63,32.04%,LAMTOR2;PDCD6;RRAGA;LAMTOR3;RRAGD;FBXO9;ITFG2;TMEM127;SEH1L;SEC13;TBC1D7;MAPKAPK5;TTI1;ENDOG;DDIT4;LAMTOR1;RRAGC;LAMTOR5;EPM2A;FLCN;MLST8;PIH1D1
gsea,Organelle Transport Along Microtubule (GO:0072384),-0.2906740240388767,-1.0454098575221231,0.3752535496957404,0.5546755054220583,1.0,4/37,5.98%,UBB;CDC42;PAFAH1B1;RAB6A
gsea,Protein K48-linked Deubiquitination (GO:0071108),0.32257785335508066,1.0451473592256793,0.40853658536585363,0.6454391246317115,1.0,5/22,9.64%,OTUD7A;OTUD3;USP34;USP8;USP29
gsea,Positive Regulation Of Phosphatidylinositol 3-Kinase Signaling (GO:0014068),0.2755870328084222,1.044632785354304,0.3866396761133603,0.6453584504463511,1.0,9/45,8.82%,NTRK3;FLT3;CBL;NTRK2;SEMA4D;PTK2;JAK2;IGF1R;ROR1
gsea,Positive Regulation Of Lymphocyte Activation (GO:0051251),0.33886675746663664,1.0438032937808122,0.39603960396039606,0.6459768617864742,1.0,4/18,9.35%,FGF10;PRKDC;LCK;GNAO1
gsea,Negative Regulation Of miRNA Transcription (GO:1902894),0.35900686204835885,1.0431467780122352,0.38396624472573837,0.6461266423738927,1.0,5/15,15.97%,NFIB;PPARD;PPARG;POU5F1;PPARA
gsea,Alpha-Amino Acid Metabolic Process (GO:1901605),0.3281509168114127,1.0429005896734465,0.4017278617710583,0.645307936703414,1.0,6/22,13.04%,RIMKLA;RIMKLB;IYD;CBS;MTHFD1;SLC25A12
gsea,Positive Regulation Of Lipid Metabolic Process (GO:0045834),0.35202613814147543,1.0422871952618724,0.40524193548387094,0.6454172633945148,1.0,4/15,5.95%,SORBS1;FLNB;RPTOR;DISP3
gsea,Positive Regulation Of NF-kappaB Transcription Factor Activity (GO:0051092),-0.24395717024130592,-1.0421588356062543,0.36608863198458574,0.5608652813842923,1.0,12/90,12.39%,PPIA;RPS3;MTPN;IL18;USP14;PRKD1;UBE2N;CLU;NPM1;UBE2V1;CX3CL1;MTDH
gsea,Positive Regulation Of Nucleic Acid-Templated Transcription (GO:1903508),-0.20400000145110472,-1.0419527345807555,0.33575317604355714,0.5606531041412539,1.0,75/396,19.48%,MT3;APOE;YWHAH;JUN;MORF4L1;MLLT11;NME2;CNBP;NR2F2;WBP2;MORF4L2;MEF2C;PPP3CB;EGR1;RNF187;TBL1XR1;PSMC5;NAT14;HNRNPAB;CITED2;SFR1;RNF6;USP22;FZD2;NIF3L1;CHD3;MED4;TAF10;NPM1;RBBP7;INHBA;RORB;HMGN5;SOX9;PHF20;UBE2V1;RUVBL1;ATF7IP;CEBPB;BAMBI;MRGBP;FZD4;EPO;MRPL12;RNF10;PCBD2;ENY2;TBL1X;ILK;NFIL3;TADA2B;ID2;SNX5;POU3F1;TRIM44;TFAM;SMAD2;KAT6A;POU3F3;PHF5A;BCL10;HCFC1;CREB3L2;YY1;SOX4;ELF1;ARNT2;FOXK1;CXXC1;PDGFB;MED22;TADA3;CREB1;TAF5;CAPN3
gsea,"Phagocytosis, Engulfment (GO:0006911)",-0.3702877678633979,-1.0413870936601903,0.3939393939393939,0.5612382298633937,1.0,2/16,2.76%,RAC1;CDC42
gsea,Lung Development (GO:0030324),0.316895930501923,1.0412471971517026,0.41019955654101997,0.6465635777976532,1.0,4/23,8.45%,PKD1;FGF10;ITGA3;NPHP3
gsea,Cytoskeleton-Dependent Intracellular Transport (GO:0030705),0.34058989810779,1.0412264958651603,0.41106719367588934,0.6452409563031307,1.0,9/19,15.60%,HOOK1;CCDC88A;KIF1B;DYNC1I1;CCDC88C;KIF1C;HOOK2;DYNC1I2;HOOK3
gsea,Regulation Of Transcription Regulatory Region DNA Binding (GO:2000677),-0.35886553593831305,-1.040844642532926,0.4,0.5617280309101976,1.0,5/15,24.01%,PARK7;RNF220;HEY1;MAD2L2;SIN3A
gsea,Regulation Of Rho Protein Signal Transduction (GO:0035023),-0.26883394269399263,-1.040802141023148,0.416044776119403,0.5611664202214379,1.0,8/55,11.45%,DYNLL1;APOE;RAC1;ARHGDIA;KCTD13;STMN1;RTN4R;EPS8L1
gsea,Organic Substance Transport (GO:0071702),0.23265944146665596,1.0407880061801098,0.37719298245614036,0.6448818688279528,1.0,25/119,13.36%,RYR2;PKD1;NRG1;CHRNA4;RYR3;TRPC5;CAMK2A;LRP2;SPNS2;ABCA5;TRPM7;CHKA;CACNG3;TRPC3;ABCA3;SLC22A4;PKD2;CHRNA7;SLC29A4;NDC1;FYN;TRPC1;MYH9;TOM1;ABCA4
gsea,Positive Regulation Of Cell-Cell Adhesion (GO:0022409),0.3169110136534068,1.0406564619468626,0.4020618556701031,0.6438154802092974,1.0,5/22,10.28%,ANK3;TJP1;LCK;GCNT2;PTPN23
gsea,Regulation Of Double-Strand Break Repair (GO:2000779),-0.24319024033261522,-1.0400652715391054,0.3862332695984704,0.562140398050424,1.0,20/77,21.19%,MORF4L1;MORF4L2;DEK;BCL7B;ACTR2;UBE2N;BRD7;PML;OTUB1;PPP4C;RUVBL1;MRGBP;SPIRE1;SMARCE1;SIRT6;BCL7C;ACTL6B;SMARCB1;DMAP1;DPF2
gsea,Regulation Of Cell-Matrix Adhesion (GO:0001952),0.26611997848349417,1.0399612653329033,0.3779527559055118,0.6441359432289103,1.0,15/50,16.82%,MACF1;LIMCH1;ROCK1;NF1;MAP4K4;CLASP1;CASK;PTK2;NEXMIF;FYN;SLC9A1;CDH13;EPHA3;PTPRA;CCL25
gsea,"Nuclear-Transcribed mRNA Catabolic Process, Nonsense-Mediated Decay (GO:0000184)",0.30022861975245413,1.0394613762326959,0.3831041257367387,0.6439613111048922,1.0,6/27,8.27%,SMG1;SKIC2;SKIC3;GSPT1;NCBP1;UPF3B
gsea,Regulation Of Glycolytic Process (GO:0006110),0.2817588237996461,1.0370374276067467,0.4020408163265306,0.6483809010437858,1.0,10/34,15.97%,PRKAG2;GCK;RPTOR;CBFA2T3;MTOR;ARNT;HDAC4;SLC2A6;PRXL2C;PPARA
gsea,Regulation Of JUN Kinase Activity (GO:0043506),-0.2999448892630351,-1.0369741740662792,0.4161849710982659,0.5678362631113406,1.0,3/31,4.97%,RPS3;DNAJA1;GSTP1
gsea,Regulation Of Neurotransmitter Secretion (GO:0046928),0.29830985053293624,1.0369465245727512,0.3798767967145791,0.647284020703658,1.0,11/29,15.09%,MCTP1;CAMK2A;CASK;RIMS1;MYOF;KCNMB4;SNCAIP;RIMS2;OTOF;PREPL;PNKD
gsea,Signal Transduction In Response To DNA Damage (GO:0042770),0.26346390698049327,1.0367370867653805,0.4029535864978903,0.6464159827795432,1.0,9/46,12.42%,MAPK14;ATRX;PAXIP1;DONSON;CHEK2;HUS1;MAPK12;ERCC4;CHEK1
gsea,Blood Circulation (GO:0008015),0.31245942129285653,1.0365160559747313,0.3665943600867679,0.6455700844545907,1.0,6/25,9.46%,ROCK1;SGCZ;MYOF;SGCD;TRDN;ADCY6
gsea,Amyloid Fibril Formation (GO:1990000),-0.34705988544664634,-1.036488804116096,0.41260162601626016,0.5681937119893208,1.0,3/16,7.14%,FKBP1A;HNRNPA1;SNCA
gsea,mRNA 3'-End Processing (GO:0031124),0.27619153167300964,1.03622100417156,0.39832285115303984,0.6449862841095335,1.0,13/38,18.77%,NCBP1;CPSF7;SCAF8;RPRD2;PAPOLA;SYMPK;TUT1;CSTF2;TENT4B;RPRD1A;TENT2;NUDT21;CSTF3
gsea,Chromosome Organization (GO:0051276),-0.3235337406513431,-1.0362196694485728,0.38095238095238093,0.5681162398286556,1.0,9/23,32.49%,H4C9;CENPW;KAT6A;CENPV;LIG4;NAA10;LDB1;XPA;MSH6
gsea,Membrane Organization (GO:0061024),-0.22226288292194638,-1.035771995010143,0.36345776031434185,0.5683943242209861,1.0,29/140,17.53%,VAMP2;HSPA8;REEP5;AP2M1;WASL;SYP;VAPA;SH3GLB1;MTCH1;VPS28;NAPG;VTI1B;SNX3;EMD;CHMP2A;TSG101;CHMP6;SAR1A;TOR1AIP2;STAM2;TIMM50;VPS4A;CTDNEP1;UBAP1;SNAP29;VAMP3;CHMP4C;TMEM33;CHMP7
gsea,Mitotic Metaphase Plate Congression (GO:0007080),-0.2857099716728121,-1.0352430637085344,0.4085820895522388,0.568818409930225,1.0,13/38,27.50%,RAB11A;BOD1;CHMP2A;CHMP6;VPS4A;SEH1L;NUDC;CHMP4C;CHMP7;CHAMP1;NUP62;KIF18A;CHMP3
gsea,Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:0008625),-0.3515383069375733,-1.0340277457866753,0.4093567251461988,0.5707404978129672,1.0,6/18,25.77%,BAX;GABARAP;DELE1;DIABLO;DAXX;CASP8AP2
gsea,Adenylate Cyclase-Modulating G Protein-Coupled Receptor Signaling Pathway (GO:0007188),0.24132309441820873,1.0334548536309947,0.39574468085106385,0.6501736709504817,1.0,23/75,17.76%,PDE2A;GABBR2;ADCY8;ADCY2;GRM8;ADGRB1;ADCY9;GNA12;ADCYAP1R1;ADGRB2;GPR161;GNAO1;ADCY6;ADGRF4;GRK5;RIMS2;CHRM2;ADCY5;ADGRF2;CRHR1;PTH1R;CNR1;TCP11
gsea,Regulation Of Dopamine Secretion (GO:0014059),-0.34767807258877176,-1.033390918092878,0.4196078431372549,0.5713564220370181,1.0,6/16,20.52%,SYT5;KCNA2;SNCA;SYT11;SYT6;CHRNB2
gsea,Regulation Of Phosphatidylinositol 3-Kinase Signaling (GO:0014066),0.25778764631713424,1.0332641985723003,0.3879668049792531,0.6492834357820325,1.0,11/61,8.82%,NTRK3;FLT3;CBL;PIP5K1B;NTRK2;SEMA4D;PTK2;JAK2;PPP1R16B;IGF1R;ROR1
gsea,Positive Regulation Of Neuron Projection Development (GO:0010976),0.2450646541569052,1.03300900339067,0.37449392712550605,0.6485570753436174,1.0,18/76,15.08%,NLGN1;LRRC7;MARK2;NTRK3;PACSIN1;CUX2;LRP8;NTRK2;SETX;P3H1;ROR1;PTK7;RELN;DPYSL3;ALK;EPHA3;DAB2IP;CAPRIN1
gsea,Negative Regulation Of Protein Secretion (GO:0050709),0.31849348828638346,1.0328388271444913,0.41020408163265304,0.6476072696167878,1.0,6/22,13.08%,PRKN;SERGEF;RHBDF1;RAB11FIP3;CCN3;RAB11FIP5
gsea,Apoptotic Process (GO:0006915),-0.2245491768864304,-1.032663793303552,0.36380255941499084,0.5723000752199485,1.0,31/150,23.01%,GAPDH;PPIA;DYNLL1;NSG1;VDAC1;BAX;PPP2CA;PPP2R1A;MAGEH1;BOK;BAD;RTN4;PARP1;RHOB;HSPD1;FAM162A;TNFSF12;CAPN3;NFKBIA;PDCD2L;IRF3;KREMEN1;DPF2;CIDEB;EMP2;BBC3;RFK;CFLAR;DDIT4;DIABLO;ERCC3
gsea,Cellular Response To Nutrient Levels (GO:0031669),0.24869208572274215,1.032099006468763,0.3939393939393939,0.6480222843568249,1.0,17/64,16.47%,PRKAG2;RPTOR;OTUD3;ELAPOR1;WRN;VPS41;RICTOR;EHMT2;PPARD;MTOR;STK26;RRAGB;RIPOR1;JMY;ZFYVE1;PPARA;WDR45
gsea,Regulation Of Mitochondrial Translation (GO:0070129),-0.3236282488508386,-1.0319667802718904,0.387037037037037,0.5730491996289875,1.0,3/22,9.74%,UQCC2;COA3;C1QBP
gsea,Nuclear Export (GO:0051168),0.27952522571046867,1.0318410496325296,0.41082164328657317,0.6473245741608303,1.0,17/40,22.04%,PKD1;RANBP2;ATXN1;XPO6;NUP188;XPO5;DDX39A;NUP98;STRADA;MALT1;XPO4;POM121;STRADB;WASHC4;RANBP17;NUP155;CSE1L
gsea,Regulation Of Cytoplasmic Translation (GO:2000765),-0.3370536933311563,-1.0311881883687972,0.4027237354085603,0.5740922879105176,1.0,5/20,16.43%,PKM;YBX1;PABPC1;FMR1;PARP16
gsea,Positive Regulation Of Cilium Assembly (GO:0045724),0.32858409563236357,1.0307143447475686,0.4211618257261411,0.6486502669557801,1.0,4/20,6.45%,CROCC;CCDC88A;IFT88;ENTR1
gsea,Vascular Transport (GO:0010232),0.26458253203511317,1.0306502611888768,0.3911290322580645,0.6474669639490811,1.0,13/62,13.44%,ATP2B4;SLCO3A1;ABCC5;SLC6A1;LRP2;ATP8A1;SLC24A3;SLC1A1;SLC5A3;SLC29A4;SLC7A8;SLC16A2;SLC5A6
gsea,Negative Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010972),-0.3304854370259757,-1.030301186687607,0.444,0.5754038261759993,1.0,7/20,22.93%,INIP;BABAM2;VPS4A;CHMP4C;UIMC1;RAD50;RBBP8
gsea,Regulation Of Cell Junction Assembly (GO:1901888),0.3490702061007494,1.0294169787807725,0.41566265060240964,0.6489912881499952,1.0,3/16,3.94%,ROCK1;TJP1;SETD5
gsea,Late Endosome To Lysosome Transport (GO:1902774),-0.3607412064992406,-1.0291425619327492,0.4108527131782946,0.5771704989209029,1.0,5/15,17.53%,CHMP2A;CHMP6;VPS4A;CHMP4C;CHMP7
gsea,Protein Complex Oligomerization (GO:0051259),-0.24130548990593098,-1.0290132833292596,0.4049904030710173,0.5767441266099228,1.0,15/76,16.63%,POLQ;NINJ1;SNCA;BOK;G3BP2;CUTC;EHD3;CHMP2A;AQP11;ALAD;FKRP;OXA1L;BCL10;TMEM70;KCNC3
gsea,Synaptic Vesicle Transport Along Microtubule (GO:0099517),-0.3612149902734548,-1.027401739145304,0.4107485604606526,0.578826147825413,1.0,6/15,24.70%,BLOC1S4;BLOC1S5;AP3S2;AP3M1;AP3M2;BLOC1S3
gsea,Anterograde Synaptic Vesicle Transport (GO:0048490),-0.3612149902734548,-1.027401739145304,0.4107485604606526,0.578826147825413,1.0,6/15,24.70%,BLOC1S4;BLOC1S5;AP3S2;AP3M1;AP3M2;BLOC1S3
gsea,Negative Regulation Of ERK1 And ERK2 Cascade (GO:0070373),-0.2873044361170629,-1.027214252256073,0.39139344262295084,0.5785617373582729,1.0,18/38,33.85%,DUSP3;SPRY2;TIMP3;GSTP1;PIN1;LYN;EZR;EPHA4;PTPN1;LMO3;PTEN;DUSP6;FLCN;DLG1;SIRPA;CNKSR3;SPRED1;SMAD4
gsea,Negative Regulation Of Axon Extension (GO:0030517),0.3146275142856617,1.0269495830268394,0.4198019801980198,0.6535980585972626,1.0,6/26,8.80%,PTPRS;SEMA5B;TRIM46;MAP2;SEMA4D;DIP2B
gsea,Regulation Of Cellular Response To Growth Factor Stimulus (GO:0090287),0.34416592581736616,1.026609327082115,0.41280353200883,0.6531094588606037,1.0,3/15,12.27%,DOK5;ITGA3;PCSK6
gsea,Regulation Of Cardiac Muscle Hypertrophy (GO:0010611),-0.33966210385562645,-1.026321861164903,0.4024640657084189,0.5798416018440382,1.0,4/17,10.36%,RGS2;MTPN;MLIP;PARP1
gsea,DNA Damage Response (GO:0006974),0.19838710932144868,1.0261684265536666,0.3401360544217687,0.6528767340248289,1.0,46/321,11.64%,UBE2E2;UBR5;SMG1;TAOK1;MACROD2;TRIP12;HERC2;PRKDC;APC;RPTOR;CHRNA4;MAPK14;ATRX;NIPBL;MAPT;INO80;STXBP4;BCL6;RNF169;SHPRH;NCOA6;NFAT5;BRSK1;SPINDOC;SETX;TOPBP1;RECQL5;NABP1;PSME4;MAPKAPK2;TDP1;WDHD1;WRN;USP47;BAZ1B;ZBTB4;FMN2;MSH3;MTOR;CHEK2;HUS1;USP3;MAPK12;ERCC4;TAF1;KMT5B
gsea,Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045),0.2350011403046335,1.0257082438214211,0.40332640332640335,0.6526645708625584,1.0,13/86,8.66%,UBE2E2;PKD1;FGF10;APC;RPTOR;ANKRD17;INO80;SMARCA4;ARID2;CCND2;PKD2;DPF3;SMARCA2
gsea,Protein Targeting To Peroxisome (GO:0006625),-0.3400166653069513,-1.025690879748475,0.41404805914972276,0.5805433665234647,1.0,4/16,26.88%,PEX12;ZFAND6;PEX19;PEX5
gsea,Mitotic Cytokinetic Process (GO:1902410),-0.35182642941818054,-1.0252891750315838,0.43159922928709055,0.5807809462973481,1.0,6/16,21.21%,CHMP2A;CHMP6;VPS4A;CHMP4C;CHMP7;RHOA
gsea,Negative Regulation Of Cell Differentiation (GO:0045596),-0.2254138647528735,-1.0244130064469223,0.3836363636363636,0.5819596126136781,1.0,33/143,20.09%,ACTB;CALR;SPRY2;BCL7B;PPP2CA;ANP32B;TRIB2;RIOX1;CHADL;GPS2;ITGAV;RORB;SOX9;WWTR1;BAMBI;EID2B;ID2;JAG1;RANBP3L;SMAD7;HOPX;HEY1;SS18;EPHA4;LIMD1;SKIC8;SOX4;BCL7C;EFEMP1;ACTL6B;ASCL1;NFKBIA;CDC73
gsea,Amino Acid Catabolic Process (GO:0009063),-0.29849443657599384,-1.0243560695136977,0.4335378323108384,0.5814374822531272,1.0,14/28,39.64%,ALDH6A1;GOT2;CARNMT1;DBT;BLMH;IVD;KMO;ALDH5A1;MTRR;SLC25A44;IL4I1;HNMT;ETFB;BCKDHA
gsea,Regulation Of Epidermal Growth Factor-Activated Receptor Activity (GO:0007176),0.33817832199469866,1.023216983205177,0.4405458089668616,0.6574206401562392,1.0,5/17,16.63%,ZFYVE28;CBL;NCK2;SNX6;EGF
gsea,Regulation Of Viral Genome Replication (GO:0045069),-0.2909247724534171,-1.0224639617143043,0.4076923076923077,0.5848707198197295,1.0,2/31,2.81%,PPIA;BANF1
gsea,Positive Regulation Of Transcription Initiation By RNA Polymerase II (GO:0060261),-0.2658568365451539,-1.0223877271237811,0.40925925925925927,0.5843478129703901,1.0,17/48,29.56%,MED10;MED4;TAF10;PSMC6;MED19;TAF11;MED31;MED9;MED21;MED22;TAF5;MED7;TAF7;ZNHIT1;TAF12;MED11;MED30
gsea,Determination Of Heart Left/Right Asymmetry (GO:0061371),0.321644822377257,1.0223343115292054,0.4384133611691023,0.6583218425129324,1.0,11/21,28.01%,MICAL2;PKD2;NPHP3;SMO;MEGF8;CCDC40;SETDB2;CCDC39;BBS5;NOTCH1;DVL2
gsea,Regulation Of Lipid Metabolic Process (GO:0019216),0.2786515510089206,1.0219736570546418,0.41244239631336405,0.6578692533687857,1.0,12/36,17.45%,PRKAG2;RORA;DISP3;PLCG2;NCOA2;CCDC3;PPARD;ADIPOR1;RUBCNL;PPARG;PPARA;OPA3
gsea,Cell-Cell Signaling By Wnt (GO:0198738),0.3257696643936373,1.0219409044841663,0.4280155642023346,0.6566126265859142,1.0,4/21,7.94%,PKD1;USP34;PLCG2;PKD2
gsea,Histone H3-K4 Methylation (GO:0051568),0.3103294122247348,1.0216521554253222,0.41386554621848737,0.655982442160637,1.0,7/22,12.33%,KMT2A;NCOA6;KMT2C;HCFC2;KMT2B;PAXIP1;DPY30
gsea,Aortic Valve Development (GO:0003176),0.3201566798423907,1.0216222313703505,0.41379310344827586,0.6547411106174003,1.0,8/21,21.73%,SLIT1;ROCK1;EFNA1;ROBO1;ELN;HEY2;RBPJ;AXIN2
gsea,Cell Migration Involved In Sprouting Angiogenesis (GO:0002042),0.3455850533570969,1.0214479240366376,0.40408163265306124,0.6538625530148385,1.0,4/15,15.21%,GPLD1;PIK3R3;EFNB2;ROBO1
gsea,Cellular Nitrogen Compound Biosynthetic Process (GO:0044271),-0.33601946590822274,-1.0211491498115184,0.44696969696969696,0.5862237955174969,1.0,7/18,26.68%,SPTSSA;GCH1;ARG2;CYB5R3;CYB5B;AKT1;SPHK2
gsea,Arachidonic Acid Metabolic Process (GO:0019369),-0.33102264474690807,-1.0204272118608086,0.416988416988417,0.5871378015451152,1.0,6/21,18.33%,GPX4;PTGDS;PTGES3;CBR1;DAGLB;PNPLA8
gsea,Positive Regulation Of Peptide Hormone Secretion (GO:0090277),0.3096269083692134,1.0204256270290535,0.40828402366863903,0.6549595089205115,1.0,4/24,4.76%,FLNB;GCK;MYRIP;MCU
gsea,Negative Regulation Of Smooth Muscle Cell Proliferation (GO:0048662),-0.32312641732481007,-1.0203840090101437,0.40619307832422585,0.5865552342940532,1.0,7/22,15.91%,APOE;MEF2C;TPM1;OGN;CDKN1B;IGFBP5;BMPR2
gsea,GPI Anchor Biosynthetic Process (GO:0006506),-0.30756897058370847,-1.0195944654014013,0.4037735849056604,0.587555006084481,1.0,9/27,27.36%,PIGK;DPM3;DPM2;PIGH;PGAP4;DPM1;PIGM;PIGP;MPPE1
gsea,Negative Regulation Of Developmental Growth (GO:0048640),-0.3161338220644963,-1.0195110941108165,0.4142581888246628,0.5870640591501297,1.0,5/22,10.13%,MT3;FGF13;RNF6;RTN4;RTN4R
gsea,Cellular Response To Growth Factor Stimulus (GO:0071363),-0.22971406532108524,-1.019281134000831,0.4015151515151515,0.5868702425239195,1.0,34/116,27.78%,EEF1A1;RACK1;APLP2;DUSP3;SPRY2;MEF2C;PLK5;RAMP2;PRKD1;EMD;SOX9;RAP1A;ZFP36L1;SMAD7;EGR3;BMPR2;PDGFB;EHD1;BMP6;BMPR1B;HYAL2;SMAD9;HTRA2;RAB35;PTPN11;AKT1;RELA;HYAL1;MARS1;VSTM2A;BMPR1A;RPS6KB1;HAS1;CPNE3
gsea,Protein Autoubiquitination (GO:0051865),-0.2571826222474437,-1.0191247226236104,0.4279918864097363,0.5865343451859703,1.0,10/56,15.72%,UBE3A;RNF220;RNF187;RNF11;STUB1;BABAM2;RNF10;DDB2;RNF208;RNF185
gsea,Protein Localization To Golgi Apparatus (GO:0034067),0.31177851778943755,1.0190997424749655,0.4291417165668663,0.6568788007060706,1.0,4/25,5.26%,VPS13A;VPS13C;VPS13D;GBF1
gsea,Regulation Of Response To External Stimulus (GO:0032101),-0.24828392301792962,-1.0188684650705462,0.43243243243243246,0.5864054214963309,1.0,16/69,22.03%,TMSB4X;PARK7;APLP2;P2RY12;USP14;ELMOD2;SPATA2;CX3CL1;SEMA7A;HCK;NMT1;DAGLB;SAMHD1;SHPK;TKFC;LETMD1
gsea,Positive Regulation Of DNA-templated Transcription Initiation (GO:2000144),-0.2616817920877959,-1.017998883967081,0.39473684210526316,0.5875286524558577,1.0,13/51,21.34%,JUN;MED10;MED4;TAF10;MED19;TAF11;MED31;MED9;MED21;MED22;TAF5;MED7;TAF7
gsea,Phosphatidylglycerol Metabolic Process (GO:0046471),0.3533134626503187,1.017789273654357,0.42147117296222664,0.6586414530301007,1.0,6/16,20.35%,SERAC1;MBOAT2;TAFAZZIN;PGS1;PLA2G3;PLA2G4A
gsea,Positive Regulation Of Mitotic Nuclear Division (GO:0045840),0.33404331399127607,1.017542536913382,0.43487394957983194,0.6578756489245792,1.0,11/17,31.06%,ANAPC5;NSMCE2;EGF;NUSAP1;PHIP;ANAPC7;LRP5;CUL3;INSR;RB1;RGCC
gsea,Regulation Of Catabolic Process (GO:0009894),-0.32309945173988075,-1.017461966788919,0.44646464646464645,0.5879205909054235,1.0,5/20,20.85%,UBE3A;ODC1;CHMP6;SIRT6;NUB1
gsea,RNA Export From Nucleus (GO:0006405),-0.25139603643370956,-1.0169706424766167,0.425531914893617,0.5882917611096584,1.0,15/57,21.65%,RAN;HNRNPA2B1;RBM8A;HNRNPA1;ALKBH5;MAGOH;CHTOP;FMR1;MAGOHB;SRSF3;NUP107;DDX39B;UPF2;THOC7;NCBP2
gsea,Response To Estradiol (GO:0032355),-0.33340339021967946,-1.0162861868715287,0.437137330754352,0.589087257826123,1.0,9/18,38.18%,H2AZ1;SSTR2;SSTR1;FAM210B;NRIP1;KAT5;NCOA3;STAT3;EGFR
gsea,Negative Regulation Of Response To External Stimulus (GO:0032102),-0.23315002605509672,-1.0162515135576193,0.4114391143911439,0.5885116723826163,1.0,18/86,17.46%,APOE;DUSP3;BANF1;YWHAZ;GPS2;ATG12;C1QBP;RTN4R;PARP1;OTULIN;TEK;METRNL;SHARPIN;MUL1;NLRC3;EPHA4;VPS35;TRAF3IP1
gsea,Positive Regulation Of Cellular Catabolic Process (GO:0031331),-0.22634434596644334,-1.0161848213364495,0.43186180422264875,0.5879941984977353,1.0,28/108,23.92%,HMGB1;APOE;TMEM59;ZBTB20;SQSTM1;PLK2;PRKD1;SH3GLB1;IRS2;SNCA;BAD;MTLN;GSK3B;MTDH;LAPTM5;TRIM32;CNOT8;DAGLB;ADAM9;SVIP;PTPN1;GRSF1;TBK1;PIK3C2A;ENDOG;USP20;SNX33;P2RX7
gsea,Protein Targeting To Lysosome (GO:0006622),-0.31149672604127876,-1.015685385218592,0.42217898832684825,0.5884045509199668,1.0,5/24,15.96%,HSPA8;CLU;VPS4A;LAPTM5;LAMP2
gsea,Negative Regulation Of BMP Signaling Pathway (GO:0030514),0.2896030170254496,1.0155049486565106,0.4215885947046843,0.6613128096829903,1.0,12/31,25.15%,LRP2;GPR155;NOG;SMURF2;LEMD3;PPARG;BMPER;TRIM33;FBN1;TNFAIP6;GREM2;SKI
gsea,Regulation Of Monoatomic Ion Transmembrane Transport (GO:0034765),0.3257777063122886,1.0141027619478988,0.4228456913827655,0.6632998717666833,1.0,5/21,7.38%,GRIN2A;GRIN1;KCNJ6;WNK1;WNK3
gsea,Activation Of Protein Kinase Activity (GO:0032147),-0.2616809159023929,-1.0140389901775164,0.41050583657587547,0.5912322510376197,1.0,6/55,7.41%,MT3;PPIA;PARK7;ZFP91;IL18;PINK1
gsea,DNA Replication Initiation (GO:0006270),-0.33717064560511606,-1.0139396338288307,0.4419551934826884,0.5907845999540406,1.0,5/17,23.08%,ORC1;PURA;CDC45;NOC3L;ORC4
gsea,Receptor-Mediated Endocytosis (GO:0006898),-0.23817324815506058,-1.0136872756423598,0.39664804469273746,0.5906431731087746,1.0,18/94,17.47%,RNASEK;APOE;CLTA;CD81;AP2M1;CANX;RAMP2;SNCA;RAB31;RALA;AP2B1;HIP1R;LDLR;NLGN3;RAMP1;CLTB;LRP1B;AP2S1
gsea,Negative Regulation Of Nucleic Acid-Templated Transcription (GO:1903507),-0.1986551220355376,-1.0127047143580512,0.4180790960451977,0.5919489701103867,1.0,94/321,26.08%,HSPA8;JUN;SET;EID1;BASP1;TLE5;CALR;NR2F2;ZBTB18;EIF4A2;SNW1;NDUFA13;CBX3;SAP18;YWHAQ;CITED2;RIOX1;CDK5R1;ELK3;CHD3;BRD7;PML;RBBP7;RORB;PFDN5;PARP1;SOX9;UBE2V1;HNRNPK;ATF7IP;THAP7;CRYAB;KCTD1;ZBTB14;ZBTB21;CEBPA;CBX5;NFIL3;EID2B;ID4;ID2;ZBTB33;TLE1;CDKN1B;SMARCE1;ZBTB38;NKRF;SMAD2;KAT6A;KLF10;POU3F3;HEY1;CBX4;COMMD7;LIMD1;ID3;ENO1;FOXK1;THRA;NKX6-2;PDGFB;BRMS1;PHB2;EID2;UIMC1;ASCL1;CAPN3;HEXIM2;DMAP1;KMT5A;CTCF;PLCB1;PA2G4;RING1;TAF7;RLIM;BCOR;XRCC6;DAXX;MLX;CCAR2;ARID4A;SUMO1;SIN3A;HMGA1;CBY1;HDAC10;CBFA2T2;SALL1;RELA;CD38;RSF1;TLE2;LANCL2
gsea,Regulation Of Cell Communication (GO:0010646),0.2804951249671043,1.0125924988013384,0.4144329896907217,0.6655874252677554,1.0,11/35,18.75%,RYR2;SLC8A1;TRDN;SOCS2;GRK5;GRK4;MGLL;ITGB8;HCN1;GRK6;CAMK2D
gsea,Endoplasmic Reticulum To Cytosol Transport (GO:1903513),-0.35581284857248885,-1.0118026479336384,0.4189189189189189,0.5931862326090874,1.0,8/15,30.56%,FAF2;VCP;OS9;SEC61B;DERL1;DERL2;HSP90B1;HERPUD1
gsea,Sensory Organ Development (GO:0007423),-0.27994997856632575,-1.011249606009905,0.4269230769230769,0.59370611301244,1.0,20/42,33.87%,BHLHE22;NEUROD2;RAB18;SCO2;SALL2;ATOH7;HIPK1;BMPR1B;ASCL1;PBX1;TGFB2;STRA6;MYO7A;BLOC1S3;NEUROD6;ZDHHC16;POLR2D;FREM2;NEUROD1;OLIG2
gsea,Peptidyl-Tyrosine Phosphorylation (GO:0018108),0.26198106785401754,1.0110801454475582,0.41350210970464135,0.6679674764532937,1.0,13/48,14.14%,FLT3;LCK;ABL2;PTK2;JAK2;EPHB2;IGF1R;RELN;FYN;ERBB4;TTBK1;ALK;EPHA3
gsea,Negative Regulation Of Protein Modification Process (GO:0031400),-0.2518299226089271,-1.009961677132004,0.4405458089668616,0.5958332905921132,1.0,4/66,1.50%,PPIA;PRNP;YWHAB;PARK7
gsea,Regulation Of Double-Strand Break Repair Via Nonhomologous End Joining (GO:2001032),0.3301875987819399,1.0076058039280271,0.42685370741482964,0.6749356303380488,1.0,8/19,21.97%,PRKDC;WRAP53;KMT5B;PNKP;SETMAR;SHLD2;MRNIP;HSF1
gsea,Sodium Ion Transmembrane Transport (GO:0035725),-0.26386555827462477,-1.007515077492098,0.44646464646464645,0.6004338009419431,1.0,7/51,10.01%,ATP1B1;ATP1A1;ATP1A3;ATP1B2;KCNK1;SCN1B;ATP1A2
gsea,Cellular Response To Xenobiotic Stimulus (GO:0071466),0.3342465273318117,1.0074201096381707,0.4442105263157895,0.6740615190138812,1.0,2/15,2.65%,GPLD1;PPM1E
gsea,Regulation Of Response To Biotic Stimulus (GO:0002831),0.3090041719790546,1.007223163470389,0.4363256784968685,0.6732444516533287,1.0,4/23,9.63%,DAPK1;TRAF3;LRP8;ERAP1
gsea,Response To cAMP (GO:0051591),0.29606734781935085,1.0069195961314608,0.45806451612903226,0.6726886948247746,1.0,8/27,20.11%,PDE2A;AKAP6;DGKQ;PKD2;INPP5K;AKAP9;HCN1;DMTN
gsea,Cellular Response To Peptide (GO:1901653),-0.27851778029123875,-1.0047730026659696,0.4578313253012048,0.6056815236565095,1.0,7/35,13.10%,PRNP;RPL17;ATP1A3;GJA1;XBP1;GSK3B;ZFP36L1
gsea,Positive Regulation Of Cell Cycle Process (GO:0090068),0.23688563265529972,1.004319264137038,0.4201312910284464,0.6776281387459583,1.0,29/71,27.28%,PRKCE;ATRX;PKP4;INO80;CSPP1;MAD1L1;SPAG5;WIZ;SPAST;SIRT2;DYNC1LI1;NUMA1;EGF;CENPJ;BIRC5;CDC14B;CDC25B;NUSAP1;SMC2;CDC14A;NUDT16;PHIP;SMC6;CEP120;LRP5;CUL3;CEP295;SMC5;INSR
gsea,Regulation Of Regulated Secretory Pathway (GO:1903305),-0.29003150839775016,-1.0040121295110298,0.4407766990291262,0.6066239564893374,1.0,3/30,4.72%,RAB3A;SEPTIN5;SYT5
gsea,Regulation Of Organelle Assembly (GO:1902115),0.23984943985329676,1.0039068086636362,0.44086021505376344,0.6772635363235159,1.0,22/69,20.36%,IFT140;IFT88;SDCCAG8;PIKFYVE;CDKL1;TBC1D9B;EPHB2;INTU;CEP76;DYNLT2B;TBC1D12;MSN;EVI5;RABEP2;TBC1D24;CENPJ;TBC1D17;VPS11;SGSM3;WDPCP;TBC1D2;PDCD6IP
gsea,Positive Regulation Of Protein Targeting To Membrane (GO:0090314),0.3254319031528716,1.0036301001165506,0.4437869822485207,0.6766124530351082,1.0,3/19,4.15%,ANK3;TCAF1;C2CD5
gsea,G2/M Transition Of Mitotic Cell Cycle (GO:0000086),0.295243795207886,1.0030570587849192,0.4456066945606695,0.6767337834342898,1.0,8/26,20.21%,CDK14;CCDC57;BRSK1;DNM2;CHEK2;PLK3;BACH1;CDC25B
gsea,Primary Neural Tube Formation (GO:0014020),-0.301612270041083,-1.0023411975257188,0.4651600753295669,0.6089220314927634,1.0,6/23,22.97%,DYNLL1;VASP;BCL10;VANGL2;TGFB2;FUZ
gsea,Tube Closure (GO:0060606),-0.301612270041083,-1.0023411975257188,0.4651600753295669,0.6089220314927634,1.0,6/23,22.97%,DYNLL1;VASP;BCL10;VANGL2;TGFB2;FUZ
gsea,Regulation Of Presynapse Assembly (GO:1905606),-0.34404534359036043,-1.0015056916587184,0.4435483870967742,0.6094293665934437,1.0,5/15,17.43%,SLITRK2;SNCA;SLITRK3;IL1RAPL1;VPS35
gsea,Regulation Of Presynapse Organization (GO:0099174),-0.34404534359036043,-1.0015056916587184,0.4435483870967742,0.6094293665934437,1.0,5/15,17.43%,SLITRK2;SNCA;SLITRK3;IL1RAPL1;VPS35
gsea,Negative Regulation Of Cellular Response To Growth Factor Stimulus (GO:0090288),0.25758214404209073,1.001032565499042,0.4470338983050847,0.6800357601669198,1.0,13/51,16.84%,ATP2B4;LRP2;CASK;GPR155;HGS;NOG;SMURF2;LEMD3;NIBAN2;PPARG;DAB2IP;BMPER;TRIM33
gsea,Positive Regulation Of Canonical Wnt Signaling Pathway (GO:0090263),-0.24813213030947023,-1.0006574159547568,0.4342629482071713,0.6106234731093023,1.0,20/68,23.54%,FGFR2;RNF220;SEMA5A;CSNK1E;GPRC5B;TBL1XR1;ZEB2;PIN1;ATP6AP2;RUVBL1;BAMBI;TBL1X;ILK;NRARP;SOX4;VCP;CSNK1G2;JRK;CCAR2;DKK2
gsea,Modification-Dependent Protein Catabolic Process (GO:0019941),-0.20930581306444174,-0.9988966419738805,0.4348697394789579,0.6137589928057554,1.0,43/163,26.59%,UBB;RPS27A;NDFIP1;PSMC2;UBA52;SQSTM1;NEDD8;RBX1;RNF6;PINK1;UBA1;UBE2S;RNF11;RNF7;STUB1;RNF5;PPP1R11;ANAPC11;RNF168;XBP1;NDFIP2;PCYOX1;RNF114;TRIM32;RNF185;OS9;ELOC;RNF126;UBE2H;NUB1;RLIM;RNF13;LONP1;RNF166;RNF34;UBQLN4;PSMD11;KEAP1;HERC3;RNF144B;RNF26;KCTD10;NTAN1
gsea,Negative Regulation Of Ossification (GO:0030279),-0.3559565815391549,-0.9987228931905815,0.44212523719165087,0.6134520697919441,1.0,4/15,25.06%,MEF2C;SOX9;BCOR;TRPM4
gsea,Notch Signaling Pathway (GO:0007219),0.281907481545672,0.9983503036669111,0.4437367303609342,0.6851154498586776,1.0,11/32,21.91%,NOTCH2;SORBS2;SUSD5;GMDS;DTX1;MAML3;DLL3;HEY2;ADAM17;RBPJ;GALNT11
gsea,Mismatch Repair (GO:0006298),-0.3196760532424444,-0.9983389846579332,0.4653284671532847,0.6135883827945089,1.0,9/22,32.49%,PCNA;RPA3;RNASEH2C;TDG;RNASEH2A;MLH1;MLH3;POLD3;MSH6
gsea,Positive Regulation Of Calcium Ion Transmembrane Transport (GO:1904427),0.30443759665449843,0.9974774820815506,0.48884381338742394,0.685808093779929,1.0,7/24,14.11%,GRIN1;CACNB2;AKAP6;TRPC3;PLCG1;TRPC1;ANK2
gsea,Positive Regulation Of Kinase Activity (GO:0033674),0.23911713089651426,0.9964323333917122,0.44349680170575695,0.687038878106536,1.0,16/70,15.49%,PRKAG2;NTRK3;FLT3;NTRK2;PTK2;AXIN1;MAP3K5;IGF1R;ROR1;RELN;ERBB4;GAS6;ALK;IQGAP1;XRCC5;CENPE
gsea,Negative Regulation Of Inflammatory Response (GO:0050728),-0.24382626229837795,-0.9961017116180985,0.44680851063829785,0.6175777389924859,1.0,13/64,17.43%,APOE;PLK2;GSTP1;GPS2;OTULIN;TEK;METRNL;LYN;RPS19;SHARPIN;NLRC3;HCK;VPS35
gsea,Regulation Of Actin Cytoskeleton Reorganization (GO:2000249),0.3070709875063604,0.9952704831882978,0.44206008583690987,0.6886191040728438,1.0,4/21,5.93%,NOTCH2;BCAS3;ABL2;CARMIL1
gsea,Cellular Component Assembly (GO:0022607),-0.2045291304403341,-0.9942582657247798,0.4589285714285714,0.6208288440609316,1.0,25/186,13.72%,RTN1;VAMP2;ARL6IP1;ELOB;CAPZA2;CDC42;STX7;CHCHD10;AP2M1;WASL;YWHAZ;LIMD2;PPP2R1A;PDGFA;NAPG;RTN4;PML;CSNK2B;P3H4;ADD2;SOX9;VCPIP1;EZR;PIERCE2;NLGN3
gsea,Cellular Response To cAMP (GO:0071320),0.303831925070888,0.9940321532093035,0.4698275862068966,0.6902580971715718,1.0,7/23,20.11%,PDE2A;AKAP6;PKD2;INPP5K;AKAP9;HCN1;DMTN
gsea,Regulation Of Peptide Hormone Secretion (GO:0090276),-0.30652565618058736,-0.9939896575252664,0.47297297297297297,0.6207309491145364,1.0,4/24,7.56%,UQCC2;PPP3CB;ENSA;SNAP25
gsea,Glutamine Family Amino Acid Metabolic Process (GO:0009064),-0.3060543181170373,-0.9936365802604954,0.4692622950819672,0.6207981838547204,1.0,10/23,31.89%,NIT2;GOT2;GCLM;UCP2;CAD;ALDH5A1;DGLUCY;GLUD1;DDAH1;GCLC
gsea,Negative Regulation Of Wnt Signaling Pathway (GO:0030178),0.2301722780727637,0.9930447061230547,0.46875,0.6912822373260331,1.0,18/101,11.37%,HECW1;CHD8;PRKN;RBMS3;APC;ZNRF3;HDAC1;RNF43;AXIN1;CCDC88C;TRABD2B;NPHP3;NPHP4;NOG;TLE3;LMBR1L;ANKRD6;STK4
gsea,Protein Mannosylation (GO:0035268),-0.3260160324855981,-0.9928517968716478,0.48,0.6217777605676568,1.0,7/18,24.63%,DPM3;DPM2;FKRP;TMTC4;DPM1;RXYLT1;POMT1
gsea,Regulation Of Cholesterol Metabolic Process (GO:0090181),-0.3511094966912319,-0.9925346447685238,0.45038167938931295,0.6217472906658699,1.0,1/15,0.59%,APOE
gsea,"Retrograde Protein Transport, ER To Cytosol (GO:0030970)",-0.33836052769268354,-0.9922717095660754,0.4364326375711575,0.6216000235787684,1.0,7/16,24.62%,FAF2;VCP;OS9;SEC61B;DERL1;DERL2;HSP90B1
gsea,Protein-Containing Complex Organization (GO:0043933),-0.22292373509399235,-0.9920484492008103,0.47358490566037736,0.621436399285553,1.0,16/98,17.22%,VAMP2;ELOB;CAPZA2;CHCHD10;AP2M1;WASL;PPP2R1A;NAPG;PML;CSNK2B;SOX9;NUP205;SEH1L;VAMP3;NIFK;CD247
gsea,Negative Regulation Of Phosphoprotein Phosphatase Activity (GO:0032515),-0.3283134321939274,-0.9917175210126788,0.46954813359528486,0.6214960983559821,1.0,4/17,12.17%,FKBP1A;PPP1R11;GSK3B;PPP1R1B
gsea,Nucleocytoplasmic Transport (GO:0006913),-0.2593237930413196,-0.9910906085303748,0.455078125,0.622203370037052,1.0,11/46,17.07%,ANP32A;HNRNPA1;NPM1;NUP50;NUP37;NUP205;SEH1L;SEC13;CDKN1B;NUP107;LSG1
gsea,peptidyl-S-diacylglycerol-L-cysteine Biosynthetic Process From Peptidyl-Cysteine (GO:0018231),0.3239305349514469,0.9904233197348804,0.4520547945205479,0.6949656434048155,1.0,4/19,10.99%,ZDHHC21;ZDHHC2;ZDHHC14;ZDHHC1
gsea,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.3239305349514469,0.9904233197348804,0.4520547945205479,0.6949656434048155,1.0,4/19,10.99%,ZDHHC21;ZDHHC2;ZDHHC14;ZDHHC1
gsea,Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050730),-0.2564067550616243,-0.9900082571491448,0.45330739299610895,0.6239537771388969,1.0,7/52,9.54%,PRNP;EPHA7;RAP2B;CD81;PDGFA;VTN;BANK1
gsea,Leukocyte Cell-Cell Adhesion (GO:0007159),0.34239667800613843,0.9896304663117323,0.46218487394957986,0.6955935244910576,1.0,5/16,19.58%,ROCK1;SEMA4D;MSN;ITGA4;TNIP1
gsea,Outflow Tract Septum Morphogenesis (GO:0003148),-0.3414343795236139,-0.9890816784724581,0.4704761904761905,0.625235474301091,1.0,6/15,26.47%,FGFR2;NELL2;BMPR2;TGFB2;ROBO2;BMPR1A
gsea,Negative Regulation Of ERBB Signaling Pathway (GO:1901185),0.3306469351564074,0.9887161245024845,0.45867768595041325,0.6965982041339629,1.0,7/17,18.98%,ZFYVE28;CBL;PTPN2;DAB2IP;PTPN3;MVP;ITGA1
gsea,Positive Regulation Of Glucose Transmembrane Transport (GO:0010828),0.3135982364165808,0.9883768166356294,0.4633663366336634,0.6961798218784796,1.0,3/21,8.24%,SORBS1;C2CD5;AKT2
gsea,Steroid Metabolic Process (GO:0008202),-0.293840561500407,-0.9881933782478349,0.4664310954063604,0.6265284411117878,1.0,15/30,36.61%,MSMO1;SCP2;CBR1;HSD17B10;FDFT1;GBA2;CYP46A1;BDH1;HSD3B2;LSS;RDH5;CYP27A1;LGMN;DHCR24;CYP7B1
gsea,mRNA Export From Nucleus (GO:0006406),-0.24755187251759944,-0.9878700538908876,0.4941860465116279,0.6265644880537126,1.0,15/56,21.65%,HNRNPA2B1;RBM8A;ALKBH5;MAGOH;CHTOP;FMR1;MAGOHB;SRSF3;POLDIP3;ENY2;NUP107;DDX39B;UPF2;THOC7;NCBP2
gsea,Protein Dephosphorylation (GO:0006470),-0.22262550006898185,-0.9878264646728453,0.49203187250996017,0.6259906167308661,1.0,12/106,7.04%,PPP3CA;DUSP3;NCK1;DUSP7;PPP3R1;PPP1CA;PPP2CA;PPP3CB;PPP2R1A;PPM1D;PDXP;SBF1
gsea,Positive Regulation Of Protein Secretion (GO:0050714),-0.2572977752327529,-0.9875379748505647,0.45525291828793774,0.6258974424088474,1.0,15/49,23.80%,PPIA;IER3IP1;IRS2;NNAT;BAD;TMED10;EZR;ATP13A2;SIRT6;SOX4;ADAM9;BMP6;TGFB2;MYH10;ARF6
gsea,Protein Alkylation (GO:0008213),-0.31561842062749745,-0.9854974692620082,0.4619771863117871,0.6295776119536007,1.0,10/20,33.01%,FAM98B;EEF1AKMT1;LCMT1;SNRPB;PRMT1;ETF1;METTL22;PCMT1;ETFBKMT;EEF1AKMT2
gsea,Protein Ubiquitination (GO:0016567),-0.1919552441626503,-0.9852800220033493,0.46705426356589147,0.6293729191392187,1.0,75/331,23.29%,UBB;ENC1;RACK1;RPS27A;UBE3A;UBA52;RNF220;NEUROD2;TRIM35;KLHL9;UBE2J1;KCTD13;NEDD8;RNF187;RNF227;RBX1;RNF6;UBE2N;PINK1;UBA1;UBE2S;FBXO9;RNF11;RNF7;STUB1;OTULIN;UBE2V1;FBXO32;ANAPC11;TRIM24;RNF168;SDE2;VCPIP1;BABAM2;RNF10;PEX12;DDB2;MKRN1;ASB5;ARRDC4;WSB2;RNF208;RNF114;CBFB;MUL1;DDA1;TRIM44;PJA2;TRIM32;RNF185;ATG3;UBE2QL1;PCNP;PRPF19;BLMH;VCP;FBXW7;OS9;FBXL3;ELOC;RNF126;PELI2;RNF139;UBE2H;NUB1;CBLL1;FBXO25;RNF138;RLIM;RNF13;MIB2;RNF44;RAD51;TRAF2;RNF166
gsea,JNK Cascade (GO:0007254),0.28961675889038696,0.9852298593802726,0.48148148148148145,0.7023111923310111,1.0,5/25,12.52%,MAPK10;MAP3K7;MAP3K5;TNFRSF19;MAP4K3
gsea,Response To Lipid (GO:0033993),0.24243195134794535,0.9851309251255973,0.4636752136752137,0.7012496252371558,1.0,16/56,21.07%,NOS1;LIAS;JAK2;PLCG2;MAPKAPK2;SOCS2;OVCA2;ASXL1;STRN3;RARG;PPARG;FER;TNFRSF11A;PTPN22;ADAM17;PAQR8
gsea,Heterochromatin Organization (GO:0070828),0.27285176197305944,0.9833387761587594,0.4906832298136646,0.7042345138676629,1.0,7/32,13.49%,UBR5;TRIP12;BAZ2A;SETDB1;SCMH1;SIRT2;UBR2
gsea,Transport Across Blood-Brain Barrier (GO:0150104),0.25116091694315457,0.9828072897703606,0.45875251509054327,0.7042108092865418,1.0,11/63,9.84%,ATP2B4;SLCO3A1;ABCC5;SLC6A1;LRP2;ATP8A1;SLC24A3;SLC1A1;SLC5A3;SLC29A4;SLC7A8
gsea,Regulation Of Vascular Associated Smooth Muscle Cell Proliferation (GO:1904705),0.30000488200085834,0.9824132214897993,0.47283702213279677,0.7038243782680395,1.0,2/24,0.76%,PRKG1;TAFA5
gsea,Positive Regulation Of DNA Recombination (GO:0045911),-0.2572275448219405,-0.9816184094533525,0.4634146341463415,0.636360301442747,1.0,7/44,11.26%,MORF4L1;MORF4L2;ACTR2;HMCES;PARP1;RUVBL1;MRGBP
gsea,Cell-Cell Junction Assembly (GO:0007043),0.2472936946588367,0.9815716561044086,0.4816247582205029,0.704500150596979,1.0,13/53,13.62%,CDH12;TBCD;PKP4;CTNND2;TJP1;TLN2;PATJ;MPDZ;FBF1;EPB41L3;CDH11;PKP2;CDH13
gsea,Positive Regulation Of Double-Strand Break Repair (GO:2000781),-0.2268837241067051,-0.9807691790224299,0.48659003831417624,0.6375088321705006,1.0,19/75,22.65%,MORF4L1;MORF4L2;BCL7B;ACTR2;UBE2N;BRD7;PARP1;RUVBL1;MRGBP;SPIRE1;SMARCE1;SIRT6;SHLD1;BCL7C;ACTL6B;SMARCB1;DMAP1;DPF2;MAD2L2
gsea,Positive Regulation Of Cold-Induced Thermogenesis (GO:0120162),-0.23983011861107775,-0.9806816196920635,0.48,0.6370154871302084,1.0,14/61,21.28%,GNAS;APLP2;IL18;FABP5;ADRB1;CEBPB;GJA1;DIO2;SIRT6;ADIPOR2;GPR3;THRA;UCP2;CNKSR2
gsea,Positive Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901992),0.24581622090260596,0.9797979091045445,0.4989293361884368,0.7073933384638054,1.0,9/48,14.62%,UBE2E2;FGF10;RPTOR;ANKRD17;CCND2;ANAPC5;MECP2;KMT2E;NSMCE2
gsea,Positive Regulation Of Epithelial Cell Migration (GO:0010634),0.23707639431865377,0.9793978089621195,0.4960159362549801,0.707063255874312,1.0,15/73,11.53%,SMOC2;EPB41L4B;PRKCE;FGF10;GPLD1;MAP4K4;CLASP1;RREB1;BCAS3;PTK2;PLCG2;IQSEC1;PIK3CD;MTOR;PLCG1
gsea,Response To Axon Injury (GO:0048678),-0.3278698415201823,-0.9792632686337042,0.4875239923224568,0.6392614875086087,1.0,5/17,17.81%,P2RY12;SOD1;DHFR;FLRT3;GAP43
gsea,Negative Regulation Of Cell Migration (GO:0030336),-0.21737143173716317,-0.9790586352066011,0.5020491803278688,0.6390387160063719,1.0,39/113,29.35%,DYNLL1;PFN2;RAC1;CALR;RAP2B;NAV3;DUSP3;ARPIN;ATP1B2;TPM1;SIN3B;CITED2;RBBP7;CX3CL1;GJA1;VCL;RHOB;JAG1;SMAD7;IGFBP5;EPHA4;BRMS1;THY1;HYAL2;FUZ;MIA3;ARID4A;GTPBP4;SIN3A;FOXO3;BMPR1A;EVL;PTEN;HAS1;ING1;NDRG4;MCC;MACIR;DAG1
gsea,Regulation Of Immune Response (GO:0050776),0.26729026573111364,0.9787375739267136,0.5054945054945055,0.70737359658941,1.0,6/37,9.70%,DENND1B;BCL6;SPNS2;LRP8;ERAP1;CFP
gsea,Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901990),-0.2376897274258176,-0.9786245367704041,0.4868421052631579,0.6392779228118558,1.0,16/67,21.19%,APLP2;PLK5;BCL7B;PPP2CA;CDK4;BRD7;PSME3;ZFP36L1;ID2;CDKN1B;SMARCE1;NEK6;BCL7C;ACTL6B;SMARCB1;DPF2
gsea,Regulation Of mRNA Catabolic Process (GO:0061013),-0.26901866139413216,-0.9784903577708487,0.46153846153846156,0.6388906013263678,1.0,10/41,16.85%,SERBP1;RBM8A;MAGOH;FMR1;MAGOHB;ZFP36L1;CSDC2;CNOT8;APEX1;PUM1
gsea,Positive Regulation Of Wnt Signaling Pathway (GO:0030177),-0.23345265337554047,-0.9783055324048031,0.4755381604696673,0.6386047643429679,1.0,26/86,25.06%,ATP6V0C;FGFR2;RNF220;SEMA5A;CSNK1E;GPRC5B;TBL1XR1;ZEB2;PIN1;ATP6AP2;RUVBL1;BAMBI;TBL1X;ILK;NRARP;SOX4;VCP;CDC73;CSNK1G2;JRK;SPIN1;CCAR2;DKK2;SALL1;CSNK2A1;TRPM4
gsea,RNA Biosynthetic Process (GO:0032774),-0.29149963398216083,-0.9770328385806601,0.49387755102040815,0.6406033549301773,1.0,15/25,39.24%,NAT14;TAF10;TBPL1;ZFP36L1;TAF5;TAF7;RSF1;TAF12;HELB;ZFP36L2;TAF13;POLR2A;SMARCA5;PRMT5;PRIM1
gsea,Positive Regulation Of Viral Genome Replication (GO:0045070),-0.30451941223713047,-0.9768277663007331,0.4543726235741445,0.64040168630241,1.0,1/21,0.20%,PPIA
gsea,Negative Regulation Of Intracellular Steroid Hormone Receptor Signaling Pathway (GO:0033144),0.3130013506985646,0.97627519969232,0.4746450304259635,0.7119316308532857,1.0,6/21,16.79%,PIAS2;SMARCA4;HDAC1;CNOT1;STRN3;VPS11
gsea,Nuclear Transport (GO:0051169),-0.2711872458348694,-0.9753882213967748,0.49122807017543857,0.6429071217258725,1.0,12/35,26.33%,ANP32A;NPM1;NUP50;NUP37;NUP205;SEH1L;SEC13;NUP107;NUP35;RSRC1;NUP62;NUP85
gsea,mRNA Transcription By RNA Polymerase II (GO:0042789),0.27000319546762913,0.9750352223796774,0.49795918367346936,0.7134620485250098,1.0,9/33,14.25%,TFCP2;NCOA2;NCBP1;THRB;NCOA1;TAF1;TAF6;PPARG;NCBP3
gsea,Negative Regulation Of Immune System Process (GO:0002683),-0.30596929872363515,-0.9747906808396398,0.5122873345935728,0.6435541750441094,1.0,5/21,20.54%,GPS2;SOX9;LYN;GPR108;TSPAN6
gsea,Sphingolipid Metabolic Process (GO:0006665),-0.23332607907759995,-0.9747121242281122,0.48859315589353614,0.6430271118568404,1.0,7/74,6.81%,SERINC1;TECR;PPP2CA;PPP2R1A;PRKD1;SPTSSA;NSMAF
gsea,RNA Stabilization (GO:0043489),-0.28875802567696773,-0.9743552922011315,0.497131931166348,0.6431112970197032,1.0,6/26,16.71%,ZCCHC17;YBX1;CIRBP;PABPC1;DKC1;TRDMT1
gsea,Regulation Of Actin Filament Polymerization (GO:0030833),0.25597340927209367,0.9742696305940544,0.5030181086519114,0.7139930498047589,1.0,10/49,9.85%,PAK3;BIN1;PRKCE;TENM1;ARFGEF1;CARMIL1;SSH3;SSH2;NCK2;ARHGAP18
gsea,Cardiac Muscle Tissue Development (GO:0048738),0.29147834378812676,0.9733496500053589,0.48232848232848236,0.7149405876735304,1.0,6/26,11.28%,NRG1;NOTCH2;SGCZ;SGCD;TAFAZZIN;TTN
gsea,Intrinsic Apoptotic Signaling Pathway In Response To Endoplasmic Reticulum Stress (GO:0070059),-0.3126276977342261,-0.9726646601248088,0.4925373134328358,0.6459867175808055,1.0,6/20,23.33%,SELENOK;BAX;CEBPB;BBC3;TRAF2;BRSK2
gsea,Regulation Of Centriole Replication (GO:0046599),-0.343069207405035,-0.9723089634488951,0.501937984496124,0.6460164500744614,1.0,4/15,25.90%,PLK2;NPM1;NUP62;SASS6
gsea,Female Gamete Generation (GO:0007292),0.32019237282395163,0.9715860278453304,0.48484848484848486,0.717855831045589,1.0,19/19,68.02%,FMN2;MEI4;USP9X;PRDM9;DMC1;KMT2D;MDK;MCM9;MARF1;NANOS1;PIWIL2;PARN;MCM8;DIAPH2;NANOS3;METTL3;GDF9;TOB2;PTN
gsea,Regulation Of Telomere Maintenance Via Telomere Lengthening (GO:1904356),-0.34286206454420487,-0.970449242902711,0.4855371900826446,0.6493538592907896,1.0,3/15,11.14%,HNRNPA2B1;PARP1;TERF1
gsea,Protein Modification By Small Protein Conjugation (GO:0032446),-0.19139750441042647,-0.9703442756245986,0.502868068833652,0.6488832256878203,1.0,74/278,26.53%,UBB;ENC1;RACK1;RPS27A;SUMO2;UBA52;RNF220;NEUROD2;TRIM35;KLHL9;COPS6;EYA1;KCTD13;NEDD8;NSMCE3;RNF227;RBX1;RNF6;UBE2N;PINK1;UBA1;FBXO9;PML;RNF7;STUB1;OTULIN;GPS1;FBXO32;ANAPC11;TRIM24;RNF168;SDE2;VCPIP1;MKRN1;COPS8;ASB5;ARRDC4;RNF208;MUL1;TRIM44;PJA2;TRIM32;CBX4;UBA2;UBA3;ATG3;PCNP;VCP;FBXW7;OS9;FBXL3;ELOC;RNF126;RNF139;NUB1;CBLL1;FBXO25;RNF138;RLIM;MIB2;RNF44;ATG10;SUMO1;RNF103;DCUN1D5;RNF34;KEAP1;TRPM4;SKP1;HERC3;UCHL3;RNF26;KCTD10;COPS7A
gsea,Positive Regulation Of JNK Cascade (GO:0046330),0.2435153159295608,0.9702707776413121,0.46853146853146854,0.7196964039658615,1.0,13/53,14.38%,TAOK1;TRAF3;AXIN1;MTURN;MAP3K5;WNT7A;SH3RF3;ANKRD6;TNFRSF19;SH3RF1;TNIK;TAOK2;DAB2IP
gsea,Vascular Endothelial Growth Factor Receptor Signaling Pathway (GO:0048010),-0.3025024400924037,-0.9700659651027466,0.4932301740812379,0.6487866922172646,1.0,4/21,10.65%,PDCD6;VEGFC;PRKD1;VEGFB
gsea,Protein K63-linked Deubiquitination (GO:0070536),-0.2758167917851737,-0.9700502847596508,0.5029940119760479,0.6481387382509489,1.0,8/28,22.84%,USP50;USP27X;SPATA2;BABAM2;MPND;UIMC1;YOD1;USP20
gsea,Response To Organonitrogen Compound (GO:0010243),-0.2735284567790159,-0.9698602851571677,0.5110663983903421,0.6478657125391079,1.0,13/32,23.70%,CCDC47;CLU;RNF5;XBP1;RNF185;VCP;CREB1;RNF139;CHRNB2;UBXN6;ADORA1;BRSK2;DERL1
gsea,Regulation Of Arp2/3 Complex-Mediated Actin Nucleation (GO:0034315),-0.3036941209972712,-0.9697460484088669,0.4891518737672584,0.6474308466904215,1.0,2/22,2.42%,ARF1;BRK1
gsea,Positive Regulation Of Bone Mineralization (GO:0030501),0.29014144224220767,0.9687431836947417,0.5116279069767442,0.7220293306958746,1.0,3/26,3.15%,SLC8A1;ANO6;FBN2
gsea,Negative Regulation Of Innate Immune Response (GO:0045824),-0.273187273505791,-0.9686324348441652,0.48770491803278687,0.6490639347077446,1.0,8/34,18.90%,BANF1;YWHAZ;ATG12;PARP1;RPS19;MUL1;NLRC3;SAMHD1
gsea,Rac Protein Signal Transduction (GO:0016601),-0.3251409110892573,-0.9682445071737881,0.4812623274161736,0.6492275283600302,1.0,2/17,2.42%,RAC1;BRK1
gsea,Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042509),0.28161129762489534,0.9677667619186142,0.47096774193548385,0.7229980019483296,1.0,6/27,10.37%,FLT3;IL31RA;OCRL;JAK2;PTPN2;ERBB4
gsea,Dephosphorylation (GO:0016311),-0.21193305324235576,-0.9661400856465835,0.5200764818355641,0.6530848963502488,1.0,25/123,20.98%,PLPPR4;PPP3CA;DUSP3;PPP3R1;PPP1CA;PPP2CA;PPP3CB;PPP2R1A;PPM1D;PDXP;SBF1;PLPPR5;TIMM50;PPP2R5D;CTDNEP1;NANP;PPP1CC;DUSP8;PLPP3;PTPN1;DUSP5;FRA10AC1;PPP2R5A;UBLCP1;PSPH
gsea,Platelet-Derived Growth Factor Receptor Signaling Pathway (GO:0048008),-0.3351075658474498,-0.9661356182131055,0.5009746588693957,0.6524179947030656,1.0,8/15,35.49%,PDGFA;PTPN1;PDGFB;PDGFD;PIK3C2A;NR4A3;BCAR1;PDGFC
gsea,Regulation Of G0 To G1 Transition (GO:0070316),-0.2855102359315915,-0.9655328373564567,0.5087040618955513,0.6530043100148271,1.0,10/29,21.19%,BCL7B;BRD7;FOXO4;SMARCE1;BCL7C;ACTL6B;RRM1;SMARCB1;RRM2B;DPF2
gsea,Regulation Of Transferase Activity (GO:0051338),-0.3196346818781619,-0.9655057776498291,0.5151515151515151,0.6523758429358749,1.0,7/17,30.53%,BAG5;HPF1;PARP4;EMP2;JMJD8;NABP2;LDB1
gsea,Regulation Of Biomineral Tissue Development (GO:0070167),0.342582045095256,0.9654013343191113,0.49700598802395207,0.7273438825798898,1.0,3/15,3.90%,ROCK1;TXLNG;ECM1
gsea,Skeletal System Development (GO:0001501),0.2327583752676629,0.96530474775191,0.49786324786324787,0.726253317862949,1.0,25/87,17.87%,PCSK5;DYM;PKD1;TGFBR1;SPEF2;TRIP11;NPR3;COL19A1;XYLT1;P3H1;SOX5;NOG;DEAF1;MMP16;CDH11;BMP1;DLL3;EVC;EXT1;PAPSS1;COL9A2;SH3PXD2B;PTH1R;ITGB8;CHD7
gsea,Regulation Of Transcription Elongation By RNA Polymerase II (GO:0034243),0.22768213684152824,0.965061973805911,0.4880952380952381,0.7255049041366343,1.0,11/72,10.76%,SRCAP;CDK12;INTS11;INTS2;ELL2;RECQL5;NCBP1;INTS1;INTS6;TCERG1;MED14
gsea,Positive Regulation Of TOR Signaling (GO:0032008),-0.2622041616554508,-0.9648928753177313,0.5307692307692308,0.6530459042951381,1.0,7/42,14.87%,LAMTOR2;RRAGA;LAMTOR3;RRAGD;PIP4P1;SEH1L;SEC13
gsea,Regulation Of Protein Targeting To Membrane (GO:0090313),0.30039043269331966,0.9646499742448746,0.48804780876494025,0.7251950970642262,1.0,3/22,4.15%,ANK3;TCAF1;C2CD5
gsea,Regulation Of Fibroblast Migration (GO:0010762),0.3242671323837099,0.9646271439100579,0.5078125,0.7239239661019877,1.0,4/17,10.07%,PRKCE;PTK2;GNA12;ARHGEF7
gsea,Response To Peptide (GO:1901652),0.306398531694418,0.9640581905905579,0.5221774193548387,0.7240232051173013,1.0,6/20,15.00%,CACNA1A;CACNA1B;CHRNA7;FYN;STAT2;INAVA
gsea,Regulation Of Protein Localization To Membrane (GO:1905475),0.3011676966410904,0.9639290466424081,0.4880952380952381,0.7230303010263956,1.0,7/22,13.69%,PRKN;ZDHHC2;GPC3;SLC5A3;NECAB2;FYN;SPTBN1
gsea,Regulation Of Neutrophil Chemotaxis (GO:0090022),-0.33655679520122206,-0.9621340628261797,0.5134649910233393,0.6583361883155595,1.0,2/15,9.74%,RAC1;C1QBP
gsea,Triglyceride Metabolic Process (GO:0006641),0.30732266359273214,0.9620722048195944,0.5080645161290323,0.7261510745931875,1.0,7/19,15.48%,GCK;LPIN1;LMF1;PNPLA2;DGAT1;GK5;LPIN2
gsea,Carboxylic Acid Transport (GO:0046942),-0.27760827265388527,-0.9618842883819028,0.4957805907172996,0.6582236723733988,1.0,19/37,41.79%,PSAP;SLC38A2;SLC16A11;SLC3A1;SLC16A1;SLC38A5;SLC16A4;SLC25A29;SLC6A13;SLC7A10;SLC3A2;SLC7A14;SLC16A10;SLC16A14;SLC16A6;PDPN;SLC6A11;SLC38A1;SLC7A1
gsea,Glycerolipid Catabolic Process (GO:0046503),0.3311496645081272,0.9610352257989393,0.508298755186722,0.7273568514135924,1.0,7/15,22.47%,PLA2G4E;GDPD1;PNPLA6;LYPLA2;MGLL;PLA2G4A;ENPP6
gsea,Cell-Matrix Adhesion (GO:0007160),0.22727896383363552,0.9594941064185009,0.5135746606334841,0.7297501199725374,1.0,24/72,21.96%,SORBS1;PKD1;THBS3;ACTN2;BCR;ITGA8;ITGA3;TIAM1;ARHGEF7;ECM2;CDH11;L1CAM;BCAT2;TAOK2;MKLN1;THSD1;ITGB8;ITGA4;ITGA1;CD44;COL13A1;TRIP6;TESK2;ADAMTS13
gsea,Mitophagy (GO:0000423),-0.3319592070882134,-0.9594001729740819,0.5110663983903421,0.6629773915413558,1.0,4/16,12.77%,SQSTM1;MAP1LC3B;PINK1;RIMOC1
gsea,Positive Regulation Of Organelle Assembly (GO:1902117),0.2387758873824167,0.9585702089885098,0.5191919191919192,0.7306480048417121,1.0,14/54,16.67%,CROCC;ELAPOR1;CCDC88A;IFT88;ENTR1;SPAG5;CNOT1;HTT;RAB3GAP2;ATG2A;CAPRIN1;NUMA1;WDR45;CENPJ
gsea,Regulation Of mRNA Processing (GO:0050684),-0.27116773754080714,-0.9581872977996431,0.5317460317460317,0.664813997930097,1.0,6/31,13.10%,RBM8A;MAGOH;HNRNPK;MAGOHB;SRSF3;ZFP36L1
gsea,Positive Regulation Of Protein Tyrosine Kinase Activity (GO:0061098),0.27809119678059496,0.9576313796004378,0.5108481262327417,0.7316395738596478,1.0,7/27,12.01%,DOCK3;SRCIN1;LRP8;EFNA1;RELN;DLG4;GAS6
gsea,"Alternative mRNA Splicing, Via Spliceosome (GO:0000380)",0.3237588438292449,0.9562297858314368,0.5203252032520326,0.7336310790624764,1.0,2/16,0.28%,CELF4;SFPQ
gsea,Vacuolar Transport (GO:0007034),0.25264906715108926,0.9552850548489878,0.49673202614379086,0.7346454564905307,1.0,7/41,11.53%,VPS13A;VPS13C;VPS13D;VPS41;VPS54;AP1G2;VTI1A
gsea,Connective Tissue Development (GO:0061448),0.2898111889199207,0.9543003287145907,0.5091277890466531,0.7357367726467461,1.0,8/27,19.72%,PKD1;VPS13B;TRIP11;SOX5;SOX8;SH3PXD2B;ITGB8;CD44
gsea,Negative Regulation Of Microtubule Depolymerization (GO:0007026),0.3146523533135057,0.9536212825402668,0.51171875,0.7360759597551167,1.0,6/17,16.46%,TAOK1;CLASP1;ATXN7;KATNB1;CLASP2;ARHGEF2
gsea,Regulation Of Telomere Maintenance Via Telomerase (GO:0032210),-0.25243035308641526,-0.9534557534258259,0.5038022813688213,0.6743726969885603,1.0,11/46,19.64%,CCT2;CCT6A;HNRNPA1;TERF1;CCT7;MAPK3;CCT5;CCT8;HNRNPC;MAPKAPK5;MAPK1
gsea,Regulation Of Myoblast Differentiation (GO:0045661),-0.25277812644789355,-0.9533951746511756,0.5391969407265774,0.6737878378472492,1.0,13/43,21.05%,MEF2C;AKIRIN1;BRD7;SOX9;ZFP36L1;EID2B;RANBP3L;SMARCE1;BTG1;SOX4;ACTL6B;SMARCB1;PLCB1
gsea,Regulation Of Cell Adhesion Mediated By Integrin (GO:0033628),0.31172366668515195,0.95267564782148,0.5126582278481012,0.7370088753827635,1.0,4/18,8.86%,NRG1;PTK2;EFNA1;NEXMIF
gsea,Lysosomal Transport (GO:0007041),-0.22203303993260623,-0.9525322006755194,0.5223048327137546,0.674908680902557,1.0,19/90,20.40%,PSAP;ARL8B;TMEM106B;LAMP1;PINK1;EHD3;CHMP2A;TSG101;CHMP6;RHOB;VPS4A;LAPTM5;ATP13A2;CHMP4C;VPS35;CHMP7;PLEKHF2;USE1;AP3M1
gsea,Regulation Of Cell-Substrate Adhesion (GO:0010810),0.26148531585042617,0.951891267370099,0.510593220338983,0.7375749883750387,1.0,11/35,17.01%,TBCD;NF1;SPOCK1;PTK2;JAK2;GCNT2;RSU1;ECM2;PKP2;CORO2B;NDNF
gsea,Negative Regulation Of DNA Recombination (GO:0045910),-0.29343390178374795,-0.95084454737399,0.5169172932330827,0.677902049718992,1.0,12/23,41.48%,POLQ;SHLD1;KMT5A;MAD2L2;UBQLN4;KAT5;HELB;MSH6;ZRANB3;MSH2;FBH1;TERF2IP
gsea,Regulation Of Sprouting Angiogenesis (GO:1903670),-0.3054959065821151,-0.9507001587426516,0.5019762845849802,0.6775409388243169,1.0,9/22,31.27%,PKM;GLUL;EPN1;JMJD8;JAK1;S100A1;PIK3CB;CEMIP2;RHOJ
gsea,Clathrin-Dependent Endocytosis (GO:0072583),0.2849809640589027,0.9505598724481507,0.49176954732510286,0.7394490177089602,1.0,5/26,6.66%,FCHO2;ITSN1;STON2;OCRL;ITSN2
gsea,Actin Filament Bundle Organization (GO:0061572),0.2873948564514275,0.9491373672434046,0.5083333333333333,0.7415374252666282,1.0,6/23,13.82%,MYO1B;LIMA1;PLS1;ESPN;DPYSL3;EPS8
gsea,Cellular Response To Hydrogen Peroxide (GO:0070301),-0.3032323510577829,-0.9486407946011253,0.5230125523012552,0.6813269307034737,1.0,5/20,18.38%,RPS3;CLU;OSER1;RHOB;FXN
gsea,Regulation Of SMAD Protein Signal Transduction (GO:0060390),0.3335290820418468,0.9485187133219418,0.5122950819672131,0.7417466223542435,1.0,4/15,13.62%,TGFBR1;JAK2;CCN3;PPARG
gsea,Embryonic Organ Development (GO:0048568),0.2466103382731445,0.9482907437628543,0.5477707006369427,0.7409817495199752,1.0,6/46,7.94%,PCSK5;PKD1;RARB;KMT2A;PBX4;PKD2
gsea,Regulation Of Fatty Acid Oxidation (GO:0046320),-0.3287579604389752,-0.9468395571370554,0.5244360902255639,0.6845161862069528,1.0,3/15,11.91%,APLP2;SOX9;FABP3
gsea,Non-Canonical Wnt Signaling Pathway (GO:0035567),-0.2791893778747334,-0.9461195324196798,0.5476635514018692,0.6853710494725096,1.0,5/31,11.30%,RAC1;CDC42;FZD3;FZD2;FZD4
gsea,Positive Regulation Of Small Molecule Metabolic Process (GO:0062013),0.28597957276251473,0.9452915346319325,0.5349301397205589,0.746874776473039,1.0,7/23,14.92%,PRKCE;RPTOR;GPLD1;AKT2;MTOR;ARNT;PRXL2C
gsea,Endocytosis (GO:0006897),-0.20606403799896872,-0.9445748056676895,0.557504873294347,0.688017726485736,1.0,58/144,34.54%,RNASEK;APOE;CDC42;CSNK1E;SYP;DPYSL2;MESD;CYTH2;OCIAD1;EHD3;EPN1;RAB22A;AXL;HIP1R;LDLR;MAPK3;NLGN3;PACSIN2;SNX5;LRP1B;CD302;RAB11FIP2;EHD1;MAPK1;RAB5A;EPS15;AP3M1;PIK3C2A;RAB5B;IL10RA;CSNK1G2;ADORA1;ARHGAP27;AP3M2;STEAP2;SNX33;INPPL1;M6PR;WASF1;STAB2;PLD4;CORO1A;EHD4;ANXA11;AP1S1;CTTN;MYO1E;RHOJ;OCIAD2;RABEPK;CORO1C;PECAM1;MYD88;LRP12;DAB2;RAB34;PICALM;MERTK
gsea,Defense Response To Symbiont (GO:0140546),0.22764902999020312,0.9435400882628836,0.5544554455445545,0.7497084943722768,1.0,10/60,14.25%,AGBL4;LYST;MOV10;SERINC5;TRAF3;NCBP1;USP29;STAT2;IRF2;NCBP3
gsea,Proteoglycan Metabolic Process (GO:0006029),0.3115807532561323,0.9427868948093718,0.5506072874493927,0.7501265956496441,1.0,5/19,14.57%,CHST11;HS3ST4;XYLT1;CHST10;CHST9
gsea,Negative Regulation Of Cellular Metabolic Process (GO:0031324),-0.2777349052924732,-0.9420010111051296,0.5405405405405406,0.6930366250130886,1.0,4/28,9.35%,MT3;PINK1;ITGAV;YBX1
gsea,Positive Regulation Of Glucose Import (GO:0046326),0.3189522324201105,0.9417292744347385,0.5267326732673268,0.7513418272485423,1.0,2/17,8.24%,SORBS1;AKT2
gsea,Regulation Of Cellular Component Size (GO:0032535),-0.26250063013174474,-0.9416565681917464,0.562152133580705,0.693080313547308,1.0,8/36,19.88%,RAC1;MTPN;PPP1CA;RAB22A;EZR;ATP13A2;RDX;PEX11B
gsea,Heart Looping (GO:0001947),0.30470878915930644,0.9409520227218647,0.553941908713693,0.7518654649069425,1.0,10/19,28.01%,MICAL2;PKD2;NPHP3;SMO;CCDC40;SETDB2;CCDC39;BBS5;NOTCH1;DVL2
gsea,Myofibril Assembly (GO:0030239),-0.2964579885083807,-0.9390722732849902,0.5310834813499112,0.6978028961358759,1.0,7/24,21.91%,TPM1;MYLK3;CSRP2;MYL9;CSRP1;CAPN3;CFLAR
gsea,Protein K63-linked Ubiquitination (GO:0070534),-0.2559265554168041,-0.9382228143543879,0.5663551401869159,0.6990340566293315,1.0,12/41,23.26%,ZFP91;UBE2N;UBE2S;STUB1;RNF5;UBE2V1;RNF168;ARRDC4;PRPF19;RNF126;TRAF3IP2;TRAF2
gsea,Protein Glycosylation (GO:0006486),-0.2057947016787014,-0.9363231850585058,0.5956607495069034,0.7023418947552685,1.0,12/119,8.15%,TMEM258;PMM1;TMEM59;DPM3;KRTCAP2;PDCD6;B3GALT2;PLOD2;DAD1;PSMD2;DDOST;SERP2
gsea,Regulation Of Lipid Biosynthetic Process (GO:0046890),-0.3085115095352308,-0.9358858107071818,0.556640625,0.7025678065489188,1.0,7/17,21.93%,APOE;ZBTB20;EIF6;THRSP;MID1IP1;CREB1;FITM2
gsea,Protein Modification By Small Protein Removal (GO:0070646),0.21867376225973822,0.9353773684015593,0.5755813953488372,0.7635608806641354,1.0,17/83,12.65%,OTUD7A;PRKN;OTUD3;USP7;USP34;USP32;SENP1;USP47;USP48;USP8;USP24;USP29;COPS4;USP11;ZRANB1;USP4;SENP5
gsea,Positive Regulation Of Cytoskeleton Organization (GO:0051495),-0.24417212140874484,-0.9342979147179182,0.5643939393939394,0.7052250892078785,1.0,14/55,18.85%,PFN2;NCK1;SEMA5A;CFL2;PDXP;PFN1;PFDN2;MYLK3;CX3CL1;TEK;VASP;HCK;FCHSD1;SYNPO
gsea,Regulation Of Epithelial Cell Proliferation (GO:0050678),-0.24411627580657735,-0.9338378740796035,0.5447470817120622,0.7054849424859427,1.0,11/52,15.21%,FGFR2;NME2;MAGED1;PRKD1;BAD;HRAS;SOX9;AQP11;ZFP36L1;NME1;NLRC3
gsea,Negative Regulation Of Cell Population Proliferation (GO:0008285),-0.18856332462448575,-0.9338023944490291,0.6672932330827067,0.704843059402367,1.0,79/244,31.46%,FTH1;DYNLL1;APOE;APLP2;MAGED1;TOB1;GSTP1;BTG2;PPM1D;NPM1;PML;HRAS;IGFBP7;GSDME;INHBA;EMD;CSNK2B;DNAJA3;SOX9;TMEM127;FABP3;FOXO4;LYN;AQP11;CEBPA;COPS8;DNAJB2;NME1;OGN;CDKN1B;FABP7;NLRC3;TRIM32;GAS8;KLF10;IGFBP5;BMPR2;BTG1;OPRM1;CGRRF1;MED9;SOX4;WARS1;BMPR1B;RNF139;CDC73;CTCF;B4GALT7;CD300A;TGFB2;FUZ;GTPBP4;ADAMTS8;HMGA1;TBRG1;B2M;NUP62;GPNMB;TMEM115;MFN2;THAP12;PTEN;ING1;NDRG4;ATRAID;DDAH1;MCC;PRKRA;CDKN2D;STK11;MAP2K1;TINF2;CGREF1;TESC;NUDT6;POLR2D;FLCN;CD33;EEF1E1
gsea,Glycerophospholipid Metabolic Process (GO:0006650),-0.2464867314136956,-0.9323448932530256,0.5791505791505791,0.7072339041024641,1.0,6/46,10.58%,SERINC1;GDE1;PAFAH1B1;LCAT;PLA2G7;PRDX6
gsea,Phospholipid Transport (GO:0015914),-0.2450842174491347,-0.9321911969569013,0.5742971887550201,0.7068497145975343,1.0,8/44,15.85%,APOE;VAPA;TRIAP1;SCP2;PRELID3A;LDLR;PLTP;PRELID1
gsea,Positive Regulation Of Ossification (GO:0045778),0.270286742682814,0.932183750180519,0.564755838641189,0.7699043953581506,1.0,3/30,3.15%,SLC8A1;ANO6;FBN2
gsea,Regulation Of Histone Modification (GO:0031056),-0.31161872279366715,-0.9315942011459865,0.5534709193245778,0.7074151512895277,1.0,5/17,19.51%,UBE2N;NFYB;HPF1;TADA3;MBIP
gsea,Establishment Or Maintenance Of Apical/Basal Cell Polarity (GO:0035088),0.28225597143351194,0.93158729612937,0.5425101214574899,0.7699305886652841,1.0,5/22,15.06%,MARK2;DLG5;PATJ;DLG4;SCRIB
gsea,Spindle Assembly (GO:0051225),0.23094881514166915,0.9314890392624272,0.5849802371541502,0.7688391453492811,1.0,15/59,16.43%,CEP192;INO80;NEK7;CLASP1;LSM14A;FLNA;KIFC1;CCDC61;CHEK2;TUBGCP5;STARD9;MAPRE1;CLASP2;NUMA1;KASH5
gsea,Macrophage Activation (GO:0042116),0.2890787496051802,0.9314401309753102,0.5568181818181818,0.7676230365847653,1.0,4/21,6.94%,MAPT;CRTC3;JAK2;PLCG2
gsea,Glycerophospholipid Catabolic Process (GO:0046475),-0.3024232112911904,-0.9304247711501372,0.5459882583170255,0.7092161272972358,1.0,5/18,18.33%,GDE1;PLA2G7;PRDX6;ABHD16A;PNPLA8
gsea,Fibroblast Growth Factor Receptor Signaling Pathway (GO:0008543),-0.27470239918404693,-0.9304111172714068,0.5435606060606061,0.7085378023459826,1.0,6/26,15.55%,FGFR2;FLRT2;RAB14;FGFR1;FIBP;FLRT3
gsea,Regulation Of Protein Tyrosine Kinase Activity (GO:0061097),-0.2615351052229138,-0.9302713072406631,0.549618320610687,0.7081275381623909,1.0,9/31,21.44%,PRNP;RAP2B;GPRC5B;EPHA4;CSF1R;PTPN1;PDGFB;THY1;HYAL2
gsea,Protein Acylation (GO:0043543),-0.26027490920340235,-0.9296212526673208,0.5783132530120482,0.7088208172933045,1.0,11/35,30.35%,SELENOK;GLUL;GTF2B;KAT6A;ZDHHC17;ZDHHC12;ZDHHC23;ZDHHC15;ZDHHC8;NAA10;ZDHHC16
gsea,Response To Molecule Of Bacterial Origin (GO:0002237),0.2619536914847352,0.9293499355356578,0.5769230769230769,0.7712714357514927,1.0,9/30,19.62%,NOS1;LIAS;JAK2;MAPKAPK2;INAVA;FER;TNFRSF11A;PTPN22;ADAM17
gsea,Regulation Of Synaptic Vesicle Exocytosis (GO:2000300),0.30352257697761686,0.9291285932772727,0.5447154471544715,0.7704852758446022,1.0,4/17,14.97%,NLGN1;RIMS1;RIMS2;PREPL
gsea,Positive Regulation Of Interleukin-1 Beta Production (GO:0032731),-0.31083286691017986,-0.9284098022885964,0.5247148288973384,0.7106859091250001,1.0,2/20,5.58%,USP50;EGR1
gsea,Cellular Response To Ketone (GO:1901655),0.2685742030046683,0.927144131825965,0.5755813953488372,0.7738383256748862,1.0,6/27,12.01%,ADCY8;ADCY2;TRERF1;ADCY6;MSN;GAS6
gsea,Regulation Of Cell Cycle G1/S Phase Transition (GO:1902806),-0.23187108715998156,-0.927007048926918,0.5935613682092555,0.7129764680603246,1.0,17/57,21.19%,APLP2;PLK5;BCL7B;PPP2CA;METTL13;BRD7;PSME3;ID2;CDKN1B;SMARCE1;BCL7C;ACTL6B;FBXW7;PHB2;SMARCB1;CDC73;DPF2
gsea,Phosphatidylserine Metabolic Process (GO:0006658),-0.31941561346684433,-0.926008802123136,0.5571142284569138,0.7144798624966903,1.0,1/15,0.35%,SERINC1
gsea,Protein Deacetylation (GO:0006476),-0.25837935709599535,-0.924920088960171,0.5737373737373738,0.7160706643381561,1.0,7/38,15.81%,MORF4L1;MORF4L2;TBL1XR1;CHD3;RBBP7;TBL1X;SIRT6
gsea,Positive Regulation Of Cell-Substrate Junction Organization (GO:0150117),0.2916439903497593,0.9246817445711978,0.5958333333333333,0.778321003711055,1.0,5/21,9.36%,NRG1;ROCK1;MAP4K4;COL16A1;IQSEC1
gsea,Positive Regulation Of Chromosome Organization (GO:2001252),-0.2759754798004939,-0.9245513791014733,0.593939393939394,0.7161486152962774,1.0,12/25,36.86%,RAD21;PML;NCAPH2;TERF1;SIRT6;RAD50;LIG4;KAT5;TINF2;FEN1;SHCBP1L;PPP1R10
gsea,Nuclear-Transcribed mRNA Catabolic Process (GO:0000956),-0.21986289592857733,-0.9244687615376199,0.61,0.7156172171466414,1.0,18/77,23.21%,DDX5;RBM8A;MAGOH;PNRC1;POLR2G;NBDY;MAGOHB;EXOSC4;ZFP36L1;UPF3A;LSM1;CNOT8;CNOT6L;UPF2;NCBP2;EXOSC9;PELO;CNOT11
gsea,Protein Deubiquitination (GO:0016579),0.21513981140754124,0.9234675559212832,0.5945945945945946,0.7798882763314817,1.0,15/80,11.49%,OTUD7A;PRKN;OTUD3;USP7;USP34;USP32;USP47;USP48;USP8;USP24;USP29;USP11;USP3;ZRANB1;USP4
gsea,Pattern Recognition Receptor Signaling Pathway (GO:0002221),0.2794171000362623,0.922752307995975,0.5720823798627003,0.7802976938713825,1.0,4/24,7.64%,TRAF3;MAP3K7;PLCG2;MAPKAPK2
gsea,Negative Regulation Of Smoothened Signaling Pathway (GO:0045879),-0.296458032270926,-0.9226264932623327,0.5623762376237624,0.7188902231245341,1.0,2/21,8.50%,RACK1;HHIP
gsea,Cellular Response To Mechanical Stimulus (GO:0071260),0.2747425588664813,0.9221856718822662,0.5738758029978587,0.7802284042588322,1.0,8/28,20.55%,PDE2A;MAP3K2;SLC9A1;CHEK1;TMEM150C;PIEZO2;NFKB1;MAP2K4
gsea,Receptor Internalization (GO:0031623),-0.26082487226745404,-0.9215278541574566,0.5561904761904762,0.7204761554583029,1.0,7/36,14.52%,CD81;AP2M1;RAMP2;SNCA;RAB31;RALA;RAMP1
gsea,Positive Regulation Of MAP Kinase Activity (GO:0043406),-0.23164012980223075,-0.9214396576306468,0.5783132530120482,0.719947940945903,1.0,12/60,19.30%,RPS3;RASGRP1;MEF2C;DIRAS2;PDGFA;FGFR1;HRAS;ERP29;ADAM9;PTPN1;PDGFB;PDGFD
gsea,Positive Regulation Of Transcription Elongation By RNA Polymerase II (GO:0032968),-0.24722439495512855,-0.9212861320038894,0.5867446393762183,0.7195568002467037,1.0,11/40,21.65%,MED10;MED4;EAPP;MED19;MED31;MED9;MED21;MED22;CDC73;MED7;NCBP2
gsea,Regulation Of Cell Development (GO:0060284),0.25072680674706727,0.9210773898339343,0.5940803382663847,0.7816301216974006,1.0,14/36,26.21%,KAT6B;DOCK7;MYSM1;BRD1;BRPF3;GRN;FXR1;HLTF;HEY2;FBXO22;BRPF1;PER2;BHLHE40;HDAC9
gsea,"Negative Regulation Of Gene Expression, Epigenetic (GO:0045814)",-0.25026097303180295,-0.9208529683788891,0.5923809523809523,0.7197229644192202,1.0,6/40,15.81%,HMGB1;CBX3;PPM1D;MACROH2A1;SPTY2D1;SIRT6
gsea,Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010389),-0.2876312857848879,-0.9204155245282877,0.5794392523364486,0.7198911577248505,1.0,5/22,22.00%,RAB11A;CDK4;RRM1;RRM2B;RCC2
gsea,Regulation Of Neurogenesis (GO:0050767),-0.24630609714931073,-0.9192624403755577,0.5725190839694656,0.721640352614592,1.0,9/44,19.46%,APLP2;SNW1;NAP1L1;CX3CL1;TRIM32;HEY1;PRUNE1;OPRM1;ASCL1
gsea,Regulation Of Behavior (GO:0050795),-0.32698942969761874,-0.91901967508785,0.5576923076923077,0.7214128332022466,1.0,1/15,0.59%,APOE
gsea,Peptidyl-Lysine Modification (GO:0018205),-0.21644418758170608,-0.9171416969890358,0.6107011070110702,0.7247505224088338,1.0,12/74,17.79%,PARK7;SUMO2;EYA1;PLOD2;NSMCE3;NNAT;PML;P3H4;EEF1AKMT1;CBX4;UBA2;NDUFAB1
gsea,Amide Transport (GO:0042886),-0.296246488418786,-0.916785514453195,0.5821782178217821,0.7248178172253322,1.0,5/23,15.02%,VAPA;GJA1;AQP11;PLTP;SLC38A5
gsea,Positive Regulation Of Biomineral Tissue Development (GO:0070169),0.26842559335559935,0.9158187646497734,0.5726141078838174,0.7926999369709499,1.0,3/28,3.15%,SLC8A1;ANO6;FBN2
gsea,Defense Response To Virus (GO:0051607),-0.21098595934819508,-0.9155596063009506,0.6374269005847953,0.7267430976552173,1.0,26/88,29.00%,BNIP3L;NCK1;TTC4;TRIM35;USP27X;UBE2N;ZCCHC3;PML;EXOSC4;G3BP1;TRIM32;RNF185;PQBP1;SAMHD1;PHB2;TBK1;IRF3;NDUFAF4;DDIT4;USP20;MAVS;RELA;TRIM8;CHMP3;DHX16;IFI27
gsea,Regulation Of DNA Metabolic Process (GO:0051052),-0.2041842052615088,-0.9146253491230015,0.6584440227703985,0.7280309367293933,1.0,23/109,21.34%,NUCKS1;SUB1;CHRAC1;PPP2CA;PPP2R1A;NSMCE3;PDGFA;UBE2N;USP22;MPV17;TAF10;UBE2V1;RUVBL1;BABAM2;ENY2;TADA2B;ZBTB38;YY1;TADA3;TAF5;UIMC1;ACTR8;TAF7
gsea,RNA Polyadenylation (GO:0043631),-0.2725304209785059,-0.9142614839981354,0.6003976143141153,0.7280807137885887,1.0,6/24,20.57%,CPSF2;ZCCHC7;PABPC1;GRSF1;CDC73;SSU72
gsea,Tight Junction Assembly (GO:0120192),0.2830086856282752,0.9136241349850371,0.586,0.7964210625024262,1.0,4/22,9.53%,APC;TBCD;PATJ;MPDZ
gsea,Positive Regulation Of Rho Protein Signal Transduction (GO:0035025),-0.315095556584084,-0.9135996986450282,0.5641025641025641,0.728746364247292,1.0,9/18,40.24%,RAC1;RTN4R;LPAR1;MCF2L;F2RL2;GPR35;ADGRG1;ARRB1;GPR18
gsea,Protein Localization To Cell Surface (GO:0034394),0.2892042291671586,0.9135856005617294,0.547945205479452,0.7951478728041315,1.0,5/19,14.11%,FGF10;FLNA;USP4;GGA3;ANK2
gsea,Regulation Of Cell Size (GO:0008361),-0.2881606177105698,-0.9133584098698811,0.5703275529865125,0.728528600030263,1.0,2/20,3.36%,RAC1;MTPN
gsea,Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900015),-0.28027587375514185,-0.9129855902173197,0.6086105675146771,0.7285555318010553,1.0,17/25,47.61%,APLP2;CUEDC2;NLRC3;CHID1;PLD4;MACIR;SIRPA;MYD88;PLD3;STAT3;MAPK9;PER1;TREM2;HIF1A;ABCD2;PDCD4;PYCARD
gsea,Axonemal Dynein Complex Assembly (GO:0070286),0.2794088850129841,0.9123711277924322,0.5876288659793815,0.7966760768351197,1.0,9/22,23.34%,DNAH5;ODAD4;SPAG1;DNAAF4;DNAI4;DNAAF5;DNAH8;CCDC40;CCDC39
gsea,Internal Peptidyl-Lysine Acetylation (GO:0018393),-0.2530022394381264,-0.91085987386712,0.6179337231968811,0.7322602915116412,1.0,13/35,31.64%,MORF4L1;MORF4L2;TAF10;RUVBL1;MRGBP;TADA3;DMAP1;EPC2;TAF12;KAT5;TAF6L;YEATS4;ACTL6A
gsea,Protein Polyubiquitination (GO:0000209),0.18881557956667036,0.9105277421736641,0.6606425702811245,0.7998007468259978,1.0,38/184,18.36%,UBE2E2;UBR5;PRKN;MYCBP2;HUWE1;TRIP12;HACE1;CDC27;UBE3C;TRAF3;UBE4A;SHPRH;ZNRF2;RNF216;DCAF15;KLHL3;ZNRF1;ANAPC5;TRIM71;RNF20;TAF1;TRIM2;KLHL20;BTRC;WSB1;RNF41;MARCHF6;PELI3;ANKIB1;NEDD4L;ANAPC1;UBE4B;NPEPPS;UBE2L3;DZIP3;UBE2R2;NT5C2;RNF144A
gsea,Negative Regulation Of Viral Genome Replication (GO:0045071),0.3022819962688176,0.9100378675913585,0.5781893004115226,0.7995697268167268,1.0,6/18,19.58%,TASOR;SETDB1;PROX1;INPP5K;ILF3;TNIP1
gsea,Post-Transcriptional Regulation Of Gene Expression (GO:0010608),0.2250053907560987,0.9099917061057062,0.6346153846153846,0.7983270429006646,1.0,14/55,20.10%,CYFIP1;ZC3H7A;ATXN2;GCN1;CELF1;GCNT2;TRIM71;YTHDC1;GIGYF2;EIF2S1;NUDT21;MATR3;ELP2;LARP4
gsea,Response To Insulin (GO:0032868),0.22683685887706825,0.9097401677442142,0.6206896551724138,0.7975830568615787,1.0,15/62,17.58%,SORBS1;GCK;PRKDC;GPLD1;C2CD5;AKT2;CPEB1;LPIN1;MYO5A;PPARG;INPP5K;LPIN2;FER;SLC39A14;DENND4C
gsea,Respiratory Tube Development (GO:0030323),0.2865103420456156,0.9090650154335221,0.591792656587473,0.7978180617055033,1.0,3/19,8.45%,PCSK5;ITGA3;NPHP3
gsea,Cellular Response To Alcohol (GO:0097306),0.25058145125423315,0.9088564957754364,0.6065573770491803,0.7969488131157013,1.0,7/34,12.28%,ADCY8;GPLD1;ADCY2;ADCY6;SMO;GRAMD1B;OSBPL7
gsea,Response To Tumor Necrosis Factor (GO:0034612),-0.2347201311432612,-0.9083872450080753,0.639921722113503,0.7366984269551672,1.0,19/53,30.03%,RPS3;GSDME;BAG4;CX3CL1;GCH1;ERBIN;ZFP36L1;TRIM32;ZFAND6;ADAM9;NFKBIA;NUB1;HYAL2;AKT1;RELA;HYAL1;IGBP1;SMPD1;CACTIN
gsea,Nuclear Envelope Organization (GO:0006998),-0.3101316248464197,-0.9065371281466973,0.606,0.7400079825970666,1.0,6/15,32.10%,EMD;VPS4A;TOR1A;NEMP1;LEMD2;LMNA
gsea,Nucleus Organization (GO:0006997),-0.24911368609048012,-0.9065349570353249,0.6078431372549019,0.7392807924172096,1.0,19/38,34.02%,WDR73;CHMP2A;CHMP6;NUP205;RPS19;VPS4A;SEH1L;CTDNEP1;CHMP4C;CHMP7;PITPNB;NUP35;TOR1A;USP36;CHMP3;LEMD2;LMNA;TPR;CHMP5
gsea,Actin Filament Bundle Assembly (GO:0051017),0.272835431915746,0.9061143739028044,0.6085106382978723,0.8020122441610452,1.0,6/24,13.82%,MYO1B;LIMA1;PLS1;ESPN;DPYSL3;EPS8
gsea,Positive Regulation Of Immune Response (GO:0050778),-0.2696402523186152,-0.9057005133442442,0.6159695817490495,0.7404274446747371,1.0,6/28,15.72%,CD81;AKIRIN2;GSDME;XBP1;POLR3D;RNF185
gsea,Regulation Of Macrophage Activation (GO:0043030),-0.308397510637847,-0.9051122866779671,0.5940409683426443,0.740882869129792,1.0,6/16,33.59%,CEBPA;HSPD1;PJA2;SHPK;EHHADH;CD84
gsea,Regulation Of Receptor Recycling (GO:0001919),-0.31244363485362114,-0.9047149052045426,0.587360594795539,0.7410205268612508,1.0,5/15,16.48%,AP1AR;SNCA;LDLR;VAMP3;NSF
gsea,Positive Regulation Of Secretion By Cell (GO:1903532),0.23386275890810462,0.904104797231824,0.6206185567010309,0.8054218641893264,1.0,5/50,4.27%,FRMD4A;CADPS;RAB27A;UNC13B;CLASP1
gsea,Purine Ribonucleotide Catabolic Process (GO:0009154),0.28041516533322075,0.904072433799895,0.6325678496868476,0.8041589656446648,1.0,2/22,0.95%,PDE2A;PDE9A
gsea,Organelle Fission (GO:0048285),-0.28932761399148405,-0.9039662369710939,0.6022727272727273,0.7418582940450872,1.0,7/20,21.12%,MTFR1L;MUL1;MTFP1;PEX19;UCP2;PEX11B;FIS1
gsea,Establishment Of Protein Localization To Membrane (GO:0090150),0.2226784620337518,0.9022640471120861,0.6441351888667992,0.8070640543403744,1.0,10/57,11.81%,RFTN1;RAB3IP;PIKFYVE;MICALL1;ZDHHC21;RABGEF1;ZDHHC2;ZDHHC14;ZDHHC1;RAB3GAP2
gsea,Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0007179),-0.24184858930398037,-0.9013393949624229,0.6094069529652352,0.7466191903958534,1.0,12/45,26.47%,JUN;APLP2;BAMBI;SMAD2;SMAD7;COL1A2;ADAM9;EID2;SMAD9;TGFB2;SMAD5;BMPR1A
gsea,Cellular Response To Chemokine (GO:1990869),0.30574724629961475,0.901007194635177,0.5899581589958159,0.8085939787325335,1.0,6/16,19.89%,RIPOR2;WNK1;DUSP1;CCL25;LRCH1;SLC12A2
gsea,Inflammatory Response (GO:0006954),-0.21505614956637562,-0.9006413371567981,0.6636363636363637,0.7473167505522164,1.0,8/81,11.12%,HMGB1;RAC1;PRDX5;NFKB2;IL18;TUSC2;CX3CL1;CEBPB
gsea,Non-Motile Cilium Assembly (GO:1905515),0.24978905372558974,0.9003710948469464,0.61,0.8087730398673824,1.0,6/31,11.93%,DISC1;IFT88;BBS1;CC2D2B;CC2D2A;C2CD3
gsea,Chromatin Organization (GO:0006325),0.1831854692198905,0.8991155241351706,0.6836283185840708,0.8103030584567708,1.0,35/217,12.49%,SFPQ;CHD8;YEATS2;KAT6B;BAZ2A;EHMT1;ATRX;SATB1;BRD9;MTA2;INO80;KDM2B;SMARCA4;HDAC1;MTF2;BICRA;NFRKB;ARID2;SF3B1;MYSM1;HDAC8;DPF3;CABIN1;SMARCA2;HCFC2;BAZ1B;KDM5B;MTA3;PAXIP1;BPTF;CHD1;BICRAL;CHEK1;HIRA;CHD4
gsea,Protein Import Into Nucleus (GO:0006606),-0.21439914919105282,-0.8985070425789962,0.6594488188976378,0.751068698974468,1.0,15/65,26.33%,RPL17;RAN;APLP2;HIKESHI;NUP50;SEC13;NUP107;IPO8;PHB2;RPAIN;NUP35;AKT1;NUP62;KPNA3;NUP85
gsea,Maturation Of 5.8S rRNA (GO:0000460),-0.3064691435016998,-0.8975722472712216,0.6159844054580896,0.7522225670566782,1.0,7/16,30.59%,EIF6;EXOSC4;PES1;LAS1L;MPHOSPH6;NSA2;MAK16
gsea,Respiratory System Development (GO:0060541),-0.28612144353035146,-0.8967420682612081,0.581573896353167,0.7533061028773802,1.0,2/22,2.29%,BASP1;FGFR2
gsea,Positive Regulation Of miRNA Transcription (GO:1902895),-0.26847184361145515,-0.8960135914255934,0.6146435452793835,0.7540958713327527,1.0,7/25,25.39%,JUN;EGR1;MRTFB;PDGFB;TGFB2;FOXO3;RELA
gsea,Negative Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0030512),-0.22230436436047304,-0.895172418190408,0.6405959031657356,0.7551374680576645,1.0,22/61,35.38%,FKBP1A;SPRY2;PIN1;RBBP7;STUB1;BAMBI;SMAD7;BRMS1;EID2;CIDEA;ARID4A;SIN3A;CAPN5;STRAP;LTBP1;ING1;HDAC2;SPRED1;HTRA4;ADAMTSL2;HSPA1A;IL17RD
gsea,Sprouting Angiogenesis (GO:0002040),-0.243836314070596,-0.8947714972616194,0.6660117878192534,0.7552324412023445,1.0,8/39,15.79%,SEMA5A;VEGFC;RAMP2;VEGFB;OTULIN;TEK;NRARP;EGR3
gsea,Regulation Of G Protein-Coupled Receptor Signaling Pathway (GO:0008277),0.23237314447844862,0.8947686524875885,0.6375,0.8190087184014724,1.0,18/49,22.14%,ROCK1;CAMK2A;RIC8B;RGS11;RGS7;SLC24A4;DGKQ;PDE6H;PLCE1;GRK5;GRK4;MGLL;SLC39A14;GRK6;CAMKMT;GIT2;TULP3;RPGRIP1L
gsea,Mitotic Spindle Assembly (GO:0090307),0.2468477995175851,0.8942140982418796,0.618860510805501,0.8189682234245963,1.0,7/34,10.95%,CEP192;CLASP1;LSM14A;FLNA;KIFC1;CCDC61;CHEK2
gsea,Regulation Of DNA Strand Elongation (GO:0060382),-0.3068248042674486,-0.8936387123540627,0.6,0.7568904497858694,1.0,4/15,20.43%,NUCKS1;RUVBL1;YY1;ACTR8
gsea,Regulation Of Mitochondrion Organization (GO:0010821),0.23680588481068,0.8927006290504592,0.6585365853658537,0.8209690904662045,1.0,6/46,6.95%,PDE2A;PRKN;MAPT;RAP1GDS1;CSNK2A2;SFI1
gsea,Regulation Of Fat Cell Differentiation (GO:0045598),0.23754108711759225,0.8924821564512472,0.6551724137931034,0.8200986494201773,1.0,11/47,16.38%,TRIO;PTPRR;RORA;RUNX1T1;PPARD;ANKRD26;SIRT2;ASXL1;PPARG;ASXL2;CDS1
gsea,acyl-CoA Metabolic Process (GO:0006637),-0.2897801236437799,-0.8922616588200982,0.6214689265536724,0.7589907834271062,1.0,12/18,43.79%,MCEE;HMGCS1;OXSM;ACOT6;ACOT2;ACOT9;ACSL6;ACOT12;ACOT1;ACOT8;ACOT4;SUCLA2
gsea,Negative Regulation Of Microtubule Polymerization Or Depolymerization (GO:0031111),-0.2646396099237422,-0.8914731996336418,0.6239837398373984,0.759842334218698,1.0,9/27,20.72%,NAV3;FGF13;TUBB4A;STMN1;SNCA;CLIP3;FKBP4;MID1IP1;HDGFL3
gsea,Microtubule Nucleation (GO:0007020),0.2759529216967744,0.8896739813100525,0.603082851637765,0.8252376741933388,1.0,5/22,16.67%,CCDC57;CLASP1;TUBGCP5;CLASP2;CENPJ
gsea,Melanosome Assembly (GO:1903232),0.29871631267072063,0.889058405955403,0.6041237113402061,0.8252348821904215,1.0,4/16,13.31%,HPS5;AP1B1;AP3B1;AP3S1
gsea,Positive Regulation Of Mitotic Cell Cycle (GO:0045931),-0.28503887611804013,-0.8885388794104028,0.6098039215686275,0.7651871806292243,1.0,3/20,7.26%,DUSP3;USP2;USP22
gsea,mRNA Metabolic Process (GO:0016071),0.20883005309203811,0.8866490010563114,0.701271186440678,0.8294120368810648,1.0,14/75,14.04%,SFPQ;FBXO11;SRRM4;HNRNPR;AKAP8L;CELF1;NUDT12;AGO4;NCBP1;TCERG1;SRSF1;TBRG4;SRSF5;DIS3L2
gsea,Positive Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042531),0.28227529072470325,0.886292031626161,0.6086956521739131,0.828812094518992,1.0,4/20,10.37%,FLT3;IL31RA;JAK2;ERBB4
gsea,Microglial Cell Activation (GO:0001774),-0.3199153186268437,-0.8861386446566665,0.6088560885608856,0.7696056983052497,1.0,3/15,10.86%,SNCA;CLU;CX3CL1
gsea,Telomere Organization (GO:0032200),0.2207788275998806,0.8860043490636028,0.6900212314225053,0.8280901869396512,1.0,12/52,15.29%,PRKDC;ATRX;INO80;TERF2;NFRKB;WRN;DCLRE1C;HUS1;SIRT2;ERCC4;LTO1;XRCC5
gsea,Cytosolic Transport (GO:0016482),-0.20128421340967884,-0.8856207102215174,0.7077534791252486,0.7699595123957687,1.0,28/107,23.27%,VPS29;RAB6B;BET1L;ARL1;RAB14;RAB6A;STX16;LAMP1;PIP4K2A;EHD3;VTI1B;PLEKHA3;GOSR1;LAPTM5;SNX5;VAMP3;VPS35;SYS1;PHETA1;RNF126;RAB5A;EPS15;CLN5;TBC1D10B;EMP2;VPS52;ARFRP1;VPS26B
gsea,Mitotic Spindle Organization (GO:0007052),-0.21705985310057535,-0.8854054847887973,0.6766467065868264,0.7696326987120773,1.0,21/63,28.96%,RAN;PLK2;STAG1;SMC1A;DCTN6;STMN1;RAB11A;NUDC;NEK6;VCP;RHOA;MAP9;MAP1S;MZT1;SUN2;MAP4;BCCIP;WRAP73;SMC3;INTS13;KIF3B
gsea,Establishment Or Maintenance Of Epithelial Cell Apical/Basal Polarity (GO:0045197),0.23548984985547441,0.884893769971005,0.6487025948103793,0.8292752854916364,1.0,7/36,10.85%,MARK2;MYO9A;DLG5;SH3BP1;PATJ;MSN;DLG4
gsea,Long-Chain Fatty Acid Metabolic Process (GO:0001676),-0.23894036308204844,-0.884575016888547,0.6446601941747573,0.7705908835540275,1.0,8/45,20.59%,ACSL3;GPX4;GSTP1;SCP2;ACSBG1;DAGLB;PNPLA8;PTGR1
gsea,Positive Regulation Of Cytokinesis (GO:0032467),0.28134773372961897,0.8841020058306006,0.6188524590163934,0.8297166618875627,1.0,8/20,22.03%,PRKCE;PKP4;CSPP1;SPAST;BIRC5;CDC14B;CDC25B;CDC14A
gsea,Regulation Of Early Endosome To Late Endosome Transport (GO:2000641),-0.2837348964505413,-0.8826438542591146,0.6400778210116731,0.7736492709579013,1.0,5/18,19.64%,SNX3;EZR;MAPK3;RDX;MAPK1
gsea,NAD Metabolic Process (GO:0019674),-0.3105432081988656,-0.8820445926007545,0.6397748592870544,0.7741231667014539,1.0,5/15,23.55%,MDH1;GPD1L;NMNAT3;VCP;KMO
gsea,Cellular Response To Topologically Incorrect Protein (GO:0035967),-0.28064524114081396,-0.8818810435157276,0.6337209302325582,0.7737150567424242,1.0,6/21,23.11%,BAX;TMBIM6;STUB1;DNAJC18;PTPN1;DAXX
gsea,"Protein Alpha-1,2-Demannosylation (GO:0036508)",0.31014211942736997,0.8817410051531607,0.6450980392156863,0.8335441196429787,1.0,5/15,16.30%,UGGT2;MAN1C1;MAN1A2;MARCHF6;EDEM2
gsea,Positive Regulation Of Metabolic Process (GO:0009893),-0.21397514944395835,-0.8813577466295938,0.6743295019157088,0.7739946421457083,1.0,14/65,21.28%,GNAS;APLP2;IL18;FABP5;ADRB1;CEBPB;GJA1;DIO2;SIRT6;ADIPOR2;GPR3;THRA;UCP2;CNKSR2
gsea,Positive Regulation Of Morphogenesis Of An Epithelium (GO:1905332),0.3123074668861202,0.8813314008219171,0.6201716738197425,0.8331309498433781,1.0,5/15,16.63%,NOG;PIK3CD;SMO;SOX8;EGF
gsea,Negative Regulation Of Cell Cycle G1/S Phase Transition (GO:1902807),-0.26325802309140917,-0.8799684684380197,0.6379310344827587,0.7761154327037858,1.0,8/25,27.48%,METTL13;BRD7;INHBA;FAM107A;CDC73;CRLF3;GPNMB;PTEN
gsea,Nitrogen Compound Transport (GO:0071705),-0.19789281695729946,-0.8793264112137998,0.7238095238095238,0.7767134072570608,1.0,17/107,16.50%,VAMP2;SLC15A2;ARL6IP5;RAMP2;SLC38A2;HIKESHI;SLC3A1;SLC48A1;CHMP2A;TCN2;SLC18A2;ARRDC4;RAMP1;SLC38A5;RUFY1;SLC13A4;LRP1B
gsea,Endodermal Cell Differentiation (GO:0035987),0.28455236972422304,0.8787019719816408,0.6416309012875536,0.8377864967285252,1.0,7/20,21.08%,COL11A1;LAMB1;LAMB3;COL12A1;ITGA4;COL4A2;SETD2
gsea,Sister Chromatid Segregation (GO:0000819),-0.27280032493010276,-0.8786365551629768,0.6299065420560748,0.7774100269865435,1.0,3/23,10.84%,RAN;SMC1A;ZWINT
gsea,Negative Regulation Of Epithelial To Mesenchymal Transition (GO:0010719),-0.2820054264358475,-0.8785470771465197,0.6388888888888888,0.7768409826873912,1.0,7/20,27.48%,SPRY2;PPP2CA;SMAD7;EPHA4;MAD2L2;FUZ;PTEN
gsea,Histone H3 Acetylation (GO:0043966),-0.2473812195949809,-0.8783485640561042,0.6589595375722543,0.776514106751195,1.0,9/34,21.34%,USP22;TAF10;ENY2;TADA2B;NAA60;TADA3;TAF5;MBIP;TAF7
gsea,Anterior/Posterior Pattern Specification (GO:0009952),-0.29716844925023367,-0.8772179943427807,0.6271844660194175,0.7780615012202237,1.0,5/18,16.24%,BASP1;ATP6AP2;SMAD2;BMPR2;HEY1
gsea,Left/Right Pattern Formation (GO:0060972),0.2951598023421312,0.8763377502304207,0.6333333333333333,0.8417310507209075,1.0,7/17,23.18%,DNAH5;PKD2;NPHP3;DNAAF4;MEGF8;GALNT11;SETDB2
gsea,Response To UV (GO:0009411),-0.20482151111160227,-0.876325101437013,0.7115749525616698,0.7791190539608556,1.0,14/87,15.81%,RPL26;COPS9;TRIAP1;NSMCE3;RBX1;PCNA;NPM1;CIRBP;PARP1;SDE2;DDB2;SDF4;TRIM32;SIRT6
gsea,Organelle Fusion (GO:0048284),0.2683018743535212,0.8747937153735726,0.6563786008230452,0.843789731734917,1.0,5/21,16.95%,MIGA2;EEA1;CHCHD3;VPS11;RCC1L
gsea,Nucleotide-Excision Repair (GO:0006289),-0.2293394449829505,-0.87464570946113,0.6903846153846154,0.7817342966102205,1.0,20/48,35.33%,MRPL36;CETN2;POLR2I;RPA3;GTF2H5;DDB2;COMMD1;ERCC3;GTF2H4;FSCN1;LIG4;XAB2;KAT5;POLL;POLD3;GTF2H3;XPA;RAD23B;ERCC1;RAD23A
gsea,Positive Regulation Of Cell Motility (GO:2000147),0.1868752464160422,0.8742480271094388,0.7579617834394905,0.8436606691981061,1.0,18/138,8.73%,SEMA5B;APC;TGFBR1;NTRK3;LAMB1;MAP4K4;TJP1;NTF3;CARMIL1;SEMA4D;PTK2;ACTN4;PIK3R3;TIAM1;AKT2;GCNT2;EPHB2;IGF1R
gsea,Regulation Of Epithelial To Mesenchymal Transition (GO:0010717),0.22027157691587668,0.873824281418483,0.6653465346534654,0.8431851215892702,1.0,16/54,17.80%,TGFBR1;CLASP1;PTK2;EFNA1;TIAM1;GCNT2;MARK1;MTOR;ADIPOR1;EPHA3;DAB2IP;SPRED3;CLASP2;APLF;PHLDB1;HPN
gsea,Positive Regulation Of Vacuole Organization (GO:0044090),-0.27691934435171595,-0.8733825745806778,0.6424116424116424,0.7836037778535855,1.0,3/19,7.10%,PPP3CB;SH3GLB1;PIP4K2A
gsea,Platelet Dense Granule Organization (GO:0060155),0.26967062685042986,0.8724030812377661,0.6386554621848739,0.8449902236256291,1.0,4/20,13.31%,HPS5;AP1B1;AP3B1;AP3S1
gsea,Regulation Of Chondrocyte Differentiation (GO:0032330),0.31926190999475434,0.8722520277367104,0.6044176706827309,0.8439273979232348,1.0,3/15,8.10%,TGFBR1;MBOAT2;SOX5
gsea,Cellular Component Disassembly (GO:0022411),0.2755046741633926,0.8719738466092737,0.6535947712418301,0.8431847727529287,1.0,20/20,72.49%,LAMC1;SH3PXD2B;CTSK;FURIN;ADAMTS15;ADAM8;GSN;MMP15;KIF9;WASHC1;LCP1;MMP19;ADAM15;DYRK3;ADAMTS4;MMP14;PLAAT3;EXOC8;FLOT1;CTSS
gsea,Histone Modification (GO:0016570),-0.2090191840688853,-0.871941931277873,0.7267206477732794,0.7857445490435584,1.0,25/75,31.64%,MORF4L1;MORF4L2;TBL1XR1;UBE2N;CHD3;TAF10;RBBP7;RUVBL1;MRGBP;ENY2;TBL1X;SIRT6;TADA3;BRMS1;DMAP1;EPC2;JADE2;TAF12;MIER1;KAT5;TAF6L;YEATS4;HDAC2;UBE2A;ACTL6A
gsea,Neural Crest Cell Development (GO:0014032),0.2499491830858947,0.8717049841169721,0.6448412698412699,0.8424109677763203,1.0,7/35,14.17%,SEMA5B;NRG1;SEMA4D;ERBB4;SOX8;FAM172A;RADIL
gsea,Endocytic Recycling (GO:0032456),-0.2237599036404162,-0.8713203920453202,0.6719681908548708,0.7862821011023733,1.0,22/53,30.15%,VPS29;RAB14;STX16;EHD3;SNX3;SNX17;ANKRD50;ARL4C;VPS35;EHD1;SNX4;EPS15;RAB11B;VPS52;SNX33;RAB35;ARF6;EHD4;VPS53;ATP6AP1;STX6;WIPF3
gsea,poly(A)+ mRNA Export From Nucleus (GO:0016973),0.2843157760970386,0.8695310297596812,0.6456211812627292,0.845905729765718,1.0,7/16,24.18%,PABPN1;NUP133;NXF1;THOC2;ZC3H11A;IWS1;DDX25
gsea,Mesenchymal Cell Migration (GO:0090497),0.2776345546051607,0.8689073932218745,0.639511201629328,0.8459252810740723,1.0,9/25,26.14%,SEMA5B;SEMA4D;ERBB4;SOX8;RADIL;SEMA6B;SEMA4G;SEMA6A;NELL1
gsea,Microtubule Cytoskeleton Organization Involved In Mitosis (GO:1902850),-0.23291807683368787,-0.8673810587840406,0.6878727634194831,0.7935261838027725,1.0,12/40,28.96%,RAN;PLK2;DCTN6;STMN1;NUDC;NEK6;MAP1S;SUN2;MAP4;BCCIP;INTS13;KIF3B
gsea,Lipid Biosynthetic Process (GO:0008610),0.22160910582609142,0.8669796318165714,0.6835699797160243,0.8488495450298217,1.0,7/46,8.92%,DHRS11;PCYT2;AGPS;ACACA;OLAH;CBR4;ACSS2
gsea,Positive Regulation Of Organelle Organization (GO:0010638),0.2509434114023902,0.8669595417601212,0.6612903225806451,0.8475277850353976,1.0,8/28,15.82%,ELAPOR1;C2CD5;SYNJ1;PLXNA3;AKT2;RAB3GAP2;TOM1;LNPK
gsea,Recombinational Repair (GO:0000725),-0.20356422794526519,-0.8656946334334994,0.7223264540337712,0.7961939524229628,1.0,10/82,10.38%,MORF4L1;NUCKS1;SEM1;SWI5;NSMCE3;SFR1;UBE2N;INIP;RPA3;PPP4C
gsea,Lymphocyte Differentiation (GO:0030098),0.22139776064339897,0.8653370828514445,0.6851851851851852,0.8497806553295116,1.0,14/49,19.33%,FLT3;LCK;PLCG2;PIK3R3;PTPN2;PIK3CD;LMBR1L;DCAF1;HDAC4;RABL3;ITGA4;CHD7;PTPN22;NHEJ1
gsea,DNA Damage Checkpoint Signaling (GO:0000077),0.250124980101113,0.864550054218219,0.676056338028169,0.8501941245175917,1.0,8/28,20.13%,DONSON;CHEK2;HUS1;ERCC4;CHEK1;RAD17;STK33;INTS7
gsea,Protein Monoubiquitination (GO:0006513),0.2360964020800436,0.8639506524678304,0.6702586206896551,0.850094375235938,1.0,16/38,27.43%,PRKN;HUWE1;RNF20;RNF40;KLHL22;UBE2R2;FANCA;UBE2O;ZC4H2;MARCHF7;FANCL;WAC;FAAP100;UBE2T;ITCH;FANCB
gsea,Steroid Biosynthetic Process (GO:0006694),-0.2545523372663436,-0.8638564135472445,0.6684782608695652,0.7989598978648801,1.0,14/30,32.32%,MSMO1;SQLE;SCP2;HMGCR;OSBPL9;HSD17B10;HSD3B7;FDFT1;OSBPL3;CYP46A1;HSD3B2;LSS;PMVK;CYP27A1
gsea,Positive Regulation Of Phosphatidylinositol 3-Kinase Activity (GO:0043552),-0.28512694394024185,-0.8637996673523458,0.66015625,0.7983203053413606,1.0,4/17,18.98%,P2RY12;PRKD1;TEK;PDGFB
gsea,Regulation Of Cold-Induced Thermogenesis (GO:0120161),-0.19919967552115045,-0.8637672298945677,0.7423664122137404,0.797625922279893,1.0,18/94,19.86%,GNAS;APLP2;PLCL1;IL18;FABP5;ACOT11;ADRB1;ACOT13;CEBPB;GJA1;DIO2;SIRT6;ADIPOR2;ALDH1A1;GPR3;THRA;UCP2;CIDEA
gsea,Liver Development (GO:0001889),0.27663349233349255,0.8633269006285597,0.6314699792960663,0.8501466135839941,1.0,5/20,14.08%,NF1;PKD2;NPHP3;TGFBR3;PROX1
gsea,Regulation Of Blood Circulation (GO:1903522),-0.29022379349746036,-0.8610049514896463,0.667953667953668,0.8023934662710496,1.0,6/17,25.04%,CELF2;TPM1;SRI;FXYD1;KCNJ12;S100A1
gsea,Extracellular Matrix Disassembly (GO:0022617),0.2754860123281175,0.8603177512123433,0.6275395033860045,0.8552646422892888,1.0,19/19,72.49%,LAMC1;SH3PXD2B;HPN;CTSK;FURIN;ADAMTS15;ADAM8;GSN;MMP15;KIF9;WASHC1;LCP1;MMP19;ADAM15;ADAMTS4;MMP14;EXOC8;FLOT1;CTSS
gsea,Replication Fork Processing (GO:0031297),-0.23789668322606544,-0.8602804727574237,0.7018867924528301,0.8031833802059737,1.0,9/36,23.03%,NUCKS1;CENPX;PCNA;PARP1;ASF1A;SAMHD1;RAD50;RBBP8;RAD51
gsea,Phospholipid Biosynthetic Process (GO:0008654),0.2602274050187523,0.8598666193219712,0.6940451745379876,0.8549070623998766,1.0,4/23,7.96%,SGMS1;PCYT2;DHDDS;FAR1
gsea,"RNA Splicing, Via Transesterification Reactions (GO:0000375)",-0.26218055460177275,-0.8591782358177591,0.6621880998080614,0.8046709597178487,1.0,6/24,18.37%,SF3B4;SCAF11;TXNL4A;LSM1;MPHOSPH10;SLU7
gsea,Regulation Of Endothelial Cell Apoptotic Process (GO:2000351),0.26898838414639403,0.8591254653882988,0.6951983298538622,0.855155694157237,1.0,7/21,18.52%,ANO6;KRIT1;PLCG1;GAS6;NDNF;ITGA4;MAPK7
gsea,"Nuclear-Transcribed mRNA Catabolic Process, Exonucleolytic (GO:0000291)",-0.29816469788709454,-0.8582386898608604,0.6781376518218624,0.8058343788529367,1.0,5/16,22.26%,POLR2G;EXOSC4;EXOSC3;CNOT8;EXOSC9
gsea,Microtubule Polymerization (GO:0046785),0.24577844524495931,0.8581553780117483,0.6746031746031746,0.8558354266477929,1.0,4/29,5.39%,CCDC57;MAPT;CLASP1;CKAP5
gsea,Positive Regulation Of Pathway-Restricted SMAD Protein Phosphorylation (GO:0010862),-0.2752552522740328,-0.8580598883949659,0.6635514018691588,0.8054349415830984,1.0,14/21,45.77%,INHBA;CSNK2B;BMPR2;BMP6;TGFB2;BMPR1A;SMAD4;DAB2;SDCBP;GDF9;GDF10;BMP8B;TNXB;TGFBR2
gsea,Bicellular Tight Junction Assembly (GO:0070830),0.27397317707794105,0.8577024828674334,0.654690618762475,0.8554912812972489,1.0,2/19,2.32%,APC;TBCD
gsea,Double-Strand Break Repair Via Homologous Recombination (GO:0000724),-0.19607688108672047,-0.8572049331099032,0.7522603978300181,0.8064228253144132,1.0,22/95,23.03%,MORF4L1;NUCKS1;SEM1;SWI5;NSMCE3;SFR1;UBE2N;INIP;RAD21;RPA3;PPP4C;GINS2;GINS4;CDC45;RECQL;YY1;SAMHD1;XRCC2;RNF138;MCM6;RBBP8;RAD51
gsea,Protein Lipidation (GO:0006497),-0.21361931836099118,-0.8571875749776,0.7236084452975048,0.8056942380058246,1.0,19/58,31.18%,SELENOK;DPM3;GLUL;ATG12;DPM2;ZDHHC17;PIGH;PGAP4;DPM1;ZDHHC12;ZDHHC23;ATG10;PIGM;PIGP;ZDHHC15;MPPE1;ZDHHC8;ZDHHC16;PIGB
gsea,Hemopoiesis (GO:0030097),-0.21044590639011476,-0.8564845218868937,0.7392857142857143,0.8062742811227969,1.0,25/74,33.74%,FGFR2;PINK1;INHBA;GLRX5;CEBPB;TEK;LYN;CEBPA;HIPK1;JAG1;EPOR;KAT6A;CSF1R;PDGFB;TGFB2;FST;PLD4;EVI2B;SNRK;PGM3;FLCN;KLF3;PRKX;BMI1;YTHDF2
gsea,Mitotic Sister Chromatid Segregation (GO:0000070),-0.19885616060373495,-0.8563161731649257,0.7560521415270018,0.8058226235463053,1.0,25/85,27.57%,RAN;STAG1;SMC1A;RAB11A;BOD1;CHMP2A;ZWINT;CHMP6;NCAPH2;VPS4A;SEH1L;PHF13;NUDC;CHMP4C;CHMP7;KMT5A;RHOA;MAP9;MZT1;NUP62;BCCIP;KIF18A;WRAP73;CHMP3;SMC3
gsea,Regulation Of Protein Deacetylation (GO:0090311),0.2858938376365249,0.8551005099032783,0.6489795918367347,0.8596302510823167,1.0,1/16,1.06%,YEATS2
gsea,Adenylate Cyclase-Activating G Protein-Coupled Receptor Signaling Pathway (GO:0007189),0.22478651414332104,0.8544449400872685,0.7126948775055679,0.859774117882889,1.0,13/44,17.76%,ADCY8;ADCY2;ADGRB1;ADCY9;ADGRB2;GPR161;ADCY6;ADGRF4;ADCY5;ADGRF2;CRHR1;PTH1R;TCP11
gsea,Response To Lipopolysaccharide (GO:0032496),-0.2086906849514837,-0.8539782912061092,0.7385740402193784,0.8097023121781544,1.0,15/74,21.21%,HMGB1;MEF2C;GSTP1;SNCA;NFKBIB;AXL;GCH1;ERBIN;XBP1;BCL10;ADAM9;CDC73;SHPK;VIM;RHOA
gsea,Positive Regulation Of Intracellular Transport (GO:0032388),0.23916447874045618,0.8536261671154783,0.6828752642706131,0.8600937374630298,1.0,9/35,16.24%,TENM1;ACTN2;PLA2G4E;BCAS3;SPAG5;RIPOR1;ICE1;NUMA1;EIPR1
gsea,Positive Regulation Of Exocytosis (GO:0045921),-0.25173578597563884,-0.852894072255182,0.6898608349900597,0.8110185484951461,1.0,6/26,15.39%,RAB3A;SNCA;CHMP2A;TSG101;VPS4A;ATP13A2
gsea,Positive Regulation Of Neural Precursor Cell Proliferation (GO:2000179),-0.2835930579367888,-0.8516065945094544,0.673036093418259,0.8126999943642745,1.0,4/21,10.86%,FZD3;NAP1L1;HAPLN2;CX3CL1
gsea,B Cell Activation (GO:0042113),-0.23288782647957523,-0.8513645219886216,0.7153846153846154,0.8124431709246361,1.0,8/48,14.55%,RASGRP1;SLC25A5;MEF2C;GPS2;DNAJB9;BANK1;PIK3R1;HSPD1
gsea,Regulation Of Intracellular Transport (GO:0032386),-0.23875255665656253,-0.8501440429486834,0.7082494969818913,0.8140427656680306,1.0,8/32,21.00%,REEP5;LAMP1;CRYAB;ATP13A2;APEX1;PTPN1;RNF139;RAB11B
gsea,Regulation Of Cellular Response To Transforming Growth Factor Beta Stimulus (GO:1903844),0.27369668864602575,0.8497749865477754,0.6770186335403726,0.8667935090354031,1.0,5/18,16.84%,LTBP4;ITGA3;SMURF2;PPARG;TRIM33
gsea,I-kappaB kinase/NF-kappaB Signaling (GO:0007249),0.23307125440541815,0.8497458752616954,0.7125,0.8655052450559296,1.0,8/35,19.23%,CHUK;ROCK1;MAP3K7;IKBKB;ERC1;DAB2IP;NFKB1;AZI2
gsea,Protein Export From Nucleus (GO:0006611),-0.26431528933507764,-0.8490682326368552,0.6764705882352942,0.8154096683097765,1.0,2/22,1.62%,RAN;CALR
gsea,Positive Regulation Of Stress-Activated Protein Kinase Signaling Cascade (GO:0070304),0.29433455202096753,0.8488141748305631,0.6541666666666667,0.8661401492322639,1.0,8/15,30.88%,TAOK1;TAOK2;INAVA;MID1;PDCD10;IGFBP6;STK25;TAOK3
gsea,Response To Glucocorticoid (GO:0051384),0.2874825270901564,0.8486870340533654,0.6600790513833992,0.8650595321464299,1.0,1/15,0.35%,SLIT1
gsea,Cell Cycle G1/S Phase Transition (GO:0044843),0.2289072015151993,0.8461944414096723,0.7394957983193278,0.8688701589428832,1.0,6/40,9.94%,CAMK2A;CCND2;GSPT1;USP29;TRIM71;CUL5
gsea,RNA Phosphodiester Bond Hydrolysis (GO:0090501),0.2580226044196725,0.8453751234457411,0.6970338983050848,0.8692350472028859,1.0,2/22,3.18%,ZC3H12B;DICER1
gsea,Positive Regulation Of Lipid Biosynthetic Process (GO:0046889),0.25361365317201456,0.8443051151032778,0.6754032258064516,0.8700631741147262,1.0,3/27,2.35%,SORBS1;RPTOR;GPLD1
gsea,Regulation Of Vasculature Development (GO:1901342),0.2762234414016529,0.8441060049790859,0.6528066528066528,0.8691236369244072,1.0,3/18,15.00%,NF1;KRIT1;BMPER
gsea,Carboxylic Acid Transmembrane Transport (GO:1905039),0.25316157681352114,0.8438973356758538,0.7189409368635438,0.8682329207164939,1.0,15/28,32.97%,ABCC5;SLC7A8;SLC25A10;SLC38A11;SLC5A6;SLC7A6;SLC38A6;SLC7A5;SLC16A12;SLC38A10;SLC27A1;SLC23A2;SLC19A1;SLC36A4;SLC6A8
gsea,Myeloid Leukocyte Differentiation (GO:0002573),0.2298095801663546,0.8438094328581378,0.7078651685393258,0.867093391690068,1.0,13/42,20.12%,MAPK14;IL31RA;GAB2;CBFA2T3;PIK3CD;CLPB;MYH9;PPARG;SBNO2;TNFRSF11A;FARP2;SNX10;PRTN3
gsea,Positive Regulation Of Innate Immune Response (GO:0045089),-0.27044315408472935,-0.8436973955146495,0.6713995943204868,0.8251316755712782,1.0,5/21,15.72%,USP27X;AKIRIN2;RPS19;POLR3D;RNF185
gsea,Positive Regulation Of Histone Methylation (GO:0031062),0.27842700186507113,0.8431073106449185,0.6977687626774848,0.8672045613224402,1.0,2/16,10.74%,BAZ2A;KANSL1
gsea,Protein Maturation (GO:0051604),0.19036900356868225,0.8420512511865336,0.7876857749469215,0.86793926311604,1.0,15/87,12.60%,PCSK5;ADAMTS3;TSPAN14;ECE1;ECE2;RAP1GDS1;PITRM1;DDI2;MBTPS2;MMP16;LMF1;TSPAN15;PCSK6;BMP1;CPD
gsea,Anaphase-Promoting Complex-Dependent Catabolic Process (GO:0031145),-0.2829997231316463,-0.8417234215652223,0.6680244399185336,0.8281038613097742,1.0,8/17,33.98%,ANAPC13;UBE2S;ANAPC11;CDC26;CDC16;ANAPC15;ANAPC16;FBXO31
gsea,Regulation Of Macromolecule Biosynthetic Process (GO:0010556),0.20991577014333934,0.8413870088494934,0.746031746031746,0.8680006879398368,1.0,4/48,4.61%,CYFIP1;RB1CC1;ATXN2;GCN1
gsea,Mitochondrial Calcium Ion Homeostasis (GO:0051560),0.2807367914307571,0.8410108334620394,0.7021696252465484,0.8674017818275785,1.0,4/16,11.54%,MCU;MICU1;RAP1GDS1;ANXA6
gsea,Negative Regulation Of Cell-Cell Adhesion (GO:0022408),-0.2600161082606455,-0.8408653551302105,0.6986301369863014,0.8289549799466475,1.0,8/22,25.45%,JAG1;RDX;BMP6;MAD2L2;MIA3;GTPBP4;AKT1;MYADM
gsea,mRNA Catabolic Process (GO:0006402),-0.2227091945196557,-0.8408615419480361,0.7227722772277227,0.8281893602437316,1.0,4/40,12.55%,DDX5;NBDY;LSM2;EXOSC4
gsea,tRNA Methylation (GO:0030488),-0.2352792689314736,-0.8407258176206114,0.7504587155963303,0.827670289508028,1.0,7/35,21.36%,DALRD3;TRMT112;WDR4;TRMT12;TRDMT1;LCMT2;HSD17B10
gsea,Adherens Junction Organization (GO:0034332),0.24414601373191713,0.8393812447799311,0.6833667334669339,0.8693158087768242,1.0,7/29,15.00%,CDH12;TBCD;TJP1;MTSS1;CDH11;CDH13;INAVA
gsea,Neural Crest Cell Migration (GO:0001755),0.26216589031493476,0.8392832701874169,0.6733870967741935,0.8681850649200137,1.0,5/26,14.17%,SEMA5B;SEMA4D;ERBB4;SOX8;RADIL
gsea,Regulation Of Metaphase/Anaphase Transition Of Cell Cycle (GO:1902099),-0.24025762153437552,-0.8389008511214796,0.7145669291338582,0.8303501369346022,1.0,8/29,21.19%,BCL7B;BRD7;SMARCE1;NEK6;BCL7C;ACTL6B;SMARCB1;DPF2
gsea,Regulation Of Phosphorylation (GO:0042325),-0.21091664661961934,-0.838871065898892,0.7433962264150943,0.8296347267826406,1.0,10/60,16.15%,DYNLL1;PTGES3;PPP2CA;PIN1;INHBA;LYN;ILK;NOP53;CDKN1B;BCL10
gsea,Negative Regulation Of Chemotaxis (GO:0050922),0.2612580564198996,0.8386580929571155,0.7173489278752436,0.8681133349506226,1.0,4/26,8.75%,SEMA5B;NRG1;SEMA4D;PTPN2
gsea,Regulation Of Mitochondrial Fission (GO:0090140),0.24540982409236028,0.8386382505519354,0.7069306930693069,0.8668336254587576,1.0,3/26,4.76%,PRKN;MAPT;MCU
gsea,Negative Regulation Of Type I Interferon Production (GO:0032480),0.24507200008721391,0.8384339134112142,0.6965376782077393,0.8659452592202249,1.0,3/29,5.72%,PTPRS;RNF216;NPLOC4
gsea,NIK/NF-kappaB Signaling (GO:0038061),0.2505547582876696,0.83757776517587,0.6847826086956522,0.8663666334893224,1.0,5/25,14.00%,CHUK;DICER1;MAP3K7;BTRC;MALT1
gsea,Negative Regulation Of Autophagy (GO:0010507),0.21283519714773974,0.8341056196377313,0.7697368421052632,0.8720715700010594,1.0,15/51,20.98%,RPTOR;ZKSCAN3;NRBP2;LZTS1;MTOR;SIRT2;SNRNP70;RRAGB;KLHL22;EIF4G3;WDR6;KDM4A;PTPN22;PIK3CA;FOXK2
gsea,Positive Regulation Of Protein Localization (GO:1903829),0.19854066102429208,0.8338362059182101,0.809322033898305,0.8712644806672859,1.0,11/74,10.19%,PRKN;CROCC;APC;MAPT;CCDC88A;LIMK2;ENTR1;SLC5A3;NECAB2;BICD1;FYN
gsea,Regulation Of Platelet Activation (GO:0010543),0.2846041823672254,0.8319958168887887,0.6921348314606741,0.8736537117843517,1.0,3/17,6.89%,NRG1;FLNA;JAK2
gsea,Neural Tube Closure (GO:0001843),-0.25103911287274217,-0.8318897010347949,0.7449799196787149,0.8420537714329863,1.0,7/26,24.33%,DYNLL1;VASP;BCL10;VANGL2;TGFB2;FUZ;DVL1
gsea,Regulation Of Nucleic Acid-Templated Transcription (GO:1903506),0.16230670149896093,0.8317901278656326,0.8955223880597015,0.8727290065323334,1.0,50/269,16.06%,SFPQ;SRCAP;YEATS2;KAT6B;NFIA;BAZ2A;TGFBR1;PPARGC1B;ATRX;FOXN2;RORA;FUS;RREB1;GCFC2;NSD1;ESRRG;MTF2;MYT1;SUFU;SSBP2;ACTN4;NCOA2;NSD3;SMARCA2;HCFC2;ZBTB4;WWC1;ZFAT;DNM2;FOXN3;BPTF;ONECUT1;ERC1;CHEK2;ZBTB11;BRD1;RNF20;GON4L;BRPF3;IRF2;POU5F1;TRRAP;ACVR1B;RBAK;LIN54;NONO;MED23;ZZZ3;ATF7;MLLT6
gsea,Positive Regulation Of Actin Filament Polymerization (GO:0030838),0.25244111615769566,0.831782358747931,0.7006507592190889,0.8714279788907957,1.0,5/27,9.14%,BIN1;PRKCE;TENM1;CARMIL1;NCK2
gsea,Macromolecule Catabolic Process (GO:0009057),-0.19987503914551008,-0.8316530298000906,0.7804878048780488,0.8417011997430809,1.0,22/65,31.10%,PABPC4;SQSTM1;SH3GLB1;RNF5;TRIM24;RNASEH1;EXOSC4;EXOSC3;RNASEH2C;APEX1;DFFB;USE1;CAPN3;CLN5;EXOSC9;HTRA2;UCHL3;RNASEH2A;CLN8;HNRNPD;RAB12;MUS81
gsea,Ceramide Metabolic Process (GO:0006672),0.22449971795513746,0.8315706718950877,0.7276422764227642,0.8705360081478007,1.0,7/39,14.05%,ST6GALNAC3;CERS4;SGMS1;CERS6;ALOXE3;CERS5;SGPL1
gsea,Regulation Of BMP Signaling Pathway (GO:0030510),0.21282505016659034,0.8312753785114827,0.7625272331154684,0.8697698880622707,1.0,14/52,21.38%,LRP2;GPR155;ITGA3;NOG;SMURF2;PCSK6;LEMD3;PPARG;BMPER;NUMA1;TRIM33;UBE2O;RBPJ;TNFAIP6
gsea,Plasma Membrane Invagination (GO:0099024),-0.290225534393337,-0.8312251863945,0.7120315581854043,0.8417497337451434,1.0,6/17,25.94%,CDC42;SPIRE1;GULP1;RHOA;SNX33;ALKBH4
gsea,Negative Regulation Of Axon Extension Involved In Axon Guidance (GO:0048843),0.2941702918174301,0.8306452366265475,0.6738703339882122,0.8696692325460689,1.0,2/16,6.20%,SEMA5B;SEMA4D
gsea,Telomere Maintenance (GO:0000723),0.20383684362659096,0.8303715008158224,0.7800829875518672,0.8688874405406529,1.0,12/57,15.29%,PRKDC;TENM1;INO80;TERF2;NFRKB;WRN;DCLRE1C;HUS1;ERCC4;LTO1;NSMCE2;XRCC5
gsea,Regulation Of Kinase Activity (GO:0043549),0.21849125534171876,0.8301602059278016,0.7390350877192983,0.8679601207679174,1.0,9/51,11.28%,NTRK3;MAPT;FLT3;NTRK2;IGF1R;ROR1;PLCE1;ERBB4;TTN
gsea,Organelle Disassembly (GO:1903008),0.21316826728361457,0.8291493285400715,0.756701030927835,0.8686320477968619,1.0,15/48,23.23%,RB1CC1;GBF1;PNPLA2;ULK3;ATG2A;ATG2B;HBS1L;ASCC3;ULK2;PLK3;TRIP4;HDAC6;NEDD9;ULK1;GFM2
gsea,Melanosome Organization (GO:0032438),0.23231414800608235,0.828815403589556,0.7379454926624738,0.8679979268146187,1.0,6/29,13.31%,LYST;HPS5;PIKFYVE;AP1B1;AP3B1;AP3S1
gsea,Negative Regulation Of Biomineral Tissue Development (GO:0070168),0.29532571002846514,0.8279329638096713,0.6846652267818575,0.8683697977360886,1.0,3/15,12.01%,ROCK1;ECM1;GAS6
gsea,Negative Regulation Of Neuron Differentiation (GO:0045665),-0.2739791018071534,-0.8274643664544218,0.7155797101449275,0.8479907238955223,1.0,4/18,16.24%,CALR;SOX9;GSK3B;HEY1
gsea,B Cell Differentiation (GO:0030183),0.2295247190288708,0.827250652511947,0.7430997876857749,0.8683450155230467,1.0,10/35,19.33%,FLT3;PLCG2;PIK3R3;PTPN2;PIK3CD;DCAF1;HDAC4;RABL3;ITGA4;NHEJ1
gsea,Protein Localization To Chromosome (GO:0034502),-0.2294963948721737,-0.8252612111511052,0.7333333333333333,0.851226703184283,1.0,7/33,20.93%,BOD1;RAD21;PARP1;SIRT6;IFFO1;CHMP7;CTCF
gsea,Response To Light Stimulus (GO:0009416),0.22551801878474223,0.8251661299774173,0.7453416149068323,0.8710910011051314,1.0,11/38,19.54%,MAPK10;GTF2H2;BRSK1;SLC24A4;ERCC4;MAP4K3;UBE4B;COPS3;GPR88;ERCC5;UVSSA
gsea,Positive Regulation Of Mitochondrial Fission (GO:0090141),-0.25794198170688365,-0.8247654636603993,0.7192982456140351,0.8513295997016329,1.0,6/19,21.12%,PINK1;RALA;SPIRE1;MUL1;VPS35;FIS1
gsea,Phospholipid Dephosphorylation (GO:0046839),0.2335624068602679,0.8195884433105202,0.7413441955193483,0.8802973321442966,1.0,7/29,14.77%,PLPP4;PLPPR1;OCRL;SYNJ1;MTMR1;INPP5B;INPP5K
gsea,Bile Acid Metabolic Process (GO:0008206),-0.265978756698972,-0.8195052595511543,0.7210144927536232,0.8601956305422822,1.0,7/20,26.60%,SCP2;OSBPL9;HSD17B10;HSD3B7;GBA2;OSBPL3;CYP46A1
gsea,Organelle Assembly (GO:0070925),-0.15959909368664588,-0.8192147097298174,0.945054945054945,0.8599165184471138,1.0,43/274,17.70%,GABARAPL1;ATP6V1D;STX7;ARF4;GABARAPL2;CEP19;GABARAP;MAP1LC3B;BBIP1;ACTR2;HYLS1;VPS28;UBQLN2;ATG12;RAB11A;SEPTIN7;EHD3;CFAP20;RAB1B;CFAP298;CHMP2A;TSG101;CHMP6;FMR1;NUDCD3;MAP1LC3A;IFT20;EMC6;TMEM17;TMEM216;STAM2;VPS4A;TCTN1;UBAP1;BBS2;WDR54;SNAP29;RAB32;AP3S2;CHMP4C;TRAF3IP1;CHMP7;ATG3
gsea,Wnt Signaling Pathway (GO:0016055),-0.215050442583605,-0.817958281775331,0.7461832061068703,0.8613941061146868,1.0,17/52,35.64%,CPE;CSNK1E;FZD3;FZD2;FZD4;NR4A2;WNT16;VPS35;CSNK1A1;DVL1;TCF7L1;PTEN;FZD6;WNT5B;FZD8;CELSR2;DIXDC1
gsea,Positive Regulation Of Myoblast Differentiation (GO:0045663),0.22946227107730882,0.8177929562856452,0.7910750507099391,0.8823941067120483,1.0,6/33,8.66%,RIPOR2;MAPK14;SMARCA4;ARID2;DPF3;SMARCA2
gsea,Negative Regulation Of Cell Cycle (GO:0045786),-0.20855651837564607,-0.817668847483767,0.7894736842105263,0.8611317990805627,1.0,16/51,31.00%,NR2F2;BRINP3;TRIM35;BTG2;CEBPA;RHOB;CDKN1B;BTG1;HEXIM2;HTRA2;PTEN;TSPYL2;NR4A1;LATS2;SIPA1;NUDT6
gsea,Positive Regulation Of Stress-Activated MAPK Cascade (GO:0032874),0.1931663330745844,0.8175906411905209,0.8251599147121536,0.8814684857019125,1.0,15/72,15.00%,TAOK1;TRAF3;AXIN1;MTURN;MAP3K4;MAP3K5;WNT7A;SH3RF3;ANKRD6;TNFRSF19;SH3RF1;TNIK;TAOK2;DAB2IP;INAVA
gsea,Import Into Nucleus (GO:0051170),-0.19427177767268716,-0.8173686861901804,0.8263473053892215,0.8608710598829221,1.0,14/65,26.33%,RAN;APLP2;HNRNPA1;HIKESHI;NUP50;SEC13;NUP107;IPO8;PHB2;RPAIN;AKT1;NUP62;KPNA3;NUP85
gsea,Negative Regulation Of Intracellular Signal Transduction (GO:1902532),-0.17452481544652404,-0.8172553856121373,0.8811700182815356,0.8602776731629322,1.0,51/167,31.09%,TMSB4X;RACK1;PEBP1;DUSP3;PDCD6;NDUFA13;DUSP7;GSTP1;PPP2CA;PPP2R1A;PINK1;BANK1;TMEM127;LYN;TLE1;NOP53;MUL1;NLRC3;AKT1S1;TBC1D7;DUSP8;LIMD1;MAPKAPK5;GPD1L;DUSP5;UACA;TSPAN6;NOL3;HYAL2;ENDOG;DDIT4;USP20;DUSP16;P2RX7;RNF34;RELA;MYADM;PIK3IP1;MAPKBP1;PIK3CB;PSMD10;PTEN;DUSP6;NLRX1;PIK3R2;DAG1;NDUFS3;CACTIN;HERPUD1;EPM2A;FLCN
gsea,Double-Strand Break Repair Via Nonhomologous End Joining (GO:0006303),-0.2190111526351155,-0.8158581927296964,0.7902621722846442,0.8619825952622463,1.0,2/38,4.77%,HMGB1;POLQ
gsea,Proteolysis (GO:0006508),0.16879145867563336,0.8158347184175841,0.9099099099099099,0.8833438323816408,1.0,30/176,14.42%,ADAMTS17;PCSK5;ADAMTS20;ADAMTS3;ECE1;LRP8;ECE2;ADAMTS18;PITRM1;IDE;DDI2;PLAT;SENP1;TRABD2B;ERAP1;ADAM12;CAPN15;ADAM22;MMP16;CPNE1;PCSK6;XPNPEP1;BMP1;CPD;CLPX;PEPD;MALT1;ADAMTS2;USP25;ADAMTS16
gsea,Macromolecule Modification (GO:0043412),-0.19975164656189534,-0.8154468318433624,0.8192307692307692,0.8619535795371007,1.0,15/66,21.77%,UBA52;CPE;NEDD8;PLOD2;ADPRH;FBXW2;UBE2S;PARP1;SLC35A1;LCMT1;PIGH;UBA3;PARP4;ST6GAL1;B4GALT7
gsea,Regulation Of DNA Replication (GO:0006275),-0.20006108359557706,-0.8144964197034718,0.8062015503875969,0.8628249428027738,1.0,7/61,11.14%,NUCKS1;CHRAC1;PPP2CA;PPP2R1A;PCNA;RUVBL1;TERF1
gsea,Retinoid Metabolic Process (GO:0001523),0.27498594279991717,0.814202867279352,0.7203389830508474,0.8849542607944372,1.0,2/16,4.86%,LRP2;LRP8
gsea,Non-Membrane-Bounded Organelle Assembly (GO:0140694),0.18238913163209208,0.8121977882001064,0.8497757847533632,0.887271942604409,1.0,25/96,17.18%,ATXN2;MAPT;INO80;NEK7;LSM14A;SFI1;TIA1;PATL1;BICD1;CCDC61;TUBGCP5;STARD9;MAPRE1;EIF2S1;CAPRIN1;PGM5;CENPE;ZFYVE1;CDS1;KASH5;TMOD1;FXR1;SH3PXD2B;FARP2;YTHDF3
gsea,Membrane Assembly (GO:0071709),0.23247425269194208,0.8120562729749983,0.753061224489796,0.8862194127649018,1.0,6/31,13.69%,NLGN1;PTPRD;RFTN1;SPAST;STX2;SPTBN1
gsea,tRNA Modification (GO:0006400),-0.1995101705884208,-0.8116991428563112,0.8063943161634103,0.866920814937609,1.0,10/64,17.15%,THUMPD1;TRMT112;KTI12;DUS4L;DUS1L;WDR4;TRMT12;YRDC;TRDMT1;PUSL1
gsea,RNA Modification (GO:0009451),-0.21290515967016566,-0.8112168476921311,0.7763401109057301,0.8669986239552276,1.0,19/45,40.15%,THUMPD1;NOP10;HNRNPAB;KTI12;WDR4;HENMT1;TRDMT1;LCMT2;TSR3;SSB;MRM1;OSGEP;NSUN6;RBM15;ELP5;METTL1;MRM2;METTL3;ALKBH1
gsea,Transport Along Microtubule (GO:0010970),-0.26173552581125126,-0.8100026266042992,0.7386363636363636,0.8684371123236203,1.0,4/19,14.44%,CDC42;CLIP3;COPG2;COPG1
gsea,Purine-Containing Compound Biosynthetic Process (GO:0072522),0.27248998297175603,0.8097368129936432,0.7302504816955684,0.8890201855429412,1.0,3/15,11.33%,PFAS;SLC4A7;MTHFD1
gsea,Establishment Of Protein Localization To Organelle (GO:0072594),-0.19070882616834145,-0.8085087929999674,0.860236220472441,0.8703214996218402,1.0,22/75,27.47%,RAN;APLP2;LAMP1;HIKESHI;RAB11A;PINK1;NUP50;RALA;SEC13;NUP107;IPO8;PEX19;PHB2;RPAIN;HK1;IL10RA;AKT1;NUP62;KPNA3;NUP85;ZDHHC15;HK2
gsea,Determination Of Bilateral Symmetry (GO:0009855),0.2796962331176839,0.8080927592244873,0.7520661157024794,0.890604628956031,1.0,3/15,8.45%,DNAH5;PKD2;NPHP3
gsea,Mitotic Nuclear Division (GO:0140014),0.22669604112406008,0.8078732260134209,0.7916666666666666,0.8897293875894238,1.0,10/33,15.32%,INO80;CLASP1;KLHDC8B;KIFC1;SPAG5;SPAST;KLHL22;EPS8;CLASP2;CTDP1
gsea,Regulation Of Myotube Differentiation (GO:0010830),0.26375716816319134,0.8078675991151285,0.736734693877551,0.8884410792429711,1.0,8/18,26.21%,MAPK14;HDAC1;CCN3;HDAC4;FBXO22;SMYD1;HDAC3;HDAC9
gsea,Multivesicular Body Sorting Pathway (GO:0071985),-0.26059105019206275,-0.807590209298678,0.7379032258064516,0.8711683475370927,1.0,5/20,17.53%,CHMP2A;CHMP6;VPS4A;CHMP4C;CHMP7
gsea,Positive Regulation Of Signaling Receptor Activity (GO:2000273),0.25170098594749757,0.806608658770769,0.7681451612903226,0.8894297391022981,1.0,6/22,11.62%,SHANK3;HDAC1;JAK2;EPHB2;RELN;TAF1
gsea,Mitotic Cytokinesis (GO:0000281),0.21265498667468719,0.8048625484156069,0.8292682926829268,0.8910921603296034,1.0,15/45,22.21%,APC;ROCK1;EXOC6B;KLHDC8B;USP8;SPAST;ARL3;SPTBN1;MITD1;EXOC6;BIRC5;PDCD6IP;NUSAP1;EXOC2;EXOC5
gsea,Negative Regulation Of T Cell Activation (GO:0050868),0.27272719958083386,0.8045975825287554,0.7415730337078652,0.8902423401470536,1.0,3/17,7.84%,RIPOR2;DLG5;TNFRSF21
gsea,Glial Cell Development (GO:0021782),0.2592076255167526,0.8043148913547542,0.7434869739478958,0.8894451789041695,1.0,7/19,28.88%,NF1;NRROS;PICK1;NSUN5;MYRF;EIF2B3;EIF2B2
gsea,Establishment Of Protein Localization To Extracellular Region (GO:0035592),-0.23132986665850153,-0.8035750360727284,0.7532956685499058,0.877267734080548,1.0,15/31,37.41%,RAB3A;CANX;COPG2;COPG1;MIA3;TVP23B;ARL4D;RAB12;NECAB3;SVBP;PREB;RAB13;RAB3D;MIA2;RAB8A
gsea,Nuclear Migration (GO:0007097),0.2789687389954006,0.8030701688602916,0.7608247422680412,0.8902996053961465,1.0,4/15,17.12%,DOCK7;TMEM201;HOOK3;CLMN
gsea,Lysosome Localization (GO:0032418),-0.22038968886175372,-0.8029123154142593,0.7969052224371374,0.8775820122293103,1.0,4/35,12.69%,RAB3A;TMEM106B;CHGA;PIP4P1
gsea,Mononuclear Cell Differentiation (GO:1903131),0.267433076110137,0.8026838236404339,0.7188940092165899,0.8896140732769877,1.0,5/19,13.62%,FLT3;IL31RA;GAS6;MYH9;PPARG
gsea,Regulation Of Axon Extension Involved In Axon Guidance (GO:0048841),0.2686066774153036,0.8004168121319928,0.7221135029354208,0.8922416250813182,1.0,11/20,32.14%,SEMA5B;SEMA4D;SEMA6B;MEGF8;SEMA4G;SEMA6A;NELL1;SEMA4F;SEMA3E;SEMA3D;VEGFA
gsea,Negative Regulation Of Epidermal Growth Factor Receptor Signaling Pathway (GO:0042059),0.2551655529912981,0.8002097979630646,0.7642276422764228,0.8913278069317264,1.0,7/19,18.98%,ZFYVE28;PTPN2;DAB2IP;PTPN3;SNX6;MVP;ITGA1
gsea,Positive Regulation Of Cell Division (GO:0051781),0.2500999971060543,0.7984965112241852,0.7293388429752066,0.8930298265477526,1.0,5/22,11.30%,PRKCE;PKP4;CSPP1;SPAST;SIRT2
gsea,Negative Regulation Of Epithelial Cell Apoptotic Process (GO:1904036),-0.2528527540505276,-0.7983853781080662,0.7591240875912408,0.8844658914335917,1.0,3/23,11.97%,SEMA5A;RAMP2;TEK
gsea,Selective Autophagy (GO:0061912),0.2007072796625547,0.7977178388342892,0.8210526315789474,0.8930548210011438,1.0,10/50,14.68%,PRKN;RB1CC1;WDFY3;KLHL3;TAFAZZIN;AMBRA1;ULK3;ATG2A;ATG2B;LRBA
gsea,Base-Excision Repair (GO:0006284),0.2269432706457886,0.7969289543889061,0.7853982300884956,0.8931178757544596,1.0,4/31,8.67%,HUWE1;APEX2;WRN;USP47
gsea,Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090092),-0.24391644485359554,-0.7968730364422874,0.774859287054409,0.8861415054361711,1.0,9/24,33.85%,FKBP1A;SMAD2;SMAD7;EID2;FST;DKK3;LATS2;NREP;SMAD4
gsea,Rho Protein Signal Transduction (GO:0007266),0.21717320407928498,0.7966914219133655,0.7991803278688525,0.8922345835276352,1.0,10/41,15.72%,MYO9B;ROCK1;SHTN1;GNA12;TNFRSF25;ARHGEF3;CDH13;RIPOR1;EPS8;LIMK1
gsea,Regulation Of Amide Metabolic Process (GO:0034248),0.20969769723319015,0.7966907243859643,0.7930327868852459,0.8909574626932706,1.0,4/39,4.61%,CYFIP1;ROCK1;ATXN2;GCN1
gsea,Cell Chemotaxis (GO:0060326),-0.2295634043753999,-0.796530700430198,0.7667910447761194,0.885922523223633,1.0,2/31,3.64%,ENC1;SEMA5A
gsea,Negative Regulation Of Tumor Necrosis Factor Production (GO:0032720),-0.24293549688049376,-0.7952781583782931,0.7741347905282332,0.886459785375984,1.0,10/25,31.96%,GSTP1;CX3CL1;ARG2;SYT11;NLRC3;CIDEA;EHHADH;CACTIN;CD33;SIRPA
gsea,Negative Regulation Of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903556),-0.24293549688049376,-0.7952781583782931,0.7741347905282332,0.886459785375984,1.0,10/25,31.96%,GSTP1;CX3CL1;ARG2;SYT11;NLRC3;CIDEA;EHHADH;CACTIN;CD33;SIRPA
gsea,Spermatid Development (GO:0007286),0.24470016683736082,0.7950167134401236,0.7552742616033755,0.892500565828761,1.0,9/23,24.80%,NME5;RIMBP3;EIF4G3;TDRD5;YTHDC2;FXR1;RSPH1;DDX25;EPC1
gsea,Negative Regulation Of GTPase Activity (GO:0034260),0.27521141995767395,0.7945619506562573,0.7286324786324786,0.8919815516930095,1.0,4/17,7.24%,BCAS3;GMIP;WNK1;RRP1B
gsea,Import Into Cell (GO:0098657),0.22539561629206628,0.7935880516199958,0.7759674134419552,0.8923416852051402,1.0,10/31,17.34%,LRP2;SLC22A4;SLC5A3;SLC7A8;LRRC8C;LRRC8D;SLC16A2;SLC5A6;SLC39A14;SLC29A2
gsea,Actin Filament Polymerization (GO:0030041),-0.2416246676429229,-0.7922949620338834,0.7912524850894632,0.8906245928041926,1.0,5/25,19.24%,RAC1;WASL;PSTPIP2;SPIRE1;FAM107A
gsea,Regulation Of Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0010803),0.22655025691561304,0.7921232543738551,0.8,0.8934351496351923,1.0,12/31,22.16%,PRKN;MAPKAPK2;CCDC3;IKBKB;PTPN2;CPNE1;GAS6;PELI3;PPP2CB;RFFL;TRAIP;ULK1
gsea,Transcription By RNA Polymerase III (GO:0006383),-0.23024937747004098,-0.7917891044147948,0.7689243027888446,0.890659845432052,1.0,9/27,26.80%,POLR2F;POLR3H;SNAPC5;ZFP36L1;IVNS1ABP;SNAPC1;SNAPC2;POLR2L;RO60
gsea,Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0000079),-0.19825978287446458,-0.7916783064933337,0.8380952380952381,0.8900492133830105,1.0,16/58,27.48%,CDK5R2;NR2F2;CDC37;CDK5R1;CEBPA;CDKN1B;CCND3;PDGFB;HEXIM2;CCNG2;GTPBP4;CCNI;AKT1;BCCIP;PSMD10;PTEN
gsea,Positive Regulation Of Stem Cell Population Maintenance (GO:1902459),-0.21851601408269788,-0.7909864816726032,0.8213592233009709,0.8903696794981788,1.0,12/39,24.01%,BCL7B;RBBP7;SMARCE1;SIRT6;SS18;BCL7C;ACTL6B;BRMS1;SMARCB1;DPF2;ARID4A;SIN3A
gsea,Organic Anion Transport (GO:0015711),-0.20879800329112225,-0.7904693617361925,0.8084714548802947,0.8903901488083344,1.0,13/48,28.35%,SLC25A4;SLC35B3;SLC35A1;SLC35C2;SLC25A24;SLC35B1;SLC25A23;SLC4A3;SLC4A10;SLCO1C1;SLC25A17;SLCO2B1;SLC2A1
gsea,Acetylcholine Receptor Signaling Pathway (GO:0095500),-0.2745664669894815,-0.7891066437531931,0.7718940936863544,0.8918413906805441,1.0,6/15,22.97%,LY6H;CDK5R1;GNA11;CHRNB2;PLCB1;LYPD1
gsea,Male Gonad Development (GO:0008584),-0.25153871803503514,-0.7889936428256614,0.7905282331511839,0.891209556316608,1.0,5/20,22.64%,INHBA;SOX9;ADAM21;MAMLD1;TGFB2
gsea,Osteoclast Differentiation (GO:0030316),0.25540479583175213,0.7879553285577338,0.7483296213808464,0.8990088901717399,1.0,6/19,19.00%,MAPK14;GAB2;SBNO2;TNFRSF11A;FARP2;SNX10
gsea,Visual System Development (GO:0150063),0.240177709456027,0.7874322139541082,0.7867494824016563,0.8985932494475505,1.0,4/27,7.31%,SIPA1L3;PAX6;ADAMTS18;PBX4
gsea,Regulation Of Protein Modification Process (GO:0031399),0.20940755522865834,0.7871175222849991,0.815677966101695,0.8977795191944039,1.0,9/39,16.13%,RB1CC1;CCDC88A;PTK2;CCDC88C;PPP1R16B;ASPSCR1;STAT2;RABL3;FER
gsea,Regulation Of Calcium Ion Transmembrane Transport (GO:1903169),0.2754647587334979,0.7845466295890738,0.7766990291262136,0.9005951533230847,1.0,4/15,10.19%,NOS1AP;NOS1;TRDN;FYN
gsea,Nucleic Acid-Templated Transcription (GO:0097659),0.2212458587771653,0.7833814832099733,0.8198757763975155,0.9011641427080322,1.0,6/32,11.39%,FUBP3;PDE10A;TAF1B;DIDO1;THRB;DTX1
gsea,Negative Regulation Of Telomere Maintenance Via Telomere Lengthening (GO:1904357),0.24740229721077045,0.7832549901055712,0.7794117647058824,0.900088964481807,1.0,5/22,13.06%,TENM1;TERF2;ERCC4;EXOSC10;TENT4B
gsea,"Regulation Of Nuclear-Transcribed mRNA Catabolic Process, Deadenylation-Dependent Decay (GO:1900151)",0.24997566510594552,0.7827999485360734,0.7716535433070866,0.8995624327228476,1.0,3/20,11.07%,TNRC6C;TNRC6B;CNOT1
gsea,DNA Integrity Checkpoint Signaling (GO:0031570),0.2167908413643345,0.7825395792478136,0.8387755102040816,0.8986907675474944,1.0,9/34,20.13%,TIPIN;DONSON;CHEK2;HUS1;ERCC4;CHEK1;SETMAR;RAD17;INTS7
gsea,Regulatory ncRNA Processing (GO:0070918),0.23342233101124327,0.7817593468403908,0.8,0.8986291888771366,1.0,4/25,9.74%,ZC3H7A;DICER1;AGO4;TRIM71
gsea,Regulation Of Phosphatidylinositol 3-Kinase Activity (GO:0043551),-0.23477649137261514,-0.7814869327895099,0.8,0.9023937038204749,1.0,8/25,29.10%,P2RY12;PRKD1;TEK;PIK3R1;PDGFB;PIK3IP1;WDR91;PIK3R2
gsea,Glycolipid Metabolic Process (GO:0006664),0.2366210892996335,0.7808898581164238,0.7823529411764706,0.8987575479441874,1.0,1/24,0.31%,ST6GALNAC3
gsea,Calcium-Dependent Cell-Cell Adhesion Via Plasma Membrane Cell Adhesion Molecules (GO:0016339),0.22764938706055343,0.7806710462774443,0.8083140877598153,0.8978376647417318,1.0,2/28,1.83%,NLGN1;CDH12
gsea,Positive Regulation Of Ras Protein Signal Transduction (GO:0046579),-0.2248272522813071,-0.7764812922748902,0.8018867924528302,0.9093501622492165,1.0,4/33,11.31%,RAC1;RASGRP1;RTN4R;EPO
gsea,Cytoskeleton-Dependent Cytokinesis (GO:0061640),-0.19033017919900677,-0.775632567252482,0.8644400785854617,0.909870112477476,1.0,17/62,24.14%,CFL1;SEPTIN5;STMN1;DCTN3;SEPTIN7;SEPTIN3;RASA1;RHOB;VPS4A;SPIRE1;JTB;RHOA;EXOC3;MYH10;SNX33;RAB35;SEPTIN4
gsea,mRNA Polyadenylation (GO:0006378),0.23016854881958335,0.7738812740158708,0.7907444668008048,0.9070308183016834,1.0,7/23,18.77%,SCAF8;PAPOLA;SYMPK;TUT1;TENT4B;TENT2;CSTF3
gsea,Sphingolipid Biosynthetic Process (GO:0030148),0.1901903105283199,0.7733524792208284,0.8833333333333333,0.906531615675345,1.0,10/61,14.05%,ST6GALNAC5;CERS4;SPNS2;SGMS1;CERS6;LARGE1;ALOXE3;HACD1;CERS5;SGPL1
gsea,Regulation Of Spindle Assembly (GO:0090169),-0.23665429902319174,-0.7733391217251588,0.8085106382978723,0.9125935578789709,1.0,10/26,34.92%,CHMP2A;CHMP6;CHMP4C;CHMP7;SASS6;DRG1;CHMP3;TPR;CHMP5;HSPA1A
gsea,Positive Regulation Of Amyloid Precursor Protein Catabolic Process (GO:1902993),-0.264314296189637,-0.772615425709515,0.7849686847599165,0.912891545862163,1.0,4/17,25.39%,CLU;LYN;EPHA4;RELA
gsea,Negative Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090101),-0.18282969114693842,-0.7713616579449138,0.8727272727272727,0.9139909077270467,1.0,17/84,25.30%,FKBP1A;SPRY2;SKIL;PIN1;RBBP7;STUB1;BAMBI;SMAD7;NBL1;BRMS1;EID2;CIDEA;ARID4A;SIN3A;FST;CAPN5;STRAP
gsea,Vesicle-Mediated Transport To The Plasma Membrane (GO:0098876),-0.18517530367366083,-0.771326743091709,0.8824701195219123,0.9132237931656576,1.0,20/72,23.80%,VPS29;RAB14;STX16;EHD3;SNX3;SNX17;ANKRD50;ARL4C;COMMD1;VPS35;EHD1;SNX4;EPS15;RAB11B;VPS52;STEAP2;OSBPL5;SNX33;RAB35;ARF6
gsea,Negative Regulation Of Telomere Maintenance Via Telomerase (GO:0032211),0.26235076552755354,0.7712592944014405,0.7824267782426778,0.9083375764366056,1.0,4/17,13.06%,TENM1;TERF2;EXOSC10;TENT4B
gsea,Regulation Of Pathway-Restricted SMAD Protein Phosphorylation (GO:0060393),-0.22641077113372632,-0.7704498285415554,0.8264150943396227,0.913736907552917,1.0,8/30,26.47%,PIN1;INHBA;CSNK2B;SMAD7;BMPR2;BMP6;TGFB2;BMPR1A
gsea,Chondrocyte Differentiation (GO:0002062),0.2623094745310315,0.7703783622729887,0.75,0.9083236291257304,1.0,5/23,11.18%,GPLD1;NFIB;SOX5;WNT7A;CCN3
gsea,Atrioventricular Valve Morphogenesis (GO:0003181),-0.26727942725411835,-0.7689397692691616,0.7732793522267206,0.9151543767422841,1.0,6/15,26.47%,OLFM1;BMPR2;HEY1;SOX4;TGFB2;BMPR1A
gsea,Organic Hydroxy Compound Transport (GO:0015850),-0.24701372485078188,-0.768914751302501,0.8174603174603174,0.9143703557254655,1.0,10/19,40.75%,VAPA;SLC16A1;SLC10A3;STRA6;SLCO1C1;SLCO2B1;POLR2D;SLC10A1;SLC44A1;ABCC4
gsea,Rescue Of Stalled Ribosome (GO:0072344),-0.2420393935792231,-0.768111165416873,0.8003992015968064,0.9147441605064621,1.0,8/21,29.08%,RACK1;MTRFR;MTRES1;SKIC8;PELO;TCF25;KLHDC10;RCHY1
gsea,Positive Regulation Of Epithelial To Mesenchymal Transition (GO:0010718),-0.23162030689787944,-0.7670381749621176,0.8136272545090181,0.9154950677616923,1.0,7/29,22.64%,OLFM1;WWTR1;BAMBI;JAG1;SMAD2;EMP2;TGFB2
gsea,Response To Cytokine (GO:0034097),0.1894288798417901,0.766211845117501,0.8920086393088553,0.9131329272855094,1.0,19/66,21.08%,AKAP6;KHSRP;FLT3;NFAT5;JAK2;MAPKAPK2;IL1R1;KLHL20;MAP4K3;DPYSL3;HDAC4;YTHDC2;AFF3;TNFRSF11A;NFKB1;TIMP2;CDK9;LIFR;SETD2
gsea,rRNA Transcription (GO:0009303),0.2567823537254672,0.7653251133923128,0.7505154639175258,0.9131336018459173,1.0,4/16,15.31%,GTF3C2;TAF1B;GTF3C1;GTF3C4
gsea,Regulation Of Mitotic Metaphase/Anaphase Transition (GO:0030071),-0.20343600172778287,-0.764314407334611,0.8659003831417624,0.9186196218743854,1.0,10/41,21.19%,BCL7B;BRD7;ANAPC11;LCMT1;SMARCE1;NEK6;BCL7C;ACTL6B;SMARCB1;DPF2
gsea,Protein Palmitoylation (GO:0018345),-0.22706193713490724,-0.7637045587702712,0.8306122448979592,0.9186441230005343,1.0,9/27,31.08%,SELENOK;GLUL;ZDHHC17;ZDHHC12;ZDHHC23;ZDHHC15;ZDHHC8;ZDHHC16;GOLGA7B
gsea,Regulation Of Mitotic Nuclear Division (GO:0007088),-0.2199106879899195,-0.7634033735675129,0.8403041825095057,0.9182792249153242,1.0,8/33,25.64%,AURKAIP1;PIN1;PDXP;LCMT1;MKI67;PDGFB;NUP62;KIF20B
gsea,Regulation Of Exosomal Secretion (GO:1903541),-0.25818578586400864,-0.7628331859652907,0.7751479289940828,0.9182893047264317,1.0,4/15,14.01%,CHMP2A;TSG101;CHMP6;VPS4A
gsea,Regulation Of Erythrocyte Differentiation (GO:0045646),0.22220049093927913,0.7625825497300602,0.8387799564270153,0.9158363013661157,1.0,6/29,15.79%,PRKDC;MAPK14;BRD1;ARNT;ACVR1B;MAPK11
gsea,Odontogenesis (GO:0042476),-0.27106828259774046,-0.7625402260372469,0.7938931297709924,0.9178918435755419,1.0,5/15,22.76%,FGFR2;INHBA;COL1A2;TGFB2;BCOR
gsea,Positive Regulation Of Notch Signaling Pathway (GO:0045747),-0.2308403378501594,-0.7614938559300831,0.8330058939096268,0.9185396826591428,1.0,6/24,24.16%,TM2D3;JAG1;BMP2K;ENHO;TGFB2;ROBO2
gsea,Apical Junction Assembly (GO:0043297),-0.23161045779181028,-0.7601550715491743,0.7919191919191919,0.9196339634252717,1.0,13/25,37.00%,RAMP2;CTNNA1;VCL;CLDN10;ARL2;RHOA;OCEL1;PAK2;DLG1;PECAM1;PKN2;RAB13;PARD3
gsea,Positive Regulation Of Protein Import Into Nucleus (GO:0042307),-0.24530675489507653,-0.7584045094680054,0.8043912175648703,0.9212529106305491,1.0,6/20,23.94%,RAN;RBM22;PIK3R1;DMAP1;HYAL2;MAVS
gsea,Positive Regulation Of Interleukin-2 Production (GO:0032743),-0.261958559057404,-0.7582334037463428,0.7744360902255639,0.9206955613416319,1.0,1/16,1.43%,RPS3
gsea,Pore Complex Assembly (GO:0046931),-0.2565266703890647,-0.7565393364817156,0.7928286852589641,0.9222804701621329,1.0,4/16,15.27%,BAD;RTN4;NUP205;NUP107
gsea,Negative Regulation Of Osteoblast Differentiation (GO:0045668),-0.2370669695946866,-0.7558917406890566,0.8160469667318982,0.9223734550522311,1.0,5/25,17.12%,RIOX1;RORB;SOX9;RANBP3L;LIMD1
gsea,Negative Regulation Of Organelle Assembly (GO:1902116),0.21070713863810103,0.7557115058238839,0.8609406952965235,0.9242281189282543,1.0,11/34,23.35%,MPHOSPH9;LIMK2;ODF2L;TBC1D30;EVI5L;CDK10;SCFD1;USP10;MTM1;RBM14;LRRK2
gsea,Positive Regulation Of Leukocyte Cell-Cell Adhesion (GO:1903039),-0.24316773575401635,-0.7550969474501452,0.8147448015122873,0.9226380679419026,1.0,9/21,35.31%,CD47;HSPD1;THY1;CCDC88B;RHOA;RELA;NR4A3;SIRPA;CYRIB
gsea,Development Of Primary Male Sexual Characteristics (GO:0046546),-0.239714581105012,-0.7550810983363634,0.8178506375227687,0.9218505265249222,1.0,5/20,22.64%,INHBA;SOX9;ADAM21;MAMLD1;TGFB2
gsea,Positive Regulation Of Telomere Maintenance (GO:0032206),-0.1967607390330237,-0.7550583622416654,0.8797595190380761,0.9210695658479645,1.0,11/46,20.43%,HNRNPA2B1;PML;RUVBL1;TERF1;MAPK3;SIRT6;YY1;MAPKAPK5;MAPK1;RAD50;ACTR8
gsea,Regulation Of Protein Import Into Nucleus (GO:0042306),-0.22589808358065847,-0.7527545329963253,0.8264299802761341,0.9233958893411431,1.0,10/28,29.10%,RAN;RBM22;PIK3R1;SIRT6;DMAP1;HYAL2;SUMO1;MAVS;CHP1;PIK3R2
gsea,Regulation Of T Cell Proliferation (GO:0042129),0.2269600449405219,0.7527451647704069,0.8518518518518519,0.9269658885637037,1.0,4/25,9.14%,DLG5;JAK2;TNFRSF21;NCK2
gsea,Smoothened Signaling Pathway (GO:0007224),0.22482003342484128,0.7511846841853449,0.8137651821862348,0.9277705780409138,1.0,6/26,14.81%,DISP3;CC2D2A;SMO;EVC2;ULK3;TCTN2
gsea,Histone mRNA Metabolic Process (GO:0008334),-0.23484826202134906,-0.7507288389041697,0.8271844660194175,0.9254120665129238,1.0,8/22,27.89%,CPSF2;EXOSC4;LSM1;MBLAC1;SLBP;NCBP2;SSB;XRN1
gsea,Protein Localization To Lysosome (GO:0061462),-0.20490745518131737,-0.7505950020163956,0.856353591160221,0.9247969302705752,1.0,6/39,15.92%,CD81;RTN4;VPS4A;LAPTM5;ATP13A2;KICS2
gsea,Cellular Response To Transforming Growth Factor Beta Stimulus (GO:0071560),-0.19266463908556816,-0.7474577270997571,0.8790983606557377,0.9281495703377428,1.0,13/63,22.64%,JUN;APLP2;MEF2C;SOX9;BAMBI;ZFP36L1;SMAD2;SMAD7;COL1A2;ADAM9;HYAL2;SMAD9;TGFB2
gsea,SCF-dependent Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0031146),-0.20432205433888173,-0.7471160568561953,0.8670520231213873,0.9278125075262843,1.0,6/35,19.34%,FBXL16;RBX1;FBXO9;FBXO6;FBXW7;FBXL3
gsea,Vesicle Cargo Loading (GO:0035459),-0.24606969060019576,-0.7470617598184078,0.8189473684210526,0.9270686848720269,1.0,4/17,14.87%,TMED2;SAR1A;TMED10;SEC13
gsea,Response To Organic Cyclic Compound (GO:0014070),-0.23120233321168837,-0.7430146662748163,0.8138613861386138,0.9317079770897346,1.0,12/24,35.43%,ARL6IP5;IL18;CLU;IGFBP5;CREB1;CHRNB2;ADORA1;CDKN2D;TIPARP;TPR;STAT3;GLDC
gsea,Protein Secretion (GO:0009306),-0.19550531086199627,-0.7420081160993334,0.8802281368821293,0.9322046736763777,1.0,3/46,4.17%,RAB3A;PARK7;CANX
gsea,Sensory Perception (GO:0007600),-0.22018384044549077,-0.7395691919697369,0.8659003831417624,0.9345133131095087,1.0,15/28,41.02%,GNAS;KCNA2;OPRM1;CHRNB2;P2RX7;MYO7A;PDYN;WHRN;OPRL1;PENK;RETREG1;TRPV2;MME;NTSR2;P2RX4
gsea,Cellular Response To Unfolded Protein (GO:0034620),-0.25366062426705094,-0.7393247833222955,0.8030018761726079,0.9339815734659437,1.0,5/16,23.11%,BAX;TMBIM6;HSPD1;PTPN1;DAXX
gsea,Regulation Of Neuroblast Proliferation (GO:1902692),-0.2485365356541057,-0.73739577073727,0.8073022312373225,0.9356227553097121,1.0,3/18,10.86%,FZD3;HAPLN2;CX3CL1
gsea,Protein Sumoylation (GO:0016925),-0.200583570827435,-0.7370122931414398,0.8582677165354331,0.9353059294473021,1.0,4/36,8.67%,SUMO2;EYA1;NSMCE3;PML
gsea,Negative Regulation Of Cell-Matrix Adhesion (GO:0001953),0.22316939392297971,0.7348912428050554,0.8411764705882353,0.947383845008976,1.0,4/23,8.86%,MAP4K4;CASK;BCAS3;NEXMIF
gsea,Regulation Of Telomere Maintenance In Response To DNA Damage (GO:1904505),0.2455720754807751,0.734099261602099,0.8311195445920304,0.9470211213758919,1.0,2/15,6.80%,INO80;NFRKB
gsea,Response To Peptide Hormone (GO:0043434),-0.20605766987112617,-0.7339641207151887,0.88,0.9382666490696102,1.0,7/35,19.25%,EIF6;GNAI1;XBP1;ZFP36L1;IGFBP5;EIF2B5;CREB1
gsea,Positive Regulation Of miRNA Metabolic Process (GO:2000630),-0.20906522701800723,-0.7334339370923625,0.8644400785854617,0.9380866828768082,1.0,8/30,25.39%,JUN;EGR1;HRAS;MRTFB;PDGFB;TGFB2;FOXO3;RELA
gsea,Organonitrogen Compound Catabolic Process (GO:1901565),-0.18545418355825638,-0.7331048129507648,0.9064327485380117,0.9376413438548863,1.0,15/56,25.79%,SQSTM1;TRHDE;GGACT;TST;PLA2G7;RNF5;TRIM24;PNPLA8;USE1;CAPN3;GNPDA1;CLN5;HTRA2;AMDHD2;UCHL3
gsea,Positive Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046427),0.23359448729023802,0.7329889884992898,0.8450106157112527,0.9470249611364836,1.0,10/21,30.44%,CAMK2A;JAK2;ERBB4;CENPJ;GHR;EP300;NOTCH1;KIT;PTK2B;IL4
gsea,B Cell Receptor Signaling Pathway (GO:0050853),0.2407279026042468,0.732455594138149,0.854586129753915,0.9463882736616118,1.0,4/21,10.00%,RFTN1;LCK;PLCG2;PIK3CD
gsea,Regulation Of Nucleotide-Excision Repair (GO:2000819),-0.2186200299505877,-0.730166227668878,0.8560157790927022,0.9403709597479464,1.0,7/26,21.19%,BCL7B;BRD7;SMARCE1;BCL7C;ACTL6B;SMARCB1;DPF2
gsea,mRNA Transcription (GO:0009299),-0.1994009515853907,-0.7298438842256703,0.8982035928143712,0.939954111147827,1.0,12/36,31.59%,DDX5;TAF10;TAF11;CREB1;TAF5;TAF7;NCBP2;TAF12;RXRB;ZBTB1;NR1H2;HIPK3
gsea,Organonitrogen Compound Biosynthetic Process (GO:1901566),0.16540023226669456,0.7285690506181478,0.9574468085106383,0.9498275679217626,1.0,14/93,14.05%,SLC44A5;PCSK5;DMD;CERS4;SPNS2;SGMS1;CHKA;CERS6;LARGE1;SLC44A2;HACD1;BCAT2;CERS5;SGPL1
gsea,Bile Acid Biosynthetic Process (GO:0006699),-0.2428118403744426,-0.728037429136721,0.8553113553113553,0.9412711975858582,1.0,6/18,26.60%,SCP2;OSBPL9;HSD17B10;HSD3B7;OSBPL3;CYP46A1
gsea,Regulation Of Insulin Receptor Signaling Pathway (GO:0046626),-0.20827531611227124,-0.7263617305657826,0.8732673267326733,0.9424449348156898,1.0,3/32,7.10%,NUCKS1;NCK1;PIP4K2A
gsea,Response To Ionizing Radiation (GO:0010212),-0.1849900345179927,-0.7263025720626078,0.924901185770751,0.9416882764542724,1.0,17/58,31.03%,COP1;SWI5;EYA1;INIP;RNF168;BABAM2;RHOB;H2AX;UIMC1;RAD9B;RAD51;LIG4;STK11;KAT5;SMPD1;NABP2;KDM4D
gsea,Negative Regulation Of Insulin Receptor Signaling Pathway (GO:0046627),-0.22987433204100022,-0.7249284491734065,0.8611670020120724,0.9424126492552357,1.0,2/22,7.10%,NCK1;PIP4K2A
gsea,Fatty Acid Beta-Oxidation (GO:0006635),-0.18941269873571356,-0.7238535649821045,0.9009174311926605,0.9428237692428408,1.0,22/44,42.65%,SCP2;MTLN;ACOX1;ECHDC1;IVD;HSD17B10;SLC25A17;EHHADH;CROT;GCDH;MCAT;ACADVL;CRAT;ACOX3;ECI1;ACAA2;ACAT2;ETFB;ECHDC2;ACOT8;DECR1;CPT2
gsea,L-amino Acid Transport (GO:0015807),-0.2428312524355655,-0.7233782618969287,0.8011583011583011,0.9425302300531058,1.0,5/19,22.58%,SLC38A2;SLC38A5;SFXN1;SLC1A3;SLC6A17
gsea,Negative Regulation Of DNA-binding Transcription Factor Activity (GO:0043433),0.1677377389623624,0.7217791557633045,0.9565217391304348,0.9564203337358704,1.0,15/87,14.38%,PKD1;CHUK;USP7;TRAF3;FLNA;SUFU;MTURN;PKD2;PAXIP1;TAF1;GAS6;BTRC;PROX1;HDAC4;DAB2IP
gsea,Regulation Of p38MAPK Cascade (GO:1900744),-0.21500583786139277,-0.7208000115833064,0.8672897196261682,0.944650555503753,1.0,4/26,17.01%,RASGRP1;EZR;PJA2;RELL2
gsea,GPI Anchor Metabolic Process (GO:0006505),-0.22263395728189958,-0.7190756984574177,0.8778195488721805,0.9457563461701142,1.0,8/24,27.36%,DPM3;DPM2;PIGH;PGAP4;DPM1;PIGM;PIGP;MPPE1
gsea,Phospholipase C-activating G Protein-Coupled Receptor Signaling Pathway (GO:0007200),-0.20307652701988954,-0.7180590707449505,0.8867924528301887,0.9460961170788674,1.0,17/37,41.58%,P2RY12;GNA11;GRM1;OPRM1;HTR2A;OPRD1;LPAR1;DRD5;OPRL1;F2RL2;GPR35;TACR1;ADRA1D;GPR83;GPR18;AGT;HTR2B
gsea,Mitochondrial Fusion (GO:0008053),0.23797751436303308,0.7169939342836829,0.8574181117533719,0.9604732454356448,1.0,3/16,16.95%,MIGA2;CHCHD3;RCC1L
gsea,Peroxisome Organization (GO:0007031),-0.21991187609569202,-0.7156719817532401,0.8770161290322581,0.9479135007067909,1.0,7/22,36.30%,PEX12;PEX19;PEX11B;FIS1;PLAAT3;MFF;PEX11A
gsea,Branched-Chain Amino Acid Metabolic Process (GO:0009081),0.2510007106946816,0.7140546696432044,0.845679012345679,0.9623795936906127,1.0,4/15,16.71%,MCCC1;BCAT2;PCCB;BCKDK
gsea,Positive Regulation Of T Cell Differentiation (GO:0045582),-0.19456389974796826,-0.712645771411938,0.9150943396226415,0.9503100176055211,1.0,19/39,38.27%,BRD7;XBP1;SMARCE1;SOX4;ACTL6B;SMARCB1;SART1;FOXO3;SOX12;KAT5;ZBTB1;ACTL6A;GLI3;PNP;SMARCD2;IL4I1;VSIR;SMARCD1;NCKAP1L
gsea,Axoneme Assembly (GO:0035082),-0.22366488760146264,-0.7114122310608445,0.8886861313868614,0.9507717011095084,1.0,9/22,33.49%,PIERCE2;GAS8;DNAAF2;TTLL3;CFAP46;DNAAF10;SPAG17;CCDC65;TOGARAM1
gsea,Peptide Metabolic Process (GO:0006518),0.1900843770592383,0.7097186760105575,0.9148073022312373,0.9655640033611845,1.0,7/39,12.60%,PCSK5;DMD;LTA4H;IDE;ERAP1;MIPEP;CPD
gsea,Interleukin-1-Mediated Signaling Pathway (GO:0070498),0.2322028221602671,0.7087709637398768,0.8524590163934426,0.9652726001736115,1.0,3/17,10.83%,MAP3K7;IKBKB;IL1R1
gsea,Cellular Response To Type I Interferon (GO:0071357),0.2449346613182512,0.707946505353915,0.85,0.9634852637856233,1.0,3/15,14.25%,TRAF3;STAT2;HDAC4
gsea,Type I Interferon-Mediated Signaling Pathway (GO:0060337),0.2449346613182512,0.707946505353915,0.85,0.9634852637856233,1.0,3/15,14.25%,TRAF3;STAT2;HDAC4
gsea,Positive Regulation Of Autophagosome Assembly (GO:2000786),-0.2334189087112309,-0.705880791306414,0.8544698544698545,0.9555757935885087,1.0,2/15,7.10%,SH3GLB1;PIP4K2A
gsea,Alpha-Amino Acid Catabolic Process (GO:1901606),-0.22094591082697465,-0.7058515513062147,0.8757281553398059,0.9547887166015827,1.0,7/21,28.05%,ALDH6A1;GOT2;BLMH;IVD;HSD17B10;KMO;MTRR
gsea,Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120032),0.17358935958245403,0.7048953504956905,0.9478957915831663,0.9652784096220637,1.0,18/62,20.11%,IFT140;IFT88;SDCCAG8;CDKL1;TBC1D9B;PPP1R16B;INTU;DYNLT2B;EVI5;RABEP2;TBC1D24;FER;TBC1D17;FXR1;SGSM3;WDPCP;TBC1D2;DMTN
gsea,Carbohydrate Derivative Transport (GO:1901264),-0.24796956390299452,-0.7047708137381675,0.8396039603960396,0.9550098472872395,1.0,2/16,13.31%,SLC15A2;PLTP
gsea,Negative Regulation Of mRNA Processing (GO:0050686),0.24879829203020443,0.7041241217578708,0.8562753036437247,0.9646932504742034,1.0,10/15,31.72%,SFSWAP;SRSF6;RBM20;SRSF4;PTBP1;SRSF10;RBMX;SRSF7;PCBP4;SRSF9
gsea,Positive Regulation Of Phosphate Metabolic Process (GO:0045937),0.22107530963427374,0.7040509686195546,0.8816067653276956,0.9634699893866501,1.0,2/21,2.77%,ROCK1;DSCAM
gsea,Intracellular Lipid Transport (GO:0032365),0.23507439454861656,0.7026982071106525,0.8464912280701754,0.963492858076147,1.0,3/16,16.31%,SLC25A20;GRAMD1B;ABCD4
gsea,Regulation Of Stem Cell Population Maintenance (GO:2000036),-0.18364815166553006,-0.7026562556742996,0.927063339731286,0.9562618537697677,1.0,17/49,31.99%,BCL7B;RBBP7;SMARCE1;SIRT6;SS18;BCL7C;ACTL6B;BRMS1;SMARCB1;DPF2;ARID4A;SIN3A;ING1;TAF6L;HDAC2;ACTL6A;PTN
gsea,Epithelial Cell Migration (GO:0010631),0.20339746087842175,0.7018369760987859,0.8780487804878049,0.9630374675231635,1.0,10/30,26.18%,ROCK1;TNFRSF25;CDH13;KANK1;STARD13;PIK3CA;MEN1;DAAM2;NELL1;PXN
gsea,Monoubiquitinated Protein Deubiquitination (GO:0035520),-0.205359140419429,-0.7016883743874134,0.8978388998035364,0.9563259363177549,1.0,11/31,31.53%,USP22;TAF10;ENY2;TADA2B;TADA3;TAF5;TAF7;TAF12;TAF6L;USP16;USP1
gsea,Vasculogenesis (GO:0001570),-0.2340234523849058,-0.6995063996962868,0.8809980806142035,0.9576311520503248,1.0,3/18,18.41%,RAMP2;RASA1;EGFL7
gsea,Interstrand Cross-Link Repair (GO:0036297),-0.2013254127032502,-0.6994702794341046,0.9157303370786517,0.9568426540641531,1.0,11/32,33.43%,NUCKS1;CENPX;RNF168;VCP;RAD51;FSCN1;FANCE;XPA;DCLRE1B;FAAP20;XRCC3
gsea,Regulation Of Intracellular Estrogen Receptor Signaling Pathway (GO:0033146),-0.22482946163642656,-0.6984156084021567,0.8624229979466119,0.9570027126962696,1.0,1/19,3.44%,WBP2
gsea,Positive Regulation Of Response To Biotic Stimulus (GO:0002833),0.22010828383930758,0.6977789925491593,0.8875255623721882,0.9656852240176719,1.0,5/22,17.53%,RIOK3;POLR3G;SLC15A4;GRN;DHX9
gsea,Melanosome Localization (GO:0032400),-0.24365882551011736,-0.6972475458653308,0.8565891472868217,0.9572399417298658,1.0,5/15,24.70%,RAB11A;BBS2;BLOC1S5;RAB11B;BLOC1S3
gsea,Endoderm Formation (GO:0001706),-0.2386787055896517,-0.6955872492061798,0.867816091954023,0.958025439605265,1.0,3/18,9.07%,VTN;ITGAV;INHBA
gsea,tRNA Wobble Base Modification (GO:0002097),0.24006230107672524,0.6954915297065399,0.8559837728194726,0.9665753727550849,1.0,15/15,76.02%,ALKBH8;CTU2;ELP2;MOCS3;ELP4;TRMT9B;MTO1;GTPBP3;CTU1;ELP1;ELP6;ALKBH1;ELP5;URM1;ELP3
gsea,Cellular Response To Radiation (GO:0071478),0.20817283594968486,0.694523495156005,0.9281314168377823,0.9661945242989972,1.0,4/25,11.57%,MAPK14;INO80;HUS1;ERCC4
gsea,Regulation Of Spindle Organization (GO:0090224),-0.2383900136126026,-0.692388791118177,0.8725490196078431,0.9602343375222526,1.0,6/17,34.62%,GNAI1;MAP9;NUP62;SASS6;FSD1;DCTN1
gsea,Regulation Of Centrosome Duplication (GO:0010824),-0.2136186891290708,-0.6914113526064224,0.8851224105461394,0.9603628870838569,1.0,4/23,16.46%,PLK2;NPM1;CHMP2A;CHMP4C
gsea,Positive Regulation Of Receptor Signaling Pathway Via STAT (GO:1904894),0.22671629997490272,0.6906055529605628,0.896049896049896,0.9684414549687612,1.0,7/19,24.08%,CAMK2A;JAK2;ERBB4;CENPJ;MGAT5;GHR;EP300
gsea,Carbohydrate Derivative Biosynthetic Process (GO:1901137),-0.2194288777143971,-0.6905016541890798,0.869215291750503,0.9603939918948038,1.0,5/20,20.32%,PDCD6;TPI1;SCCPDH;RRM1;RRM2B
gsea,Membrane Protein Ectodomain Proteolysis (GO:0006509),-0.2252715492435162,-0.6899122678156083,0.8688524590163934,0.9601155835752658,1.0,2/18,7.69%,PSENEN;APH1A
gsea,Positive Regulation Of JUN Kinase Activity (GO:0043507),0.20653085230108317,0.6881416533138861,0.9196787148594378,0.9692973316180008,1.0,11/23,30.88%,MAP3K7;MAP3K4;MAP3K5;DAB2IP;TNFRSF11A;DVL3;MAP3K12;MAP3K10;DVL2;MAP4K2;TAOK3
gsea,Positive Regulation Of Translational Initiation (GO:0045948),-0.23441791427891476,-0.6829902420211075,0.8941176470588236,0.9652941518600368,1.0,9/15,46.47%,POLR2G;EIF2B5;RPS6KB1;YTHDF2;LARP1;UHMK1;CDC123;DAZL;HABP4
gsea,Regulation Of RNA Metabolic Process (GO:0051252),-0.16475250708892913,-0.6797841069083952,0.9647749510763209,0.9672166244815474,1.0,20/70,28.83%,HNRNPA1;USP22;TAF10;HNRNPF;RASA1;PRDX6;ENY2;TADA2B;MBNL1;PQBP1;TADA3;GRSF1;ZC3H10;HNRNPH3;FASTK;METTL18;USP36;TAF12;SON;PRKRA
gsea,Phosphatidylinositol 3-Kinase Signaling (GO:0014065),-0.2144663106117643,-0.6782526406683138,0.9145129224652088,0.9676304281352571,1.0,9/24,29.10%,C1QBP;PIK3R1;ZFP36L1;HTR2A;PIK3C2A;PIK3CB;LTK;PTEN;PIK3R2
gsea,Positive Regulation Of RNA Metabolic Process (GO:0051254),-0.1885132166757526,-0.6782202698593873,0.9393346379647749,0.9668388151128307,1.0,10/32,27.21%,TRMT112;SLC38A2;RBM22;HRAS;PIK3R1;U2AF2;GRSF1;DIMT1;RELA;WDR75
gsea,Negative Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901991),-0.1987356374897459,-0.677068729889054,0.9265873015873016,0.966965026322772,1.0,13/29,40.43%,BRD7;INHBA;ZFP36L1;FAM107A;CDC73;CRLF3;GPNMB;PTEN;DLG1;KANK2;ZFP36L2;JADE1;CDK2AP2
gsea,Phospholipid Catabolic Process (GO:0009395),-0.2122151763799933,-0.6769036319812507,0.8982725527831094,0.9662879040268059,1.0,3/21,14.46%,GDE1;PRDX6;ANGPTL3
gsea,tRNA Metabolic Process (GO:0006399),-0.22948310985895137,-0.6761495320684882,0.8857142857142857,0.9661047382766972,1.0,6/16,31.42%,RPP21;ZFP36L1;FARS2;DTD1;SSB;YARS2
gsea,Icosanoid Metabolic Process (GO:0006690),0.20823208125802173,0.6759259679952755,0.9227467811158798,0.9782386040940041,1.0,7/22,20.35%,MAPKAPK2;FAAH;ALOXE3;EPHX1;MGLL;DAGLA;PLA2G4A
gsea,Interferon-Mediated Signaling Pathway (GO:0140888),-0.2144090949638484,-0.6759114076955189,0.9087301587301587,0.9654633000580728,1.0,9/21,34.66%,IFNGR2;HCK;TBK1;IL10RB;JAK1;MAVS;IFI27;MYD88;IRF1
gsea,Post-Translational Protein Modification (GO:0043687),0.18283943924981305,0.6717635428525077,0.936734693877551,0.9802784375420284,1.0,8/38,18.11%,HLCS;ESCO1;JAK2;BAZ1B;DCAF1;FAM20C;PRKCD;UBE2F
gsea,Protein Acetylation (GO:0006473),0.2004382448122074,0.6710364418056973,0.9262948207171314,0.9795087247832046,1.0,2/24,5.45%,MAPT;ESCO1
gsea,tRNA Wobble Uridine Modification (GO:0002098),0.22746664860838384,0.6703488495084551,0.9100642398286938,0.978750731110879,1.0,15/15,77.28%,CTU2;ELP2;MOCS3;ELP4;TRMU;TRMT9B;MTO1;GTPBP3;CTU1;ELP1;ELP6;ELP5;URM1;ELP3;DPH3
gsea,Regulation Of mRNA Stability (GO:0043488),-0.16786465150885527,-0.6695765931987108,0.9753320683111955,0.9696016872973015,1.0,10/61,16.85%,SERBP1;NPM1;YBX1;CIRBP;PABPC1;FMR1;ZFP36L1;CSDC2;APEX1;PUM1
gsea,Glycoprotein Biosynthetic Process (GO:0009101),-0.1656927211563881,-0.6688990474385877,0.9657258064516129,0.969292065402088,1.0,6/60,8.15%,TMEM59;PDCD6;B3GALT2;DAD1;DDOST;SERP2
gsea,Protein Processing (GO:0016485),0.15586041560474626,0.6685132038888768,0.9824561403508771,0.978780770430187,1.0,25/81,24.78%,PCSK5;ADAMTS3;ECE1;ECE2;PITRM1;DDI2;MMP16;PCSK6;BMP1;CPD;PRSS12;MMEL1;ADAM17;MASP1;SPPL3;TYSND1;ADAMTS13;MYRFL;PSEN1;MYRF;YME1L1;PSEN2;TLL1;BACE1;ADAM19
gsea,Negative Regulation Of Neurogenesis (GO:0050768),-0.2225918070767533,-0.6663962877087829,0.8998073217726397,0.9703373818088571,1.0,8/21,32.40%,YWHAH;RUFY3;EFNB3;THY1;B2M;PTEN;PTN;DPYSL5
gsea,Peptidyl-Glutamic Acid Modification (GO:0018200),0.21821879987760778,0.6650180728201727,0.9305263157894736,0.9800240522716747,1.0,3/17,9.69%,TTLL11;TTLL4;TTLL5
gsea,Regulation Of Chromosome Segregation (GO:0051983),-0.2347031823649965,-0.6641802620254177,0.8884462151394422,0.9711321002623358,1.0,4/15,25.02%,NCAPH2;MKI67;PUM1;CSNK2A1
gsea,Positive Regulation Of Lymphocyte Differentiation (GO:0045621),0.18962182128113714,0.6628531522348713,0.9331797235023042,0.9802972269919111,1.0,7/33,15.76%,PRKDC;SMARCA4;ARID2;SMARCA2;GAS6;PHF10;SMARCC2
gsea,Regulation Of Cell Migration Involved In Sprouting Angiogenesis (GO:0090049),0.21026961116379875,0.6614091176406522,0.9150743099787686,0.980011086351984,1.0,20/20,79.00%,MAP3K3;STARD13;PTGS2;MAP2K5;HDAC9;PDCD10;NOTCH1;DLL4;VEGFA;ITGB1BP1;CARD10;MMRN2;FGF2;KDR;HDAC5;CIB1;RHOJ;JCAD;RHOA;PIK3C2A
gsea,Negative Regulation Of Macroautophagy (GO:0016242),0.20806631879420567,0.6603137406055561,0.9329388560157791,0.9794931787525524,1.0,8/21,23.35%,NRBP2;LZTS1;MTOR;CLEC16A;PIK3CA;SCFD1;MTM1;LRRK2
gsea,Regulation Of Stem Cell Differentiation (GO:2000736),0.17874432689575637,0.6574498082843339,0.9542743538767395,0.9801654286744412,1.0,8/39,16.42%,PRKDC;MTA2;HDAC1;MTA3;NSUN2;CHD4;PUS7;NUDT21
gsea,Negative Regulation Of Lipid Biosynthetic Process (GO:0051055),0.2261189937198859,0.656175088042401,0.8940677966101694,0.9798125139435231,1.0,7/15,30.41%,DCAF5;ERLIN1;UBR4;WDTC1;WNT4;SLC27A1;SIK1
gsea,mRNA Stabilization (GO:0048255),-0.18257069181852936,-0.652917363916617,0.9425925925925925,0.9782127378194414,1.0,4/34,10.54%,IGF2BP3;YBX1;CIRBP;PABPC1
gsea,Membrane Lipid Biosynthetic Process (GO:0046467),0.17062644574742014,0.6510571902718449,0.9814432989690721,0.9819826828298908,1.0,12/45,22.31%,CERS4;SPNS2;SGMS1;CERS6;HACD1;CERS5;SGPL1;SPTLC1;PPM1L;ST3GAL2;ELOVL1;ST3GAL4
gsea,Cell-Cell Adhesion Mediated By Cadherin (GO:0044331),0.20853500862428978,0.6494308454459815,0.9422680412371134,0.9816473999140717,1.0,10/20,28.21%,CDH12;CDH11;CDH13;FER;MMP24;CDH4;CDH10;CDH6;PCDHGB4;DCHS1
gsea,Nucleobase-Containing Compound Catabolic Process (GO:0034655),-0.18412005518964364,-0.6481503857068566,0.9609665427509294,0.9804802127258317,1.0,10/32,31.10%,PABPC4;RNASEH1;EXOSC4;EXOSC3;RNASEH2C;DFFB;EXOSC9;RNASEH2A;HNRNPD;MUS81
gsea,DNA-templated DNA Replication Maintenance Of Fidelity (GO:0045005),-0.18671009951038892,-0.6472194613739128,0.9433962264150944,0.9802270699067916,1.0,3/34,8.02%,NUCKS1;CENPX;PCNA
gsea,Positive Regulation Of Nitrogen Compound Metabolic Process (GO:0051173),0.20054965445648187,0.6464014270509968,0.9299363057324841,0.9822348579185878,1.0,9/21,21.72%,CHRNA7;WNT7A;TMEM106A;EGF;HPN;NFKB1;MAPK7;WFS1;MAP2K5
gsea,Regulation Of rRNA Processing (GO:2000232),-0.21595300086257768,-0.6457689777375811,0.9156626506024096,0.9803073409217248,1.0,5/15,27.21%,TRMT112;DIMT1;METTL18;USP36;WDR75
gsea,Gliogenesis (GO:0042063),-0.22007796792239298,-0.645607003046013,0.9344262295081968,0.979585807637579,1.0,2/17,9.53%,NDUFS2;HAPLN2
gsea,DNA-templated Transcription Elongation (GO:0006354),0.2014993718631013,0.6451494938060025,0.946058091286307,0.9817032980797554,1.0,1/21,0.80%,SRCAP
gsea,Oligodendrocyte Differentiation (GO:0048709),0.2288664303544499,0.6451017423308343,0.9029535864978903,0.9804513261783069,1.0,7/16,28.88%,PTPRZ1;SOX8;SLC8A3;NSUN5;MYRF;EIF2B3;EIF2B2
gsea,Glycolipid Biosynthetic Process (GO:0009247),-0.1781969991933068,-0.6422223323363143,0.9521072796934866,0.980864036278192,1.0,10/35,27.36%,DPM3;SCCPDH;DPM2;PIGH;PGAP4;DPM1;B4GALT6;PIGM;PIGP;MPPE1
gsea,Negative Regulation Of Metabolic Process (GO:0009892),-0.18318052599317627,-0.6406192670429643,0.9653179190751445,0.9810027138033982,1.0,4/33,10.15%,PLCL1;GSTP1;ACOT11;ACOT13
gsea,Zymogen Activation (GO:0031638),-0.2012952912421367,-0.636962219243864,0.9408284023668639,0.9823889178819827,1.0,12/23,36.79%,CYCS;PGK1;BAD;CTSH;CIDEB;CTSL;RIPK2;LGMN;MMP14;CASP8;VSIR;NLRC4
gsea,Water-Soluble Vitamin Metabolic Process (GO:0006767),0.1797310788530831,0.6362560054542368,0.9611231101511879,0.9843911566300654,1.0,2/32,4.15%,HLCS;MMAA
gsea,Modified Amino Acid Transport (GO:0072337),0.21425184583079315,0.634898966057285,0.9266247379454927,0.9838578066728374,1.0,19/19,78.60%,SLC5A6;SLC1A4;SLC7A6;SLC25A32;SLC16A12;SLC25A15;SLC7A2;SLC19A1;SLC6A8;SLC7A3;SLC46A1;SLC38A9;SLC7A11;SLC66A1;SLC7A1;PDPN;CTNS;SLC6A13;SLC25A29
gsea,Organic Cyclic Compound Biosynthetic Process (GO:1901362),0.2136882261902733,0.6317890654352717,0.9438444924406048,0.984269046718599,1.0,2/16,4.84%,DHRS11;LIAS
gsea,mRNA Modification (GO:0016556),0.18905057899966374,0.6308897217225458,0.9397089397089398,0.9834586574247055,1.0,4/26,15.39%,VIRMA;CMTR1;NSUN2;PUS7
gsea,Negative Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000134),-0.1928890032261155,-0.6288391806210233,0.9375,0.9860950394872738,1.0,7/24,27.48%,BRD7;INHBA;FAM107A;CDC73;CRLF3;GPNMB;PTEN
gsea,Peptidyl-Lysine Methylation (GO:0018022),0.1946380941212668,0.6265603694704975,0.951271186440678,0.984476200406076,1.0,2/21,9.00%,EHMT1;EHMT2
gsea,Oligodendrocyte Development (GO:0014003),-0.21714715888720565,-0.6218589167595329,0.9265873015873016,0.9888531177082028,1.0,6/15,40.81%,EIF2B5;B4GALT6;EIF2B1;EIF2B4;SOX10;HES5
gsea,Branched-Chain Amino Acid Catabolic Process (GO:0009083),-0.2081043522387194,-0.6212659962662419,0.9421841541755889,0.9883117833585975,1.0,4/17,21.36%,ALDH6A1;DBT;IVD;HSD17B10
gsea,Hematopoietic Progenitor Cell Differentiation (GO:0002244),0.20398783875970294,0.6198569368954522,0.9556025369978859,0.9864557600286353,1.0,2/16,10.32%,FLT3;LMBR1L
gsea,Neutral Amino Acid Transport (GO:0015804),0.18763679158588875,0.6190494465364518,0.9595959595959596,0.9855671498610359,1.0,9/25,26.65%,SLC1A1;SLC7A8;SLC6A7;SLC1A4;SLC7A6;SLC38A6;SLC6A6;SLC6A15;SLC7A5
gsea,Fatty Acid Catabolic Process (GO:0009062),0.15455686467389104,0.6188561176263403,0.9892241379310345,0.9843838358394449,1.0,12/51,19.21%,AUH;ACAT1;FAAH;LPIN1;PPARD;ACADM;PCCB;LPIN2;ABCD4;ACAD10;AIG1;SLC27A2
gsea,"G Protein-Coupled Receptor Signaling Pathway, Coupled To Cyclic Nucleotide Second Messenger (GO:0007187)",0.18241055741682502,0.6177440596556102,0.9722863741339491,0.9836360055327016,1.0,7/26,19.53%,CHRM3;HTR2C;CHRM2;PTH1R;HRH2;CNR1;HTR4
gsea,Amino Acid Transmembrane Transport (GO:0003333),0.17919664823015952,0.6169427988025322,0.9675456389452333,0.9827169581458043,1.0,7/30,16.26%,SLC22A4;SLC25A22;SLC7A8;SLC16A2;SLC25A12;SLC38A11;SLC7A6
gsea,Negative Regulation Of Stem Cell Population Maintenance (GO:1902455),-0.21155452823177004,-0.6153082625096622,0.9584120982986768,0.9903174712096218,1.0,5/16,31.36%,RBBP7;BRMS1;SIN3A;ING1;HDAC2
gsea,Regulation Of Actin Nucleation (GO:0051125),-0.20596309875689606,-0.6132330003165641,0.95,0.9904809649332018,1.0,6/16,35.12%,ARPIN;WASHC3;CORO1A;WHAMM;CARMIL2;ARFIP2
gsea,Regulation Of Bone Resorption (GO:0045124),0.20743992614135898,0.6119134833522785,0.9557522123893806,0.9836483795140553,1.0,2/18,6.56%,NF1;PLEKHM1
gsea,Regulation Of Calcium Ion-Dependent Exocytosis (GO:0017158),0.18483162736966519,0.6108194313687445,0.9457202505219207,0.9828825542309652,1.0,3/24,11.99%,SYT17;STX1A;SYT1
gsea,Negative Regulation Of Lymphocyte Proliferation (GO:0050672),0.20424908519619253,0.6058613332503147,0.9438202247191011,0.9836440644073186,1.0,2/16,7.84%,DLG5;TNFRSF21
gsea,Establishment Of Spindle Orientation (GO:0051294),-0.1835670452116266,-0.605230776832534,0.9621928166351607,0.9931096590100091,1.0,9/26,34.62%,PAFAH1B1;GJA1;NDE1;MAP4;KAT5;NSFL1C;LLGL2;LLGL1;DCTN1
gsea,Establishment Of Mitotic Spindle Localization (GO:0040001),0.18341775777810768,0.6042494363697636,0.9768421052631578,0.9830255032860584,1.0,5/26,16.00%,CLASP1;HTT;MAPRE1;CLASP2;NUMA1
gsea,Cytosolic Pattern Recognition Receptor Signaling Pathway (GO:0002753),-0.2080629085632157,-0.5942361163592544,0.9595375722543352,0.9966553395457259,1.0,6/15,36.19%,PHB2;TBK1;IRF3;MAVS;CYLD;TIFA
gsea,Establishment Of Mitotic Spindle Orientation (GO:0000132),-0.18763044791330807,-0.5935729718684535,0.9541984732824428,0.9960755501545379,1.0,9/22,43.57%,PAFAH1B1;GJA1;NDE1;KAT5;NSFL1C;DCTN1;FBXW11;ENKD1;GPSM1
gsea,Negative Regulation Of Cold-Induced Thermogenesis (GO:0120163),0.17082643676584452,0.586929481062489,0.9877551020408163,0.9879573857103625,1.0,10/30,22.24%,DOCK7;NPR3;TLE3;IP6K1;LNPEP;ADAM17;TFE3;NOVA2;RBPJ;NOVA1
gsea,Fat Cell Differentiation (GO:0045444),-0.15861400651141883,-0.5850976290067801,0.9803921568627451,0.9982561662760199,1.0,7/43,15.37%,CLIP3;METRNL;CEBPA;SDF4;NR4A2;BBS2;TRIM32
gsea,Purine Nucleotide Metabolic Process (GO:0006163),-0.1764603332229578,-0.5843987864437872,0.9806576402321083,0.997653548870973,1.0,11/25,43.74%,MDH1;GPD1L;IDH2;KMO;CD38;NOX1;GUK1;NUDT15;AMPD2;IDH1;GART
gsea,Transcription Elongation By RNA Polymerase II (GO:0006368),0.17927660159613035,0.5820765636998839,0.9758064516129032,0.9882664189621695,1.0,7/23,22.29%,SRCAP;CTDP1;CDK9;USP15;ELP2;SETD2;IWS1
gsea,Cellular Response To Interleukin-6 (GO:0071354),-0.1943885391012664,-0.5752946220582552,0.9610136452241715,0.9997258219426419,1.0,7/18,35.43%,SELPLG;JAK1;RELA;PTGIS;ST18;SMAD4;STAT3
gsea,Amino Acid Import Across Plasma Membrane (GO:0089718),0.1913046009842242,0.5738351911458919,0.9506172839506173,0.9894522936821482,1.0,4/19,15.19%,SLC22A4;SLC1A1;SLC7A8;SLC1A4
gsea,Regulation Of Meiotic Cell Cycle (GO:0051445),-0.1876493621737789,-0.5725402735967541,0.9744094488188977,0.9997411809035502,1.0,6/18,30.62%,ANAPC13;ANAPC11;CDC26;CDC16;ANAPC15;ANAPC16
gsea,Regulation Of Centrosome Cycle (GO:0046605),-0.19060552398053837,-0.5706656358918214,0.9681050656660413,0.9994466977275852,1.0,3/18,16.46%,NPM1;CHMP2A;CHMP4C
gsea,Membrane Protein Proteolysis (GO:0033619),-0.17098176879957916,-0.5688351471662102,0.9878048780487805,0.9991332299994423,1.0,7/26,29.85%,PSENEN;APH1A;CTSH;ADAM9;PARL;DAG1;AFG3L2
gsea,Spindle Assembly Checkpoint Signaling (GO:0071173),-0.2025330748712619,-0.5650149656257065,0.9685767097966729,0.9977327161076031,1.0,2/15,10.84%,IK;ZWINT
gsea,Mitotic Spindle Checkpoint Signaling (GO:0071174),-0.2025330748712619,-0.5650149656257065,0.9685767097966729,0.9977327161076031,1.0,2/15,10.84%,IK;ZWINT
gsea,Mitotic Spindle Assembly Checkpoint Signaling (GO:0007094),-0.2025330748712619,-0.5650149656257065,0.9685767097966729,0.9977327161076031,1.0,2/15,10.84%,IK;ZWINT
gsea,tRNA Aminoacylation For Protein Translation (GO:0006418),0.18464044072931315,0.5640744881004631,0.9711340206185567,0.9907042947269141,1.0,11/19,33.99%,LARS2;FARSA;NARS2;SARS2;DARS2;RARS2;HARS2;FARSB;MARS2;TARS2;IARS2
gsea,RNA Catabolic Process (GO:0006401),-0.14362851931086168,-0.5630080471666143,0.9962049335863378,0.9974216830410947,1.0,21/48,41.92%,PABPC4;LSM2;RNASEH1;EXOSC4;EXOSC3;RNASEH2C;LSM5;EXOSC9;RNASEH2A;HNRNPD;FEN1;YTHDF2;HSPA1A;DCP2;ZFP36L2;LSM6;EXOSC7;METTL3;CNOT10;RNASEH2B;EXOSC2
gsea,Negative Regulation Of Mitotic Metaphase/Anaphase Transition (GO:0045841),-0.1979132184596396,-0.5574219114038816,0.9628942486085343,0.9979623591756669,1.0,2/16,10.84%,IK;ZWINT
gsea,Regulation Of Chromatin Organization (GO:1902275),-0.17246808405314412,-0.556615221210598,0.9824561403508771,0.9973261705885191,1.0,5/23,24.72%,PHF20;MKI67;HCFC1;RLIM;SSRP1
gsea,Fatty Acid Oxidation (GO:0019395),-0.15215326658392736,-0.5558987593732844,0.988527724665392,0.9966774727862331,1.0,18/39,42.65%,SCP2;MTLN;ACOX1;ADIPOR2;ADH5;ECHDC1;HSD17B10;SLC25A17;EHHADH;CROT;MCAT;ILVBL;ECI1;ACAA2;ACAT2;ECHDC2;DECR1;CPT2
gsea,Amino Acid Transport (GO:0006865),-0.1601949650145718,-0.552535138508039,0.9858870967741935,0.9966158967110257,1.0,10/33,34.26%,SLC38A2;SLC3A1;SLC38A5;SLC25A29;SLC6A17;SLC7A10;SLC3A2;SLC7A14;SLC25A44;SLC16A10
gsea,Endothelial Cell Migration (GO:0043542),-0.16404742464926847,-0.5524947921372092,0.9907407407407407,0.9958045669584734,1.0,9/26,35.25%,LGALS8;EGR3;TNFSF12;RHOA;EMP2;GIPC1;NR4A1;PRKX;RAB13
gsea,Regulation Of Notch Signaling Pathway (GO:0008593),-0.1389962628589413,-0.5495879376029567,0.9962335216572504,0.9955854589979969,1.0,21/53,39.99%,TM2D3;JAG1;NRARP;HEY1;BMP2K;ENHO;EGFL7;FBXW7;TGFB2;AKT1;SREBF2;RFNG;LLGL2;LLGL1;YTHDF2;STAT3;MMP14;ARRB1;LFNG;ZBTB7A;METTL3
gsea,Negative Regulation Of Notch Signaling Pathway (GO:0045746),-0.1769876558311294,-0.5430302013592411,0.9781021897810219,0.9961240220880121,1.0,10/20,39.99%,NRARP;HEY1;EGFL7;FBXW7;YTHDF2;MMP14;ARRB1;LFNG;ZBTB7A;METTL3
gsea,Protein Deacylation (GO:0035601),-0.17630809959515575,-0.5400175621322323,0.9801587301587301,0.9958934435834789,1.0,9/19,38.45%,ABHD17A;SIRT6;LYPLA1;ABHD17C;HDAC10;LYPLAL1;SIRT5;SIRT3;PPT1
gsea,Negative Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043124),0.15219175970913734,0.5397616755109163,0.994140625,0.9947854578387839,1.0,2/31,3.95%,RIOK3;RORA
gsea,Peroxisomal Membrane Transport (GO:0015919),-0.1771031099739701,-0.5392409835342813,0.9793233082706767,0.9952028503743716,1.0,3/17,26.88%,PEX12;PEX19;PEX5
gsea,Negative Regulation Of Myeloid Leukocyte Differentiation (GO:0002762),0.17973714799014232,0.5325294510685045,0.9931506849315068,0.9947834762143828,1.0,4/16,21.38%,PTPN2;MAFB;FBN1;TNFAIP6
gsea,L-alpha-amino Acid Transmembrane Transport (GO:1902475),0.15633035017590877,0.5257513800784428,0.9847826086956522,0.9945891811243482,1.0,6/31,16.26%,SLC1A1;SLC25A22;SLC7A8;SLC25A12;SLC1A4;SLC7A6
gsea,Zinc Ion Transmembrane Transport (GO:0071577),-0.17226573627882485,-0.5173142292543098,0.9878296146044625,0.9979952566514911,1.0,4/17,26.79%,SLC39A3;SLC30A1;SLC39A13;SLC39A7
gsea,Regulation Of DNA Recombination (GO:0000018),-0.15497380685216539,-0.5152486640973138,1.0,0.9974454317945161,1.0,12/26,42.20%,PPP4C;SIRT6;RAD50;RAD51;USP51;KPNA2;MSH6;THOC1;ZRANB3;MSH2;TERF2IP;KDM1A
gsea,Nuclear-Transcribed mRNA poly(A) Tail Shortening (GO:0000289),0.16390111750761943,0.4838830358433932,0.994059405940594,0.9979636246219828,1.0,17/17,83.63%,TUT4;CNOT2;TNKS1BP1;CNOT4;PAN2;SAMD4B;TUT7;CNOT7;CNOT9;CNOT3;PNLDC1;CNOT6;PARN;CNOT10;CNOT11;CNOT6L;CNOT8
gsea,"Nuclear-Transcribed mRNA Catabolic Process, Deadenylation-Dependent Decay (GO:0000288)",-0.1349601972039544,-0.4823045004340218,1.0,0.9999403533987836,1.0,6/34,23.21%,EXOSC3;LSM1;CNOT8;CNOT6L;EXOSC9;CNOT11
gsea,Myeloid Cell Development (GO:0061515),0.15531930786381354,0.47564267214486633,0.9977924944812362,0.9972744021533967,1.0,17/18,70.80%,FLNA;NRROS;DMTN;THPO;SH2B3;KIT;ALAS1;LYAR;SRC;ALAS2;MED1;NCKAP1L;APP;GP1BB;ATP6AP1;EVI2B;FOXP1
gsea,Intraciliary Anterograde Transport (GO:0035720),-0.16226613367008916,-0.4676911362139474,0.9959183673469387,1.0,1.0,7/15,43.00%,IFT20;TRAF3IP1;IFT46;IFT52;IFT22;IFT27;IFT74
gsea,Positive Regulation Of BMP Signaling Pathway (GO:0030513),-0.16346668985585514,-0.45690182250205014,0.9981343283582089,0.9998522368644577,1.0,2/15,15.91%,SMAD2;BMPR2
gsea,Histone H4-K5 Acetylation (GO:0043981),-0.14374537195646758,-0.41678740368631584,0.9979838709677419,0.9994541108327396,1.0,5/15,41.95%,PHF20;JADE2;JADE1;MEAF6;MCRS1
gsea,Histone H4-K8 Acetylation (GO:0043982),-0.14374537195646758,-0.41678740368631584,0.9979838709677419,0.9994541108327396,1.0,5/15,41.95%,PHF20;JADE2;JADE1;MEAF6;MCRS1
